,A549 SARS-CoV-2,A549 SARS-CoV-2,A549 SARS-CoV-2,NHBE SARS-CoV-2,NHBE SARS-CoV-2,NHBE SARS-CoV-2
,count,p-value,c-score,count,p-value,c-score
cytokine-mediated signaling pathway (GO:0019221),1.00,6.95E-03,6.06E+05,1.00,2.79E-04,6.06E+05
regulation of immune response (GO:0050776),0.42,3.64E-07,7.11E+02,0.74,1.04E-02,1.85E+02
cellular response to cytokine stimulus (GO:0071345),0.66,2.50E-04,6.55E+05,1.00,2.50E-04,6.55E+05
cellular response to interferon-gamma (GO:0071346),0.66,1.46E-02,5.61E+02,0.79,3.50E-02,3.97E+02
positive regulation of response to external stimulus (GO:0032103),0.46,3.83E-02,5.26E+02,0.79,2.28E-02,2.79E+02
inflammatory response (GO:0006954),0.44,5.30E-05,6.46E+02,0.54,3.90E-04,1.47E+02
interferon-gamma-mediated signaling pathway (GO:0060333),0.58,1.03E-03,6.97E+02,0.64,9.63E-04,6.97E+02
protein modification by small protein removal (GO:0070646),0.43,4.89E-02,1.74E+02,0.44,2.49E-02,1.68E+02
mRNA processing (GO:0006397),0.37,2.88E-06,7.02E+02,0.62,3.98E-04,6.99E+02
neutrophil activation involved in immune response (GO:0002283),0.48,4.57E-02,2.39E+02,0.64,9.44E-03,1.93E+02
neutrophil mediated immunity (GO:0002446),0.48,4.93E-02,2.39E+02,0.62,1.02E-02,1.93E+02
neutrophil degranulation (GO:0043312),0.47,4.21E-02,2.46E+02,0.62,8.99E-03,2.00E+02
cellular protein modification process (GO:0006464),0.38,2.17E-02,1.39E+02,0.36,1.93E-03,1.20E+02
extracellular matrix organization (GO:0030198),0.28,1.29E-02,1.43E+02,0.87,2.05E-02,1.70E+02
regulation of T cell proliferation (GO:0042129),0.42,1.40E-04,4.13E+02,0.56,4.68E-02,4.13E+02
regulation of cell population proliferation (GO:0042127),0.35,1.61E-02,8.99E+01,0.56,1.21E-02,1.29E+02
positive regulation of cytokine production (GO:0001819),0.30,4.04E-03,1.38E+02,0.62,3.58E-02,1.63E+02
DNA metabolic process (GO:0006259),0.35,2.34E-02,2.63E+02,0.38,7.56E-04,6.60E+01
response to interferon-gamma (GO:0034341),0.33,9.89E-05,8.19E+02,0.46,4.68E-02,5.27E+02
cellular response to chemokine (GO:1990869),0.33,8.06E-05,3.65E+03,0.49,1.04E-02,4.57E+02
"mRNA splicing, via spliceosome (GO:0000398)",0.35,2.08E-06,7.38E+02,0.54,1.69E-04,6.89E+02
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.35,3.31E-06,7.02E+02,0.54,4.30E-04,6.75E+02
DNA repair (GO:0006281),0.35,2.83E-02,3.13E+02,0.31,4.65E-03,9.47E+01
positive regulation of defense response (GO:0031349),0.39,1.65E-02,8.24E+02,0.49,1.65E-02,4.33E+02
chemokine-mediated signaling pathway (GO:0070098),0.33,6.02E-05,3.99E+03,0.46,1.03E-02,5.04E+02
positive regulation of chemotaxis (GO:0050921),0.28,6.20E-04,3.42E+02,0.67,4.79E-02,5.09E+02
protein deubiquitination (GO:0016579),0.40,2.00E-02,1.65E+02,0.31,2.45E-02,1.38E+02
cellular response to DNA damage stimulus (GO:0006974),0.36,4.34E-02,1.29E+02,0.31,4.69E-02,1.10E+02
protein dephosphorylation (GO:0006470),0.35,4.78E-06,8.07E+01,0.28,3.90E-02,7.46E+01
regulation of transcription by RNA polymerase II (GO:0006357),0.25,2.62E-03,6.14E+01,0.18,2.62E-03,2.17E+01
skin development (GO:0043588),0.41,2.84E-02,5.46E+02,0.49,3.37E-12,3.61E+02
defense response to symbiont (GO:0140546),0.36,3.55E-02,9.11E+05,0.38,7.76E-06,9.11E+05
positive regulation of MAPK cascade (GO:0043410),0.32,2.73E-02,2.95E+02,0.51,4.68E-02,2.95E+02
positive regulation of cellular process (GO:0048522),0.33,2.58E-02,1.23E+02,0.69,2.65E-02,1.61E+02
positive regulation of intracellular signal transduction (GO:1902533),0.34,3.80E-03,8.17E+01,0.41,4.07E-02,4.74E+01
positive regulation of cell motility (GO:2000147),0.31,1.22E-02,2.17E+02,0.69,1.42E-02,1.43E+02
defense response to virus (GO:0051607),0.37,3.55E-02,8.98E+05,0.31,7.76E-06,8.98E+05
epidermis development (GO:0008544),0.38,1.83E-04,1.44E+03,0.69,2.21E-22,2.15E+03
monocyte chemotaxis (GO:0002548),0.32,2.73E-02,1.86E+03,0.59,2.01E-02,1.32E+03
positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.23,9.07E-03,3.03E+02,0.54,3.13E-02,2.77E+02
cellular response to type I interferon (GO:0071357),0.29,1.25E-02,4.58E+03,0.44,1.25E-02,7.22E+02
type I interferon signaling pathway (GO:0060337),0.29,1.25E-02,4.58E+03,0.44,1.25E-02,7.22E+02
regulation of cell migration (GO:0030334),0.27,1.01E-02,1.24E+02,0.64,4.83E-03,1.09E+02
ubiquitin-dependent protein catabolic process (GO:0006511),0.34,1.45E-02,2.86E+02,0.28,1.45E-02,2.81E+02
negative regulation of macromolecule metabolic process (GO:0010605),0.25,3.99E-02,6.13E+01,0.49,4.69E-02,1.12E+02
positive regulation of cell migration (GO:0030335),0.35,1.30E-02,1.66E+02,0.51,2.75E-02,1.07E+02
regulation of angiogenesis (GO:0045765),0.19,9.51E-03,1.93E+02,0.77,1.12E-02,3.20E+02
"regulation of transcription, DNA-templated (GO:0006355)",0.20,1.07E-02,1.43E+02,0.33,3.84E-03,5.89E+01
positive regulation of DNA-binding transcription factor activity (GO:0051091),0.37,2.44E-02,2.48E+02,0.36,3.68E-02,1.49E+02
lymphocyte migration (GO:0072676),0.30,5.45E-05,1.98E+03,0.51,1.90E-02,8.10E+02
apoptotic process (GO:0006915),0.33,2.85E-02,1.50E+02,0.46,3.55E-02,1.33E+02
positive regulation of protein phosphorylation (GO:0001934),0.34,4.81E-03,5.19E+01,0.49,2.93E-02,5.19E+01
regulation of apoptotic process (GO:0042981),0.36,3.54E-02,1.33E+02,0.31,4.96E-03,1.33E+02
positive regulation of T cell proliferation (GO:0042102),0.30,1.16E-02,4.43E+02,0.49,4.53E-02,2.00E+02
cellular response to tumor necrosis factor (GO:0071356),0.33,2.85E-02,2.58E+02,0.31,1.16E-02,9.12E+01
regulation of innate immune response (GO:0045088),0.32,1.25E-02,7.36E+02,0.26,1.25E-02,7.36E+02
cellular response to interleukin-1 (GO:0071347),0.35,2.14E-02,3.48E+02,0.28,2.43E-03,1.16E+02
protein ubiquitination (GO:0016567),0.27,9.45E-03,1.70E+02,0.23,1.91E-02,1.70E+02
negative regulation of lymphocyte proliferation (GO:0050672),0.31,3.07E-05,1.05E+03,0.44,1.82E-02,1.05E+03
"negative regulation of transcription, DNA-templated (GO:0045892)",0.25,2.99E-02,3.78E+01,0.26,3.21E-02,5.89E+01
neutrophil chemotaxis (GO:0030593),0.28,1.22E-03,3.00E+03,0.38,4.99E-02,3.68E+02
ribosome biogenesis (GO:0042254),0.34,1.07E-04,7.28E+02,0.38,2.81E-08,6.10E+02
positive regulation of cell population proliferation (GO:0008284),0.28,2.93E-03,1.85E+02,0.56,4.90E-02,9.74E+01
antigen receptor-mediated signaling pathway (GO:0050851),0.42,6.48E-06,3.62E+02,0.41,3.95E-03,8.87E+01
regulation of type I interferon production (GO:0032479),0.30,4.61E-02,3.49E+02,0.28,4.61E-02,1.09E+02
positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.36,4.51E-03,4.56E+02,0.26,2.88E-02,2.78E+02
hemidesmosome assembly (GO:0031581),0.30,2.73E-02,1.68E+04,0.72,1.10E-07,1.34E+03
positive regulation of macromolecule metabolic process (GO:0010604),0.25,3.50E-02,1.01E+02,0.54,3.55E-02,1.35E+02
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.36,2.99E-02,3.97E+02,0.36,2.99E-02,2.52E+02
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.36,3.07E-02,3.00E+02,0.36,3.07E-02,2.18E+02
organelle assembly (GO:0070925),0.28,2.97E-02,6.37E+01,0.31,2.48E-03,5.25E+01
external encapsulating structure organization (GO:0045229),0.21,4.15E-02,2.22E+02,0.82,2.05E-02,1.04E+02
"positive regulation of transcription, DNA-templated (GO:0045893)",0.24,4.99E-02,1.03E+02,0.13,3.22E-17,8.33E+01
granulocyte chemotaxis (GO:0071621),0.25,1.44E-03,2.85E+03,0.33,3.63E-04,3.46E+02
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.32,4.57E-07,5.57E+01,0.23,2.17E-05,5.62E+01
protein phosphorylation (GO:0006468),0.29,4.69E-02,6.67E+01,0.26,3.46E-02,3.22E+01
cellular macromolecule biosynthetic process (GO:0034645),0.38,6.03E-03,5.88E+02,0.23,2.93E-05,2.26E+02
gene expression (GO:0010467),0.33,1.74E-02,1.04E+03,0.41,1.74E-02,9.91E+02
lymphocyte chemotaxis (GO:0048247),0.27,5.31E-04,1.75E+03,0.46,2.01E-02,7.08E+02
response to interleukin-1 (GO:0070555),0.18,3.32E-03,7.47E+02,0.33,5.62E-04,2.74E+02
neutrophil migration (GO:1990266),0.25,1.93E-03,2.66E+03,0.33,4.10E-04,3.21E+02
regulation of viral genome replication (GO:0045069),0.30,2.79E-04,6.33E+03,0.38,2.79E-04,6.33E+03
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.19,2.61E-02,3.12E+02,0.46,1.36E-02,1.81E+02
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.36,9.19E-03,6.82E+02,0.31,9.19E-03,6.82E+02
transcription by RNA polymerase II (GO:0006366),0.27,2.62E-03,1.08E+02,0.23,2.62E-03,1.07E+02
positive regulation of type I interferon production (GO:0032481),0.28,4.88E-02,4.22E+02,0.31,3.80E-02,1.98E+02
positive regulation of T cell activation (GO:0050870),0.26,3.38E-04,3.77E+02,0.44,4.68E-02,1.66E+02
double-strand break repair (GO:0006302),0.24,9.58E-03,1.66E+02,0.21,4.61E-02,1.66E+02
positive regulation of gene expression (GO:0010628),0.23,3.09E-03,2.35E+02,0.51,2.32E-02,9.78E+01
ribonucleoprotein complex biogenesis (GO:0022613),0.28,3.49E-02,3.79E+02,0.31,2.50E-04,3.79E+02
extracellular structure organization (GO:0043062),0.17,3.95E-02,2.24E+02,0.82,2.05E-02,1.05E+02
regulation of ERK1 and ERK2 cascade (GO:0070372),0.21,2.03E-03,1.96E+02,0.41,2.28E-04,1.70E+02
ribonucleoprotein complex assembly (GO:0022618),0.29,3.76E-03,4.97E+02,0.46,4.95E-04,4.11E+02
positive regulation of cytosolic calcium ion concentration (GO:0007204),0.21,1.40E-04,3.63E+02,0.38,6.79E-03,8.86E+01
interleukin-1-mediated signaling pathway (GO:0070498),0.34,3.34E-02,2.41E+02,0.36,3.20E-02,1.76E+02
cellular protein metabolic process (GO:0044267),0.40,3.00E-02,2.52E+02,0.31,4.69E-02,2.24E+02
macroautophagy (GO:0016236),0.27,4.56E-02,2.43E+02,0.26,4.56E-02,2.43E+02
negative regulation of nucleic acid-templated transcription (GO:1903507),0.25,2.99E-02,5.11E+01,0.23,3.92E-02,5.11E+01
rRNA processing (GO:0006364),0.30,3.99E-02,5.55E+02,0.33,3.99E-02,4.57E+02
negative regulation of intracellular signal transduction (GO:1902532),0.35,4.67E-02,1.38E+02,0.26,8.96E-06,1.09E+02
DNA replication (GO:0006260),0.27,1.53E-03,2.73E+02,0.13,4.47E-02,1.57E+02
positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.22,4.50E-02,6.66E+02,0.54,1.16E-02,6.66E+02
histone acetylation (GO:0016573),0.25,3.22E-02,1.36E+02,0.26,4.26E-02,1.76E+02
modification-dependent protein catabolic process (GO:0019941),0.27,1.74E-02,2.27E+02,0.26,1.74E-02,2.27E+02
positive regulation of apoptotic process (GO:0043065),0.27,4.85E-02,9.82E+01,0.31,4.85E-02,9.82E+01
mitotic cell cycle phase transition (GO:0044772),0.27,1.03E-02,1.43E+02,0.15,2.82E-02,6.64E+01
innate immune response (GO:0045087),0.23,4.56E-03,9.59E+02,0.21,4.56E-03,9.59E+02
positive regulation of lymphocyte proliferation (GO:0050671),0.23,1.65E-02,3.77E+02,0.36,4.68E-02,1.66E+02
positive regulation of phosphorylation (GO:0042327),0.25,2.15E-02,6.01E+01,0.41,3.17E-02,1.83E+01
regulation of inflammatory response (GO:0050727),0.15,1.78E-05,3.14E+02,0.49,1.39E-03,1.12E+02
mitochondrial translation (GO:0032543),0.27,8.55E-04,1.54E+02,0.23,2.83E-02,1.54E+02
negative regulation of apoptotic process (GO:0043066),0.29,3.90E-13,9.92E+01,0.31,2.53E-02,8.56E+01
negative regulation of viral process (GO:0048525),0.25,2.79E-04,6.00E+03,0.28,2.79E-04,6.00E+03
cell cycle G2/M phase transition (GO:0044839),0.28,2.34E-02,1.13E+02,0.15,3.58E-02,1.13E+02
positive regulation of monocyte chemotaxis (GO:0090026),0.21,4.89E-02,2.06E+03,0.51,4.32E-02,5.07E+02
"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.26,3.07E-03,3.36E+02,0.23,3.07E-03,3.36E+02
ncRNA processing (GO:0034470),0.32,1.62E-02,4.66E+02,0.26,1.62E-02,3.73E+02
regulation of GTPase activity (GO:0043087),0.32,3.01E-03,2.68E+02,0.49,4.22E-03,1.13E+02
regulation of cellular macromolecule biosynthetic process (GO:2000112),0.25,1.33E-03,9.65E+01,0.10,4.69E-06,2.71E+01
protein polyubiquitination (GO:0000209),0.27,1.25E-02,2.11E+02,0.18,1.25E-02,1.90E+02
"complement activation, classical pathway (GO:0006958)",0.27,6.59E-03,8.66E+03,0.49,4.54E-05,8.66E+03
positive regulation of transcription by RNA polymerase II (GO:0045944),0.23,1.13E-16,9.65E+01,0.13,6.65E-15,7.19E+01
regulation of endothelial cell migration (GO:0010594),0.33,8.92E-03,3.29E+02,0.36,1.73E-02,1.66E+02
glycerophospholipid biosynthetic process (GO:0046474),0.22,3.68E-02,1.17E+02,0.31,2.90E-02,1.17E+02
NIK/NF-kappaB signaling (GO:0038061),0.32,1.83E-02,4.66E+02,0.33,1.83E-02,2.84E+02
positive regulation of angiogenesis (GO:0045766),0.09,9.32E-04,2.09E+02,0.69,2.06E-03,6.64E+02
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.31,3.42E-02,2.31E+02,0.18,2.60E-02,1.92E+02
negative regulation of programmed cell death (GO:0043069),0.32,4.69E-02,1.30E+02,0.23,1.16E-16,1.13E+02
protein modification by small protein conjugation (GO:0032446),0.26,1.08E-04,1.94E+02,0.15,3.87E-02,1.51E+02
humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.25,1.86E-02,5.89E+03,0.49,5.90E-05,5.89E+03
regulation of T cell differentiation (GO:0045580),0.20,1.38E-04,1.38E+03,0.46,9.27E-03,1.35E+03
regulation of immune effector process (GO:0002697),0.33,6.56E-03,1.46E+03,0.44,2.93E-02,5.44E+02
G1/S transition of mitotic cell cycle (GO:0000082),0.25,3.16E-02,9.74E+01,0.10,4.59E-03,3.47E+01
response to cytokine (GO:0034097),0.32,2.12E-02,4.76E+02,0.18,5.34E-03,4.91E+01
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.25,2.99E-02,7.60E+01,0.23,4.48E-02,5.55E+01
regulation of tumor necrosis factor production (GO:0032680),0.18,1.06E-02,2.24E+02,0.41,1.12E-02,6.09E+02
snRNA transcription (GO:0009301),0.25,3.81E-02,1.74E+02,0.21,3.81E-02,1.74E+02
snRNA transcription by RNA polymerase II (GO:0042795),0.25,3.72E-02,1.78E+02,0.21,3.72E-02,1.78E+02
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.27,3.83E-02,5.21E+01,0.38,4.13E-02,5.21E+01
negative regulation of viral genome replication (GO:0045071),0.21,2.79E-04,8.25E+03,0.31,2.79E-04,8.25E+03
G2/M transition of mitotic cell cycle (GO:0000086),0.27,2.34E-02,1.15E+02,0.15,3.58E-02,1.15E+02
negative regulation of T cell activation (GO:0050868),0.25,1.40E-04,1.15E+03,0.46,9.83E-03,1.13E+03
regulation of interleukin-6 production (GO:0032675),0.22,2.60E-02,2.63E+02,0.21,8.60E-03,1.25E+02
dendritic cell chemotaxis (GO:0002407),0.17,3.84E-02,1.15E+03,0.46,6.71E-03,7.08E+02
cellular response to molecule of bacterial origin (GO:0071219),0.25,8.72E-04,3.40E+02,0.23,4.51E-02,1.18E+02
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.32,3.11E-02,9.27E+02,0.21,1.26E-04,2.05E+02
positive regulation of immune response (GO:0050778),0.21,1.41E-02,6.05E+02,0.41,1.41E-02,6.05E+02
positive regulation of nucleic acid-templated transcription (GO:1903508),0.23,4.69E-02,1.29E+02,0.18,8.84E-03,4.08E+01
response to interferon-beta (GO:0035456),0.22,8.39E-03,2.02E+03,0.26,8.39E-03,2.02E+03
negative regulation of leukocyte degranulation (GO:0043301),0.14,6.59E-03,1.58E+03,0.46,1.74E-02,1.58E+03
autophagosome assembly (GO:0000045),0.26,4.04E-02,1.18E+02,0.26,4.04E-02,1.18E+02
regulation of signal transduction by p53 class mediator (GO:1901796),0.25,3.31E-02,1.06E+02,0.10,1.19E-06,5.91E+01
regulation of cytokine-mediated signaling pathway (GO:0001959),0.30,4.16E-02,2.08E+02,0.21,4.16E-02,1.38E+02
DNA-dependent DNA replication (GO:0006261),0.30,3.08E-02,4.78E+02,0.23,1.15E-03,2.47E+02
intracellular protein transport (GO:0006886),0.25,4.29E-02,2.32E+02,0.18,4.29E-02,2.32E+02
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.14,3.18E-03,2.60E+02,0.54,2.51E-02,2.60E+02
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.44,1.40E-02,6.34E+02,0.10,1.12E-06,6.84E+01
antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.44,1.92E-02,6.10E+02,0.10,9.19E-08,8.26E+01
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.44,1.16E-02,6.51E+02,0.10,5.84E-07,7.40E+01
dendritic cell migration (GO:0036336),0.17,4.35E-02,9.93E+02,0.46,6.79E-03,5.92E+02
nuclear-transcribed mRNA catabolic process (GO:0000956),0.31,3.81E-02,7.05E+02,0.38,3.81E-02,6.76E+02
phosphorylation (GO:0016310),0.23,9.95E-05,3.60E+01,0.26,1.59E-02,4.31E+01
I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.28,4.86E-02,1.47E+02,0.15,4.86E-02,1.47E+02
positive regulation of vasculature development (GO:1904018),0.11,2.92E-03,1.61E+02,0.54,4.17E-03,7.83E+02
positive regulation of inflammatory response (GO:0050729),0.18,3.20E-03,9.32E+02,0.28,3.43E-03,5.79E+01
peptidyl-serine modification (GO:0018209),0.23,2.71E-02,5.38E+01,0.15,4.07E-02,9.08E+01
positive regulation of epithelial cell migration (GO:0010634),0.35,2.54E-02,3.05E+02,0.21,4.47E-06,7.78E+01
regulation of nucleic acid-templated transcription (GO:1903506),0.25,1.16E-03,1.11E+02,0.10,2.05E-04,1.83E+01
transcription-coupled nucleotide-excision repair (GO:0006283),0.24,3.39E-02,1.78E+02,0.23,4.30E-04,9.73E+01
histone modification (GO:0016570),0.23,4.13E-03,8.18E+01,0.18,4.94E-02,9.50E+01
mitochondrial translational termination (GO:0070126),0.26,5.29E-04,1.98E+02,0.18,3.74E-03,1.98E+02
rRNA metabolic process (GO:0016072),0.30,3.96E-02,5.55E+02,0.23,9.91E-06,4.58E+02
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.27,2.54E-02,1.51E+02,0.33,2.74E-02,2.47E+02
epidermal cell differentiation (GO:0009913),0.26,9.67E-04,9.29E+02,0.38,1.10E-07,8.91E+02
supramolecular fiber organization (GO:0097435),0.29,1.43E-02,1.15E+02,0.44,9.41E-04,7.37E+01
mitotic spindle organization (GO:0007052),0.28,6.04E-05,3.28E+02,0.21,9.58E-03,3.28E+02
autophagy of nucleus (GO:0044804),0.24,4.39E-02,2.91E+02,0.26,4.39E-02,2.91E+02
cellular response to oxygen-containing compound (GO:1901701),0.21,3.74E-02,9.85E+01,0.18,4.20E-02,5.91E+01
translational elongation (GO:0006414),0.26,8.55E-04,2.46E+02,0.18,1.30E-03,2.46E+02
translational termination (GO:0006415),0.26,6.72E-04,1.76E+02,0.18,4.05E-03,1.76E+02
mitochondrial translational elongation (GO:0070125),0.26,5.29E-04,1.98E+02,0.18,3.74E-03,1.98E+02
regulation of intracellular signal transduction (GO:1902531),0.25,3.74E-02,8.52E+01,0.10,8.15E-10,5.88E+01
microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.27,2.90E-04,4.39E+02,0.21,3.58E-02,4.39E+02
RNA processing (GO:0006396),0.24,3.72E-06,4.02E+02,0.26,3.72E-06,3.44E+02
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.28,2.87E-02,4.47E+02,0.21,3.09E-03,1.82E+02
negative regulation of cellular process (GO:0048523),0.23,1.42E-02,8.10E+01,0.31,1.42E-02,8.10E+01
protein transport (GO:0015031),0.25,1.05E-02,1.48E+02,0.23,2.82E-02,1.48E+02
autophagosome organization (GO:1905037),0.25,4.04E-02,1.24E+02,0.26,4.04E-02,1.24E+02
cellular response to lipopolysaccharide (GO:0071222),0.23,1.22E-03,3.22E+02,0.15,4.86E-02,1.12E+02
positive regulation of endothelial cell migration (GO:0010595),0.33,4.54E-02,3.44E+02,0.18,1.99E-04,9.07E+01
regulation of monocyte chemotaxis (GO:0090025),0.18,6.71E-03,1.40E+03,0.46,3.25E-02,1.40E+03
mitotic sister chromatid segregation (GO:0000070),0.27,2.71E-05,5.69E+02,0.21,2.47E-02,3.45E+02
positive regulation of binding (GO:0051099),0.28,3.29E-02,2.13E+02,0.15,2.97E-02,2.13E+02
RNA metabolic process (GO:0016070),0.24,4.77E-02,1.68E+02,0.31,3.68E-02,1.43E+02
regulation of cytokine production (GO:0001817),0.11,4.91E-02,1.74E+02,0.28,4.82E-03,3.40E+01
regulation of mitotic cell cycle phase transition (GO:1901990),0.25,2.71E-05,3.96E+02,0.21,3.87E-02,1.78E+02
positive regulation of protein modification process (GO:0031401),0.27,4.93E-02,1.60E+02,0.33,2.30E-02,1.50E+01
positive regulation of interleukin-6 production (GO:0032755),0.23,3.80E-02,4.29E+02,0.26,7.80E-03,2.01E+02
peptidyl-tyrosine dephosphorylation (GO:0035335),0.29,9.03E-03,1.95E+02,0.13,1.39E-02,9.81E+01
peptidyl-serine phosphorylation (GO:0018105),0.23,1.96E-05,7.77E+01,0.10,3.23E-05,4.64E+01
"transcription, DNA-templated (GO:0006351)",0.23,5.41E-10,1.15E+02,0.10,8.66E-11,1.15E+02
exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.24,3.03E-02,1.83E+02,0.15,3.03E-02,1.83E+02
T cell activation (GO:0042110),0.21,4.81E-03,4.69E+02,0.38,1.60E-02,4.69E+02
negative regulation of T cell proliferation (GO:0042130),0.19,7.22E-03,4.31E+02,0.38,2.26E-02,2.33E+02
keratinocyte differentiation (GO:0030216),0.27,1.51E-03,1.29E+03,0.38,1.10E-07,5.27E+02
"DNA-templated transcription, termination (GO:0006353)",0.24,3.31E-02,9.73E+01,0.18,3.31E-02,1.13E+02
B cell receptor signaling pathway (GO:0050853),0.11,2.73E-05,5.07E+02,0.51,2.12E-02,5.07E+02
negative regulation of transcription by RNA polymerase II (GO:0000122),0.21,5.26E-03,2.73E+01,0.10,4.60E-04,1.61E+01
positive regulation of lipid kinase activity (GO:0090218),0.12,2.85E-02,6.05E+02,0.49,1.98E-02,6.05E+02
proteasomal protein catabolic process (GO:0010498),0.27,6.52E-03,1.87E+02,0.13,9.57E-04,1.60E+02
"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.24,1.05E-02,4.37E+02,0.31,7.82E-03,4.02E+02
positive regulation of locomotion (GO:0040017),0.22,4.81E-03,5.77E+02,0.36,1.34E-02,5.77E+02
tRNA transport (GO:0051031),0.24,1.60E-02,6.04E+02,0.31,2.11E-02,3.23E+02
tRNA export from nucleus (GO:0006409),0.24,1.60E-02,9.28E+02,0.31,4.62E-02,3.65E+02
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.24,1.60E-02,9.28E+02,0.31,4.62E-02,3.65E+02
regulation of gene expression (GO:0010468),0.24,4.94E-02,4.99E+01,0.21,4.91E-02,4.40E+01
ncRNA export from nucleus (GO:0097064),0.25,1.60E-02,8.72E+02,0.26,1.60E-02,4.02E+02
negative regulation of cytokine production (GO:0001818),0.14,1.13E-02,2.81E+02,0.31,4.12E-02,5.74E+01
chromatin remodeling (GO:0006338),0.25,2.47E-02,1.73E+02,0.10,2.22E-12,1.73E+02
negative regulation of immune response (GO:0050777),0.14,1.38E-04,7.48E+01,0.49,4.12E-02,5.54E+02
regulation of chemotaxis (GO:0050920),0.17,5.30E-03,5.52E+02,0.44,1.36E-02,5.52E+02
"DNA-templated transcription, initiation (GO:0006352)",0.21,3.59E-02,1.14E+02,0.10,3.59E-02,1.14E+02
regulation of anatomical structure morphogenesis (GO:0022603),0.17,8.34E-03,3.77E+02,0.36,1.62E-02,3.24E+01
T cell receptor signaling pathway (GO:0050852),0.35,2.70E-03,4.45E+02,0.10,1.54E-08,7.58E+01
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.25,4.20E-02,7.68E+02,0.18,4.20E-02,2.68E+02
ribosomal large subunit biogenesis (GO:0042273),0.24,6.22E-03,4.47E+02,0.18,6.22E-03,2.36E+02
protein K48-linked ubiquitination (GO:0070936),0.23,3.05E-03,1.72E+02,0.18,3.05E-03,1.72E+02
negative regulation of dendritic cell apoptotic process (GO:2000669),0.15,1.36E-02,1.92E+03,0.51,1.36E-02,1.92E+03
positive regulation of macromolecule biosynthetic process (GO:0010557),0.27,4.10E-02,1.90E+02,0.18,9.52E-03,1.12E+02
regulation of cell cycle process (GO:0010564),0.26,1.48E-03,1.96E+02,0.10,9.92E-05,4.52E+01
positive regulation of programmed cell death (GO:0043068),0.21,4.49E-02,6.11E+01,0.18,1.60E-02,3.61E+01
negative regulation of ERBB signaling pathway (GO:1901185),0.25,4.12E-02,8.69E+02,0.18,4.12E-02,3.03E+02
positive regulation of tumor necrosis factor production (GO:0032760),0.14,1.93E-03,4.22E+02,0.18,4.68E-02,1.12E+03
protein K63-linked deubiquitination (GO:0070536),0.19,2.21E-02,2.69E+02,0.26,2.21E-02,2.69E+02
response to UV (GO:0009411),0.25,7.02E-03,1.14E+02,0.10,1.81E-05,5.81E+01
positive regulation of interleukin-1 production (GO:0032732),0.25,4.89E-02,2.18E+02,0.33,4.29E-02,7.59E+02
enzyme linked receptor protein signaling pathway (GO:0007167),0.14,1.86E-03,1.47E+02,0.33,1.48E-02,6.66E+01
negative regulation of B cell activation (GO:0050869),0.14,3.83E-02,1.16E+03,0.38,4.99E-02,1.16E+03
dephosphorylation (GO:0016311),0.22,4.51E-03,2.72E+01,0.10,7.57E-03,1.79E+01
tumor necrosis factor-mediated signaling pathway (GO:0033209),0.27,4.68E-02,9.75E+01,0.23,4.68E-02,6.70E+01
cell cycle G1/S phase transition (GO:0044843),0.22,3.76E-03,8.53E+01,0.10,2.95E-03,3.82E+01
regulation of B cell proliferation (GO:0030888),0.18,2.77E-03,1.45E+03,0.44,3.07E-02,1.45E+03
postreplication repair (GO:0006301),0.22,4.69E-02,1.90E+02,0.21,2.05E-02,6.93E+02
collagen fibril organization (GO:0030199),0.20,6.19E-03,7.15E+02,0.41,9.46E-03,3.04E+02
synapse pruning (GO:0098883),0.22,8.96E-03,3.73E+03,0.21,1.30E-03,3.73E+03
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.27,1.80E-02,4.44E+02,0.13,3.02E-03,5.87E+01
response to lipopolysaccharide (GO:0032496),0.19,9.12E-05,1.47E+03,0.10,1.70E-02,3.04E+01
membrane organization (GO:0061024),0.25,1.92E-02,2.53E+02,0.18,1.92E-02,1.37E+02
positive regulation of receptor-mediated endocytosis (GO:0048260),0.27,2.01E-02,5.24E+02,0.31,2.01E-02,7.33E+02
positive regulation of translation (GO:0045727),0.25,4.07E-02,1.77E+02,0.26,4.07E-02,1.77E+02
nucleotide-excision repair (GO:0006289),0.24,8.78E-04,2.49E+02,0.15,4.03E-03,7.95E+01
chromosome organization (GO:0051276),0.21,4.79E-04,6.46E+01,0.13,2.92E-02,2.44E+02
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.23,2.04E-04,9.97E+01,0.10,7.71E-03,4.22E+01
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.13,4.64E-02,2.07E+02,0.28,1.10E-02,8.07E+01
regulation of phagocytosis (GO:0050764),0.14,3.95E-02,2.28E+02,0.38,3.89E-02,1.77E+02
mRNA 3'-end processing (GO:0031124),0.23,4.27E-05,5.86E+02,0.18,4.27E-05,5.86E+02
positive regulation of protein binding (GO:0032092),0.26,3.37E-02,3.71E+02,0.21,2.18E-02,3.71E+02
regulation of response to biotic stimulus (GO:0002831),0.15,2.84E-02,5.46E+02,0.13,4.35E-02,2.63E+02
mitochondrion organization (GO:0007005),0.21,3.81E-02,1.28E+02,0.15,5.36E-05,4.70E+01
mRNA export from nucleus (GO:0006406),0.23,2.43E-02,8.59E+02,0.18,2.43E-02,7.07E+02
mRNA transport (GO:0051028),0.23,2.43E-02,7.20E+02,0.18,2.43E-02,6.37E+02
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.23,2.43E-02,8.83E+02,0.18,2.43E-02,6.79E+02
Golgi organization (GO:0007030),0.23,6.18E-09,1.53E+02,0.10,1.44E-11,1.42E+02
regulation of organelle assembly (GO:1902115),0.18,2.17E-02,1.55E+02,0.18,2.17E-02,1.55E+02
positive regulation of lymphocyte activation (GO:0051251),0.20,1.27E-03,9.72E+02,0.23,1.54E-02,1.48E+02
negative regulation of myeloid leukocyte mediated immunity (GO:0002887),0.12,1.16E-02,1.22E+03,0.36,1.16E-02,1.22E+03
cellular response to lipid (GO:0071396),0.15,3.80E-03,1.72E+02,0.21,4.39E-02,2.35E+01
nuclear export (GO:0051168),0.23,4.32E-02,4.25E+02,0.18,4.32E-02,4.02E+02
MAPK cascade (GO:0000165),0.22,4.49E-02,7.61E+01,0.18,3.82E-02,7.61E+01
cardiac muscle tissue development (GO:0048738),0.05,5.83E-03,2.12E+02,0.56,4.58E-02,3.00E+02
double-strand break repair via nonhomologous end joining (GO:0006303),0.22,2.98E-03,4.66E+01,0.15,3.79E-02,3.39E+01
cell-substrate junction assembly (GO:0007044),0.24,4.63E-02,4.36E+03,0.49,1.04E-04,2.74E+02
cytosolic transport (GO:0016482),0.23,1.60E-03,8.38E+01,0.13,1.60E-03,8.34E+01
negative regulation of cell population proliferation (GO:0008285),0.07,3.75E-02,6.93E+01,0.28,2.06E-02,1.65E+03
cell junction disassembly (GO:0150146),0.23,3.32E-03,8.22E+03,0.26,3.90E-04,8.22E+03
regulation of cellular component movement (GO:0051270),0.22,2.00E-03,9.84E+01,0.13,6.33E-04,5.44E+01
regulation of T cell activation (GO:0050863),0.20,2.42E-04,6.75E+02,0.26,2.38E-06,1.48E+02
organelle organization (GO:0006996),0.23,5.90E-03,1.11E+02,0.10,1.25E-16,1.08E+02
regulation of protein kinase activity (GO:0045859),0.29,4.81E-02,1.92E+02,0.21,4.81E-02,1.92E+02
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.14,2.41E-03,3.95E+02,0.18,4.68E-02,1.05E+03
calcium-mediated signaling (GO:0019722),0.18,4.08E-03,1.11E+02,0.36,4.71E-02,1.07E+02
RNA 3'-end processing (GO:0031123),0.23,3.69E-04,3.84E+02,0.18,3.69E-04,4.03E+02
spliceosomal snRNP assembly (GO:0000387),0.24,3.42E-03,3.20E+02,0.26,3.42E-03,3.20E+02
protein autoubiquitination (GO:0051865),0.22,1.26E-02,4.89E+01,0.10,1.91E-03,4.00E+01
peptidyl-threonine phosphorylation (GO:0018107),0.22,7.05E-04,5.85E+01,0.10,5.15E-04,3.81E+01
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.23,1.48E-02,3.33E+02,0.13,1.48E-02,3.33E+02
positive regulation of interleukin-1 beta production (GO:0032731),0.23,3.93E-02,2.52E+02,0.31,3.75E-02,8.65E+02
regulation of interleukin-12 production (GO:0032655),0.17,7.07E-03,2.68E+02,0.33,2.16E-02,1.89E+02
mitotic metaphase plate congression (GO:0007080),0.25,4.69E-02,4.48E+02,0.21,4.69E-02,4.48E+02
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.19,9.63E-04,4.83E+03,0.18,9.63E-04,4.83E+03
chromatin organization (GO:0006325),0.23,4.16E-11,1.24E+02,0.10,2.50E-12,1.30E+02
negative regulation of gene expression (GO:0010629),0.22,2.73E-12,9.98E+01,0.15,1.55E-11,7.99E+01
stress-activated MAPK cascade (GO:0051403),0.21,5.75E-05,5.67E+01,0.13,1.15E-02,5.93E+01
protein deneddylation (GO:0000338),0.23,3.69E-04,1.53E+03,0.18,3.69E-04,1.53E+03
regulation of DNA binding (GO:0051101),0.24,2.90E-02,2.49E+02,0.18,5.74E-03,1.06E+02
RNA export from nucleus (GO:0006405),0.23,2.43E-02,7.03E+02,0.18,2.43E-02,5.85E+02
peptide cross-linking (GO:0018149),0.27,1.40E-04,1.13E+03,0.23,3.39E-04,2.65E+02
regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.27,4.00E-03,2.77E+02,0.23,4.32E-02,1.73E+02
protein-containing complex subunit organization (GO:0043933),0.24,4.79E-02,1.22E+02,0.18,4.77E-02,8.76E+01
negative regulation of B cell proliferation (GO:0030889),0.14,5.44E-03,2.86E+03,0.38,2.28E-02,2.86E+03
regulation of cell adhesion (GO:0030155),0.23,3.75E-02,1.55E+02,0.21,3.75E-02,1.15E+02
protein targeting (GO:0006605),0.25,2.10E-02,1.23E+02,0.18,1.18E-02,1.23E+02
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.22,3.46E-02,2.44E+02,0.18,1.10E-04,4.64E+01
regulation of cytosolic calcium ion concentration (GO:0051480),0.11,1.30E-02,2.26E+02,0.36,1.74E-02,6.90E+01
microglial cell activation (GO:0001774),0.23,1.42E-03,7.72E+02,0.21,1.03E-02,3.75E+02
protein ADP-ribosylation (GO:0006471),0.14,3.14E-02,2.96E+02,0.33,1.37E-02,1.22E+03
regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.27,1.89E-02,4.04E+02,0.26,1.19E-02,2.27E+02
regulation of glycoprotein biosynthetic process (GO:0010559),0.07,1.99E-02,1.10E+03,0.46,1.99E-02,1.10E+03
positive regulation of immune effector process (GO:0002699),0.17,3.74E-03,5.99E+02,0.26,2.42E-03,6.06E+01
peptidyl-lysine modification (GO:0018205),0.22,5.36E-05,9.24E+01,0.10,1.12E-03,5.63E+01
post-Golgi vesicle-mediated transport (GO:0006892),0.24,2.47E-02,1.59E+02,0.10,8.01E-08,9.67E+01
intrinsic apoptotic signaling pathway (GO:0097193),0.21,9.97E-03,2.91E+02,0.13,4.93E-03,2.80E+01
phosphatidylinositol biosynthetic process (GO:0006661),0.10,2.12E-09,1.26E+02,0.13,1.98E-02,2.51E+01
regulation of lymphocyte differentiation (GO:0045619),0.11,5.85E-03,4.51E+02,0.38,1.74E-02,4.51E+02
positive regulation of kinase activity (GO:0033674),0.17,4.08E-02,5.04E+02,0.36,6.17E-03,5.04E+02
negative regulation of blood coagulation (GO:0030195),0.20,6.88E-03,1.31E+03,0.44,2.87E-02,4.53E+02
cellular response to lectin (GO:1990858),0.25,4.68E-02,1.10E+02,0.26,4.68E-02,8.41E+01
stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.25,4.68E-02,1.10E+02,0.26,4.68E-02,8.41E+01
positive regulation of phagocytosis (GO:0050766),0.16,1.17E-02,5.82E+02,0.36,3.49E-02,2.00E+02
translation (GO:0006412),0.25,3.35E-10,5.65E+02,0.23,9.23E-06,4.52E+02
response to ionizing radiation (GO:0010212),0.21,1.70E-04,4.47E+01,0.08,1.91E-03,2.35E+01
hematopoietic progenitor cell differentiation (GO:0002244),0.05,1.98E-02,4.01E+02,0.44,3.70E-02,4.01E+02
pre-replicative complex assembly (GO:0036388),0.24,3.87E-02,6.53E+02,0.28,4.44E-02,2.06E+02
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.27,2.44E-02,1.46E+02,0.05,1.99E-02,1.90E+01
negative regulation of protein phosphorylation (GO:0001933),0.25,4.31E-02,7.74E+01,0.21,4.31E-02,1.54E+02
protein stabilization (GO:0050821),0.22,5.85E-11,1.16E+02,0.15,4.69E-02,1.16E+02
spliceosomal complex assembly (GO:0000245),0.21,1.79E-02,1.92E+02,0.31,4.65E-03,2.15E+02
protein localization to organelle (GO:0033365),0.23,1.57E-02,1.18E+02,0.10,2.95E-08,7.62E+01
protein localization to nucleus (GO:0034504),0.21,2.23E-13,1.79E+02,0.10,3.47E-11,1.68E+02
protein import (GO:0017038),0.21,4.07E-10,1.30E+02,0.10,5.89E-09,1.08E+02
histone deacetylation (GO:0016575),0.20,1.48E-02,8.40E+01,0.13,1.48E-02,8.40E+01
positive regulation of protein kinase B signaling (GO:0051897),0.07,5.34E-03,3.83E+02,0.33,2.03E-02,5.38E+01
positive regulation of protein kinase activity (GO:0045860),0.23,2.27E-02,3.26E+02,0.18,3.86E-05,3.26E+02
RNA splicing (GO:0008380),0.22,1.67E-03,3.65E+02,0.18,1.67E-03,3.34E+02
cellular response to organic cyclic compound (GO:0071407),0.12,3.57E-02,1.56E+02,0.28,2.42E-03,2.46E+01
positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.22,4.26E-02,3.16E+02,0.23,1.62E-02,7.22E+02
positive regulation of GTPase activity (GO:0043547),0.18,6.56E-03,2.27E+02,0.28,1.53E-02,9.29E+01
regulation of complement activation (GO:0030449),0.21,2.85E-02,1.58E+03,0.21,2.74E-02,5.91E+02
"DNA-templated transcription, elongation (GO:0006354)",0.22,2.34E-05,1.32E+02,0.10,1.58E-08,1.31E+02
transcription elongation from RNA polymerase II promoter (GO:0006368),0.22,3.58E-05,1.48E+02,0.10,5.80E-09,1.48E+02
regulation of cell cycle G2/M phase transition (GO:1902749),0.25,6.04E-05,4.67E+02,0.10,5.94E-05,3.73E+01
positive regulation of granulocyte chemotaxis (GO:0071624),0.19,4.99E-02,1.72E+03,0.28,4.99E-02,4.77E+02
RNA transport (GO:0050658),0.23,3.66E-02,3.33E+02,0.18,3.66E-02,3.33E+02
regulation of T cell mediated cytotoxicity (GO:0001914),0.19,5.41E-03,6.77E+02,0.13,3.07E-02,2.54E+01
"nucleotide-excision repair, DNA incision (GO:0033683)",0.23,1.19E-02,3.46E+02,0.18,1.19E-02,3.46E+02
regulation of interleukin-1 beta production (GO:0032651),0.15,5.91E-03,1.44E+02,0.33,4.68E-02,5.21E+02
regulation of RNA splicing (GO:0043484),0.24,3.22E-02,1.93E+02,0.18,1.19E-03,1.92E+02
cellular defense response (GO:0006968),0.12,4.92E-03,2.82E+02,0.33,2.05E-02,1.17E+02
establishment of T cell polarity (GO:0001768),0.18,3.95E-02,3.45E+03,0.23,1.04E-02,3.45E+03
regulation of cell cycle (GO:0051726),0.22,2.46E-02,4.62E+01,0.10,1.04E-04,2.23E+01
regulation of cellular protein metabolic process (GO:0032268),0.24,2.05E-02,1.17E+02,0.18,2.05E-02,1.17E+02
organelle disassembly (GO:1903008),0.21,1.83E-04,1.35E+02,0.10,5.86E-05,8.27E+01
vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.21,4.69E-02,1.03E+06,0.18,7.15E-03,1.03E+06
negative regulation of G0 to G1 transition (GO:0070317),0.12,2.03E-02,1.31E+02,0.03,4.25E-03,2.69E+01
regulation of blood vessel endothelial cell migration (GO:0043535),0.21,3.13E-02,2.41E+02,0.15,3.49E-02,8.07E+01
regulation of cell-matrix adhesion (GO:0001952),0.24,1.16E-02,4.18E+02,0.33,4.13E-02,4.18E+02
positive regulation of leukocyte chemotaxis (GO:0002690),0.25,3.53E-02,5.68E+02,0.13,2.97E-02,1.28E+02
regulation of protein binding (GO:0043393),0.23,1.29E-02,1.54E+02,0.15,3.76E-02,1.50E+02
maturation of SSU-rRNA (GO:0030490),0.22,4.02E-02,1.95E+02,0.18,4.02E-02,1.76E+02
response to tumor necrosis factor (GO:0034612),0.09,3.93E-02,5.44E+02,0.26,9.12E-04,1.92E+02
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.22,5.28E-05,5.68E+02,0.10,1.96E-05,4.70E+01
innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.23,4.76E-02,9.69E+01,0.26,4.76E-02,7.97E+01
positive regulation of T cell mediated immunity (GO:0002711),0.18,4.95E-02,5.17E+02,0.03,1.48E-02,9.37E+01
positive regulation of cellular biosynthetic process (GO:0031328),0.21,3.14E-02,1.23E+02,0.18,3.14E-02,6.59E+01
regulation of calcium ion-dependent exocytosis (GO:0017158),0.05,3.00E-02,1.08E+03,0.59,3.70E-02,1.08E+03
mitotic nuclear division (GO:0140014),0.24,4.67E-04,3.28E+02,0.13,1.35E-02,2.55E+02
endomembrane system organization (GO:0010256),0.22,1.10E-09,1.09E+02,0.10,4.05E-12,9.65E+01
mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.22,3.40E-04,3.94E+02,0.10,9.61E-05,5.55E+01
receptor signaling pathway via STAT (GO:0097696),0.31,1.68E-02,1.47E+03,0.03,4.57E-02,7.96E+01
immune response-activating cell surface receptor signaling pathway (GO:0002429),0.05,1.86E-02,4.44E+02,0.38,2.38E-02,4.44E+02
DNA replication initiation (GO:0006270),0.19,5.00E-03,6.71E+02,0.13,8.20E-03,6.71E+02
regulation of translation (GO:0006417),0.22,1.79E-02,3.92E+02,0.18,1.79E-02,3.34E+02
"regulation of DNA-templated transcription, initiation (GO:2000142)",0.21,3.61E-02,1.77E+02,0.15,3.61E-02,1.35E+02
digestive tract development (GO:0048565),0.06,4.12E-03,1.33E+03,0.36,1.22E-02,1.56E+02
positive regulation of glycoprotein biosynthetic process (GO:0010560),0.17,2.88E-02,6.74E+02,0.21,2.88E-02,6.74E+02
cellular response to starvation (GO:0009267),0.21,5.94E-06,7.03E+01,0.10,2.96E-07,5.61E+01
ERBB signaling pathway (GO:0038127),0.22,2.22E-02,4.53E+02,0.21,2.22E-02,6.07E+01
positive regulation of glycoprotein metabolic process (GO:1903020),0.16,3.95E-02,3.45E+03,0.23,1.04E-02,3.45E+03
membrane depolarization during action potential (GO:0086010),0.09,1.34E-02,6.26E+02,0.51,3.59E-02,4.45E+02
cellular protein localization (GO:0034613),0.23,1.44E-07,8.04E+01,0.10,1.29E-11,7.22E+01
regulation of protein kinase B signaling (GO:0051896),0.08,3.71E-02,2.72E+02,0.33,3.71E-02,3.63E+01
regulation of DNA replication (GO:0006275),0.20,6.59E-04,6.36E+01,0.15,2.01E-02,4.69E+01
cortical actin cytoskeleton organization (GO:0030866),0.25,2.14E-02,1.94E+03,0.13,3.97E-02,6.19E+02
peptidyl-threonine modification (GO:0018210),0.22,7.32E-04,5.53E+01,0.10,4.73E-04,3.62E+01
positive regulation of T cell migration (GO:2000406),0.17,2.19E-03,6.58E+02,0.26,1.98E-02,5.53E+02
"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.21,4.57E-07,2.84E+02,0.10,7.95E-06,2.34E+02
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.22,2.59E-04,6.36E+01,0.10,2.08E-03,3.32E+01
positive regulation of organelle assembly (GO:1902117),0.28,9.23E-03,6.93E+02,0.23,1.63E-02,2.74E+02
double-strand break repair via homologous recombination (GO:0000724),0.20,3.24E-03,3.70E+02,0.10,3.24E-03,3.70E+02
regulation of autophagy (GO:0010506),0.21,3.86E-08,9.64E+01,0.10,8.75E-12,9.64E+01
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.06,4.43E-02,8.61E+02,0.26,4.52E-05,7.38E+01
regulation of interferon-beta production (GO:0032648),0.09,2.68E-02,7.59E+02,0.21,3.29E-02,3.51E+02
regulation of humoral immune response (GO:0002920),0.17,3.53E-02,1.43E+03,0.21,2.97E-02,5.30E+02
protein-containing complex assembly (GO:0065003),0.21,2.71E-02,1.07E+02,0.10,1.42E-11,1.05E+02
regulation of TOR signaling (GO:0032006),0.21,2.72E-02,2.01E+02,0.18,2.72E-02,2.01E+02
multivesicular body organization (GO:0036257),0.22,3.22E-02,2.33E+02,0.18,3.22E-02,2.33E+02
multivesicular body assembly (GO:0036258),0.22,3.22E-02,2.45E+02,0.18,3.22E-02,2.45E+02
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.18,1.17E-02,6.43E+02,0.18,4.86E-02,1.13E+02
positive regulation of mononuclear cell migration (GO:0071677),0.17,4.34E-02,1.13E+03,0.23,4.46E-02,2.71E+02
response to prostaglandin (GO:0034694),0.16,3.95E-02,3.45E+03,0.23,1.04E-02,3.45E+03
protein mono-ADP-ribosylation (GO:0140289),0.15,2.37E-02,9.12E+02,0.26,1.03E-02,3.65E+03
regulation of cellular response to heat (GO:1900034),0.20,2.93E-17,4.45E+02,0.15,2.41E-02,3.15E+02
regulation of interferon-gamma production (GO:0032649),0.12,2.73E-02,3.18E+02,0.23,1.66E-02,1.53E+02
mitotic cytokinesis (GO:0000281),0.23,3.51E-02,1.50E+02,0.10,4.65E-04,4.43E+01
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.20,1.79E-06,4.29E+01,0.10,8.08E-04,3.15E+01
positive regulation of protein tyrosine kinase activity (GO:0061098),0.08,3.49E-02,8.16E+02,0.23,2.75E-02,2.85E+02
negative regulation of interleukin-12 production (GO:0032695),0.07,2.67E-03,1.36E+03,0.26,1.51E-03,1.41E+02
regulation of establishment of endothelial barrier (GO:1903140),0.26,4.57E-02,1.07E+03,0.10,8.00E-03,3.62E+01
vascular wound healing (GO:0061042),0.03,3.87E-02,1.66E+03,0.41,4.07E-02,1.66E+03
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.22,2.60E-04,4.87E+02,0.10,4.60E-04,4.06E+01
positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.11,4.58E-02,1.13E+03,0.15,2.61E-02,3.46E+02
regulation of response to DNA damage stimulus (GO:2001020),0.22,9.26E-04,6.91E+01,0.10,1.00E-03,3.41E+01
anterior/posterior pattern specification (GO:0009952),0.04,5.42E-05,4.81E+02,0.38,4.88E-02,1.44E+02
import into nucleus (GO:0051170),0.19,2.70E-12,2.07E+02,0.15,4.81E-02,1.30E+02
positive thymic T cell selection (GO:0045059),0.04,3.95E-02,1.71E+03,0.26,9.57E-04,1.06E+06
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.16,4.96E-02,1.14E+02,0.13,7.11E-03,5.27E+01
cellular response to interferon-beta (GO:0035458),0.14,7.71E-03,3.05E+03,0.26,7.71E-03,3.05E+03
antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.19,3.56E-03,2.92E+03,0.18,3.24E-02,1.91E+02
establishment of lymphocyte polarity (GO:0001767),0.17,1.16E-02,2.48E+03,0.23,1.16E-02,2.48E+03
regulation of peptide hormone secretion (GO:0090276),0.04,3.88E-02,1.67E+02,0.33,2.05E-02,5.54E+01
positive regulation of phospholipase activity (GO:0010518),0.02,3.85E-02,6.92E+02,0.31,4.79E-02,1.11E+03
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.21,2.14E-03,2.40E+02,0.26,4.40E-02,2.40E+02
negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.20,3.38E-02,2.55E+02,0.15,4.08E-03,4.94E+01
regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.01,3.70E-02,3.34E+03,0.31,4.79E-02,5.29E+03
recombinational repair (GO:0000725),0.17,1.36E-02,2.33E+02,0.13,1.36E-02,2.33E+02
epidermal growth factor receptor signaling pathway (GO:0007173),0.15,1.48E-02,7.05E+02,0.28,1.48E-02,2.47E+02
negative regulation of binding (GO:0051100),0.19,2.90E-04,2.93E+01,0.15,7.51E-04,5.19E+01
positive regulation of alpha-beta T cell activation (GO:0046635),0.20,2.44E-02,1.08E+03,0.08,4.05E-02,3.05E+02
complement receptor mediated signaling pathway (GO:0002430),0.06,1.55E-02,1.46E+03,0.36,1.16E-02,1.46E+03
regulation of mRNA stability (GO:0043488),0.23,2.45E-02,5.38E+02,0.21,2.45E-02,4.76E+02
negative regulation of inflammatory response (GO:0050728),0.10,2.37E-03,6.52E+01,0.38,2.55E-02,1.50E+02
regulation of posttranscriptional gene silencing (GO:0060147),0.19,1.57E-09,2.01E+02,0.15,4.65E-03,1.19E+02
regulation of gene silencing by RNA (GO:0060966),0.19,1.57E-09,2.01E+02,0.15,4.65E-03,1.19E+02
positive regulation of signal transduction (GO:0009967),0.25,4.03E-02,1.82E+02,0.15,4.03E-02,1.29E+02
heart development (GO:0007507),0.02,2.11E-02,2.81E+01,0.41,3.77E-02,7.04E+01
positive regulation of cellular protein metabolic process (GO:0032270),0.21,4.16E-03,1.68E+02,0.18,4.16E-03,1.61E+02
cellular response to ionizing radiation (GO:0071479),0.23,1.14E-04,6.64E+01,0.10,7.28E-03,2.80E+01
regulation of protein transport (GO:0051223),0.27,3.80E-03,1.28E+03,0.15,4.09E-02,4.05E+02
protein sumoylation (GO:0016925),0.21,4.78E-02,1.97E+02,0.10,1.10E-04,1.02E+02
eye morphogenesis (GO:0048592),0.13,4.12E-02,2.15E+03,0.38,1.97E-02,2.15E+03
negative regulation of RNA splicing (GO:0033119),0.20,3.31E-02,2.52E+02,0.23,1.41E-02,2.10E+02
positive regulation of dendritic cell antigen processing and presentation (GO:0002606),0.15,1.16E-02,2.48E+03,0.23,1.16E-02,2.48E+03
positive regulation of antigen processing and presentation (GO:0002579),0.15,1.16E-02,2.48E+03,0.23,1.16E-02,2.48E+03
axonal transport (GO:0098930),0.22,2.16E-02,6.72E+02,0.18,2.23E-02,2.36E+02
positive regulation of cell cycle process (GO:0090068),0.20,3.96E-02,3.50E+02,0.13,7.00E-04,3.50E+02
"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.21,2.71E-02,1.78E+02,0.10,5.06E-11,1.59E+02
regulation of endothelial cell apoptotic process (GO:2000351),0.08,1.82E-02,7.33E+02,0.26,3.75E-03,4.45E+01
regulation of inflammatory response to antigenic stimulus (GO:0002861),0.11,2.67E-03,4.49E+01,0.38,4.80E-02,2.70E+02
dicarboxylic acid biosynthetic process (GO:0043650),0.22,1.78E-02,1.16E+03,0.23,4.07E-02,7.76E+02
"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.22,4.02E-02,2.21E+02,0.18,4.02E-02,2.21E+02
mRNA metabolic process (GO:0016071),0.21,1.06E-04,2.82E+02,0.18,1.06E-04,2.82E+02
"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.21,4.07E-02,2.89E+02,0.18,4.07E-02,2.89E+02
protein K63-linked ubiquitination (GO:0070534),0.20,2.47E-03,6.70E+01,0.10,1.62E-02,4.26E+01
regulation of cell cycle phase transition (GO:1901987),0.25,1.12E-03,3.02E+02,0.18,3.20E-02,1.40E+02
anaphase-promoting complex-dependent catabolic process (GO:0031145),0.25,8.13E-03,3.73E+02,0.18,3.08E-02,1.81E+02
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.14,3.29E-02,2.21E+02,0.33,1.87E-02,5.09E+02
autophagy of mitochondrion (GO:0000422),0.21,1.98E-03,7.23E+01,0.10,2.06E-04,4.71E+01
regulation of smooth muscle cell proliferation (GO:0048660),0.14,3.26E-02,2.82E+02,0.15,4.65E-02,1.72E+02
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.15,4.13E-02,2.23E+02,0.05,4.78E-02,1.56E+02
eosinophil chemotaxis (GO:0048245),0.16,1.40E-02,2.55E+03,0.26,3.72E-03,5.58E+02
eosinophil migration (GO:0072677),0.16,1.40E-02,2.55E+03,0.26,3.72E-03,5.58E+02
regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.14,2.31E-02,6.52E+02,0.15,2.31E-02,6.08E+02
regulation of protein phosphorylation (GO:0001932),0.24,4.46E-02,5.57E+01,0.10,6.69E-05,2.98E+01
blood circulation (GO:0008015),0.03,3.18E-02,5.64E+02,0.41,4.53E-02,2.22E+02
regulation of calcium-mediated signaling (GO:0050848),0.07,4.50E-02,4.75E+02,0.33,4.25E-02,2.75E+02
positive regulation of phospholipase C activity (GO:0010863),0.02,1.22E-02,2.03E+02,0.36,4.79E-02,5.39E+02
DNA duplex unwinding (GO:0032508),0.21,2.96E-02,1.72E+02,0.15,2.96E-02,1.72E+02
mitochondrion disassembly (GO:0061726),0.20,4.46E-03,6.73E+01,0.10,5.46E-04,4.18E+01
negative regulation of kinase activity (GO:0033673),0.21,3.11E-02,1.77E+02,0.18,3.11E-02,1.77E+02
peptidyl-threonine dephosphorylation (GO:0035970),0.22,8.82E-03,1.14E+02,0.10,1.60E-02,3.53E+01
sinoatrial node development (GO:0003163),0.08,4.99E-02,2.09E+03,0.51,2.59E-02,1.85E+03
nuclear membrane organization (GO:0071763),0.21,3.31E-02,2.10E+02,0.18,3.31E-02,2.10E+02
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.05,3.07E-02,4.16E+02,0.26,4.31E-02,2.81E+01
negative regulation of leukocyte apoptotic process (GO:2000107),0.07,2.28E-02,8.42E+02,0.26,2.28E-02,8.42E+02
positive regulation of interferon-beta production (GO:0032728),0.05,1.63E-02,1.13E+03,0.21,2.70E-02,5.17E+02
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),0.12,9.63E-04,5.95E+03,0.13,9.63E-04,5.95E+03
"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",0.12,9.63E-04,5.95E+03,0.13,9.63E-04,5.95E+03
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.15,1.84E-03,1.64E+03,0.13,4.78E-02,1.45E+02
regulation of endothelial cell development (GO:1901550),0.24,7.32E-03,2.40E+03,0.10,1.13E-02,6.05E+01
negative regulation of apoptotic signaling pathway (GO:2001234),0.21,3.66E-02,1.56E+02,0.10,6.49E-05,5.53E+01
negative regulation of lymphocyte activation (GO:0051250),0.05,2.44E-02,7.72E+02,0.26,1.67E-03,8.74E+01
regulation of protein localization to plasma membrane (GO:1903076),0.21,3.54E-02,5.46E+02,0.10,1.16E-07,7.83E+01
"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.19,4.55E-02,4.24E+02,0.13,2.90E-02,8.69E+01
positive regulation of neutrophil chemotaxis (GO:0090023),0.08,4.32E-02,1.15E+03,0.28,4.32E-02,5.75E+02
negative regulation of leukocyte activation (GO:0002695),0.06,1.86E-02,7.52E+02,0.33,9.33E-03,7.52E+02
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.08,4.67E-02,5.71E+02,0.31,1.56E-02,9.18E+02
histone monoubiquitination (GO:0010390),0.20,7.14E-05,1.98E+02,0.10,3.81E-06,1.46E+02
Golgi to plasma membrane transport (GO:0006893),0.20,3.69E-04,8.55E+01,0.10,2.80E-05,7.60E+01
regulation of purine nucleotide metabolic process (GO:1900542),0.20,2.92E-09,3.54E+02,0.10,5.94E-07,1.55E+02
defense response to bacterium (GO:0042742),0.18,5.40E-03,1.29E+03,0.15,1.98E-02,1.40E+02
regulation of cellular catabolic process (GO:0031329),0.21,3.75E-02,1.97E+02,0.10,4.57E-03,1.96E+01
response to host defenses (GO:0052200),0.09,3.04E-02,2.40E+03,0.15,3.04E-02,2.40E+03
modulation by symbiont of host defense response (GO:0052031),0.09,3.04E-02,2.40E+03,0.15,3.04E-02,2.40E+03
regulation of interleukin-10 production (GO:0032653),0.16,2.73E-02,2.90E+02,0.26,3.66E-02,1.51E+02
negative regulation of dendritic cell differentiation (GO:2001199),0.04,2.70E-02,2.99E+02,0.26,1.53E-02,2.94E+02
negative regulation of leukocyte differentiation (GO:1902106),0.04,2.70E-02,2.99E+02,0.26,1.53E-02,2.94E+02
negative regulation of production of molecular mediator of immune response (GO:0002701),0.10,1.54E-02,2.01E+03,0.38,4.22E-03,1.58E+03
regulation of defense response to virus by host (GO:0050691),0.14,4.30E-02,1.13E+03,0.13,3.41E-02,1.65E+02
regulation of macroautophagy (GO:0016241),0.20,2.46E-06,8.71E+01,0.10,1.77E-08,8.71E+01
mononuclear cell differentiation (GO:1903131),0.04,2.53E-02,3.14E+02,0.26,2.53E-02,4.45E+02
regulation of mitotic nuclear division (GO:0007088),0.14,1.37E-02,2.33E+02,0.18,4.90E-02,2.90E+02
modulation by symbiont of host process (GO:0044003),0.19,3.23E-02,1.50E+03,0.18,4.39E-02,1.50E+03
negative regulation of immune system process (GO:0002683),0.06,2.09E-02,5.41E+02,0.41,1.03E-02,5.41E+02
regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.19,4.74E-02,1.41E+02,0.13,3.68E-03,3.58E+01
ciliary basal body-plasma membrane docking (GO:0097711),0.21,4.13E-03,3.31E+01,0.08,6.04E-03,1.56E+01
phosphatidylinositol metabolic process (GO:0046488),0.06,8.99E-05,6.00E+01,0.13,1.93E-02,2.67E+01
positive regulation of protein metabolic process (GO:0051247),0.19,3.32E-02,1.92E+02,0.10,1.60E-02,3.66E+01
regulation of cellular response to stress (GO:0080135),0.19,3.02E-20,3.49E+02,0.10,4.34E-15,3.00E+02
vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.21,4.35E-02,3.69E+02,0.26,2.75E-02,3.69E+02
autophagosome maturation (GO:0097352),0.20,6.75E-03,8.47E+01,0.10,1.25E-05,8.47E+01
regulation of carbohydrate catabolic process (GO:0043470),0.20,3.95E-10,4.39E+02,0.10,1.05E-07,1.87E+02
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.06,3.37E-03,7.30E+02,0.31,1.48E-02,1.17E+03
negative regulation of signal transduction in absence of ligand (GO:1901099),0.06,3.37E-03,7.30E+02,0.31,1.48E-02,1.17E+03
protein targeting to membrane (GO:0006612),0.22,4.64E-02,1.35E+02,0.10,3.11E-03,3.16E+01
regulation of G0 to G1 transition (GO:0070316),0.13,1.80E-02,1.21E+02,0.03,9.63E-03,2.07E+01
negative regulation of multicellular organismal process (GO:0051241),0.20,4.68E-02,1.48E+02,0.13,3.42E-02,1.84E+01
positive regulation of neutrophil migration (GO:1902624),0.12,4.99E-02,9.56E+02,0.28,4.99E-02,4.77E+02
negative regulation of mRNA processing (GO:0050686),0.21,2.64E-02,2.96E+02,0.18,2.64E-02,2.96E+02
negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.21,2.56E-02,2.01E+02,0.18,2.56E-02,2.01E+02
protein modification process (GO:0036211),0.21,4.99E-02,9.63E+01,0.18,4.99E-02,9.63E+01
regulation of telomere maintenance (GO:0032204),0.21,4.14E-02,3.50E+02,0.18,4.14E-02,3.50E+02
"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.21,2.47E-02,3.28E+02,0.18,2.47E-02,3.28E+02
positive regulation of smooth muscle cell proliferation (GO:0048661),0.10,3.15E-02,3.06E+02,0.13,1.73E-02,4.06E+02
positive regulation of innate immune response (GO:0045089),0.11,9.27E-03,1.52E+03,0.10,9.27E-03,1.49E+03
"regulation of DNA-templated transcription, elongation (GO:0032784)",0.19,1.57E-04,1.10E+02,0.10,1.08E-03,1.06E+02
positive regulation of blood vessel endothelial cell migration (GO:0043536),0.21,3.13E-02,2.92E+02,0.15,4.65E-02,1.76E+02
Golgi ribbon formation (GO:0090161),0.22,4.71E-02,7.35E+02,0.18,4.71E-02,7.35E+02
peptide biosynthetic process (GO:0043043),0.23,3.35E-10,6.81E+02,0.21,8.11E-03,3.50E+02
positive regulation of cell-matrix adhesion (GO:0001954),0.22,2.58E-02,3.23E+02,0.18,2.63E-02,6.63E+01
"alternative mRNA splicing, via spliceosome (GO:0000380)",0.20,3.31E-02,2.27E+02,0.18,3.31E-02,2.27E+02
negative regulation of protein kinase activity (GO:0006469),0.20,4.49E-02,1.01E+02,0.18,4.49E-02,1.01E+02
negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.08,2.50E-03,4.57E+01,0.33,2.98E-02,2.73E+02
cellular response to UV (GO:0034644),0.21,1.03E-02,5.90E+01,0.10,1.34E-04,3.84E+01
cell chemotaxis (GO:0060326),0.02,4.74E-03,9.90E+02,0.26,3.01E-02,2.26E+01
nervous system development (GO:0007399),0.05,5.84E-03,4.30E+01,0.41,1.20E-02,3.69E+01
positive regulation of response to biotic stimulus (GO:0002833),0.12,9.83E-03,1.13E+03,0.08,9.83E-03,1.13E+03
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.19,4.79E-02,1.73E+02,0.18,3.83E-02,2.84E+02
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.02,3.42E-02,2.16E+02,0.36,4.17E-02,6.78E+01
intra-Golgi vesicle-mediated transport (GO:0006891),0.21,1.06E-03,1.37E+02,0.10,9.61E-05,1.37E+02
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.20,4.67E-02,1.66E+02,0.10,1.64E-02,2.54E+01
"retrograde transport, endosome to Golgi (GO:0042147)",0.21,7.82E-03,1.25E+02,0.13,7.82E-03,1.25E+02
sprouting angiogenesis (GO:0002040),0.03,1.39E-02,1.42E+03,0.41,4.48E-02,5.96E+02
regulated exocytosis (GO:0045055),0.06,3.42E-02,2.00E+02,0.41,2.65E-02,3.20E+01
transcription by RNA polymerase I (GO:0006360),0.13,4.02E-02,1.83E+02,0.15,4.02E-02,1.83E+02
regulation of interleukin-2 production (GO:0032663),0.07,1.53E-03,2.90E+02,0.28,3.09E-02,3.60E+02
"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.19,2.74E-02,6.35E+01,0.03,1.55E-02,2.36E+01
regulation of mRNA polyadenylation (GO:1900363),0.21,1.97E-03,6.03E+02,0.18,1.97E-03,6.03E+02
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.06,4.61E-02,5.54E+01,0.36,4.07E-02,9.39E+01
negative regulation of mitotic cell cycle phase transition (GO:1901991),0.23,2.60E-02,2.92E+02,0.18,2.15E-02,1.90E+02
regulation of vesicle-mediated transport (GO:0060627),0.23,2.68E-02,2.77E+02,0.18,3.23E-02,1.51E+02
immunological synapse formation (GO:0001771),0.13,1.54E-02,1.55E+03,0.23,1.54E-02,1.55E+03
regulation of phospholipase C activity (GO:1900274),0.02,4.10E-02,1.25E+03,0.31,4.79E-02,1.99E+03
positive regulation of protein catabolic process (GO:0045732),0.21,4.27E-02,1.39E+02,0.10,2.15E-05,5.14E+01
nuclear membrane reassembly (GO:0031468),0.20,4.31E-14,4.55E+02,0.10,2.76E-09,1.74E+02
positive regulation of telomere maintenance via telomerase (GO:0032212),0.20,4.02E-02,1.92E+02,0.23,2.37E-03,1.92E+02
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.20,4.02E-02,1.69E+02,0.23,4.03E-03,1.69E+02
regulation of telomerase RNA localization to Cajal body (GO:1904872),0.20,3.89E-02,4.74E+02,0.23,1.74E-03,4.74E+02
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.21,2.75E-02,4.90E+02,0.18,2.75E-02,3.52E+02
poly(A)+ mRNA export from nucleus (GO:0016973),0.22,3.08E-02,3.00E+02,0.18,3.08E-02,3.00E+02
macrophage activation (GO:0042116),0.13,7.71E-03,4.68E+02,0.15,7.73E-04,4.68E+02
insulin receptor signaling pathway (GO:0008286),0.19,8.29E-05,4.22E+01,0.18,4.54E-02,4.22E+01
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.24,2.62E-03,1.64E+03,0.23,2.62E-03,9.09E+02
receptor-mediated endocytosis (GO:0006898),0.15,4.88E-02,1.66E+02,0.21,2.53E-02,8.26E+01
cell morphogenesis involved in differentiation (GO:0000904),0.19,2.63E-02,1.00E+02,0.18,2.82E-02,4.60E+02
protein localization to chromosome (GO:0034502),0.20,1.83E-04,8.57E+01,0.10,8.70E-03,2.99E+01
positive regulation of signaling receptor activity (GO:2000273),0.15,5.76E-03,9.62E+02,0.13,3.62E-02,9.07E+02
negative regulation of type I interferon production (GO:0032480),0.13,2.19E-02,8.99E+02,0.08,2.75E-02,2.76E+02
regulation of chemokine production (GO:0032642),0.11,1.89E-02,4.26E+02,0.21,1.28E-02,2.42E+02
"regulation of gene expression, epigenetic (GO:0040029)",0.20,3.55E-02,1.32E+02,0.18,3.55E-02,1.32E+02
response to hydrogen peroxide (GO:0042542),0.21,1.72E-02,4.84E+02,0.10,1.46E-04,4.39E+01
cellular response to reactive oxygen species (GO:0034614),0.21,4.33E-02,2.05E+02,0.10,1.53E-04,3.81E+01
IRE1-mediated unfolded protein response (GO:0036498),0.21,4.66E-03,7.63E+02,0.10,4.53E-08,1.17E+02
nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.21,2.59E-02,4.72E+02,0.18,5.01E-04,4.72E+02
selective autophagy (GO:0061912),0.21,2.95E-02,2.78E+02,0.15,2.77E-02,1.42E+02
cellular response to nicotine (GO:0071316),0.16,3.54E-02,3.81E+03,0.10,2.92E-02,4.47E+02
"protein localization to chromosome, telomeric region (GO:0070198)",0.18,5.02E-03,1.16E+02,0.15,1.45E-02,1.99E+03
telomere maintenance via recombination (GO:0000722),0.08,2.39E-02,8.01E+02,0.18,2.39E-02,8.01E+02
phospholipid biosynthetic process (GO:0008654),0.20,1.05E-02,2.09E+02,0.18,1.05E-02,2.09E+02
positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.08,4.29E-03,4.14E+02,0.23,9.26E-03,4.21E+01
regulation of gene silencing by miRNA (GO:0060964),0.19,2.24E-11,2.26E+02,0.15,2.19E-02,1.52E+02
negative regulation of T cell mediated cytotoxicity (GO:0001915),0.08,2.60E-02,1.71E+03,0.33,4.85E-02,1.71E+03
regulation of generation of precursor metabolites and energy (GO:0043467),0.19,6.09E-08,1.92E+02,0.10,4.40E-06,1.04E+02
receptor signaling pathway via JAK-STAT (GO:0007259),0.25,1.76E-02,1.13E+03,0.00,1.00E+00,0.00E+00
ERAD pathway (GO:0036503),0.20,2.73E-02,2.22E+02,0.10,1.56E-06,5.83E+01
mRNA splice site selection (GO:0006376),0.21,2.02E-02,3.42E+02,0.26,3.39E-02,3.71E+02
signal transduction in response to DNA damage (GO:0042770),0.16,3.45E-03,9.24E+01,0.03,4.33E-02,1.01E+01
cellular response to interleukin-6 (GO:0071354),0.20,4.02E-02,4.75E+02,0.13,4.02E-02,4.05E+02
negative regulation of cell cycle G2/M phase transition (GO:1902750),0.23,2.45E-02,2.92E+02,0.18,2.45E-02,2.52E+02
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.23,2.48E-02,3.19E+02,0.18,2.48E-02,2.67E+02
embryonic eye morphogenesis (GO:0048048),0.08,3.72E-02,4.85E+03,0.38,1.00E-02,4.85E+03
regulation of DNA repair (GO:0006282),0.18,3.33E-03,4.51E+01,0.13,1.61E-02,7.13E+02
histone H4 acetylation (GO:0043967),0.20,2.95E-03,7.46E+01,0.10,1.01E-03,3.89E+01
extrinsic apoptotic signaling pathway (GO:0097191),0.22,4.96E-02,1.21E+02,0.10,9.37E-05,6.88E+01
nucleic acid-templated transcription (GO:0097659),0.15,3.68E-03,3.17E+01,0.18,1.78E-02,5.55E+02
regulation of mitotic cell cycle (GO:0007346),0.23,4.34E-02,2.27E+02,0.10,1.33E-13,1.40E+02
positive regulation of cardiocyte differentiation (GO:1905209),0.00,1.00E+00,0.00E+00,0.28,2.68E-02,3.65E+03
negative regulation of cell cycle process (GO:0010948),0.07,3.84E-04,6.38E+01,0.03,3.86E-02,1.10E+01
negative regulation of endothelial cell apoptotic process (GO:2000352),0.01,2.84E-02,5.97E+02,0.26,2.16E-03,7.03E+01
calcium-mediated signaling using intracellular calcium source (GO:0035584),0.08,4.13E-02,8.18E+02,0.33,5.37E-03,3.81E+02
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.01,4.07E-02,3.51E+02,0.44,3.62E-02,4.05E+02
axon guidance (GO:0007411),0.02,4.00E-02,6.32E+01,0.31,1.98E-02,6.32E+01
internal peptidyl-lysine acetylation (GO:0018393),0.20,6.69E-04,1.18E+02,0.18,2.92E-02,5.71E+02
leukocyte cell-cell adhesion (GO:0007159),0.06,8.10E-03,3.11E+03,0.05,4.81E-02,6.87E+01
regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.11,4.35E-02,1.86E+02,0.00,1.00E+00,0.00E+00
cortical cytoskeleton organization (GO:0030865),0.19,3.25E-02,7.99E+02,0.15,4.71E-02,2.49E+02
positive regulation of RNA metabolic process (GO:0051254),0.21,3.15E-02,3.14E+02,0.10,1.18E-03,6.65E+01
regulation of dendritic cell apoptotic process (GO:2000668),0.07,2.01E-02,9.56E+02,0.26,2.01E-02,9.56E+02
positive regulation of positive chemotaxis (GO:0050927),0.01,3.70E-02,1.07E+03,0.26,4.79E-02,1.71E+03
regulation of dendritic cell antigen processing and presentation (GO:0002604),0.10,4.13E-02,1.29E+03,0.21,1.74E-02,1.29E+03
RIG-I signaling pathway (GO:0039529),0.11,1.94E-02,1.85E+03,0.13,1.67E-02,2.40E+02
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.21,1.73E-02,1.19E+02,0.13,1.73E-02,7.99E+01
retrograde axonal transport (GO:0008090),0.19,2.16E-02,1.84E+03,0.18,4.39E-02,2.91E+02
regulation of autophagosome assembly (GO:2000785),0.21,3.26E-03,1.13E+02,0.10,9.57E-05,5.95E+01
mRNA modification (GO:0016556),0.18,2.74E-02,1.23E+02,0.08,1.60E-02,3.92E+01
positive regulation of nuclear division (GO:0051785),0.10,3.80E-03,5.97E+02,0.26,4.02E-02,7.40E+02
regulation of microglial cell activation (GO:1903978),0.06,1.69E-02,1.25E+03,0.41,1.69E-02,1.06E+03
potassium ion transmembrane transport (GO:0071805),0.00,1.00E+00,0.00E+00,0.26,1.53E-03,2.77E+01
positive regulation of telomerase activity (GO:0051973),0.17,3.67E-02,3.97E+01,0.28,4.62E-02,1.01E+03
regulation of wound healing (GO:0061041),0.20,2.97E-02,4.82E+02,0.18,4.13E-02,2.09E+02
regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.12,3.11E-02,1.45E+03,0.10,4.11E-02,4.97E+02
ribosomal small subunit biogenesis (GO:0042274),0.19,5.02E-05,1.60E+02,0.10,2.06E-04,1.60E+02
regulation of glycolytic process (GO:0006110),0.19,4.64E-06,8.30E+01,0.10,6.87E-05,5.46E+01
Fc-epsilon receptor signaling pathway (GO:0038095),0.21,4.64E-02,2.17E+02,0.18,4.64E-02,2.04E+02
Fc receptor signaling pathway (GO:0038093),0.21,4.64E-02,2.10E+02,0.18,4.64E-02,1.97E+02
positive regulation of defense response to virus by host (GO:0002230),0.11,3.76E-02,1.57E+03,0.10,9.50E-03,1.41E+02
macrophage migration (GO:1905517),0.12,3.34E-02,2.76E+03,0.26,4.15E-02,6.85E+02
negative regulation of epithelial cell apoptotic process (GO:1904036),0.01,2.90E-02,4.02E+02,0.26,8.23E-03,4.10E+01
establishment of protein localization to organelle (GO:0072594),0.24,4.86E-02,1.78E+02,0.10,1.19E-09,1.37E+02
positive regulation of Wnt signaling pathway (GO:0030177),0.19,4.48E-02,1.52E+02,0.18,4.64E-02,1.52E+02
negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.22,3.54E-02,5.19E+02,0.15,4.93E-02,2.64E+02
negative regulation of translation (GO:0017148),0.20,1.61E-10,1.64E+02,0.10,5.79E-10,1.14E+02
protein auto-ADP-ribosylation (GO:0070213),0.04,3.32E-02,7.35E+02,0.18,1.03E-02,3.65E+03
regulation of DNA metabolic process (GO:0051052),0.21,2.15E-02,3.80E+02,0.10,1.64E-04,4.51E+01
positive regulation of interleukin-8 production (GO:0032757),0.12,9.74E-03,2.66E+02,0.13,3.73E-02,2.66E+02
positive regulation of hydrolase activity (GO:0051345),0.25,5.57E-03,3.66E+02,0.08,2.21E-03,1.23E+02
regulation of lipid metabolic process (GO:0019216),0.22,4.45E-02,1.26E+02,0.10,5.36E-05,3.68E+01
gene silencing by miRNA (GO:0035195),0.19,2.81E-04,8.36E+01,0.18,4.79E-02,2.61E+02
"regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.13,7.60E-03,3.45E+03,0.08,4.78E-02,1.91E+02
regulation of regulatory T cell differentiation (GO:0045589),0.01,2.84E-02,3.89E+01,0.26,6.09E-03,7.02E+01
histone H3 acetylation (GO:0043966),0.08,4.96E-02,4.08E+01,0.08,2.42E-02,4.00E+01
regulation of mRNA catabolic process (GO:0061013),0.21,2.45E-02,7.44E+02,0.18,2.45E-02,7.00E+02
proteolysis involved in cellular protein catabolic process (GO:0051603),0.21,3.22E-02,1.16E+02,0.10,1.96E-05,4.66E+01
regulation of stem cell differentiation (GO:2000736),0.22,4.64E-02,1.89E+02,0.18,3.15E-02,1.21E+02
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.19,4.37E-02,1.31E+02,0.10,4.08E-04,2.73E+01
small GTPase mediated signal transduction (GO:0007264),0.19,9.45E-03,3.92E+01,0.10,5.20E-04,3.92E+01
purine-containing compound biosynthetic process (GO:0072522),0.20,2.35E-04,1.17E+02,0.10,6.38E-03,3.05E+01
regulation of mitotic metaphase/anaphase transition (GO:0030071),0.22,1.41E-02,2.74E+02,0.10,1.85E-02,2.00E+01
positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.15,1.76E-02,1.13E+03,0.03,4.67E-02,5.83E+01
RNA methylation (GO:0001510),0.05,2.73E-03,4.80E+01,0.00,1.00E+00,0.00E+00
positive regulation of chemokine production (GO:0032722),0.14,1.55E-02,3.18E+02,0.15,3.80E-02,2.00E+02
calcium ion transport (GO:0006816),0.05,3.59E-02,2.17E+02,0.36,3.34E-02,1.92E+02
mesoderm development (GO:0007498),0.04,4.77E-02,4.75E+02,0.33,4.09E-02,4.75E+02
negative regulation of interleukin-10 production (GO:0032693),0.15,4.57E-02,1.07E+03,0.15,4.27E-02,6.31E+02
B cell activation involved in immune response (GO:0002312),0.12,2.70E-02,4.02E+03,0.31,7.62E-03,4.02E+03
positive regulation of cellular component movement (GO:0051272),0.14,4.19E-02,6.25E+02,0.15,7.91E-03,2.69E+02
apoptotic mitochondrial changes (GO:0008637),0.07,4.19E-02,3.29E+02,0.13,4.10E-02,3.29E+02
regulation of protein ubiquitination (GO:0031396),0.21,5.54E-04,4.99E+01,0.10,1.92E-04,3.13E+01
regulation of positive chemotaxis (GO:0050926),0.01,3.70E-02,2.80E+03,0.26,4.79E-02,4.44E+03
cardiac muscle cell differentiation (GO:0055007),0.05,2.31E-02,5.77E+02,0.41,4.08E-03,5.77E+02
positive regulation of cellular component biogenesis (GO:0044089),0.25,1.27E-02,1.26E+02,0.10,1.98E-05,4.15E+01
regulation of proteolysis (GO:0030162),0.23,1.90E-02,5.68E+02,0.15,4.64E-02,1.75E+02
cellular response to hydrogen peroxide (GO:0070301),0.19,3.65E-02,3.58E+02,0.10,4.32E-03,2.71E+01
extracellular matrix assembly (GO:0085029),0.03,3.20E-02,9.93E+01,0.31,2.44E-02,8.57E+02
negative regulation of signal transduction (GO:0009968),0.01,3.57E-02,7.79E+01,0.21,2.30E-02,1.45E+01
aortic valve development (GO:0003176),0.00,1.00E+00,0.00E+00,0.46,3.83E-02,2.94E+02
ribosomal large subunit assembly (GO:0000027),0.21,6.83E-03,7.57E+02,0.23,6.83E-03,7.57E+02
renal system development (GO:0072001),0.00,3.37E-02,1.93E+02,0.44,2.05E-02,1.93E+02
regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.21,4.40E-02,2.27E+02,0.18,2.75E-02,1.79E+02
regulation of hematopoietic stem cell differentiation (GO:1902036),0.21,4.35E-02,2.22E+02,0.18,2.75E-02,1.97E+02
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.21,2.73E-02,2.16E+02,0.18,3.08E-02,9.95E+01
regulation of cellular amino acid metabolic process (GO:0006521),0.21,3.99E-02,3.38E+02,0.18,2.45E-02,2.35E+02
aortic valve morphogenesis (GO:0003180),0.01,4.92E-02,1.72E+02,0.46,3.70E-02,3.42E+02
regulation of keratinocyte proliferation (GO:0010837),0.12,1.06E-02,1.55E+03,0.36,1.02E-02,2.57E+03
positive regulation of protein localization to plasma membrane (GO:1903078),0.21,4.39E-02,1.84E+02,0.10,1.27E-04,4.37E+01
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.03,3.22E-02,5.71E+02,0.33,1.81E-02,2.13E+02
Ras protein signal transduction (GO:0007265),0.19,2.19E-04,5.01E+01,0.18,8.81E-03,2.35E+02
regulation of ATP metabolic process (GO:1903578),0.19,7.98E-08,1.56E+02,0.10,3.84E-06,9.51E+01
protein import into nucleus (GO:0006606),0.19,7.51E-12,1.93E+02,0.10,1.19E-09,1.37E+02
fructose 6-phosphate metabolic process (GO:0006002),0.13,3.70E-02,2.09E+03,0.13,4.71E-02,1.03E+03
negative regulation of epithelial cell proliferation (GO:0050680),0.04,4.56E-02,1.39E+02,0.28,3.63E-04,6.26E+02
cilium assembly (GO:0060271),0.09,1.19E-02,8.70E+01,0.08,1.19E-02,8.70E+01
mRNA cleavage involved in mRNA processing (GO:0098787),0.17,2.47E-02,3.28E+02,0.15,2.47E-02,3.28E+02
RNA stabilization (GO:0043489),0.19,1.07E-02,2.62E+02,0.21,1.07E-02,1.04E+03
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.11,5.31E-03,1.57E+02,0.13,2.48E-02,1.39E+02
B cell activation (GO:0042113),0.07,1.52E-02,5.18E+02,0.28,1.52E-02,5.18E+02
translesion synthesis (GO:0019985),0.15,7.59E-03,2.01E+02,0.10,3.87E-02,7.76E+02
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.20,4.10E-02,3.37E+02,0.13,4.10E-02,3.37E+02
negative regulation of type 2 immune response (GO:0002829),0.12,4.72E-03,1.43E+04,0.21,4.72E-03,1.14E+04
positive regulation of protein localization to nucleus (GO:1900182),0.20,5.12E-03,1.85E+02,0.15,2.45E-02,3.03E+02
positive regulation of regulatory T cell differentiation (GO:0045591),0.09,1.55E-02,1.68E+03,0.23,3.31E-02,7.56E+01
myeloid cell activation involved in immune response (GO:0002275),0.09,6.56E-03,1.54E+03,0.23,3.47E-02,3.62E+01
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.19,4.09E-04,6.96E+01,0.10,1.55E-04,6.96E+01
cellular response to chemical stress (GO:0062197),0.21,4.78E-02,1.47E+02,0.18,4.94E-02,1.11E+02
negative regulation of autophagy (GO:0010507),0.21,4.57E-02,2.23E+02,0.18,4.57E-02,1.13E+02
negative regulation of vascular endothelial cell proliferation (GO:1905563),0.09,4.68E-02,1.15E+04,0.28,4.68E-02,1.01E+03
regulation of axon extension involved in axon guidance (GO:0048841),0.09,1.05E-02,1.13E+03,0.18,1.05E-02,1.13E+03
positive regulation of protein localization to cell periphery (GO:1904377),0.21,4.39E-02,1.84E+02,0.10,4.08E-04,4.37E+01
negative regulation of ion transport (GO:0043271),0.04,2.46E-02,3.31E+02,0.31,2.46E-02,3.31E+02
positive regulation of lymphocyte migration (GO:2000403),0.15,2.85E-02,1.36E+03,0.31,1.98E-02,1.22E+03
"RNA splicing, via transesterification reactions (GO:0000375)",0.19,4.57E-07,3.67E+02,0.10,7.95E-06,3.67E+02
positive regulation of cellular protein localization (GO:1903829),0.23,5.66E-03,1.74E+02,0.10,1.93E-04,3.45E+01
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.19,2.99E-02,1.54E+02,0.10,7.43E-03,3.64E+01
positive regulation of autophagy (GO:0010508),0.20,2.00E-04,5.26E+01,0.10,1.15E-05,5.26E+01
transcription initiation from RNA polymerase II promoter (GO:0006367),0.08,3.59E-02,1.47E+02,0.08,3.59E-02,1.47E+02
positive regulation of proteolysis (GO:0045862),0.13,1.37E-02,2.33E+02,0.13,3.60E-02,2.90E+02
regulation of lipid storage (GO:0010883),0.12,3.20E-02,6.44E+02,0.10,3.81E-02,1.01E+02
regulation of saliva secretion (GO:0046877),0.10,3.32E-03,1.54E+03,0.31,4.07E-02,1.54E+03
positive regulation of epithelial cell proliferation (GO:0050679),0.04,2.84E-02,3.77E+02,0.28,3.65E-02,3.77E+02
cellular response to dsRNA (GO:0071359),0.08,7.67E-03,3.48E+03,0.10,7.67E-03,3.48E+03
ubiquitin-dependent ERAD pathway (GO:0030433),0.19,2.55E-02,2.77E+02,0.10,1.38E-06,6.55E+01
negative regulation of protein binding (GO:0032091),0.18,5.18E-03,2.96E+02,0.10,2.13E-02,4.36E+01
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.17,2.47E-02,9.31E+01,0.15,4.53E-03,8.25E+01
leukocyte aggregation (GO:0070486),0.10,2.51E-02,2.18E+04,0.18,2.03E-02,1.75E+03
epithelial cell development (GO:0002064),0.04,2.44E-02,2.57E+02,0.31,4.09E-02,4.46E+02
membrane depolarization (GO:0051899),0.06,8.34E-03,4.83E+02,0.38,3.70E-02,3.42E+02
positive regulation of mitotic nuclear division (GO:0045840),0.11,5.41E-03,4.16E+02,0.18,4.12E-02,5.17E+02
"positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",0.12,7.60E-03,3.45E+03,0.13,1.29E-02,1.13E+02
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.21,3.08E-02,1.98E+02,0.18,3.08E-02,1.56E+02
regulation of cellular amine metabolic process (GO:0033238),0.21,2.45E-02,4.33E+02,0.18,2.45E-02,3.01E+02
purine nucleobase biosynthetic process (GO:0009113),0.21,2.58E-02,1.07E+06,0.18,2.58E-02,1.60E+03
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.21,3.08E-02,4.00E+02,0.18,3.08E-02,2.87E+02
regulation of establishment of planar polarity (GO:0090175),0.21,3.08E-02,1.73E+02,0.18,3.08E-02,1.24E+02
regulation of cellular ketone metabolic process (GO:0010565),0.21,2.45E-02,2.66E+02,0.18,2.45E-02,1.80E+02
positive regulation of catalytic activity (GO:0043085),0.21,2.47E-02,2.54E+02,0.10,7.10E-04,3.71E+01
peptidyl-tyrosine modification (GO:0018212),0.03,4.69E-02,4.99E+02,0.31,4.57E-02,1.67E+02
regulation of cytokine production involved in immune response (GO:0002718),0.05,1.43E-02,4.92E+02,0.38,4.20E-02,3.92E+02
"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)",0.20,3.95E-02,6.50E+03,0.00,1.00E+00,0.00E+00
embryonic organ morphogenesis (GO:0048562),0.06,1.44E-02,7.68E+02,0.36,4.13E-02,7.68E+02
regulation of microtubule-based process (GO:0032886),0.19,1.22E-02,5.14E+01,0.10,5.67E-03,3.24E+01
regulation of bone mineralization (GO:0030500),0.04,4.38E-02,1.64E+02,0.38,4.88E-02,5.32E+02
mitotic nuclear membrane reassembly (GO:0007084),0.19,2.03E-13,4.56E+02,0.10,2.45E-09,1.87E+02
mitotic nuclear membrane organization (GO:0101024),0.19,2.03E-13,4.56E+02,0.10,2.45E-09,1.87E+02
positive regulation of cell cycle G1/S phase transition (GO:1902808),0.21,4.97E-02,3.58E+02,0.15,4.12E-02,3.58E+02
positive regulation of cellular catabolic process (GO:0031331),0.20,3.73E-04,6.44E+01,0.10,3.14E-06,6.44E+01
termination of RNA polymerase II transcription (GO:0006369),0.20,4.05E-08,3.09E+02,0.10,2.45E-04,2.21E+02
protein-containing complex disassembly (GO:0032984),0.20,2.04E-04,9.43E+01,0.10,2.16E-07,9.43E+01
regulation of toll-like receptor signaling pathway (GO:0034121),0.01,4.09E-02,4.24E+02,0.13,4.21E-02,4.24E+02
regulation of neutrophil chemotaxis (GO:0090022),0.08,2.78E-02,8.15E+02,0.23,4.30E-02,4.06E+02
positive regulation of DNA biosynthetic process (GO:2000573),0.18,1.34E-03,9.48E+01,0.18,3.43E-03,4.89E+02
regulation of exit from mitosis (GO:0007096),0.19,4.25E-02,2.66E+02,0.13,4.25E-02,2.66E+02
response to metal ion (GO:0010038),0.20,4.83E-02,1.76E+02,0.23,4.83E-02,2.20E+02
regulation of protein serine/threonine kinase activity (GO:0071900),0.21,4.84E-02,9.83E+01,0.10,6.31E-04,2.57E+01
positive regulation of T cell differentiation (GO:0045582),0.08,4.83E-02,4.14E+02,0.31,4.83E-02,1.57E+02
pre-mRNA cleavage required for polyadenylation (GO:0098789),0.17,2.47E-02,3.66E+02,0.15,2.47E-02,3.66E+02
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.04,4.84E-03,1.05E+03,0.10,3.82E-02,1.86E+02
histone lysine methylation (GO:0034968),0.08,1.39E-02,3.21E+02,0.08,1.39E-02,3.21E+02
regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.20,3.10E-02,6.74E+02,0.18,3.10E-02,6.74E+02
positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.20,2.98E-02,1.51E+06,0.18,2.98E-02,1.40E+06
peptide antigen assembly with MHC protein complex (GO:0002501),0.14,5.72E-03,5.05E+03,0.08,2.05E-02,4.37E+02
histone H2A ubiquitination (GO:0033522),0.08,4.64E-02,8.24E+01,0.08,8.00E-03,4.46E+01
negative regulation of mast cell activation (GO:0033004),0.02,3.80E-02,1.49E+02,0.26,3.06E-02,1.28E+02
DNA integrity checkpoint signaling (GO:0031570),0.10,2.52E-02,1.56E+02,0.00,1.00E+00,0.00E+00
dendritic cell differentiation (GO:0097028),0.01,2.76E-02,6.92E+02,0.33,3.90E-02,3.35E+02
regulation of protein localization to nucleus (GO:1900180),0.22,2.22E-03,3.11E+02,0.10,5.74E-03,2.70E+01
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.22,3.62E-02,3.71E+02,0.10,2.48E-03,6.16E+01
sister chromatid segregation (GO:0000819),0.18,2.25E-02,7.47E+02,0.10,3.24E-03,7.47E+02
positive regulation of T cell mediated cytotoxicity (GO:0001916),0.14,3.23E-02,7.76E+02,0.00,1.00E+00,0.00E+00
positive regulation of glial cell migration (GO:1903977),0.10,3.25E-02,2.80E+03,0.13,3.31E-02,1.39E+03
protein monoubiquitination (GO:0006513),0.20,1.21E-04,1.26E+02,0.10,4.91E-03,5.19E+01
protein-DNA complex assembly (GO:0065004),0.20,2.06E-02,2.32E+02,0.10,1.08E-12,1.26E+02
mRNA destabilization (GO:0061157),0.20,1.88E-05,8.98E+01,0.10,9.14E-05,8.98E+01
positive regulation of establishment of protein localization (GO:1904951),0.19,3.54E-02,6.61E+02,0.21,2.37E-03,4.52E+02
regulation of canonical Wnt signaling pathway (GO:0060828),0.21,3.46E-02,8.70E+01,0.13,1.03E-02,5.48E+02
interleukin-12-mediated signaling pathway (GO:0035722),0.20,1.81E-02,6.93E+02,0.13,4.43E-02,2.15E+02
cellular response to interleukin-12 (GO:0071349),0.20,1.81E-02,6.58E+02,0.13,4.44E-02,2.04E+02
intermediate filament bundle assembly (GO:0045110),0.16,4.99E-02,5.29E+03,0.31,1.20E-03,2.40E+03
posttranscriptional regulation of gene expression (GO:0010608),0.20,4.21E-02,1.63E+02,0.10,4.67E-05,1.08E+02
regulation of blood circulation (GO:1903522),0.02,2.61E-02,3.58E+02,0.38,3.82E-02,3.58E+02
positive regulation of multicellular organismal process (GO:0051240),0.06,1.57E-02,1.18E+02,0.10,4.17E-02,7.56E+01
regulation of lymphocyte activation (GO:0051249),0.04,4.04E-03,1.25E+03,0.21,4.22E-02,6.20E+01
positive regulation of macrophage migration (GO:1905523),0.10,4.89E-02,9.28E+02,0.21,4.15E-02,5.07E+02
regulation of peptidyl-serine phosphorylation (GO:0033135),0.20,4.76E-02,1.16E+02,0.10,9.39E-05,3.28E+01
regulation of translational initiation (GO:0006446),0.21,3.72E-02,3.40E+02,0.10,6.16E-14,2.93E+02
regulation of stress-activated MAPK cascade (GO:0032872),0.18,5.23E-04,6.04E+01,0.18,4.39E-02,6.41E+02
regulation of stem cell population maintenance (GO:2000036),0.18,2.23E-03,1.64E+02,0.10,2.85E-05,1.63E+02
ribosome disassembly (GO:0032790),0.20,7.68E-04,1.93E+06,0.10,5.34E-03,3.35E+02
positive regulation of neuroinflammatory response (GO:0150078),0.10,1.14E-02,1.66E+03,0.15,1.69E-02,1.45E+03
peptidyl-proline hydroxylation (GO:0019511),0.18,9.90E-03,1.64E+03,0.08,3.33E-02,2.85E+01
response to endoplasmic reticulum stress (GO:0034976),0.21,4.39E-02,1.29E+02,0.10,2.50E-09,8.88E+01
epithelial cell morphogenesis (GO:0003382),0.08,1.89E-02,4.69E+02,0.23,4.62E-02,5.84E+02
regulation of clathrin-dependent endocytosis (GO:2000369),0.06,8.01E-03,7.03E+01,0.10,3.35E-02,8.92E+02
response to prostaglandin E (GO:0034695),0.07,2.01E-02,9.56E+02,0.21,2.01E-02,9.56E+02
"base-excision repair, gap-filling (GO:0006287)",0.15,7.02E-03,2.62E+02,0.08,4.84E-02,1.91E+02
positive regulation of response to DNA damage stimulus (GO:2001022),0.20,4.78E-02,1.30E+02,0.10,6.38E-03,2.95E+01
negative regulation of macroautophagy (GO:0016242),0.19,3.76E-03,5.91E+01,0.10,4.30E-04,5.91E+01
nucleus organization (GO:0006997),0.20,1.14E-04,8.96E+01,0.10,1.01E-03,3.89E+01
lung development (GO:0030324),0.00,1.00E+00,0.00E+00,0.26,3.56E-02,3.87E+01
regulation of NIK/NF-kappaB signaling (GO:1901222),0.19,2.54E-02,1.51E+02,0.08,3.80E-03,1.86E+01
regulation of RNA metabolic process (GO:0051252),0.19,2.84E-02,2.46E+02,0.18,3.73E-02,2.46E+02
positive regulation of gene silencing by miRNA (GO:2000637),0.19,3.39E-02,4.97E+02,0.18,4.57E-02,3.24E+02
positive regulation of cellular extravasation (GO:0002693),0.10,3.72E-02,1.85E+03,0.21,2.01E-02,4.60E+02
negative regulation of neuroinflammatory response (GO:0150079),0.02,1.32E-02,1.36E+03,0.33,3.42E-02,6.68E+02
negative regulation of peptidase activity (GO:0010466),0.13,1.56E-02,7.44E+02,0.21,1.18E-02,7.44E+02
positive regulation of cell adhesion mediated by integrin (GO:0033630),0.04,4.50E-02,9.93E+02,0.21,1.66E-02,5.23E+02
cellular response to hypoxia (GO:0071456),0.18,1.17E-13,1.89E+02,0.15,4.10E-02,1.75E+02
regulation of telomere maintenance via telomerase (GO:0032210),0.18,1.38E-05,8.09E+01,0.15,3.47E-03,6.68E+01
cation transport (GO:0006812),0.01,3.07E-02,1.65E+02,0.36,2.59E-02,1.65E+02
heart contraction (GO:0060047),0.02,3.45E-03,1.55E+03,0.28,3.45E-03,1.55E+03
regulation of protein targeting to mitochondrion (GO:1903214),0.17,2.54E-02,6.56E+01,0.18,4.71E-02,2.30E+02
regulation of protein-containing complex assembly (GO:0043254),0.21,4.19E-02,3.59E+01,0.10,3.63E-04,3.41E+01
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.19,3.09E-02,9.15E+01,0.13,3.09E-02,8.57E+01
establishment of protein localization to plasma membrane (GO:0061951),0.19,1.50E-03,6.60E+01,0.10,5.46E-04,6.60E+01
regulation of phosphorylation (GO:0042325),0.19,9.78E-08,1.04E+02,0.10,1.16E-07,6.78E+01
vasculature development (GO:0001944),0.00,1.00E+00,0.00E+00,0.31,3.19E-02,7.61E+02
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.16,3.03E-02,2.00E+02,0.21,3.03E-02,2.41E+02
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.20,4.79E-02,1.27E+02,0.10,1.41E-05,5.80E+01
COPII-coated vesicle budding (GO:0090114),0.20,2.78E-11,2.68E+02,0.10,8.75E-12,2.58E+02
regulation of primary metabolic process (GO:0080090),0.20,5.69E-03,3.22E+02,0.10,7.47E-18,2.37E+02
"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.20,1.52E-09,2.21E+02,0.10,6.63E-10,2.18E+02
cellular response to insulin stimulus (GO:0032869),0.20,3.28E-07,5.47E+01,0.10,2.77E-06,4.45E+01
vesicle coating (GO:0006901),0.20,1.52E-09,2.21E+02,0.10,6.63E-10,2.18E+02
COPII vesicle coating (GO:0048208),0.20,1.52E-09,2.21E+02,0.10,6.63E-10,2.18E+02
release of sequestered calcium ion into cytosol (GO:0051209),0.08,1.98E-02,7.01E+02,0.18,1.98E-02,7.01E+02
negative regulation of sequestering of calcium ion (GO:0051283),0.08,1.98E-02,7.82E+02,0.18,1.98E-02,7.82E+02
B cell homeostasis (GO:0001782),0.00,1.00E+00,0.00E+00,0.26,7.15E-03,1.22E+02
cotranslational protein targeting to membrane (GO:0006613),0.21,2.62E-03,1.94E+03,0.15,2.62E-03,1.15E+03
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.21,9.24E-03,1.18E+03,0.15,9.24E-03,8.58E+02
cytoplasmic translation (GO:0002181),0.21,1.60E-03,1.56E+03,0.15,1.60E-03,9.23E+02
protein targeting to ER (GO:0045047),0.21,2.12E-03,2.10E+03,0.15,2.12E-03,9.96E+02
positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.11,1.57E-02,1.47E+02,0.13,1.38E-02,7.59E+02
negative regulation of angiogenesis (GO:0016525),0.01,4.73E-02,1.35E+02,0.33,2.78E-02,1.73E+02
negative regulation of wound healing (GO:0061045),0.17,3.42E-02,8.79E+02,0.31,3.39E-02,3.87E+02
"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.18,3.21E-06,1.03E+03,0.15,1.38E-03,8.64E+02
positive regulation of establishment of protein localization to telomere (GO:1904851),0.18,5.24E-05,6.79E+02,0.15,4.95E-04,5.68E+02
positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.18,9.45E-04,1.17E+02,0.15,5.60E-04,2.23E+02
regulation of protein localization to Cajal body (GO:1904869),0.18,1.34E-05,8.47E+02,0.15,7.56E-04,7.08E+02
regulation of establishment of protein localization to telomere (GO:0070203),0.18,2.00E-04,6.87E+02,0.15,7.56E-04,2.93E+02
positive regulation of protein localization to Cajal body (GO:1904871),0.18,1.34E-05,8.47E+02,0.15,7.56E-04,7.08E+02
polyamine biosynthetic process (GO:0006596),0.14,6.25E-03,2.34E+03,0.10,4.27E-02,2.40E+02
transcription initiation from RNA polymerase I promoter (GO:0006361),0.10,3.72E-03,5.94E+01,0.08,1.34E-02,3.69E+01
base-excision repair (GO:0006284),0.15,9.32E-03,1.66E+02,0.00,1.00E+00,0.00E+00
cellular response to mechanical stimulus (GO:0071260),0.06,1.04E-02,2.82E+02,0.08,4.15E-02,5.63E+01
purine ribonucleoside monophosphate catabolic process (GO:0009169),0.05,4.38E-02,2.13E+02,0.10,2.28E-02,5.56E+02
DNA replication-independent nucleosome organization (GO:0034724),0.19,1.70E-04,2.09E+02,0.10,2.06E-02,5.66E+01
regulation of mitotic sister chromatid separation (GO:0010965),0.21,6.10E-03,5.40E+02,0.03,3.32E-02,2.03E+01
inorganic cation transmembrane transport (GO:0098662),0.02,2.12E-02,2.28E+01,0.31,3.19E-02,1.05E+02
positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.22,1.60E-02,4.63E+02,0.15,1.60E-02,4.63E+02
Notch signaling pathway (GO:0007219),0.19,3.90E-02,2.18E+02,0.23,4.79E-02,1.53E+02
peptidyl-tyrosine phosphorylation (GO:0018108),0.03,4.69E-02,3.80E+02,0.26,9.57E-04,4.99E+01
positive regulation of protein targeting to mitochondrion (GO:1903955),0.18,2.01E-02,9.43E+01,0.18,4.66E-02,3.09E+02
positive regulation of interferon-gamma production (GO:0032729),0.05,4.18E-02,5.32E+02,0.18,3.11E-02,2.46E+01
embryonic digestive tract development (GO:0048566),0.05,4.10E-02,6.19E+02,0.28,4.10E-02,3.81E+02
regulation of cellular component size (GO:0032535),0.20,4.64E-02,5.02E+02,0.18,4.64E-02,1.74E+02
positive regulation of cell-cell adhesion (GO:0022409),0.11,9.53E-03,2.97E+02,0.03,2.97E-02,6.04E+01
regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.07,3.95E-02,4.87E+02,0.26,2.14E-02,4.87E+02
positive regulation of calcium ion transport into cytosol (GO:0010524),0.03,3.26E-02,4.47E+02,0.15,3.47E-02,3.37E+01
telomere maintenance (GO:0000723),0.17,3.85E-03,3.59E+01,0.05,2.18E-02,3.87E+02
negative regulation of protein ubiquitination (GO:0031397),0.16,3.74E-02,3.15E+01,0.10,6.11E-03,2.77E+01
protein deacetylation (GO:0006476),0.16,4.28E-03,1.28E+02,0.13,4.28E-03,1.28E+02
protein N-linked glycosylation (GO:0006487),0.21,4.98E-02,1.33E+02,0.10,4.73E-04,3.02E+01
negative regulation of Wnt signaling pathway (GO:0030178),0.21,2.28E-02,1.33E+02,0.13,1.03E-02,7.89E+02
positive regulation of transferase activity (GO:0051347),0.21,2.96E-02,5.89E+01,0.13,3.81E-02,1.59E+02
negative regulation of canonical Wnt signaling pathway (GO:0090090),0.21,1.95E-02,1.65E+02,0.13,1.03E-02,9.52E+02
negative regulation of bone mineralization (GO:0030502),0.07,3.25E-02,8.48E+02,0.33,2.75E-02,3.01E+03
positive regulation of ERAD pathway (GO:1904294),0.19,4.84E-02,3.87E+02,0.18,4.84E-02,3.87E+02
endocytic recycling (GO:0032456),0.20,1.84E-02,6.68E+01,0.10,4.08E-04,6.68E+01
positive regulation of mRNA catabolic process (GO:0061014),0.20,2.16E-07,1.89E+02,0.10,1.05E-06,1.89E+02
positive regulation of mitotic cell cycle phase transition (GO:1901992),0.20,1.72E-02,1.11E+02,0.10,2.93E-04,3.70E+01
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.20,7.94E-07,8.34E+01,0.10,1.35E-03,4.28E+01
integrated stress response signaling (GO:0140467),0.21,1.40E-02,4.78E+03,0.15,3.39E-02,4.59E+02
DNA synthesis involved in DNA repair (GO:0000731),0.12,9.39E-03,2.61E+02,0.03,1.61E-02,7.54E+02
negative regulation of endothelial cell proliferation (GO:0001937),0.06,1.76E-02,9.07E+02,0.18,2.15E-02,2.84E+01
negative regulation of blood vessel morphogenesis (GO:2000181),0.01,4.38E-02,1.56E+02,0.33,2.47E-02,2.00E+02
positive regulation of neuron migration (GO:2001224),0.12,2.99E-02,5.11E+02,0.13,2.99E-02,5.11E+02
positive regulation of supramolecular fiber organization (GO:1902905),0.20,4.05E-02,1.28E+02,0.10,6.20E-03,1.98E+01
synapse organization (GO:0050808),0.05,2.80E-02,1.58E+02,0.33,1.32E-03,1.58E+02
response to alcohol (GO:0097305),0.12,1.27E-02,3.22E+02,0.21,1.27E-02,2.32E+02
myeloid leukocyte differentiation (GO:0002573),0.03,4.76E-02,9.54E+02,0.10,3.22E-02,1.85E+01
response to unfolded protein (GO:0006986),0.18,1.65E-07,1.33E+02,0.18,1.46E-02,9.40E+01
regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.10,1.08E-02,4.54E+01,0.05,3.33E-02,2.00E+01
regulation of programmed cell death (GO:0043067),0.18,4.16E-05,3.74E+01,0.10,1.93E-05,3.05E+01
positive regulation of protein localization to membrane (GO:1905477),0.18,3.76E-05,4.82E+01,0.10,4.26E-06,4.82E+01
positive regulation of lymphocyte chemotaxis (GO:0140131),0.08,4.35E-02,9.93E+02,0.13,4.07E-02,2.23E+02
negative regulation of Ras protein signal transduction (GO:0046580),0.19,4.25E-02,3.05E+02,0.15,4.25E-02,3.05E+02
positive regulation of protein-containing complex assembly (GO:0031334),0.21,2.35E-02,2.13E+02,0.10,5.15E-04,3.55E+01
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.21,3.82E-02,4.45E+02,0.10,6.38E-03,3.05E+01
negative regulation of bone remodeling (GO:0046851),0.08,1.45E-02,1.55E+03,0.08,2.68E-02,4.08E+03
positive regulation of canonical Wnt signaling pathway (GO:0090263),0.19,4.14E-02,1.88E+02,0.13,3.50E-02,1.88E+02
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.19,8.50E-03,1.55E+02,0.10,1.46E-04,1.55E+02
regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.11,3.53E-02,3.14E+02,0.15,1.55E-02,2.83E+01
intraciliary transport involved in cilium assembly (GO:0035735),0.05,6.92E-06,1.63E+02,0.00,1.00E+00,0.00E+00
negative regulation of macrophage activation (GO:0043031),0.02,1.41E-02,1.15E+03,0.26,1.61E-02,8.51E+01
branching morphogenesis of an epithelial tube (GO:0048754),0.02,4.95E-02,2.28E+02,0.31,4.61E-02,2.28E+02
regulation of Wnt signaling pathway (GO:0030111),0.00,1.00E+00,0.00E+00,0.33,3.60E-02,1.62E+02
cellular response to virus (GO:0098586),0.14,9.27E-03,1.54E+03,0.08,9.27E-03,1.54E+03
RNA destabilization (GO:0050779),0.19,1.25E-03,9.01E+01,0.10,6.05E-04,7.32E+01
positive regulation of macroautophagy (GO:0016239),0.19,2.20E-04,5.95E+01,0.10,5.51E-05,5.20E+01
regulation of response to interferon-gamma (GO:0060330),0.18,2.37E-02,7.48E+02,0.10,8.00E-03,7.47E+01
establishment of mitotic spindle localization (GO:0040001),0.22,1.71E-02,3.72E+02,0.13,1.22E-02,3.72E+02
mitochondrial transport (GO:0006839),0.20,4.79E-02,1.27E+02,0.10,1.26E-03,5.04E+01
positive regulation of viral process (GO:0048524),0.20,3.61E-02,2.05E+02,0.10,1.65E-08,1.29E+02
camera-type eye development (GO:0043010),0.10,4.02E-03,1.45E+03,0.13,4.02E-03,1.45E+03
negative regulation of organelle assembly (GO:1902116),0.15,3.98E-02,3.20E+01,0.08,1.15E-02,2.02E+01
lipopolysaccharide-mediated signaling pathway (GO:0031663),0.12,2.14E-02,1.94E+03,0.08,4.05E-02,3.05E+02
regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.18,2.85E-02,1.49E+03,0.18,2.85E-02,1.49E+03
positive regulation of monooxygenase activity (GO:0032770),0.08,3.80E-03,1.28E+03,0.13,1.56E-02,9.18E+02
nuclear migration (GO:0007097),0.13,4.04E-02,3.54E+02,0.15,4.04E-02,3.54E+02
negative regulation of cell-cell adhesion (GO:0022408),0.19,4.69E-02,2.16E+02,0.18,4.71E-02,2.16E+02
mRNA polyadenylation (GO:0006378),0.19,4.83E-05,1.71E+02,0.10,1.61E-05,1.43E+02
production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.19,3.67E-03,5.21E+01,0.10,5.60E-03,3.90E+01
Golgi to plasma membrane protein transport (GO:0043001),0.19,5.27E-03,6.20E+01,0.10,6.56E-04,6.16E+01
RNA polyadenylation (GO:0043631),0.19,4.83E-05,1.71E+02,0.10,1.61E-05,1.43E+02
positive regulation by host of viral transcription (GO:0043923),0.19,8.50E-03,8.12E+01,0.10,1.96E-02,1.19E+02
regulation of natural killer cell chemotaxis (GO:2000501),0.07,1.31E-02,7.30E+03,0.13,4.35E-02,6.91E+01
regulation of RIG-I signaling pathway (GO:0039535),0.14,1.27E-02,1.15E+03,0.05,1.78E-02,2.48E+01
protein insertion into ER membrane (GO:0045048),0.22,2.48E-02,4.68E+02,0.08,2.68E-03,2.92E+01
negative regulation of cellular protein metabolic process (GO:0032269),0.20,2.33E-02,2.84E+02,0.10,4.47E-06,4.96E+01
negative regulation of tumor necrosis factor production (GO:0032720),0.03,3.07E-02,4.40E+02,0.15,3.68E-02,2.41E+01
regulation of T cell chemotaxis (GO:0010819),0.12,3.34E-02,1.25E+03,0.13,2.97E-02,2.91E+02
proteolysis (GO:0006508),0.12,4.99E-02,5.30E+01,0.23,2.92E-02,2.01E+02
second-messenger-mediated signaling (GO:0019932),0.02,9.07E-03,3.84E+01,0.26,5.70E-05,5.74E+01
cytoskeleton-dependent cytokinesis (GO:0061640),0.19,2.71E-02,4.76E+01,0.10,1.60E-02,2.35E+01
7-methylguanosine RNA capping (GO:0009452),0.16,2.96E-02,6.15E+01,0.10,4.94E-03,8.33E+01
7-methylguanosine mRNA capping (GO:0006370),0.16,2.96E-02,6.15E+01,0.10,4.94E-03,8.33E+01
purinergic nucleotide receptor signaling pathway (GO:0035590),0.09,2.12E-02,8.18E+02,0.10,4.09E-02,5.82E+02
positive regulation of vascular endothelial growth factor production (GO:0010575),0.10,2.89E-02,6.58E+02,0.23,3.52E-02,8.15E+02
metal ion transport (GO:0030001),0.04,2.74E-02,3.10E+02,0.26,3.01E-03,2.93E+01
regulation of cytokinesis (GO:0032465),0.21,6.04E-05,4.74E+02,0.08,2.62E-02,1.55E+01
protein kinase B signaling (GO:0043491),0.14,3.51E-03,1.55E+03,0.00,1.00E+00,0.00E+00
regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.15,4.68E-02,5.74E+01,0.18,2.68E-02,4.08E+03
negative regulation of bone resorption (GO:0045779),0.05,1.27E-02,2.01E+03,0.03,4.42E-02,1.57E+02
positive regulation of proteasomal protein catabolic process (GO:1901800),0.19,7.06E-05,5.39E+01,0.10,2.58E-03,3.14E+01
cellular protein-containing complex assembly (GO:0034622),0.19,3.87E-02,1.00E+02,0.10,7.91E-08,6.42E+01
establishment of protein localization to endoplasmic reticulum (GO:0072599),0.19,1.00E-04,2.37E+02,0.10,4.28E-05,1.46E+02
regulation of organelle organization (GO:0033043),0.19,1.04E-03,1.07E+03,0.10,4.63E-06,7.35E+01
response to gamma radiation (GO:0010332),0.19,3.63E-04,8.41E+01,0.10,2.99E-03,5.41E+01
negative regulation of cellular amide metabolic process (GO:0034249),0.19,3.16E-07,1.05E+02,0.10,3.26E-07,7.06E+01
positive regulation of stem cell differentiation (GO:2000738),0.03,2.07E-02,1.32E+03,0.21,2.24E-02,4.86E+01
positive regulation of microtubule polymerization (GO:0031116),0.19,4.02E-02,2.45E+02,0.18,4.02E-02,2.45E+02
positive regulation of protein polymerization (GO:0032273),0.19,3.72E-02,1.82E+02,0.18,3.72E-02,7.20E+01
wound healing (GO:0042060),0.19,2.55E-02,2.93E+02,0.18,2.65E-02,2.89E+01
ephrin receptor signaling pathway (GO:0048013),0.19,4.69E-02,1.16E+02,0.18,3.46E-02,6.38E+01
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.18,1.45E-03,4.89E+01,0.10,3.13E-03,4.67E+01
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.18,1.06E-03,1.64E+02,0.10,9.61E-05,1.64E+02
positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.18,2.00E-04,2.52E+02,0.10,1.07E-03,2.52E+02
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.16,5.27E-03,3.37E+01,0.08,7.62E-03,2.49E+01
regulation of vascular endothelial growth factor production (GO:0010574),0.09,3.11E-02,5.97E+02,0.23,3.62E-02,7.40E+02
regulation of mRNA metabolic process (GO:1903311),0.21,4.84E-02,3.87E+02,0.18,4.84E-02,3.87E+02
negative regulation of mRNA polyadenylation (GO:1900364),0.21,1.80E-02,1.14E+03,0.18,1.80E-02,1.14E+03
negative regulation of hippo signaling (GO:0035331),0.14,3.05E-02,7.03E+01,0.18,4.09E-02,8.23E+02
negative regulation of cell cycle G1/S phase transition (GO:1902807),0.23,4.79E-02,9.72E+02,0.05,2.82E-02,1.46E+01
negative regulation of protein localization to plasma membrane (GO:1903077),0.20,4.10E-02,5.82E+02,0.10,4.10E-02,3.58E+02
B cell proliferation (GO:0042100),0.09,9.24E-03,1.72E+03,0.26,9.24E-03,1.72E+03
regulation of nitric oxide biosynthetic process (GO:0045428),0.18,2.94E-02,3.65E+02,0.05,1.58E-02,1.71E+01
positive regulation of translational initiation (GO:0045948),0.20,2.68E-02,7.72E+02,0.10,1.60E-02,5.17E+01
protein complex oligomerization (GO:0051259),0.20,4.84E-02,1.29E+02,0.10,4.99E-04,3.50E+01
secondary alcohol biosynthetic process (GO:1902653),0.20,1.27E-02,3.85E+02,0.10,8.70E-03,8.54E+01
cholesterol biosynthetic process (GO:0006695),0.20,1.27E-02,3.70E+02,0.10,1.15E-02,7.67E+01
protein autophosphorylation (GO:0046777),0.17,4.69E-02,1.23E+02,0.10,9.19E-04,2.06E+01
protein lipidation (GO:0006497),0.03,3.60E-02,3.16E+01,0.05,1.04E-02,3.89E+01
mitotic DNA damage checkpoint signaling (GO:0044773),0.15,4.00E-03,2.26E+02,0.00,1.00E+00,0.00E+00
cellular response to oxidative stress (GO:0034599),0.21,1.19E-03,1.86E+02,0.10,1.61E-05,4.25E+01
regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.21,1.89E-02,3.34E+02,0.10,2.56E-05,5.66E+01
COPII-coated vesicle cargo loading (GO:0090110),0.21,1.53E-02,7.45E+02,0.10,2.19E-05,3.73E+02
non-canonical Wnt signaling pathway (GO:0035567),0.21,3.02E-02,1.23E+02,0.10,6.81E-11,1.06E+02
nitrogen compound transport (GO:0071705),0.04,4.01E-02,1.15E+02,0.23,4.95E-02,1.13E+02
circulatory system development (GO:0072359),0.00,1.00E+00,0.00E+00,0.26,1.53E-03,4.81E+01
antigen processing and presentation of endogenous peptide antigen (GO:0002483),0.19,1.55E-02,1.68E+03,0.03,3.17E-02,2.41E+01
defense response to protozoan (GO:0042832),0.01,2.10E-02,1.36E+03,0.21,4.15E-02,7.48E+02
regulation of NMDA receptor activity (GO:2000310),0.04,1.76E-02,1.08E+03,0.26,8.23E-03,4.20E+01
endoplasmic reticulum organization (GO:0007029),0.19,8.74E-07,8.56E+01,0.10,1.38E-06,6.55E+01
positive regulation of cellular amide metabolic process (GO:0034250),0.19,1.05E-08,1.23E+02,0.10,1.23E-08,9.52E+01
positive regulation of autophagosome assembly (GO:2000786),0.19,1.64E-02,1.65E+02,0.10,1.13E-02,6.05E+01
nuclear pore organization (GO:0006999),0.19,4.29E-04,2.36E+02,0.10,2.15E-04,1.30E+02
regulation of protein catabolic process (GO:0042176),0.19,2.67E-04,4.13E+01,0.10,2.30E-04,3.24E+01
nucleocytoplasmic transport (GO:0006913),0.19,5.02E-05,9.03E+01,0.10,7.10E-04,5.97E+01
regulation of B cell activation (GO:0050864),0.07,1.30E-02,2.52E+03,0.08,1.88E-02,3.17E+02
regulation of p38MAPK cascade (GO:1900744),0.09,1.02E-02,4.02E+02,0.18,3.68E-02,3.85E+02
histone deubiquitination (GO:0016578),0.18,8.82E-03,5.96E+01,0.10,1.09E-03,5.96E+01
water transport (GO:0006833),0.05,4.62E-02,1.23E+03,0.26,4.62E-02,2.85E+02
cellular response to peptide (GO:1901653),0.21,4.44E-02,2.33E+02,0.15,4.44E-02,1.19E+02
positive regulation of cell-substrate adhesion (GO:0010811),0.19,3.46E-02,1.79E+02,0.10,1.00E-03,2.58E+01
pyroptosis (GO:0070269),0.12,2.17E-03,6.61E+02,0.23,4.15E-02,6.61E+02
negative regulation of nervous system development (GO:0051961),0.11,9.00E-03,9.28E+02,0.05,3.97E-02,6.61E+02
axon development (GO:0061564),0.02,4.16E-02,3.24E+01,0.26,1.06E-02,2.51E+01
interleukin-27-mediated signaling pathway (GO:0070106),0.01,6.78E-05,9.03E+03,0.13,2.32E-02,1.54E+03
pericardium development (GO:0060039),0.07,1.74E-02,6.26E+02,0.13,1.74E-02,6.26E+02
regulation of lymphocyte proliferation (GO:0050670),0.05,4.89E-02,7.74E+02,0.23,3.47E-02,3.62E+01
protein modification by small protein conjugation or removal (GO:0070647),0.18,1.29E-02,1.31E+02,0.10,8.00E-03,4.29E+01
peptidyl-serine dephosphorylation (GO:0070262),0.18,2.73E-03,1.03E+02,0.10,1.55E-03,1.02E+02
membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.04,3.97E-02,5.84E+02,0.26,3.01E-02,5.84E+02
DNA damage checkpoint signaling (GO:0000077),0.04,1.09E-05,1.65E+02,0.00,1.00E+00,0.00E+00
positive regulation of cellular metabolic process (GO:0031325),0.19,4.69E-02,1.06E+02,0.10,2.92E-02,2.47E+02
mitotic spindle assembly (GO:0090307),0.20,2.05E-03,3.41E+02,0.10,8.68E-04,3.37E+01
post-translational protein modification (GO:0043687),0.19,2.54E-13,1.00E+02,0.10,2.46E-12,7.82E+01
positive regulation of cell cycle (GO:0045787),0.19,2.21E-06,7.86E+01,0.08,2.43E-03,4.49E+01
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.16,2.21E-02,4.24E+02,0.13,2.21E-02,4.24E+02
response to dsRNA (GO:0043331),0.08,8.39E-03,2.32E+03,0.08,8.39E-03,2.32E+03
mitotic sister chromatid cohesion (GO:0007064),0.19,8.50E-03,8.51E+01,0.10,1.96E-02,4.49E+01
positive regulation of mRNA 3'-end processing (GO:0031442),0.19,6.99E-04,2.35E+02,0.10,4.08E-04,1.95E+02
membrane protein ectodomain proteolysis (GO:0006509),0.19,2.00E-04,1.18E+02,0.10,4.21E-04,6.32E+01
histone H2B ubiquitination (GO:0033523),0.19,6.99E-04,2.60E+06,0.10,2.68E-05,2.60E+06
ATP-dependent chromatin remodeling (GO:0043044),0.19,3.28E-07,1.92E+02,0.10,3.26E-07,1.92E+02
histone ubiquitination (GO:0016574),0.19,1.45E-03,2.31E+02,0.10,1.26E-04,1.01E+02
protein poly-ADP-ribosylation (GO:0070212),0.12,2.16E-02,1.16E+03,0.08,1.03E-02,4.60E+03
regulation of telomerase activity (GO:0051972),0.18,3.72E-02,3.01E+01,0.15,4.16E-02,6.93E+02
regulation of androgen receptor signaling pathway (GO:0060765),0.18,4.46E-03,3.71E+01,0.15,3.83E-02,2.94E+02
regulation of MAPK cascade (GO:0043408),0.03,4.62E-02,2.09E+02,0.21,2.13E-02,1.37E+02
lamellipodium organization (GO:0097581),0.22,3.42E-02,3.87E+02,0.15,4.09E-02,3.87E+02
positive regulation of posttranscriptional gene silencing (GO:0060148),0.17,1.83E-03,2.94E+02,0.18,4.09E-02,1.02E+03
cellular component assembly (GO:0022607),0.17,1.72E-03,1.93E+01,0.18,2.15E-02,1.93E+01
positive regulation of miRNA metabolic process (GO:2000630),0.06,3.36E-02,2.68E+02,0.10,4.27E-02,2.40E+02
cellular response to decreased oxygen levels (GO:0036294),0.15,1.29E-02,2.22E+01,0.13,2.45E-02,2.98E+02
peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.12,7.58E-03,2.64E+03,0.08,4.78E-02,1.91E+02
positive regulation of myeloid leukocyte differentiation (GO:0002763),0.06,4.74E-02,5.17E+02,0.13,3.98E-02,2.05E+01
spliceosomal tri-snRNP complex assembly (GO:0000244),0.14,2.65E-02,4.88E+02,0.15,2.65E-02,4.88E+02
basement membrane assembly (GO:0070831),0.03,4.71E-02,1.19E+03,0.21,2.24E-02,2.96E+03
cellular response to growth factor stimulus (GO:0071363),0.19,3.68E-02,1.46E+02,0.08,8.00E-03,1.59E+01
positive regulation of T cell chemotaxis (GO:0010820),0.07,2.85E-02,1.36E+03,0.13,2.88E-02,3.22E+02
negative regulation of interleukin-6 production (GO:0032715),0.10,3.54E-02,5.02E+02,0.08,2.03E-02,2.76E+02
cellular response to heat (GO:0034605),0.17,2.91E-05,1.09E+02,0.18,2.70E-02,5.17E+02
generation of neurons (GO:0048699),0.02,7.59E-03,3.28E+01,0.26,4.11E-02,7.04E+01
regulation of mRNA processing (GO:0050684),0.19,3.63E-09,3.30E+02,0.10,3.60E-08,2.69E+02
ESCRT complex disassembly (GO:1904896),0.19,5.59E-03,2.34E+02,0.10,3.72E-03,8.57E+01
ESCRT III complex disassembly (GO:1904903),0.19,5.59E-03,2.34E+02,0.10,3.72E-03,8.57E+01
membrane protein proteolysis (GO:0033619),0.19,3.15E-05,9.42E+01,0.10,1.38E-04,5.19E+01
"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.19,1.33E-03,1.03E+02,0.10,4.78E-03,5.66E+01
maturation of LSU-rRNA (GO:0000470),0.19,3.76E-03,1.44E+02,0.10,1.82E-03,5.91E+01
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.19,2.34E-07,9.33E+01,0.10,2.27E-04,5.64E+01
chaperone cofactor-dependent protein refolding (GO:0051085),0.18,4.75E-02,1.34E+02,0.15,4.75E-02,1.34E+02
establishment of protein localization to membrane (GO:0090150),0.20,4.35E-02,1.79E+02,0.10,1.14E-02,2.55E+01
protein N-linked glycosylation via asparagine (GO:0018279),0.20,4.22E-02,3.22E+02,0.10,1.58E-04,6.16E+01
protein glycosylation (GO:0006486),0.20,3.68E-02,4.38E+02,0.10,1.16E-02,1.29E+01
peptidyl-asparagine modification (GO:0018196),0.20,4.22E-02,3.09E+02,0.10,5.81E-05,7.20E+01
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.22,2.91E-02,4.92E+02,0.08,1.01E-02,2.62E+01
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.22,2.91E-02,4.92E+02,0.08,1.01E-02,2.62E+01
sphingolipid metabolic process (GO:0006665),0.17,2.80E-02,1.53E+02,0.18,4.94E-02,9.28E+01
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.18,1.38E-06,9.50E+01,0.10,3.97E-08,9.38E+01
global genome nucleotide-excision repair (GO:0070911),0.18,4.83E-05,1.51E+02,0.10,1.61E-05,1.51E+02
Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.18,4.36E-06,8.18E+01,0.10,1.44E-07,8.07E+01
Fc-gamma receptor signaling pathway (GO:0038094),0.18,2.05E-06,9.03E+01,0.10,6.18E-08,8.91E+01
regulation of type I interferon-mediated signaling pathway (GO:0060338),0.21,3.45E-03,2.31E+03,0.10,3.45E-03,2.31E+03
negative regulation of phagocytosis (GO:0050765),0.05,9.33E-03,7.61E+02,0.13,9.33E-03,7.61E+02
error-free translesion synthesis (GO:0070987),0.16,2.93E-02,1.96E+02,0.13,2.77E-02,5.70E+01
negative regulation of cell junction assembly (GO:1901889),0.16,3.66E-03,6.58E+02,0.13,2.32E-02,5.48E+02
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.10,3.26E-02,4.64E+02,0.08,3.02E-02,2.59E+01
regulation of nitric-oxide synthase activity (GO:0050999),0.07,6.49E-03,3.76E+02,0.13,1.73E-02,6.08E+02
plasma membrane invagination (GO:0099024),0.02,9.45E-03,2.32E+02,0.33,9.45E-03,2.32E+02
positive regulation of cytoskeleton organization (GO:0051495),0.13,4.33E-02,1.46E+02,0.08,4.33E-02,5.61E+01
intermediate filament organization (GO:0045109),0.08,2.04E-02,1.59E+03,0.31,1.28E-02,7.08E+02
cilium organization (GO:0044782),0.04,1.00E-04,4.68E+01,0.00,1.00E+00,0.00E+00
protein localization to Golgi apparatus (GO:0034067),0.20,2.23E-02,6.07E+01,0.10,1.20E-02,3.24E+01
regulation of transforming growth factor beta2 production (GO:0032909),0.06,5.27E-03,7.30E+03,0.10,3.74E-02,2.09E+03
negative regulation of DNA binding (GO:0043392),0.02,4.68E-02,5.78E+01,0.13,4.97E-02,3.56E+02
natural killer cell mediated cytotoxicity (GO:0042267),0.06,4.99E-02,4.20E+02,0.13,4.99E-02,1.67E+02
response to interferon-alpha (GO:0035455),0.08,9.59E-03,2.20E+03,0.00,1.00E+00,0.00E+00
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.18,6.90E-03,3.07E+01,0.08,7.75E-04,3.07E+01
potassium ion transport (GO:0006813),0.00,1.00E+00,0.00E+00,0.26,1.33E-04,4.16E+01
nuclear envelope organization (GO:0006998),0.19,5.73E-03,5.17E+01,0.10,1.13E-02,2.76E+01
regulation of cellular amide metabolic process (GO:0034248),0.19,1.06E-03,1.37E+02,0.10,9.61E-05,1.37E+02
positive regulation of transcription by RNA polymerase I (GO:0045943),0.19,3.78E-03,7.99E+01,0.10,7.15E-03,6.32E+01
protein localization to membrane (GO:0072657),0.19,1.78E-04,3.17E+01,0.10,1.76E-04,2.90E+01
regulation of RNA export from nucleus (GO:0046831),0.19,3.21E-06,1.00E+03,0.10,2.65E-05,8.64E+02
regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.19,3.27E-05,1.12E+02,0.10,1.73E-06,1.07E+02
regulation of Ras protein signal transduction (GO:0046578),0.19,1.78E-04,3.22E+01,0.10,1.92E-02,1.99E+01
protein exit from endoplasmic reticulum (GO:0032527),0.19,1.57E-06,2.50E+02,0.10,3.81E-06,1.60E+02
sterol biosynthetic process (GO:0016126),0.19,1.27E-02,3.29E+02,0.10,9.73E-03,5.70E+01
nucleosome organization (GO:0034728),0.19,2.20E-04,4.41E+01,0.10,9.02E-05,3.87E+01
positive regulation of mitotic cell cycle (GO:0045931),0.19,2.82E-02,4.76E+01,0.10,2.43E-02,2.54E+01
MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.16,7.40E-03,2.98E+01,0.05,1.04E-02,2.23E+01
regulation of interleukin-8 production (GO:0032677),0.09,3.90E-02,1.86E+02,0.10,4.68E-02,1.86E+02
negative regulation of cell development (GO:0010721),0.10,1.29E-02,6.26E+02,0.00,1.00E+00,0.00E+00
regulation of cell cycle G1/S phase transition (GO:1902806),0.21,2.34E-02,3.46E+02,0.08,4.12E-02,3.46E+02
positive regulation of catabolic process (GO:0009896),0.15,3.79E-02,1.89E+02,0.08,1.35E-02,2.13E+01
positive regulation of B cell proliferation (GO:0030890),0.03,2.02E-02,6.49E+02,0.28,2.02E-02,2.88E+02
positive regulation of interferon-alpha production (GO:0032727),0.09,1.34E-03,2.43E+03,0.03,3.11E-02,1.06E+02
cellular iron ion homeostasis (GO:0006879),0.22,1.63E-02,2.84E+02,0.08,2.41E-02,1.70E+01
regulation of cell adhesion mediated by integrin (GO:0033628),0.10,3.95E-02,2.17E+02,0.13,3.95E-02,3.16E+02
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.18,1.04E-04,1.72E+02,0.10,4.03E-05,1.72E+02
modulation by host of viral genome replication (GO:0044827),0.19,3.09E-02,6.11E+02,0.10,4.80E-04,9.49E+01
mitochondrial membrane organization (GO:0007006),0.19,3.35E-02,2.61E+02,0.10,1.34E-02,3.69E+01
cardiac muscle cell action potential (GO:0086001),0.04,4.91E-02,2.83E+02,0.26,3.40E-02,2.83E+02
regulation of mononuclear cell migration (GO:0071675),0.12,1.23E-02,7.30E+02,0.08,4.15E-02,3.97E+02
porphyrin-containing compound catabolic process (GO:0006787),0.04,7.59E-03,5.07E+02,0.28,5.86E-04,5.07E+02
heme catabolic process (GO:0042167),0.04,7.59E-03,5.07E+02,0.28,5.86E-04,5.07E+02
glomerulus vasculature development (GO:0072012),0.01,4.62E-02,2.96E+03,0.26,3.06E-02,1.28E+02
tRNA modification (GO:0006400),0.04,8.01E-03,2.85E+01,0.00,1.00E+00,0.00E+00
spindle assembly (GO:0051225),0.18,3.05E-03,2.57E+01,0.08,3.78E-03,1.82E+01
cellular senescence (GO:0090398),0.21,3.31E-02,4.24E+02,0.08,2.43E-02,2.66E+01
production of small RNA involved in gene silencing by RNA (GO:0070918),0.15,4.89E-02,2.35E+02,0.10,1.45E-02,1.39E+03
vasculogenesis (GO:0001570),0.04,4.25E-02,3.29E+02,0.31,4.25E-02,3.29E+02
neuron migration (GO:0001764),0.05,4.04E-02,1.67E+02,0.15,4.07E-02,4.71E+02
regulation of immature T cell proliferation in thymus (GO:0033084),0.04,4.84E-03,4.11E+03,0.10,1.94E-02,5.05E+03
immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.04,2.85E-02,4.26E+02,0.23,8.23E-03,7.55E+01
regulation of T-helper cell differentiation (GO:0045622),0.14,5.72E-03,5.05E+03,0.00,1.00E+00,0.00E+00
protein export from nucleus (GO:0006611),0.18,1.62E-03,9.11E+01,0.10,1.55E-04,9.11E+01
regulation of mRNA 3'-end processing (GO:0031440),0.18,1.83E-03,1.40E+02,0.10,1.07E-03,1.16E+02
protein localization to plasma membrane (GO:0072659),0.18,2.95E-04,3.32E+01,0.10,6.76E-04,3.32E+01
signal peptide processing (GO:0006465),0.18,1.12E-02,1.27E+02,0.10,7.29E-03,1.16E+02
positive regulation of cellular component organization (GO:0051130),0.21,1.89E-02,6.87E+01,0.13,4.85E-02,6.87E+01
negative regulation of mRNA 3'-end processing (GO:0031441),0.20,1.92E-02,9.52E+02,0.18,1.92E-02,9.52E+02
DNA replication checkpoint signaling (GO:0000076),0.11,6.72E-03,4.96E+02,0.08,2.70E-02,8.98E+01
natural killer cell mediated immunity (GO:0002228),0.05,4.64E-02,1.92E+02,0.13,4.64E-02,1.92E+02
negative regulation of signaling (GO:0023057),0.09,3.22E-02,7.38E+02,0.10,4.36E-02,8.25E+01
embryonic organ development (GO:0048568),0.02,4.82E-02,1.35E+02,0.33,3.11E-02,4.75E+01
axonogenesis (GO:0007409),0.02,4.43E-02,4.95E+01,0.26,1.00E-02,4.95E+01
negative regulation of protein localization to cell periphery (GO:1904376),0.19,3.54E-02,5.82E+02,0.08,1.13E-02,2.76E+01
histone H3-K14 acetylation (GO:0044154),0.05,4.83E-02,1.47E+06,0.03,2.12E-02,6.95E+01
cellular response to exogenous dsRNA (GO:0071360),0.08,7.59E-03,4.35E+03,0.08,7.59E-03,4.35E+03
response to organic cyclic compound (GO:0014070),0.12,2.09E-02,4.99E+02,0.00,1.00E+00,0.00E+00
positive regulation of nucleocytoplasmic transport (GO:0046824),0.19,3.20E-02,3.06E+02,0.10,4.67E-05,5.50E+01
positive regulation of viral genome replication (GO:0045070),0.19,2.84E-02,5.46E+02,0.10,3.25E-06,1.22E+02
positive regulation of protein ubiquitination (GO:0031398),0.20,4.27E-03,3.80E+01,0.08,1.08E-02,2.23E+01
acute inflammatory response (GO:0002526),0.08,1.30E-02,5.97E+02,0.10,2.32E-02,7.40E+02
positive regulation of protein autophosphorylation (GO:0031954),0.04,2.31E-02,6.08E+02,0.18,3.25E-02,1.63E+03
negative regulation of stress-activated MAPK cascade (GO:0032873),0.12,3.68E-02,3.85E+02,0.21,3.68E-02,3.85E+02
regulation of leukocyte tethering or rolling (GO:1903236),0.00,1.00E+00,0.00E+00,0.26,4.07E-02,7.76E+02
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.14,4.55E-02,3.43E+02,0.03,4.81E-02,6.77E+01
ureteric bud development (GO:0001657),0.00,1.00E+00,0.00E+00,0.33,3.17E-02,7.00E+01
nucleotide-sugar biosynthetic process (GO:0009226),0.21,3.70E-02,9.28E+02,0.10,5.09E-03,3.89E+01
positive regulation of fibroblast proliferation (GO:0048146),0.02,2.26E-02,7.07E+02,0.13,1.09E-02,3.51E+02
aggrephagy (GO:0035973),0.19,2.40E-02,6.77E+02,0.13,2.35E-02,9.17E+01
endoderm formation (GO:0001706),0.10,9.13E-03,6.72E+02,0.15,5.40E-03,2.94E+02
maintenance of protein location in nucleus (GO:0051457),0.16,3.39E-02,1.95E+02,0.15,3.39E-02,1.95E+02
cellular response to misfolded protein (GO:0071218),0.11,3.39E-02,1.95E+02,0.15,3.39E-02,1.95E+02
modulation by host of symbiont process (GO:0051851),0.19,4.21E-02,4.83E+02,0.10,1.34E-02,3.69E+01
regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.19,7.36E-04,1.84E+03,0.10,1.14E-03,2.93E+01
positive regulation of telomere maintenance (GO:0032206),0.19,3.47E-03,6.15E+01,0.10,3.33E-02,2.74E+01
regulation of receptor-mediated endocytosis (GO:0048259),0.11,2.16E-02,6.08E+02,0.21,3.72E-02,2.66E+02
microtubule nucleation (GO:0007020),0.14,4.04E-02,8.58E+01,0.08,2.47E-02,3.75E+01
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.14,5.73E-03,6.11E+01,0.15,4.09E-02,5.82E+02
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.11,2.04E-02,2.54E+02,0.08,9.48E-03,7.75E+01
positive regulation of receptor signaling pathway via STAT (GO:1904894),0.11,4.06E-02,5.99E+02,0.08,2.51E-02,2.81E+01
regulation of cellular extravasation (GO:0002691),0.03,4.01E-02,2.40E+03,0.26,2.40E-02,8.46E+01
synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.06,2.89E-02,4.44E+02,0.08,2.89E-02,4.44E+02
ruffle organization (GO:0031529),0.12,3.95E-02,9.35E+02,0.13,1.98E-02,9.35E+02
negative regulation of leukocyte proliferation (GO:0070664),0.02,2.55E-02,7.75E+02,0.13,2.66E-02,5.26E+03
positive regulation of protein secretion (GO:0050714),0.15,2.17E-02,1.75E+01,0.18,3.73E-02,2.16E+02
regulation of neuroinflammatory response (GO:0150077),0.10,3.52E-05,9.28E+02,0.08,3.42E-02,4.52E+02
telomere organization (GO:0032200),0.12,2.24E-03,3.18E+01,0.05,1.91E-02,4.82E+02
regulation of amyloid-beta formation (GO:1902003),0.19,3.74E-02,3.16E+02,0.10,2.24E-02,2.18E+01
regulation of DNA damage checkpoint (GO:2000001),0.06,4.07E-02,7.04E+02,0.08,4.07E-02,7.04E+02
regulation of transcription by RNA polymerase I (GO:0006356),0.14,2.41E-02,4.24E+01,0.26,4.62E-02,5.43E+02
protein K11-linked ubiquitination (GO:0070979),0.19,3.67E-03,4.85E+01,0.08,1.60E-02,2.05E+01
regulation of MHC class I biosynthetic process (GO:0045343),0.11,4.72E-03,1.43E+04,0.13,2.10E-02,1.14E+04
leukocyte tethering or rolling (GO:0050901),0.05,3.42E-02,7.08E+02,0.23,3.42E-02,7.08E+02
cellular response to amyloid-beta (GO:1904646),0.07,4.42E-02,4.31E+02,0.15,2.26E-02,2.33E+02
skeletal system development (GO:0001501),0.00,1.00E+00,0.00E+00,0.26,1.48E-03,3.26E+01
DNA modification (GO:0006304),0.05,8.23E-03,1.30E+02,0.00,1.00E+00,0.00E+00
regulation of response to external stimulus (GO:0032101),0.04,3.97E-02,1.13E+01,0.05,1.93E-02,1.03E+01
regulation of defense response to virus (GO:0050688),0.18,2.60E-02,1.15E+03,0.08,9.70E-04,7.28E+01
positive regulation of protein import into nucleus (GO:0042307),0.17,7.94E-03,4.01E+01,0.10,4.03E-03,3.24E+01
positive regulation of protein import (GO:1904591),0.17,5.27E-03,4.35E+01,0.10,2.48E-03,3.44E+01
regulation of insulin secretion (GO:0050796),0.02,4.68E-02,1.07E+02,0.26,2.65E-02,3.98E+01
"mRNA cis splicing, via spliceosome (GO:0045292)",0.18,8.50E-03,7.28E+01,0.10,9.70E-04,7.33E+01
nuclear pore complex assembly (GO:0051292),0.18,6.99E-04,2.35E+02,0.10,4.08E-04,1.95E+02
regulation of cytoplasmic transport (GO:1903649),0.18,1.12E-02,8.02E+01,0.10,7.29E-03,5.74E+01
protein localization to lysosome (GO:0061462),0.18,6.69E-04,7.97E+01,0.10,2.62E-04,6.03E+01
"retrograde protein transport, ER to cytosol (GO:0030970)",0.18,1.18E-05,2.86E+02,0.10,4.28E-05,1.86E+02
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.18,5.77E-04,1.83E+02,0.10,3.10E-04,1.51E+02
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.18,9.45E-04,1.17E+02,0.10,2.99E-03,9.56E+01
intracellular steroid hormone receptor signaling pathway (GO:0030518),0.18,8.55E-04,6.51E+01,0.10,1.98E-05,6.50E+01
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.18,5.73E-03,6.88E+01,0.10,6.76E-04,6.88E+01
endosome transport via multivesicular body sorting pathway (GO:0032509),0.18,8.50E-03,4.70E+01,0.10,4.53E-03,3.52E+01
regulation of protein dephosphorylation (GO:0035304),0.18,4.50E-06,1.27E+02,0.10,3.10E-04,6.29E+01
positive regulation of RNA splicing (GO:0033120),0.18,1.74E-04,9.43E+01,0.10,5.81E-05,7.20E+01
regulation of early endosome to late endosome transport (GO:2000641),0.18,5.59E-03,1.13E+02,0.10,9.61E-05,1.12E+02
aerobic electron transport chain (GO:0019646),0.18,7.64E-03,3.10E+01,0.10,1.00E-03,2.60E+01
regulation of cell-substrate junction assembly (GO:0090109),0.18,5.08E-05,1.91E+02,0.10,1.26E-04,8.95E+01
establishment of protein localization to mitochondrion (GO:0072655),0.18,2.95E-03,4.07E+01,0.10,1.66E-02,3.47E+01
stress granule assembly (GO:0034063),0.18,6.61E-08,5.18E+02,0.10,1.74E-08,4.29E+02
"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.18,3.15E-05,2.13E+02,0.10,1.23E-05,1.75E+02
purine ribonucleoside monophosphate metabolic process (GO:0009167),0.18,3.67E-03,8.49E+01,0.10,7.64E-03,4.94E+01
mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.18,9.23E-03,2.95E+01,0.10,1.26E-03,2.47E+01
endoplasmic reticulum to cytosol transport (GO:1903513),0.18,1.38E-05,3.44E+02,0.10,6.13E-05,1.62E+02
regulation of focal adhesion assembly (GO:0051893),0.18,4.71E-09,1.73E+02,0.10,3.66E-07,9.25E+01
protein targeting to lysosome (GO:0006622),0.18,2.67E-06,2.70E+02,0.10,8.34E-06,1.91E+02
early endosome to Golgi transport (GO:0034498),0.18,1.97E-02,7.84E+01,0.10,1.29E-02,7.81E+01
positive regulation of mRNA processing (GO:0050685),0.18,5.93E-08,4.44E+02,0.10,1.49E-08,3.67E+02
pore complex assembly (GO:0046931),0.18,4.41E-04,1.37E+02,0.10,1.09E-03,5.96E+01
positive regulation of intracellular protein transport (GO:0090316),0.18,1.30E-06,6.04E+01,0.10,4.13E-07,5.02E+01
positive regulation of DNA metabolic process (GO:0051054),0.18,6.38E-04,4.41E+01,0.10,1.37E-02,2.20E+01
positive regulation of organelle organization (GO:0010638),0.15,3.21E-02,2.27E+01,0.15,4.49E-02,2.23E+02
PERK-mediated unfolded protein response (GO:0036499),0.20,1.40E-02,7.31E+03,0.13,2.61E-02,7.21E+02
regulation of actin cytoskeleton reorganization (GO:2000249),0.01,3.24E-02,4.02E+02,0.28,3.83E-02,6.50E+02
negative regulation of protein localization to membrane (GO:1905476),0.19,3.55E-02,4.45E+02,0.08,6.38E-03,2.89E+01
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.12,1.39E-02,1.60E+02,0.00,1.00E+00,0.00E+00
macrophage chemotaxis (GO:0048246),0.07,1.40E-02,3.65E+03,0.08,4.15E-02,9.12E+02
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.17,4.10E-02,3.18E+02,0.10,4.10E-02,3.18E+02
positive regulation of B cell activation (GO:0050871),0.06,4.12E-02,3.18E+02,0.15,4.12E-02,1.31E+02
positive regulation of T cell differentiation in thymus (GO:0033089),0.00,1.00E+00,0.00E+00,0.26,3.06E-02,1.28E+02
regulation of Notch signaling pathway (GO:0008593),0.19,4.50E-02,1.44E+02,0.10,1.24E-02,1.53E+01
regulation of proteasomal protein catabolic process (GO:0061136),0.19,3.42E-02,2.49E+02,0.10,2.49E-04,3.79E+01
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.19,2.82E-02,4.20E+02,0.10,4.90E-03,3.50E+01
neuron differentiation (GO:0030182),0.03,7.59E-03,2.09E+02,0.21,1.85E-02,1.47E+01
regulation of calcium ion transport (GO:0051924),0.04,3.47E-02,2.28E+02,0.18,1.56E-02,4.16E+01
metaphase/anaphase transition of cell cycle (GO:0044784),0.18,6.26E-04,1.11E+06,0.08,7.15E-03,1.64E+02
metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.18,6.26E-04,1.11E+06,0.08,7.15E-03,1.64E+02
positive regulation of chromatin binding (GO:0035563),0.04,2.01E-02,1.33E+03,0.03,4.42E-02,1.57E+02
regulation of vasculature development (GO:1901342),0.05,4.60E-03,2.64E+03,0.08,4.78E-02,7.29E+01
cellular response to fibroblast growth factor stimulus (GO:0044344),0.21,2.60E-02,2.92E+02,0.10,3.72E-03,1.79E+01
beta-catenin-TCF complex assembly (GO:1904837),0.16,2.93E-02,2.57E+01,0.18,1.56E-02,1.22E+03
iron ion homeostasis (GO:0055072),0.21,1.66E-02,2.66E+02,0.08,9.64E-03,2.03E+01
regulation of kinase activity (GO:0043549),0.05,3.00E-02,1.53E+02,0.28,4.68E-02,1.01E+02
"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.16,1.97E-02,4.67E+01,0.10,3.36E-02,6.13E+01
"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.16,1.97E-02,4.67E+01,0.10,3.36E-02,6.13E+01
protein localization to cell periphery (GO:1990778),0.18,6.26E-04,2.94E+01,0.10,6.57E-04,2.94E+01
negative regulation of protein modification process (GO:0031400),0.18,5.28E-06,7.56E+01,0.10,2.11E-06,7.56E+01
formation of translation preinitiation complex (GO:0001731),0.18,5.24E-05,6.79E+02,0.10,2.68E-05,5.68E+02
regulation of spindle assembly (GO:0090169),0.18,6.30E-04,6.55E+01,0.10,3.80E-02,3.52E+01
ribonucleoside monophosphate biosynthetic process (GO:0009156),0.18,1.29E-02,1.03E+02,0.10,8.00E-03,4.29E+01
cytoplasmic translational initiation (GO:0002183),0.18,8.91E-07,5.36E+02,0.10,2.96E-07,3.25E+02
"posttranslational protein targeting to membrane, translocation (GO:0031204)",0.18,2.79E-03,2.90E+02,0.10,1.91E-03,2.42E+02
protein localization to cytoplasmic stress granule (GO:1903608),0.18,2.79E-03,2.90E+02,0.10,1.91E-03,2.42E+02
cellular response to light stimulus (GO:0071482),0.18,1.58E-03,3.32E+01,0.10,2.48E-03,2.55E+01
dicarboxylic acid metabolic process (GO:0043648),0.18,2.30E-02,2.72E+01,0.10,1.99E-02,1.35E+01
positive regulation by host of viral process (GO:0044794),0.18,1.83E-03,1.40E+02,0.10,1.07E-03,1.16E+02
nucleic acid metabolic process (GO:0090304),0.18,2.57E-10,2.05E+02,0.10,2.04E-09,1.57E+02
nucleosome disassembly (GO:0006337),0.18,1.25E-03,9.01E+01,0.10,3.14E-03,7.32E+01
chromatin disassembly (GO:0031498),0.18,1.25E-03,9.01E+01,0.10,3.14E-03,7.32E+01
tricarboxylic acid metabolic process (GO:0072350),0.18,1.97E-02,8.62E+01,0.10,2.46E-03,7.81E+01
ribosome assembly (GO:0042255),0.18,2.97E-07,2.03E+02,0.10,4.40E-06,1.23E+02
regulation of ribonucleoprotein complex localization (GO:2000197),0.18,6.26E-04,1.10E+06,0.10,7.15E-03,1.03E+06
protein-DNA complex disassembly (GO:0032986),0.18,1.53E-04,1.34E+02,0.10,3.89E-04,1.09E+02
regulation of mRNA export from nucleus (GO:0010793),0.18,6.26E-04,1.10E+06,0.10,7.15E-03,1.03E+06
leukocyte adhesion to vascular endothelial cell (GO:0061756),0.05,3.42E-02,6.61E+02,0.23,3.42E-02,6.61E+02
mitotic DNA replication (GO:1902969),0.12,6.44E-05,4.70E+03,0.05,6.44E-05,4.70E+03
metallo-sulfur cluster assembly (GO:0031163),0.04,6.22E-03,4.74E+02,0.08,6.22E-03,4.74E+02
regulation of immunoglobulin production (GO:0002637),0.06,1.01E-03,2.52E+03,0.23,1.01E-03,8.28E+02
regulation of neurogenesis (GO:0050767),0.13,3.83E-02,2.09E+02,0.05,4.88E-02,1.47E+02
membrane protein intracellular domain proteolysis (GO:0031293),0.19,1.04E-04,1.31E+02,0.08,4.90E-03,3.92E+01
negative regulation of mitotic cell cycle (GO:0045930),0.12,3.42E-02,1.17E+02,0.00,1.00E+00,0.00E+00
parallel actin filament bundle assembly (GO:0030046),0.06,4.81E-02,3.34E+03,0.41,4.81E-02,9.93E+02
negative regulation of protein metabolic process (GO:0051248),0.19,4.32E-02,2.17E+02,0.10,7.54E-03,2.36E+01
response to ketone (GO:1901654),0.07,3.30E-02,2.56E+02,0.15,8.41E-03,2.56E+02
response to exogenous dsRNA (GO:0043330),0.08,9.27E-03,1.54E+03,0.08,9.27E-03,1.54E+03
regulation of regulated secretory pathway (GO:1903305),0.01,4.70E-02,1.86E+02,0.31,3.59E-02,2.32E+02
negative regulation of protein dephosphorylation (GO:0035308),0.18,1.04E-04,1.20E+02,0.13,4.83E-02,2.79E+02
regulation by virus of viral protein levels in host cell (GO:0046719),0.17,4.69E-02,6.58E+02,0.08,1.69E-02,6.95E+01
plasma membrane bounded cell projection assembly (GO:0120031),0.05,5.80E-04,3.52E+01,0.00,1.00E+00,0.00E+00
extracellular matrix disassembly (GO:0022617),0.10,4.47E-03,7.08E+02,0.21,4.28E-02,2.51E+02
cellular divalent inorganic cation homeostasis (GO:0072503),0.07,4.84E-02,2.02E+02,0.23,3.34E-02,1.68E+01
toll-like receptor signaling pathway (GO:0002224),0.10,4.30E-05,2.99E+03,0.00,1.00E+00,0.00E+00
positive regulation of macrophage differentiation (GO:0045651),0.13,1.83E-03,1.29E+02,0.05,3.33E-02,2.85E+01
positive regulation of calcium ion transport (GO:0051928),0.08,1.76E-02,9.07E+02,0.28,4.30E-02,2.46E+02
endothelium development (GO:0003158),0.04,3.87E-02,1.16E+03,0.26,3.42E-02,6.19E+01
regulation of acute inflammatory response (GO:0002673),0.02,3.22E-02,8.70E+02,0.26,4.39E-02,4.55E+01
regulation of calcidiol 1-monooxygenase activity (GO:0060558),0.08,3.31E-02,3.34E+03,0.03,3.37E-02,2.40E+02
regulation of cellular protein localization (GO:1903827),0.19,1.81E-02,6.93E+02,0.13,4.43E-02,2.15E+02
transcription preinitiation complex assembly (GO:0070897),0.05,2.41E-03,1.25E+02,0.05,2.51E-02,3.10E+01
regulation of cell division (GO:0051302),0.20,4.47E-02,1.61E+02,0.08,1.89E-02,1.60E+01
SA node cell action potential (GO:0086015),0.04,2.80E-02,1.85E+03,0.36,2.59E-02,1.85E+03
negative regulation of innate immune response (GO:0045824),0.01,3.45E-03,1.71E+03,0.03,3.45E-03,1.71E+03
positive regulation of mitotic sister chromatid separation (GO:1901970),0.19,3.88E-03,9.19E+01,0.10,1.29E-02,4.12E+01
positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.19,3.88E-03,9.19E+01,0.10,1.29E-02,4.12E+01
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.19,3.88E-03,9.19E+01,0.10,1.29E-02,4.12E+01
COPI-coated vesicle budding (GO:0035964),0.17,9.62E-03,1.07E+06,0.10,4.08E-04,1.03E+06
Golgi transport vesicle coating (GO:0048200),0.17,9.62E-03,1.07E+06,0.10,4.08E-04,1.03E+06
vesicle transport along microtubule (GO:0047496),0.17,2.16E-02,1.17E+03,0.10,1.91E-03,4.81E+01
COPI coating of Golgi vesicle (GO:0048205),0.17,9.62E-03,1.07E+06,0.10,4.08E-04,1.03E+06
response to amino acid starvation (GO:1990928),0.21,3.22E-02,1.14E+02,0.10,5.35E-04,3.16E+01
positive regulation of apoptotic signaling pathway (GO:2001235),0.11,1.25E-02,1.57E+03,0.08,1.25E-02,8.13E+02
DNA replication-independent nucleosome assembly (GO:0006336),0.12,7.02E-03,2.24E+02,0.00,1.00E+00,0.00E+00
regulation of defense response (GO:0031347),0.04,4.35E-02,1.44E+02,0.05,4.35E-02,1.19E+02
cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),0.01,9.55E-04,6.27E+03,0.08,6.63E-03,3.62E+02
regulation of actin filament polymerization (GO:0030833),0.10,3.86E-02,1.70E+02,0.18,3.86E-02,6.64E+01
blood vessel endothelial cell migration (GO:0043534),0.10,2.54E-02,3.54E+02,0.18,3.25E-02,1.63E+03
positive regulation of microglial cell migration (GO:1904141),0.07,3.25E-02,4.11E+03,0.13,3.31E-02,2.04E+03
nucleus localization (GO:0051647),0.05,3.62E-02,5.06E+02,0.13,3.62E-02,5.06E+02
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.18,1.81E-02,3.28E+02,0.00,1.00E+00,0.00E+00
positive regulation of peptidase activity (GO:0010952),0.12,4.09E-02,5.49E+02,0.26,4.15E-02,9.56E+02
positive regulation of homotypic cell-cell adhesion (GO:0034112),0.07,4.19E-02,2.80E+03,0.08,3.84E-02,8.29E+02
negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.04,1.43E-02,9.93E+02,0.23,3.04E-02,4.18E+01
heart process (GO:0003015),0.02,2.00E-02,1.14E+03,0.28,2.00E-02,1.14E+03
DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.05,7.68E-03,1.95E+02,0.00,1.00E+00,0.00E+00
interleukin-6-mediated signaling pathway (GO:0070102),0.16,3.01E-02,8.29E+02,0.08,1.23E-02,2.95E+01
"complement activation, alternative pathway (GO:0006957)",0.08,2.60E-02,3.34E+03,0.08,4.27E-02,2.37E+02
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.17,3.45E-06,7.97E+01,0.15,4.85E-02,1.41E+02
"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.14,3.37E-02,2.30E+02,0.00,1.00E+00,0.00E+00
dosage compensation by inactivation of X chromosome (GO:0009048),0.19,1.97E-02,1.73E+02,0.08,1.29E-02,6.09E+01
rRNA catabolic process (GO:0016075),0.06,2.27E-02,8.09E+02,0.08,4.53E-03,8.09E+02
positive regulation of autophagy of mitochondrion (GO:1903599),0.17,4.07E-02,8.27E+02,0.15,4.07E-02,8.27E+02
midbody abscission (GO:0061952),0.18,3.34E-03,8.88E+01,0.08,2.86E-02,2.75E+01
membrane fission (GO:0090148),0.16,2.30E-02,1.14E+06,0.10,1.69E-02,6.95E+01
regulation of fibroblast proliferation (GO:0048145),0.02,2.82E-02,3.80E+02,0.15,5.13E-04,6.93E+02
positive regulation of ATPase activity (GO:0032781),0.18,1.67E-06,1.30E+02,0.10,7.85E-06,7.69E+01
activation of protein kinase activity (GO:0032147),0.18,5.27E-03,2.07E+01,0.10,1.09E-03,2.07E+01
regulation of stress fiber assembly (GO:0051492),0.18,2.51E-02,2.08E+02,0.10,6.31E-06,6.23E+01
positive regulation of vacuole organization (GO:0044090),0.18,1.12E-02,1.29E+02,0.10,7.29E-03,5.74E+01
mitotic nuclear membrane disassembly (GO:0007077),0.10,4.00E-03,8.16E+02,0.05,4.07E-02,6.11E+02
mitotic cytokinetic process (GO:1902410),0.19,8.27E-04,8.26E+01,0.08,7.64E-03,3.75E+01
cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.00,1.00E+00,0.00E+00,0.26,1.53E-02,2.94E+02
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.00,1.00E+00,0.00E+00,0.26,3.34E-02,2.02E+01
protein insertion into membrane (GO:0051205),0.22,4.40E-02,5.23E+02,0.08,2.24E-02,1.63E+01
protein targeting to mitochondrion (GO:0006626),0.19,1.20E-03,4.66E+01,0.10,1.37E-02,3.77E+01
regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),0.00,2.00E-02,2.80E+03,0.26,2.00E-02,2.80E+03
regulation of T cell cytokine production (GO:0002724),0.04,1.03E-02,5.41E+02,0.08,1.03E-02,5.41E+02
positive regulation of memory T cell differentiation (GO:0043382),0.13,9.10E-03,2.96E+03,0.00,1.00E+00,0.00E+00
piecemeal microautophagy of the nucleus (GO:0034727),0.07,1.04E-02,9.54E+02,0.08,1.04E-02,9.54E+02
lysosomal microautophagy (GO:0016237),0.07,1.04E-02,9.54E+02,0.08,1.04E-02,9.54E+02
regulation of cell differentiation (GO:0045595),0.16,1.81E-02,1.86E+01,0.13,3.89E-02,1.48E+02
negative regulation of translational initiation (GO:0045947),0.15,4.65E-02,1.17E+02,0.10,8.00E-03,5.80E+01
positive regulation of leukocyte migration (GO:0002687),0.09,1.30E-02,5.46E+02,0.00,1.00E+00,0.00E+00
negative regulation of proteasomal protein catabolic process (GO:1901799),0.19,2.88E-02,3.89E+02,0.08,1.14E-03,3.49E+01
phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.08,3.13E-02,3.25E+02,0.08,3.83E-02,2.11E+02
purine nucleoside monophosphate biosynthetic process (GO:0009127),0.17,1.97E-02,6.13E+01,0.10,1.29E-02,4.12E+01
positive regulation of mRNA metabolic process (GO:1903313),0.17,1.33E-03,3.09E+02,0.10,7.27E-04,3.09E+02
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.17,2.91E-05,8.72E+01,0.10,1.47E-04,5.43E+01
negative regulation of supramolecular fiber organization (GO:1902904),0.17,1.12E-02,2.70E+01,0.10,3.78E-03,2.70E+01
receptor catabolic process (GO:0032801),0.17,2.47E-03,6.53E+01,0.10,4.53E-03,6.53E+01
tRNA methylation (GO:0030488),0.04,1.90E-02,2.88E+01,0.00,1.00E+00,0.00E+00
phosphatidylinositol dephosphorylation (GO:0046856),0.04,1.06E-02,5.77E+01,0.00,1.00E+00,0.00E+00
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.19,4.64E-02,5.33E+02,0.15,4.40E-02,5.51E+01
regulation of rRNA processing (GO:2000232),0.10,4.96E-02,1.56E+02,0.05,2.41E-02,3.43E+01
termination of RNA polymerase I transcription (GO:0006363),0.04,5.98E-03,5.61E+01,0.05,2.51E-02,1.78E+01
maintenance of protein localization in organelle (GO:0072595),0.12,3.31E-02,2.10E+02,0.13,3.31E-02,2.10E+02
protein retention in Golgi apparatus (GO:0045053),0.17,3.05E-02,7.54E+05,0.10,2.42E-02,6.49E+05
regulation of Rho protein signal transduction (GO:0035023),0.17,1.34E-02,2.16E+01,0.15,3.19E-02,6.15E+02
positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.10,3.72E-02,4.85E+03,0.05,3.68E-02,1.55E+03
regulation of mitotic spindle organization (GO:0060236),0.20,2.33E-02,1.81E+02,0.08,2.82E-02,2.71E+01
amino sugar metabolic process (GO:0006040),0.14,3.70E-02,2.09E+03,0.08,2.61E-02,8.31E+02
positive regulation by symbiont of entry into host (GO:0075294),0.12,4.99E-02,2.58E+03,0.08,3.86E-02,9.44E+01
positive regulation of viral entry into host cell (GO:0046598),0.12,4.99E-02,2.58E+03,0.08,3.86E-02,9.44E+01
GTP metabolic process (GO:0046039),0.17,2.05E-02,5.56E+01,0.10,1.29E-02,4.39E+01
positive regulation of nucleobase-containing compound transport (GO:0032241),0.17,3.05E-02,1.23E+02,0.10,2.42E-02,1.02E+02
positive regulation of RNA export from nucleus (GO:0046833),0.17,3.05E-02,1.23E+02,0.10,2.42E-02,1.02E+02
RNA localization to Cajal body (GO:0090670),0.17,3.05E-02,1.23E+02,0.10,2.42E-02,1.02E+02
scaRNA localization to Cajal body (GO:0090666),0.17,3.05E-02,1.23E+02,0.10,2.42E-02,1.02E+02
hemopoiesis (GO:0030097),0.09,3.38E-02,1.69E+02,0.13,4.68E-02,9.04E+01
regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.02,4.42E-02,5.14E+03,0.15,3.88E-02,4.10E+02
negative regulation of DNA-dependent DNA replication (GO:2000104),0.05,3.69E-02,7.05E+02,0.08,9.48E-03,1.70E+02
cardiac conduction system development (GO:0003161),0.06,4.52E-02,4.06E+02,0.26,3.25E-02,3.57E+02
regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.18,1.01E-02,5.36E+02,0.08,2.04E-02,4.00E+01
DNA strand elongation involved in DNA replication (GO:0006271),0.13,5.82E-03,7.15E+02,0.05,5.82E-03,7.15E+02
regulation of cell death (GO:0010941),0.15,4.65E-02,1.10E+02,0.15,2.01E-02,2.56E+02
monoubiquitinated protein deubiquitination (GO:0035520),0.05,4.14E-02,1.24E+03,0.08,4.14E-02,1.24E+03
regulation of activated T cell proliferation (GO:0046006),0.08,2.26E-02,5.55E+02,0.08,2.26E-02,2.43E+02
positive regulation of stress-activated MAPK cascade (GO:0032874),0.04,4.76E-02,1.14E+02,0.03,1.59E-02,4.80E+01
organic acid transport (GO:0015849),0.02,2.98E-02,3.19E+01,0.23,9.46E-03,1.43E+02
regulation of protein localization (GO:0032880),0.14,1.72E-02,3.20E+01,0.10,9.53E-04,3.20E+01
regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.14,4.35E-02,1.79E+02,0.10,5.50E-03,2.60E+01
post-transcriptional gene silencing by RNA (GO:0035194),0.08,4.89E-02,2.35E+02,0.15,4.09E-02,4.75E+02
regulation of cellular biosynthetic process (GO:0031326),0.10,2.84E-02,4.83E+02,0.08,2.68E-02,1.12E+02
regulation of T cell migration (GO:2000404),0.09,1.98E-02,8.70E+02,0.23,1.98E-02,7.48E+02
regulation of viral transcription (GO:0046782),0.13,7.34E-03,4.36E+01,0.10,1.94E-02,4.36E+01
mismatch repair (GO:0006298),0.12,5.86E-03,3.44E+02,0.00,1.00E+00,0.00E+00
regulation of response to cytokine stimulus (GO:0060759),0.04,4.40E-05,6.10E+03,0.05,4.40E-03,1.88E+02
positive regulation of Notch signaling pathway (GO:0045747),0.19,3.58E-02,3.14E+02,0.10,3.49E-03,2.85E+01
positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.04,1.24E-02,1.54E+03,0.05,3.68E-02,8.92E+02
positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.10,1.17E-02,2.55E+02,0.05,4.61E-02,1.80E+02
mitotic G2/M transition checkpoint (GO:0044818),0.14,1.19E-04,6.63E+02,0.05,4.69E-02,1.95E+02
regulation of IRE1-mediated unfolded protein response (GO:1903894),0.15,1.29E-02,5.83E+01,0.10,8.00E-03,5.80E+01
detection of virus (GO:0009597),0.01,4.78E-04,1.38E+04,0.03,3.81E-02,2.86E+02
regulation of interferon-alpha production (GO:0032647),0.02,1.73E-03,1.82E+03,0.03,4.36E-02,7.38E+01
positive regulation of calcium ion transmembrane transport (GO:1904427),0.03,3.23E-02,5.97E+02,0.08,2.12E-02,3.08E+01
negative regulation of neurogenesis (GO:0050768),0.10,1.59E-02,4.31E+02,0.05,1.62E-02,6.96E+02
nucleobase biosynthetic process (GO:0046112),0.19,4.04E-02,1.45E+06,0.10,1.91E-03,2.42E+02
regulation of retinoic acid receptor signaling pathway (GO:0048385),0.19,3.43E-02,6.02E+02,0.05,3.18E-02,2.41E+01
cellular response to amino acid starvation (GO:0034198),0.20,3.22E-02,1.16E+02,0.10,1.05E-03,2.85E+01
cellular response to arsenic-containing substance (GO:0071243),0.16,2.05E-02,8.58E+01,0.10,1.29E-02,3.36E+01
N-terminal protein amino acid acetylation (GO:0006474),0.17,3.05E-02,5.70E+01,0.10,1.96E-02,3.43E+01
cellular response to epidermal growth factor stimulus (GO:0071364),0.16,3.25E-05,9.44E+01,0.15,3.39E-02,4.05E+02
peptide transport (GO:0015833),0.05,1.89E-02,1.07E+03,0.08,1.89E-02,1.07E+03
positive regulation of natural killer cell activation (GO:0032816),0.05,4.38E-02,6.85E+02,0.08,4.38E-02,3.20E+02
response to reactive oxygen species (GO:0000302),0.19,4.13E-02,2.23E+02,0.08,2.81E-03,2.27E+01
platelet degranulation (GO:0002576),0.08,3.27E-02,3.19E+02,0.18,8.53E-04,4.68E+01
regulation of mitochondrial membrane potential (GO:0051881),0.15,3.89E-02,1.90E+02,0.10,1.94E-02,1.56E+01
proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.19,3.08E-02,2.81E+02,0.15,3.08E-02,2.81E+02
neuron fate commitment (GO:0048663),0.02,4.00E-02,1.36E+03,0.23,4.00E-02,4.61E+02
regulation of microtubule polymerization (GO:0031113),0.15,4.66E-02,1.74E+02,0.10,6.38E-03,2.73E+01
nuclear membrane disassembly (GO:0051081),0.15,5.12E-03,6.53E+02,0.10,4.11E-02,5.01E+02
caveolin-mediated endocytosis (GO:0072584),0.15,3.05E-02,1.23E+02,0.10,2.42E-02,1.02E+02
U4 snRNA 3'-end processing (GO:0034475),0.04,1.65E-02,1.02E+03,0.08,1.65E-02,1.02E+03
negative regulation of leukocyte migration (GO:0002686),0.06,2.07E-02,1.03E+03,0.15,3.68E-02,5.63E+01
regulation of cytoskeleton organization (GO:0051493),0.17,1.64E-03,6.95E+02,0.10,1.11E-02,1.68E+01
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.17,7.45E-05,6.05E+01,0.10,2.06E-04,4.13E+01
macromolecule catabolic process (GO:0009057),0.12,1.70E-02,2.87E+01,0.10,3.20E-02,2.33E+01
xenobiotic transport (GO:0042908),0.07,5.83E-03,5.38E+02,0.21,3.13E-02,5.38E+02
regulation of release of cytochrome c from mitochondria (GO:0090199),0.15,3.89E-02,1.90E+02,0.08,4.32E-02,1.16E+01
regulation of memory T cell differentiation (GO:0043380),0.12,1.04E-02,2.58E+03,0.00,1.00E+00,0.00E+00
positive regulation of nitric oxide metabolic process (GO:1904407),0.09,3.26E-02,5.71E+02,0.00,1.00E+00,0.00E+00
negative regulation of T cell differentiation (GO:0045581),0.09,7.55E-03,5.24E+03,0.08,7.55E-03,4.74E+03
regulation of potassium ion transport (GO:0043266),0.02,3.62E-02,3.56E+02,0.18,1.86E-02,3.08E+01
regulation of cellular component organization (GO:0051128),0.19,3.01E-02,3.21E+02,0.10,7.08E-03,1.77E+01
positive regulation of viral life cycle (GO:1903902),0.11,3.16E-02,8.57E+02,0.03,3.52E-02,1.76E+01
positive regulation of histone methylation (GO:0031062),0.19,1.22E-02,6.39E+01,0.08,1.85E-02,2.13E+01
mitophagy (GO:0000423),0.17,7.64E-03,1.25E+02,0.10,3.24E-02,1.04E+02
cellular protein catabolic process (GO:0044257),0.17,1.83E-03,6.35E+01,0.10,1.37E-03,3.88E+01
negative regulation by symbiont of host apoptotic process (GO:0033668),0.17,7.64E-03,3.36E+02,0.10,5.34E-03,1.04E+02
protein localization to endosome (GO:0036010),0.17,2.93E-02,8.60E+01,0.10,2.04E-02,6.72E+01
regulation of microglial cell migration (GO:1904139),0.07,3.25E-02,3.34E+03,0.13,3.31E-02,1.66E+03
endoplasmic reticulum mannose trimming (GO:1904380),0.18,2.23E-03,1.37E+02,0.08,5.09E-03,3.89E+01
regulation of endopeptidase activity (GO:0052548),0.08,1.89E-02,6.38E+02,0.13,1.19E-02,6.38E+02
amide transport (GO:0042886),0.03,4.49E-02,2.75E+02,0.23,1.98E-02,7.83E+02
lymph node development (GO:0048535),0.11,5.41E-03,4.20E+03,0.15,1.19E-02,1.59E+03
regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.14,9.62E-03,1.80E+02,0.10,7.15E-03,1.64E+02
calcium ion transmembrane import into cytosol (GO:0097553),0.07,2.01E-02,3.77E+02,0.21,1.78E-02,5.55E+02
negative regulation of ossification (GO:0030279),0.04,4.52E-02,4.27E+02,0.26,3.25E-02,1.55E+03
regulation of chromosome segregation (GO:0051983),0.16,7.37E-03,4.58E+02,0.03,4.77E-02,1.82E+01
positive regulation of nitric oxide biosynthetic process (GO:0045429),0.08,3.11E-02,5.97E+02,0.00,1.00E+00,0.00E+00
ribonucleoprotein complex disassembly (GO:0032988),0.14,2.98E-02,1.01E+03,0.15,2.98E-02,1.01E+03
primary miRNA processing (GO:0031053),0.18,5.59E-03,1.95E+02,0.10,3.72E-03,1.95E+02
synaptic vesicle membrane organization (GO:0048499),0.04,4.25E-02,2.67E+02,0.08,4.25E-02,2.67E+02
mitotic cell cycle checkpoint signaling (GO:0007093),0.12,1.13E-02,3.25E+02,0.00,1.00E+00,0.00E+00
positive regulation of DNA replication (GO:0045740),0.13,3.42E-02,7.61E+02,0.05,3.42E-02,7.61E+02
low-density lipoprotein particle remodeling (GO:0034374),0.00,1.00E+00,0.00E+00,0.26,3.31E-02,4.74E+01
DNA strand elongation (GO:0022616),0.10,5.82E-03,7.15E+02,0.10,1.45E-02,1.59E+03
regulation of telomere capping (GO:1904353),0.17,1.29E-02,7.83E+01,0.05,8.39E-03,3.03E+01
regulation of T cell apoptotic process (GO:0070232),0.06,2.60E-02,1.85E+03,0.00,1.00E+00,0.00E+00
response to amyloid-beta (GO:1904645),0.07,3.23E-02,3.23E+02,0.15,3.23E-02,1.70E+02
basement membrane organization (GO:0071711),0.12,4.78E-02,6.31E+02,0.15,2.32E-02,1.42E+03
regulation of apoptotic signaling pathway (GO:2001233),0.11,9.27E-03,1.39E+03,0.08,9.27E-03,1.39E+03
regulation of hyaluronan biosynthetic process (GO:1900125),0.03,3.07E-02,2.58E+03,0.10,3.07E-02,2.58E+03
negative regulation of interleukin-2 production (GO:0032703),0.05,3.42E-02,5.49E+02,0.08,3.42E-02,4.41E+02
positive regulation of T cell cytokine production (GO:0002726),0.06,1.04E-02,1.82E+03,0.03,2.79E-02,1.09E+02
mitotic chromosome condensation (GO:0007076),0.18,4.34E-05,1.38E+03,0.05,1.10E-02,4.10E+02
DNA topological change (GO:0006265),0.16,2.03E-04,4.89E+02,0.08,1.13E-02,6.05E+01
endothelial cell migration (GO:0043542),0.13,2.30E-02,3.20E+02,0.23,4.94E-02,2.30E+02
positive regulation of DNA repair (GO:0045739),0.12,4.69E-02,1.79E+02,0.08,4.69E-02,1.79E+02
cellular response to nutrient levels (GO:0031669),0.18,7.32E-03,3.87E+01,0.08,1.15E-02,1.54E+01
positive regulation of cell-substrate junction organization (GO:0150117),0.18,1.18E-05,1.47E+02,0.08,7.02E-04,5.41E+01
transforming growth factor beta receptor signaling pathway (GO:0007179),0.18,1.86E-03,3.63E+01,0.08,4.08E-04,2.73E+01
regulation of protein export from nucleus (GO:0046825),0.18,2.30E-02,7.30E+02,0.08,1.91E-03,4.38E+01
positive regulation of cell death (GO:0010942),0.05,3.51E-02,1.35E+02,0.10,3.51E-02,4.43E+02
plasma membrane bounded cell projection organization (GO:0120036),0.12,4.11E-02,1.35E+02,0.10,5.21E-03,1.79E+01
positive regulation of protein acetylation (GO:1901985),0.06,2.99E-02,5.11E+02,0.10,2.99E-02,5.11E+02
endothelial cell differentiation (GO:0045446),0.01,3.48E-02,7.48E+02,0.26,3.31E-02,4.74E+01
cell junction organization (GO:0034330),0.18,3.86E-02,6.77E+01,0.15,3.86E-02,6.77E+01
response to peptide hormone (GO:0043434),0.19,3.14E-02,2.17E+02,0.08,7.54E-03,2.36E+01
cellular component disassembly (GO:0022411),0.10,4.47E-03,7.08E+02,0.21,4.28E-02,2.51E+02
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.19,1.76E-02,9.07E+02,0.05,4.32E-02,1.20E+01
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.17,3.05E-02,3.40E+02,0.10,4.30E-04,5.66E+01
establishment of epithelial cell polarity (GO:0090162),0.17,3.02E-02,2.97E+02,0.10,1.91E-03,4.90E+01
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.17,3.41E-02,2.41E+02,0.10,9.10E-04,3.95E+01
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.17,3.05E-02,3.40E+02,0.10,4.30E-04,5.66E+01
regulation of vitamin D biosynthetic process (GO:0060556),0.02,3.54E-02,2.96E+03,0.08,3.35E-02,2.96E+03
histone mRNA metabolic process (GO:0008334),0.15,2.23E-02,4.37E+01,0.08,3.86E-02,1.64E+01
positive regulation of superoxide anion generation (GO:0032930),0.08,2.85E-02,2.19E+02,0.05,2.88E-02,2.19E+02
regulation of superoxide anion generation (GO:0032928),0.08,3.34E-02,1.98E+02,0.05,2.97E-02,1.98E+02
positive regulation of response to cytokine stimulus (GO:0060760),0.03,2.08E-02,3.57E+03,0.08,1.67E-02,1.80E+02
positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.12,3.05E-02,5.07E+01,0.10,2.06E-02,5.66E+01
mRNA transcription (GO:0009299),0.17,4.29E-02,8.15E+02,0.08,2.46E-03,7.81E+01
glutathione derivative biosynthetic process (GO:1901687),0.05,4.99E-02,4.41E+02,0.13,4.99E-02,4.41E+02
glutathione derivative metabolic process (GO:1901685),0.05,4.99E-02,4.41E+02,0.13,4.99E-02,4.41E+02
regulation of macrophage derived foam cell differentiation (GO:0010743),0.03,3.54E-02,1.95E+02,0.08,4.46E-02,2.71E+02
excitatory postsynaptic potential (GO:0060079),0.01,4.66E-02,8.45E+02,0.28,1.45E-02,1.48E+03
regulation of autophagy of mitochondrion (GO:1903146),0.14,2.93E-02,3.90E+01,0.10,1.78E-02,2.48E+01
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.14,2.93E-02,1.54E+02,0.10,3.72E-03,1.54E+02
cytoplasmic microtubule organization (GO:0031122),0.14,2.12E-02,2.44E+01,0.10,5.09E-03,2.04E+01
cognition (GO:0050890),0.10,2.71E-02,3.60E+02,0.15,4.13E-02,1.74E+02
apoptotic nuclear changes (GO:0030262),0.11,4.75E-02,2.85E+01,0.10,2.90E-02,3.80E+01
protein heterotetramerization (GO:0051290),0.09,2.47E-02,3.66E+02,0.08,2.47E-02,3.66E+02
actin filament capping (GO:0051693),0.17,2.55E-02,6.61E+02,0.15,3.42E-02,4.52E+02
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.17,4.55E-02,6.30E+02,0.15,3.42E-02,4.84E+02
barbed-end actin filament capping (GO:0051016),0.17,2.55E-02,6.61E+02,0.15,3.42E-02,4.52E+02
negative regulation of cell migration (GO:0030336),0.12,4.40E-02,5.02E+02,0.10,4.81E-03,3.32E+01
mitochondrial genome maintenance (GO:0000002),0.19,4.83E-02,3.18E+02,0.05,1.29E-02,4.09E+01
negative regulation of histone H3-K9 methylation (GO:0051573),0.12,4.71E-02,1.97E+02,0.00,1.00E+00,0.00E+00
MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.03,4.09E-02,3.87E+02,0.13,4.75E-02,3.87E+02
nucleotide biosynthetic process (GO:0009165),0.18,1.25E-03,9.01E+01,0.05,3.98E-02,1.82E+01
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.13,3.01E-02,8.29E+02,0.13,1.45E-02,1.59E+03
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.17,2.26E-02,2.40E+01,0.08,8.25E-04,2.06E+01
negative regulation of autophagosome assembly (GO:1902902),0.16,3.05E-02,7.03E+01,0.10,4.78E-03,5.66E+01
attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.10,2.59E-02,1.78E+02,0.00,1.00E+00,0.00E+00
cell morphogenesis involved in neuron differentiation (GO:0048667),0.00,1.00E+00,0.00E+00,0.18,1.53E-02,2.10E+01
calcium ion homeostasis (GO:0055074),0.11,3.14E-02,2.73E+02,0.08,4.81E-02,4.83E+01
ribosomal large subunit export from nucleus (GO:0000055),0.18,2.79E-03,1.40E+06,0.10,1.69E-02,1.27E+06
fibroblast growth factor receptor signaling pathway (GO:0008543),0.18,9.62E-03,1.96E+01,0.10,1.30E-02,1.68E+01
positive regulation by host of viral genome replication (GO:0044829),0.18,2.50E-03,7.70E+05,0.10,1.85E-03,7.14E+05
regulation of cell growth (GO:0001558),0.18,4.47E-03,2.93E+02,0.08,3.89E-02,1.33E+01
"protein alpha-1,2-demannosylation (GO:0036508)",0.18,5.73E-03,1.06E+02,0.08,2.99E-03,3.77E+01
regulation of lamellipodium assembly (GO:0010591),0.17,3.22E-02,4.47E+02,0.15,4.66E-02,2.74E+02
regulation of sister chromatid cohesion (GO:0007063),0.12,2.59E-02,8.71E+01,0.03,1.03E-02,3.65E+03
positive regulation of RIG-I signaling pathway (GO:1900246),0.02,9.40E-03,2.58E+03,0.00,1.00E+00,0.00E+00
regulation of heterotypic cell-cell adhesion (GO:0034114),0.06,2.89E-02,6.58E+02,0.08,4.30E-02,4.06E+02
T cell activation involved in immune response (GO:0002286),0.10,8.39E-03,2.02E+03,0.13,8.39E-03,2.02E+03
establishment of spindle orientation (GO:0051294),0.17,1.26E-02,3.56E+02,0.05,1.26E-02,3.56E+02
regulation of hippo signaling (GO:0035330),0.04,4.90E-02,2.46E+01,0.15,4.09E-02,4.75E+02
negative regulation of cAMP-mediated signaling (GO:0043951),0.01,3.59E-02,9.32E+02,0.28,3.59E-02,9.32E+02
iron-sulfur cluster assembly (GO:0016226),0.05,6.78E-03,4.17E+02,0.08,6.78E-03,4.17E+02
positive regulation of response to stimulus (GO:0048584),0.08,2.43E-02,8.24E+02,0.00,1.00E+00,0.00E+00
dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.03,3.29E-02,4.78E+01,0.00,1.00E+00,0.00E+00
negative regulation of steroid metabolic process (GO:0045939),0.04,3.59E-02,1.50E+03,0.08,3.19E-02,2.40E+03
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.17,2.79E-03,2.90E+02,0.08,1.69E-02,2.42E+02
protein localization to endoplasmic reticulum (GO:0070972),0.17,8.50E-03,7.28E+01,0.08,9.70E-04,7.28E+01
cellular response to transforming growth factor beta stimulus (GO:0071560),0.17,1.44E-03,3.35E+01,0.08,1.09E-03,2.07E+01
regulation of granulocyte chemotaxis (GO:0071622),0.07,3.02E-02,1.94E+03,0.15,4.93E-02,4.75E+02
positive regulation of glial cell proliferation (GO:0060252),0.07,3.80E-03,5.29E+03,0.00,1.00E+00,0.00E+00
regulation of glial cell proliferation (GO:0060251),0.07,7.32E-03,2.40E+03,0.00,1.00E+00,0.00E+00
positive regulation of gliogenesis (GO:0014015),0.07,5.27E-03,3.34E+03,0.00,1.00E+00,0.00E+00
cellular response to cAMP (GO:0071320),0.05,2.40E-02,6.23E+02,0.23,3.40E-02,2.71E+02
response to lipid (GO:0033993),0.02,4.87E-05,2.25E+03,0.08,4.94E-02,9.50E+01
semaphorin-plexin signaling pathway (GO:0071526),0.06,1.05E-02,6.87E+02,0.31,1.59E-02,6.87E+02
kidney development (GO:0001822),0.00,3.98E-02,1.48E+02,0.23,3.98E-02,1.48E+02
positive regulation of actin cytoskeleton reorganization (GO:2000251),0.03,4.62E-02,9.28E+02,0.05,4.79E-02,1.48E+03
positive regulation of T cell apoptotic process (GO:0070234),0.03,2.60E-02,2.09E+03,0.00,1.00E+00,0.00E+00
vesicle cytoskeletal trafficking (GO:0099518),0.11,2.16E-02,6.08E+02,0.10,1.24E-02,1.86E+01
Wnt signaling pathway (GO:0016055),0.15,1.27E-02,1.78E+01,0.15,4.09E-02,3.34E+02
mitotic recombination (GO:0006312),0.06,3.17E-02,5.11E+02,0.08,3.17E-02,5.11E+02
regulation of autophagosome maturation (GO:1901096),0.02,3.72E-02,5.07E+01,0.13,3.70E-02,1.07E+03
neutrophil activation (GO:0042119),0.05,1.69E-02,1.95E+03,0.05,1.58E-02,4.76E+01
P-body assembly (GO:0033962),0.06,1.42E-03,1.79E+03,0.13,1.42E-03,1.79E+03
regulation of nucleocytoplasmic transport (GO:0046822),0.11,8.31E-03,3.30E+03,0.08,2.06E-02,3.10E+01
regulation of protein import into nucleus (GO:0042306),0.10,1.72E-02,1.84E+01,0.10,1.47E-02,1.83E+01
positive regulation of histone modification (GO:0031058),0.12,4.19E-02,2.53E+03,0.05,2.15E-02,1.80E+01
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.08,4.00E-02,5.07E+02,0.15,4.00E-02,5.07E+02
ISG15-protein conjugation (GO:0032020),0.04,2.60E-02,4.11E+03,0.00,1.00E+00,0.00E+00
positive regulation of acute inflammatory response (GO:0002675),0.08,1.48E-02,1.25E+03,0.00,1.00E+00,0.00E+00
regulation of T cell receptor signaling pathway (GO:0050856),0.05,2.26E-02,3.05E+02,0.08,2.26E-02,2.33E+02
"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.04,1.69E-02,7.20E+02,0.08,1.69E-02,7.20E+02
endodermal cell differentiation (GO:0035987),0.10,2.16E-02,7.78E+02,0.23,1.04E-02,3.42E+02
synapse assembly (GO:0007416),0.00,1.00E+00,0.00E+00,0.15,2.44E-03,3.43E+01
positive regulation of apoptotic cell clearance (GO:2000427),0.09,1.31E-02,6.13E+03,0.08,3.31E-02,1.39E+03
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.14,3.18E-02,7.26E+01,0.10,6.05E-04,7.26E+01
actin filament organization (GO:0007015),0.14,3.32E-02,1.54E+02,0.10,6.86E-03,1.50E+01
regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.13,3.54E-02,2.40E+03,0.05,1.69E-02,6.95E+01
regulation of vesicle size (GO:0097494),0.15,2.02E-02,1.14E+06,0.08,1.69E-02,6.95E+01
Rho protein signal transduction (GO:0007266),0.02,2.94E-02,1.20E+01,0.21,4.57E-02,3.12E+02
positive regulation of viral transcription (GO:0050434),0.16,1.22E-02,3.37E+01,0.10,1.85E-02,2.89E+01
cellular response to topologically incorrect protein (GO:0035967),0.14,2.81E-04,5.55E+01,0.08,3.33E-02,3.69E+01
regulation of smooth muscle cell migration (GO:0014910),0.04,2.14E-02,1.39E+03,0.23,2.14E-02,7.26E+02
regulation of animal organ morphogenesis (GO:2000027),0.06,4.99E-02,6.48E+03,0.08,2.30E-02,8.07E+01
positive regulation of podosome assembly (GO:0071803),0.08,5.27E-03,7.30E+03,0.05,3.04E-02,2.40E+03
keratinocyte proliferation (GO:0043616),0.11,6.66E-03,3.34E+03,0.15,1.34E-02,9.93E+02
positive regulation of cell adhesion (GO:0045785),0.04,3.97E-02,1.51E+02,0.05,4.07E-02,2.53E+02
positive regulation of axon extension (GO:0045773),0.01,4.93E-02,2.57E+02,0.10,4.93E-02,2.57E+02
calcitonin family receptor signaling pathway (GO:0097646),0.02,4.83E-02,3.53E+02,0.26,4.83E-02,3.53E+02
regulation of Golgi organization (GO:1903358),0.10,3.22E-02,3.65E+02,0.08,2.86E-02,4.46E+01
establishment of Golgi localization (GO:0051683),0.16,7.64E-03,3.16E+02,0.10,5.34E-03,2.68E+02
histone exchange (GO:0043486),0.12,7.02E-03,2.33E+02,0.00,1.00E+00,0.00E+00
regulation of chondrocyte differentiation (GO:0032330),0.04,3.90E-02,2.72E+02,0.26,3.25E-02,1.40E+03
ribosome localization (GO:0033750),0.14,3.05E-02,1.23E+02,0.08,2.98E-02,1.02E+02
regulation of dephosphorylation (GO:0035303),0.15,2.05E-02,7.48E+01,0.08,1.29E-02,3.34E+01
regulation of cellular senescence (GO:2000772),0.01,4.89E-02,5.78E+01,0.08,1.58E-02,8.09E+02
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.09,8.32E-03,4.26E+01,0.08,4.90E-03,3.92E+01
integrin-mediated signaling pathway (GO:0007229),0.16,9.62E-03,2.01E+01,0.10,3.11E-03,2.01E+01
cell cycle checkpoint signaling (GO:0000075),0.11,4.00E-03,8.16E+02,0.00,1.00E+00,0.00E+00
ER-associated misfolded protein catabolic process (GO:0071712),0.15,4.68E-02,7.03E+01,0.10,7.29E-03,5.74E+01
excitatory chemical synaptic transmission (GO:0098976),0.05,4.04E-02,2.96E+02,0.05,1.45E-02,5.29E+03
negative regulation of receptor-mediated endocytosis (GO:0048261),0.15,3.76E-03,3.67E+01,0.08,1.85E-02,2.13E+01
membrane fusion (GO:0061025),0.07,1.54E-02,9.38E+02,0.08,4.10E-02,1.77E+01
angiogenesis involved in wound healing (GO:0060055),0.03,3.87E-02,9.12E+02,0.13,4.07E-02,9.12E+02
molybdopterin cofactor biosynthetic process (GO:0032324),0.03,1.06E-02,1.31E+03,0.08,1.06E-02,1.31E+03
actin polymerization or depolymerization (GO:0008154),0.10,4.72E-02,1.34E+01,0.13,4.32E-02,1.94E+02
negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.08,2.99E-02,5.11E+02,0.10,2.99E-02,5.11E+02
positive regulation of lamellipodium organization (GO:1902745),0.16,3.22E-02,4.83E+02,0.13,4.66E-02,2.96E+02
positive regulation of lamellipodium assembly (GO:0010592),0.16,3.22E-02,6.92E+02,0.13,4.30E-02,4.27E+02
regulation of nuclease activity (GO:0032069),0.01,8.27E-03,5.05E+03,0.08,1.94E-02,5.05E+03
regulation of ribonuclease activity (GO:0060700),0.01,7.39E-03,6.50E+03,0.08,1.94E-02,6.50E+03
negative regulation of interleukin-1 production (GO:0032692),0.05,2.02E-02,5.23E+02,0.08,2.02E-02,2.88E+02
regulation of protein tyrosine kinase activity (GO:0061097),0.04,2.64E-02,4.18E+02,0.23,1.46E-02,4.18E+02
sensory perception of pain (GO:0019233),0.04,1.57E-02,1.82E+03,0.15,4.67E-02,2.96E+02
kinetochore organization (GO:0051383),0.09,8.91E-04,1.78E+02,0.00,1.00E+00,0.00E+00
preassembly of GPI anchor in ER membrane (GO:0016254),0.03,2.03E-02,4.51E+01,0.00,1.00E+00,0.00E+00
positive regulation of interleukin-2 production (GO:0032743),0.08,9.07E-03,6.26E+02,0.10,1.98E-02,7.76E+02
myeloid dendritic cell differentiation (GO:0043011),0.02,4.69E-02,2.09E+03,0.15,3.68E-02,5.63E+01
negative regulation of systemic arterial blood pressure (GO:0003085),0.00,1.00E+00,0.00E+00,0.10,3.70E-02,1.72E+03
regulation of bicellular tight junction assembly (GO:2000810),0.04,3.54E-02,6.61E+02,0.13,3.35E-02,6.61E+02
regulation of cholesterol biosynthetic process (GO:0045540),0.15,3.34E-03,6.51E+01,0.08,3.49E-02,2.75E+01
stress-activated protein kinase signaling cascade (GO:0031098),0.17,8.82E-05,7.29E+01,0.08,2.76E-03,3.58E+01
regulation of cellular component biogenesis (GO:0044087),0.09,1.47E-02,1.80E+02,0.13,1.47E-02,8.50E+02
negative regulation of cytokine production involved in immune response (GO:0002719),0.08,9.33E-03,1.07E+03,0.08,9.33E-03,6.31E+02
positive regulation of p38MAPK cascade (GO:1900745),0.08,3.11E-02,6.92E+02,0.03,3.37E-02,8.81E+01
regulation of lymphocyte apoptotic process (GO:0070228),0.04,1.20E-02,2.80E+03,0.08,4.09E-02,1.55E+03
stress fiber assembly (GO:0043149),0.12,4.71E-02,6.11E+02,0.15,4.71E-02,6.11E+02
contractile actin filament bundle assembly (GO:0030038),0.12,4.71E-02,6.11E+02,0.15,4.71E-02,6.11E+02
regulation of endothelial cell proliferation (GO:0001936),0.01,4.74E-02,3.32E+01,0.28,3.17E-02,1.58E+02
positive regulation of interleukin-10 production (GO:0032733),0.04,3.62E-02,4.83E+02,0.00,1.00E+00,0.00E+00
protein maturation (GO:0051604),0.11,1.47E-02,1.46E+01,0.10,4.31E-02,1.47E+02
positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.06,7.67E-03,1.42E+03,0.08,3.55E-02,6.64E+01
cellular response to gamma radiation (GO:0071480),0.17,3.34E-03,7.34E+01,0.08,8.00E-03,5.81E+01
negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.17,5.02E-03,9.24E+01,0.08,2.99E-03,5.70E+01
regulation of neuron death (GO:1901214),0.05,4.12E-02,1.37E+02,0.08,4.57E-02,2.31E+01
regulation of epithelial cell migration (GO:0010632),0.18,1.89E-02,3.34E+02,0.08,1.37E-02,2.02E+01
negative regulation of RNA metabolic process (GO:0051253),0.12,3.54E-02,6.61E+02,0.10,1.45E-02,1.48E+03
response to molecule of bacterial origin (GO:0002237),0.04,3.80E-05,3.95E+03,0.00,1.00E+00,0.00E+00
activation of cysteine-type endopeptidase activity (GO:0097202),0.07,3.38E-02,7.48E+02,0.10,3.70E-02,9.74E+02
negative regulation of cellular catabolic process (GO:0031330),0.07,4.32E-02,1.82E+02,0.10,3.54E-02,1.29E+01
positive regulation of stem cell proliferation (GO:2000648),0.04,3.08E-02,2.47E+02,0.13,1.45E-02,1.71E+03
"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.06,2.47E-02,3.28E+02,0.13,2.47E-02,3.28E+02
aspartate family amino acid biosynthetic process (GO:0009067),0.17,7.64E-03,3.04E+02,0.10,3.24E-02,3.99E+01
negative regulation of establishment of protein localization (GO:1904950),0.17,2.93E-02,8.60E+01,0.10,2.04E-02,6.72E+01
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.08,3.09E-02,1.67E+02,0.08,1.13E-02,1.46E+02
negative regulation of cartilage development (GO:0061037),0.04,2.99E-02,6.68E+02,0.23,2.75E-02,3.01E+03
negative regulation of chondrocyte differentiation (GO:0032331),0.04,3.39E-02,6.11E+02,0.23,2.89E-02,2.76E+03
response to type I interferon (GO:0034340),0.01,8.86E-03,2.96E+03,0.03,4.42E-02,1.57E+02
positive regulation of keratinocyte proliferation (GO:0010838),0.08,2.94E-02,4.08E+03,0.13,3.74E-02,1.55E+03
positive regulation of mitochondrion organization (GO:0010822),0.06,4.86E-02,1.21E+02,0.10,4.68E-02,1.98E+01
positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.17,3.05E-02,7.15E+05,0.08,2.42E-02,1.02E+02
regulation of cyclin-dependent protein kinase activity (GO:1904029),0.14,3.31E-02,2.49E+02,0.03,3.27E-02,1.13E+01
defense response to fungus (GO:0050832),0.14,1.86E-02,4.90E+03,0.13,3.60E-02,5.77E+02
negative regulation of steroid biosynthetic process (GO:0010894),0.01,3.59E-02,8.23E+02,0.15,3.19E-02,1.33E+03
negative regulation of epithelial cell migration (GO:0010633),0.05,3.02E-02,5.35E+02,0.15,1.59E-02,3.05E+02
histone H4 deacetylation (GO:0070933),0.09,3.47E-02,8.51E+01,0.10,3.72E-03,8.57E+01
mature B cell differentiation involved in immune response (GO:0002313),0.06,4.00E-02,1.50E+03,0.15,4.00E-02,9.21E+02
histone H4-K16 acetylation (GO:0043984),0.04,3.14E-02,5.31E+01,0.00,1.00E+00,0.00E+00
regulation of adaptive immune response (GO:0002819),0.02,1.00E-02,5.83E+02,0.08,1.00E-02,5.83E+02
epithelial tube morphogenesis (GO:0060562),0.02,4.25E-02,3.16E+02,0.21,4.25E-02,3.16E+02
porphyrin-containing compound biosynthetic process (GO:0006779),0.05,3.49E-02,2.30E+02,0.08,4.32E-02,1.50E+02
histone H2A acetylation (GO:0043968),0.12,3.05E-02,7.11E+01,0.10,1.96E-02,4.49E+01
regulation of cellular metabolic process (GO:0031323),0.17,7.84E-04,3.92E+01,0.05,1.34E-02,1.66E+01
tetrahydrobiopterin metabolic process (GO:0046146),0.05,4.24E-02,8.23E+02,0.08,4.24E-02,4.69E+02
regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.05,2.99E-02,1.55E+03,0.13,2.59E-02,1.55E+03
negative regulation of biomineral tissue development (GO:0070168),0.03,3.58E-02,4.77E+02,0.15,3.25E-02,1.72E+03
mRNA catabolic process (GO:0006402),0.10,2.47E-03,2.60E+01,0.05,1.57E-02,1.61E+01
response to insulin (GO:0032868),0.16,6.30E-04,2.86E+01,0.08,2.62E-02,1.30E+01
negative regulation of oxidative stress-induced neuron death (GO:1903204),0.05,4.14E-02,6.10E+02,0.10,4.14E-02,6.10E+02
exonucleolytic trimming involved in rRNA processing (GO:0000459),0.04,2.32E-02,8.97E+01,0.00,1.00E+00,0.00E+00
"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.04,2.32E-02,8.97E+01,0.00,1.00E+00,0.00E+00
nucleosome assembly (GO:0006334),0.12,6.21E-03,4.31E+01,0.08,2.41E-02,1.59E+01
negative regulation of phosphatase activity (GO:0010923),0.14,2.23E-02,2.26E+01,0.05,3.20E-02,1.56E+01
androgen receptor signaling pathway (GO:0030521),0.15,2.05E-02,5.72E+01,0.08,2.99E-03,5.70E+01
negative regulation of cell death (GO:0060548),0.12,9.15E-03,1.88E+01,0.08,2.25E-02,3.31E+01
regulation of peptidase activity (GO:0052547),0.07,4.54E-02,1.63E+03,0.21,4.15E-02,9.04E+02
positive regulation of ion transport (GO:0043270),0.05,3.27E-02,2.75E+02,0.18,1.18E-02,2.77E+01
microtubule polymerization (GO:0046785),0.06,4.15E-02,3.94E+02,0.10,4.15E-02,3.94E+02
negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.08,4.66E-02,2.32E+02,0.10,4.94E-03,2.72E+01
NAD biosynthetic process (GO:0009435),0.04,2.75E-02,4.46E+02,0.08,4.67E-02,1.82E+03
regulation of lipid catabolic process (GO:0050994),0.08,2.30E-02,8.18E+02,0.00,1.00E+00,0.00E+00
embryonic skeletal system development (GO:0048706),0.00,1.00E+00,0.00E+00,0.21,3.56E-02,3.10E+01
protein localization to cell-cell junction (GO:0150105),0.12,3.39E-02,3.57E+03,0.13,2.07E-03,3.57E+03
negative regulation of receptor binding (GO:1900121),0.04,4.04E-02,1.16E+03,0.00,1.00E+00,0.00E+00
negative regulation of vascular permeability (GO:0043116),0.01,3.59E-02,7.35E+02,0.18,3.59E-02,7.35E+02
double-strand break repair via break-induced replication (GO:0000727),0.09,7.16E-07,7.69E+03,0.13,3.13E-02,7.69E+03
positive regulation of histone ubiquitination (GO:0033184),0.17,3.05E-02,1.23E+02,0.10,2.42E-02,1.02E+02
positive regulation of viral release from host cell (GO:1902188),0.12,4.68E-02,5.76E+01,0.03,4.02E-02,2.85E+01
protein processing (GO:0016485),0.05,4.26E-02,3.79E+02,0.10,4.58E-02,1.31E+02
mitochondrial tRNA modification (GO:0070900),0.03,3.09E-02,7.36E+01,0.00,1.00E+00,0.00E+00
protein heterooligomerization (GO:0051291),0.06,3.08E-02,2.47E+02,0.08,3.08E-02,2.47E+02
positive regulation of TOR signaling (GO:0032008),0.04,4.08E-03,3.00E+01,0.05,4.32E-02,1.92E+01
mRNA methylation (GO:0080009),0.06,5.68E-03,1.09E+02,0.05,4.59E-02,2.56E+01
regulation of histone H3-K4 methylation (GO:0051569),0.18,2.23E-03,1.01E+02,0.08,5.09E-03,3.89E+01
positive regulation of focal adhesion assembly (GO:0051894),0.18,4.62E-02,6.61E+02,0.08,5.09E-03,3.89E+01
positive regulation of calcium-mediated signaling (GO:0050850),0.01,4.64E-02,9.32E+02,0.26,4.35E-02,7.35E+02
T cell migration (GO:0072678),0.05,2.77E-02,9.93E+02,0.05,3.97E-02,7.08E+02
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.15,3.91E-02,3.01E+02,0.05,2.90E-02,1.94E+01
negative regulation of protein-containing complex assembly (GO:0031333),0.15,4.61E-02,1.39E+02,0.05,3.42E-02,1.14E+01
protein destabilization (GO:0031648),0.06,1.40E-02,4.64E+01,0.05,2.70E-02,2.18E+01
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.07,5.27E-03,1.07E+03,0.05,4.12E-02,3.72E+02
positive regulation of cell differentiation (GO:0045597),0.03,4.96E-02,7.63E+00,0.08,3.19E-02,1.26E+01
negative regulation of transferase activity (GO:0051348),0.17,3.67E-03,5.23E+01,0.08,1.60E-02,2.00E+01
positive regulation of macrophage activation (GO:0043032),0.03,1.69E-02,8.89E+02,0.23,4.10E-02,8.89E+02
positive regulation of fever generation (GO:0031622),0.08,2.44E-02,4.11E+03,0.00,1.00E+00,0.00E+00
negative regulation of keratinocyte proliferation (GO:0010839),0.02,4.19E-02,1.09E+02,0.31,2.03E-02,1.16E+04
"regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",0.03,1.06E-02,2.40E+03,0.00,1.00E+00,0.00E+00
regulation of viral life cycle (GO:1903900),0.05,2.30E-02,6.26E+02,0.05,4.90E-02,1.46E+01
neuron projection development (GO:0031175),0.16,4.97E-02,9.24E+01,0.10,7.62E-03,1.63E+01
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.16,2.47E-02,4.14E+01,0.08,1.37E-02,2.29E+01
cell fate commitment involved in formation of primary germ layer (GO:0060795),0.16,2.50E-03,7.70E+05,0.08,1.85E-03,7.14E+05
calcium-ion regulated exocytosis (GO:0017156),0.02,1.98E-02,8.89E+02,0.26,3.25E-02,8.89E+02
regulation of protein sumoylation (GO:0033233),0.10,2.04E-02,2.99E+01,0.15,3.62E-02,6.31E+01
receptor metabolic process (GO:0043112),0.14,1.80E-02,5.20E+02,0.08,1.15E-02,2.44E+01
brain morphogenesis (GO:0048854),0.04,3.62E-02,4.44E+02,0.13,4.07E-02,6.11E+02
proteasome assembly (GO:0043248),0.18,1.83E-03,2.52E+02,0.05,3.33E-02,2.85E+01
positive regulation of endocytosis (GO:0045807),0.19,3.09E-02,4.70E+02,0.13,3.09E-02,2.29E+02
negative regulation of cellular extravasation (GO:0002692),0.05,4.71E-02,7.76E+02,0.15,4.71E-02,1.54E+03
negative regulation of response to biotic stimulus (GO:0002832),0.00,1.00E+00,0.00E+00,0.08,4.97E-02,3.56E+02
cellular response to glucose starvation (GO:0042149),0.06,4.02E-02,1.78E+02,0.08,2.92E-02,1.61E+01
negative regulation of phosphorylation (GO:0042326),0.16,4.29E-04,3.12E+01,0.08,2.58E-03,2.71E+01
negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.16,2.47E-03,5.98E+01,0.08,3.80E-02,3.30E+01
progesterone receptor signaling pathway (GO:0050847),0.16,7.64E-03,1.25E+02,0.08,5.34E-03,1.04E+02
"phagocytosis, engulfment (GO:0006911)",0.02,1.36E-02,1.74E+02,0.21,4.71E-02,2.46E+02
establishment of endothelial barrier (GO:0061028),0.06,2.84E-02,5.46E+02,0.03,3.32E-02,1.44E+01
negative regulation of protein transport (GO:0051224),0.07,1.75E-02,1.40E+03,0.10,4.10E-02,2.72E+02
negative regulation of mRNA catabolic process (GO:1902373),0.16,4.60E-02,3.87E+02,0.10,1.37E-02,1.22E+03
mRNA stabilization (GO:0048255),0.16,2.47E-03,3.10E+01,0.10,1.61E-02,7.33E+02
energy reserve metabolic process (GO:0006112),0.21,3.70E-02,8.70E+02,0.05,2.47E-02,2.07E+01
positive regulation of cold-induced thermogenesis (GO:0120162),0.10,2.64E-02,1.68E+01,0.05,4.34E-03,1.68E+01
macromolecule modification (GO:0043412),0.06,3.17E-02,4.40E+01,0.10,3.24E-02,1.04E+02
histone H3-K36 methylation (GO:0010452),0.06,4.29E-02,1.34E+03,0.08,4.29E-02,1.34E+03
regulation of cell size (GO:0008361),0.18,3.20E-02,2.49E+02,0.15,3.20E-02,2.49E+02
'de novo' posttranslational protein folding (GO:0051084),0.16,6.87E-04,6.19E+01,0.08,2.65E-02,3.06E+01
negative regulation by host of viral process (GO:0044793),0.05,2.55E-02,1.39E+03,0.05,2.55E-02,5.02E+02
positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.12,3.19E-02,2.57E+01,0.08,4.96E-02,2.13E+01
regulation of amyloid fibril formation (GO:1905906),0.12,2.05E-02,3.78E+01,0.08,3.42E-02,6.11E+02
striated muscle tissue development (GO:0014706),0.00,1.00E+00,0.00E+00,0.28,4.23E-02,7.64E+01
cytoskeleton organization (GO:0007010),0.07,1.29E-02,2.08E+02,0.00,1.00E+00,0.00E+00
calcium ion transport into cytosol (GO:0060402),0.01,4.69E-02,4.46E+02,0.10,1.45E-02,1.31E+03
positive regulation of developmental process (GO:0051094),0.08,4.69E-02,8.78E+01,0.10,4.69E-02,7.28E+01
hydrogen peroxide catabolic process (GO:0042744),0.02,4.91E-02,2.96E+02,0.31,2.92E-02,1.01E+03
centromere complex assembly (GO:0034508),0.15,7.02E-03,2.42E+02,0.00,1.00E+00,0.00E+00
endoplasmic reticulum tubular network organization (GO:0071786),0.15,2.05E-02,4.18E+01,0.08,1.29E-02,3.36E+01
positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.07,1.48E-02,1.25E+03,0.00,1.00E+00,0.00E+00
tRNA surveillance (GO:0106354),0.03,1.55E-02,8.39E+05,0.00,1.00E+00,0.00E+00
nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),0.03,1.55E-02,8.39E+05,0.00,1.00E+00,0.00E+00
nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),0.03,1.55E-02,8.39E+05,0.00,1.00E+00,0.00E+00
nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),0.03,1.55E-02,8.39E+05,0.00,1.00E+00,0.00E+00
DNA geometric change (GO:0032392),0.16,1.03E-03,6.38E+01,0.05,4.96E-02,1.35E+01
negative regulation of interferon-gamma production (GO:0032689),0.05,3.01E-02,5.46E+02,0.05,3.01E-02,2.70E+02
positive regulation of cytokine production involved in immune response (GO:0002720),0.04,2.47E-02,2.51E+02,0.00,1.00E+00,0.00E+00
negative regulation of epithelial to mesenchymal transition (GO:0010719),0.02,4.72E-02,1.12E+02,0.08,4.72E-02,1.12E+02
substrate adhesion-dependent cell spreading (GO:0034446),0.15,7.40E-03,2.49E+01,0.08,1.66E-02,1.98E+01
ribosomal subunit export from nucleus (GO:0000054),0.15,1.33E-03,1.50E+02,0.08,5.58E-03,1.50E+02
regulation of type 2 immune response (GO:0002828),0.05,2.08E-02,5.05E+03,0.00,1.00E+00,0.00E+00
regulation of spindle organization (GO:0090224),0.16,5.59E-03,5.42E+01,0.05,3.98E-02,1.82E+01
negative regulation of mitochondrion organization (GO:0010823),0.16,2.30E-03,3.83E+01,0.05,2.15E-02,1.63E+01
activation of phospholipase C activity (GO:0007202),0.01,4.07E-02,2.96E+02,0.15,4.52E-02,2.96E+02
pyruvate metabolic process (GO:0006090),0.18,4.29E-02,1.48E+02,0.08,1.37E-02,1.93E+01
regulation of macrophage chemotaxis (GO:0010758),0.02,2.68E-02,7.72E+02,0.08,4.15E-02,4.20E+02
positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.05,7.32E-03,1.33E+03,0.08,3.70E-02,1.72E+03
heart looping (GO:0001947),0.01,3.52E-02,3.33E+02,0.13,4.82E-02,1.88E+01
renal filtration (GO:0097205),0.03,3.87E-02,1.03E+03,0.08,4.71E-02,1.03E+03
regulation of fever generation (GO:0031620),0.06,3.80E-03,5.29E+03,0.00,1.00E+00,0.00E+00
positive regulation of heat generation (GO:0031652),0.06,3.80E-03,5.29E+03,0.00,1.00E+00,0.00E+00
negative regulation of lipid localization (GO:1905953),0.06,3.01E-02,2.01E+03,0.00,1.00E+00,0.00E+00
positive regulation of smooth muscle cell migration (GO:0014911),0.03,2.16E-02,1.71E+03,0.21,4.62E-02,6.62E+02
DNA conformation change (GO:0071103),0.17,1.25E-03,8.19E+01,0.08,3.98E-02,1.82E+01
heme biosynthetic process (GO:0006783),0.04,3.18E-02,2.60E+02,0.08,3.90E-02,1.70E+02
RNA-dependent DNA biosynthetic process (GO:0006278),0.15,1.52E-02,3.43E+01,0.08,1.57E-02,8.43E+02
endocrine system development (GO:0035270),0.08,4.16E-02,4.61E+02,0.15,3.44E-02,4.92E+02
succinyl-CoA metabolic process (GO:0006104),0.13,3.05E-02,1.23E+02,0.10,2.42E-02,1.02E+02
regulation of gap junction assembly (GO:1903596),0.02,2.00E-02,2.40E+03,0.03,2.00E-02,2.01E+03
mitochondrial fusion (GO:0008053),0.10,3.60E-02,2.24E+01,0.08,3.98E-02,1.82E+01
negative regulation of microtubule depolymerization (GO:0007026),0.10,4.95E-02,3.15E+01,0.10,1.13E-02,2.73E+01
nucleotide-sugar metabolic process (GO:0009225),0.14,3.70E-02,1.66E+03,0.08,2.68E-02,6.34E+02
regulation of macromolecule metabolic process (GO:0060255),0.14,2.04E-02,2.00E+01,0.08,1.39E-02,2.00E+01
positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.05,3.50E-02,5.08E+01,0.03,2.92E-03,7.81E+01
regulation of protein secretion (GO:0050708),0.04,3.51E-03,4.61E+02,0.08,4.86E-02,1.06E+02
positive regulation of focal adhesion disassembly (GO:0120183),0.04,1.06E-02,1.31E+03,0.08,1.06E-02,1.31E+03
regulation of focal adhesion disassembly (GO:0120182),0.04,1.06E-02,1.31E+03,0.08,1.06E-02,1.31E+03
telomere maintenance via telomerase (GO:0007004),0.15,2.93E-02,2.81E+01,0.08,1.56E-02,8.79E+02
TORC1 signaling (GO:0038202),0.02,3.26E-02,5.82E+02,0.10,3.26E-02,5.82E+02
import into cell (GO:0098657),0.04,3.47E-02,3.53E+02,0.15,3.85E-02,2.93E+02
platelet aggregation (GO:0070527),0.18,1.72E-02,7.25E+02,0.08,5.46E-04,4.18E+01
regulation of hydrolase activity (GO:0051336),0.04,2.47E-02,1.57E+01,0.08,2.37E-03,2.23E+01
sodium-independent organic anion transport (GO:0043252),0.00,2.00E-02,1.14E+03,0.23,2.00E-02,1.14E+03
regulation of ubiquitin-protein transferase activity (GO:0051438),0.09,8.88E-03,5.23E+01,0.10,4.07E-02,2.85E+01
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.06,3.68E-02,4.68E+02,0.18,1.56E-02,1.77E+03
negative regulation of smooth muscle cell differentiation (GO:0051151),0.03,4.03E-02,1.50E+03,0.05,3.19E-02,1.50E+03
positive regulation of defense response to bacterium (GO:1900426),0.10,1.22E-02,5.42E+02,0.15,1.63E-02,4.48E+03
protein catabolic process (GO:0030163),0.02,2.55E-02,3.28E+02,0.03,4.71E-02,9.16E+00
neurotransmitter biosynthetic process (GO:0042136),0.04,2.35E-02,9.74E+02,0.15,2.75E-02,8.48E+02
regulation of receptor binding (GO:1900120),0.04,4.04E-02,1.16E+03,0.00,1.00E+00,0.00E+00
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway (GO:0090611),0.06,2.34E-02,6.50E+05,0.08,2.42E-02,6.49E+05
regulation of synapse assembly (GO:0051963),0.01,4.44E-02,2.09E+02,0.13,2.06E-02,2.09E+02
regulation of apoptotic cell clearance (GO:2000425),0.09,1.31E-02,6.13E+03,0.00,1.00E+00,0.00E+00
regulation of membrane protein ectodomain proteolysis (GO:0051043),0.06,2.47E-02,7.72E+02,0.00,1.00E+00,0.00E+00
mesonephric tubule development (GO:0072164),0.00,1.00E+00,0.00E+00,0.15,2.47E-02,4.38E+01
miRNA metabolic process (GO:0010586),0.15,1.34E-02,4.60E+01,0.08,3.00E-02,3.25E+01
negative regulation of alpha-beta T cell activation (GO:0046636),0.02,1.66E-02,2.40E+03,0.00,1.00E+00,0.00E+00
regulation of cardiac muscle cell contraction (GO:0086004),0.04,3.94E-02,3.24E+02,0.13,3.25E-02,3.24E+02
activation of protein kinase B activity (GO:0032148),0.04,4.58E-02,5.02E+02,0.10,4.79E-02,8.09E+02
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.17,4.55E-02,5.85E+02,0.08,1.78E-02,2.48E+01
positive regulation of chromosome organization (GO:2001252),0.15,5.02E-03,6.39E+01,0.03,4.57E-02,1.92E+01
regulation of MDA-5 signaling pathway (GO:0039533),0.01,1.94E-02,1.85E+03,0.03,4.27E-02,2.17E+02
negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.17,5.59E-03,1.04E+02,0.08,2.04E-02,4.00E+01
lymphocyte activation involved in immune response (GO:0002285),0.09,8.39E-03,2.44E+03,0.13,8.39E-03,2.44E+03
anterograde trans-synaptic signaling (GO:0098916),0.00,1.00E+00,0.00E+00,0.26,3.19E-02,1.23E+02
cellular response to organic substance (GO:0071310),0.10,3.90E-02,2.02E+02,0.00,1.00E+00,0.00E+00
regulation of chromatin binding (GO:0035561),0.02,2.37E-02,9.12E+02,0.00,1.00E+00,0.00E+00
positive regulation of cell cycle G2/M phase transition (GO:1902751),0.08,3.52E-02,3.42E+01,0.08,9.46E-04,1.65E+02
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.08,1.74E-02,4.96E+01,0.08,2.52E-03,1.56E+02
positive regulation of phosphate metabolic process (GO:0045937),0.08,2.84E-02,5.23E+02,0.05,4.46E-02,2.32E+01
antiviral innate immune response (GO:0140374),0.03,2.46E-02,1.68E+03,0.08,4.15E-02,7.48E+02
regulation of interleukin-1 alpha production (GO:0032650),0.05,4.60E-03,6.12E+03,0.10,4.13E-02,2.69E+02
negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.17,4.25E-02,6.31E+02,0.08,5.09E-03,5.67E+01
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.17,2.30E-02,6.26E+02,0.08,6.38E-03,5.66E+01
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.06,4.00E-02,4.21E+02,0.13,4.00E-02,4.21E+02
positive regulation of calcium ion import (GO:0090280),0.07,1.40E-02,3.30E+03,0.10,4.11E-02,9.32E+02
regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.03,6.51E-03,7.67E+05,0.00,1.00E+00,0.00E+00
peroxisomal membrane transport (GO:0015919),0.02,2.02E-02,4.35E+01,0.00,1.00E+00,0.00E+00
positive regulation of protein transport (GO:0051222),0.08,4.87E-02,1.28E+02,0.13,3.73E-02,2.28E+02
chromosome condensation (GO:0030261),0.15,1.19E-04,6.63E+02,0.05,2.45E-02,2.05E+02
synaptic vesicle exocytosis (GO:0016079),0.03,1.80E-02,8.24E+02,0.05,4.79E-02,5.90E+02
"protein localization to chromosome, centromeric region (GO:0071459)",0.12,6.55E-04,8.88E+01,0.00,1.00E+00,0.00E+00
homotypic cell-cell adhesion (GO:0034109),0.17,1.72E-02,5.57E+02,0.08,2.63E-03,2.66E+01
hippo signaling (GO:0035329),0.08,2.77E-02,9.43E+01,0.05,2.28E-02,5.91E+01
negative regulation of cell activation (GO:0050866),0.11,1.32E-02,1.36E+03,0.13,3.42E-02,8.48E+02
neuron development (GO:0048666),0.04,3.27E-02,2.69E+02,0.08,2.90E-02,1.22E+01
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.14,2.16E-02,1.11E+03,0.08,3.52E-02,2.62E+01
regulation of transforming growth factor beta production (GO:0071634),0.10,4.50E-02,3.07E+02,0.08,3.98E-02,2.98E+01
regulation of erythrocyte differentiation (GO:0045646),0.16,2.40E-02,5.00E+02,0.08,1.85E-02,2.81E+01
cellular component maintenance (GO:0043954),0.02,1.97E-02,3.12E+01,0.13,3.42E-02,7.35E+02
"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.08,4.65E-02,5.12E+01,0.05,3.86E-02,3.29E+01
monocyte differentiation (GO:0030224),0.00,1.00E+00,0.00E+00,0.08,3.70E-02,1.33E+03
nuclear mRNA surveillance (GO:0071028),0.04,1.69E-02,7.20E+02,0.08,1.69E-02,7.20E+02
regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.04,2.29E-02,1.15E+03,0.00,1.00E+00,0.00E+00
production of siRNA involved in RNA interference (GO:0030422),0.03,3.74E-02,6.76E+01,0.05,1.45E-02,3.33E+03
protein prenylation (GO:0018342),0.04,1.06E-02,2.35E+02,0.00,1.00E+00,0.00E+00
protein geranylgeranylation (GO:0018344),0.04,2.07E-02,1.11E+06,0.00,1.00E+00,0.00E+00
replication fork processing (GO:0031297),0.04,2.56E-02,4.04E+01,0.00,1.00E+00,0.00E+00
regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.06,1.96E-04,4.27E+03,0.00,1.00E+00,0.00E+00
regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.10,4.69E-02,1.06E+03,0.00,1.00E+00,0.00E+00
positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.10,4.69E-02,1.06E+03,0.00,1.00E+00,0.00E+00
regulation of dendritic cell differentiation (GO:2001198),0.06,1.98E-02,1.26E+03,0.05,1.56E-02,1.26E+03
negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.15,8.50E-03,4.51E+01,0.00,1.00E+00,0.00E+00
histone H4-K5 acetylation (GO:0043981),0.02,3.88E-02,3.89E+01,0.00,1.00E+00,0.00E+00
histone H4-K8 acetylation (GO:0043982),0.02,3.88E-02,3.89E+01,0.00,1.00E+00,0.00E+00
positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.03,2.08E-02,4.11E+03,0.00,1.00E+00,0.00E+00
regulation of epithelial to mesenchymal transition (GO:0010717),0.06,4.86E-02,1.61E+02,0.03,5.32E-03,2.52E+03
positive regulation of protein deubiquitination (GO:1903003),0.16,2.79E-03,2.90E+02,0.08,1.91E-03,2.42E+02
regulation of protein deubiquitination (GO:0090085),0.16,2.79E-03,1.40E+06,0.08,1.91E-03,1.40E+06
CRD-mediated mRNA stabilization (GO:0070934),0.16,2.50E-03,7.44E+05,0.08,2.42E-02,1.02E+02
protein-DNA complex subunit organization (GO:0071824),0.16,9.62E-03,1.97E+02,0.08,7.15E-03,1.64E+02
regulation of phosphoprotein phosphatase activity (GO:0043666),0.16,9.86E-04,5.12E+01,0.08,3.47E-04,4.49E+01
SMAD protein complex assembly (GO:0007183),0.16,2.30E-02,8.41E+01,0.08,1.69E-02,6.95E+01
nuclear transport (GO:0051169),0.16,1.85E-03,5.92E+01,0.08,5.09E-03,4.49E+01
negative regulation by symbiont of host programmed cell death (GO:0052041),0.16,7.64E-03,3.36E+02,0.08,5.34E-03,1.04E+02
substantia nigra development (GO:0021762),0.16,4.94E-03,4.43E+01,0.08,6.19E-04,3.69E+01
ATF6-mediated unfolded protein response (GO:0036500),0.16,2.41E-03,3.55E+02,0.08,1.13E-02,6.05E+01
purine nucleotide biosynthetic process (GO:0006164),0.15,3.88E-03,1.19E+02,0.00,1.00E+00,0.00E+00
heterochromatin organization (GO:0070828),0.09,4.88E-02,5.79E+01,0.08,8.00E-03,4.29E+01
"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.09,1.47E-02,1.85E+03,0.00,1.00E+00,0.00E+00
"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.09,1.31E-02,2.04E+03,0.00,1.00E+00,0.00E+00
ion homeostasis (GO:0050801),0.07,3.62E-02,5.23E+02,0.13,3.40E-02,2.83E+02
bundle of His cell to Purkinje myocyte communication (GO:0086069),0.00,1.00E+00,0.00E+00,0.15,2.98E-02,1.45E+02
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.14,4.60E-02,6.19E+02,0.05,3.82E-02,5.38E+02
negative regulation of stress fiber assembly (GO:0051497),0.14,1.18E-02,8.57E+02,0.05,2.90E-02,1.76E+01
positive regulation of protein dephosphorylation (GO:0035307),0.14,6.75E-03,3.97E+01,0.05,2.15E-02,1.63E+01
cellular response to nerve growth factor stimulus (GO:1990090),0.01,3.70E-02,7.72E+02,0.05,4.79E-02,1.24E+03
positive regulation of amyloid-beta formation (GO:1902004),0.13,3.54E-02,7.08E+02,0.03,4.77E-02,1.82E+01
negative regulation of Rho protein signal transduction (GO:0035024),0.12,3.42E-02,7.08E+02,0.10,3.42E-02,7.08E+02
positive regulation of interleukin-12 production (GO:0032735),0.04,4.15E-02,3.16E+02,0.05,4.15E-02,3.16E+02
magnesium ion transport (GO:0015693),0.06,2.10E-02,1.66E+03,0.03,2.21E-02,3.18E+01
translocation of molecules into host (GO:0044417),0.06,4.35E-02,1.25E+02,0.05,3.95E-02,3.99E+01
viral mRNA export from host cell nucleus (GO:0046784),0.06,4.35E-02,1.25E+02,0.05,3.95E-02,3.99E+01
mitochondrial gene expression (GO:0140053),0.03,8.50E-03,3.07E+01,0.00,1.00E+00,0.00E+00
myeloid dendritic cell activation (GO:0001773),0.02,4.69E-02,1.36E+03,0.15,3.51E-02,4.28E+01
"regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.02,1.66E-02,1.85E+03,0.00,1.00E+00,0.00E+00
regulation of protein localization to early endosome (GO:1902965),0.08,3.48E-02,1.55E+03,0.08,3.24E-02,8.20E+01
positive regulation of protein localization to endosome (GO:1905668),0.08,3.48E-02,1.55E+03,0.08,3.24E-02,8.20E+01
positive regulation of protein localization to early endosome (GO:1902966),0.08,3.48E-02,1.55E+03,0.08,3.24E-02,8.20E+01
regulation of necroptotic process (GO:0060544),0.15,2.67E-02,5.19E+02,0.08,7.15E-03,3.03E+01
regulation of programmed necrotic cell death (GO:0062098),0.15,1.34E-02,7.40E+01,0.08,1.91E-03,4.94E+01
Golgi localization (GO:0051645),0.15,1.97E-02,7.33E+01,0.08,1.29E-02,6.09E+01
regulation of cellular protein catabolic process (GO:1903362),0.15,2.04E-02,5.65E+01,0.08,1.23E-02,3.59E+01
protein import into peroxisome membrane (GO:0045046),0.02,3.74E-02,4.27E+01,0.00,1.00E+00,0.00E+00
cyclooxygenase pathway (GO:0019371),0.00,1.00E+00,0.00E+00,0.08,4.61E-02,4.30E+01
anterograde axonal transport (GO:0008089),0.08,2.16E-02,6.50E+02,0.08,7.43E-03,2.21E+01
polyamine metabolic process (GO:0006595),0.14,1.15E-02,9.21E+02,0.05,2.06E-02,3.10E+01
regulation of PERK-mediated unfolded protein response (GO:1903897),0.15,1.64E-02,1.46E+02,0.08,1.51E-03,1.45E+02
cellular response to unfolded protein (GO:0034620),0.15,8.82E-05,8.41E+01,0.08,2.43E-02,4.94E+01
Arp2/3 complex-mediated actin nucleation (GO:0034314),0.15,2.05E-02,4.18E+01,0.08,4.59E-02,3.36E+01
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.12,1.34E-03,2.31E+03,0.05,1.34E-03,2.31E+03
mRNA transcription by RNA polymerase II (GO:0042789),0.14,2.30E-02,8.41E+01,0.08,1.69E-02,6.95E+01
regulation of mitochondrion organization (GO:0010821),0.13,1.71E-02,2.52E+01,0.05,3.42E-02,1.18E+01
protein acetylation (GO:0006473),0.03,8.01E-03,6.46E+01,0.00,1.00E+00,0.00E+00
regulation of epithelial cell proliferation (GO:0050678),0.02,4.47E-03,4.15E+01,0.15,2.65E-02,3.28E+01
negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.06,8.11E-04,9.70E+02,0.08,8.11E-04,9.70E+02
regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),0.17,1.64E-02,1.46E+02,0.08,1.13E-02,6.05E+01
regulation of NK T cell activation (GO:0051133),0.04,3.32E-02,1.85E+03,0.00,1.00E+00,0.00E+00
positive regulation of NK T cell activation (GO:0051135),0.04,3.32E-02,1.50E+03,0.00,1.00E+00,0.00E+00
positive regulation of toll-like receptor signaling pathway (GO:0034123),0.03,1.75E-02,1.34E+03,0.05,4.09E-02,4.24E+02
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),0.09,3.89E-02,1.97E+02,0.00,1.00E+00,0.00E+00
"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.09,2.72E-02,1.75E+03,0.00,1.00E+00,0.00E+00
positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.02,2.05E-02,4.18E+02,0.08,4.15E-02,5.43E+02
regulation of alpha-beta T cell proliferation (GO:0046640),0.01,4.74E-02,1.88E+02,0.05,4.78E-02,1.88E+02
"regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.01,4.74E-02,1.88E+02,0.05,4.78E-02,1.88E+02
regulation of signal transduction (GO:0009966),0.03,4.00E-02,6.55E+01,0.08,4.00E-02,6.55E+01
membrane assembly (GO:0071709),0.10,2.93E-02,1.82E+01,0.10,3.59E-02,2.24E+02
negative regulation of synapse organization (GO:1905809),0.01,3.04E-02,3.81E+03,0.05,3.04E-02,3.81E+03
regulation of chromosome separation (GO:1905818),0.04,4.69E-02,1.06E+03,0.03,3.32E-02,8.16E+01
positive regulation of MHC class I biosynthetic process (GO:0045345),0.04,2.00E-02,4.44E+03,0.03,2.00E-02,4.44E+03
regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.07,2.42E-02,7.05E+05,0.08,2.42E-02,7.14E+05
cellular glucan metabolic process (GO:0006073),0.13,4.68E-02,5.70E+01,0.08,7.29E-03,5.70E+01
regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.02,1.66E-02,2.40E+03,0.00,1.00E+00,0.00E+00
positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.01,3.89E-02,5.06E+02,0.21,4.77E-02,5.06E+02
regulation of interleukin-17 production (GO:0032660),0.03,3.22E-02,4.64E+02,0.00,1.00E+00,0.00E+00
death-inducing signaling complex assembly (GO:0071550),0.03,3.54E-02,2.40E+03,0.00,1.00E+00,0.00E+00
modulation by symbiont of host apoptotic process (GO:0052150),0.14,2.30E-02,2.43E+02,0.08,1.69E-02,6.95E+01
positive regulation of cellular protein catabolic process (GO:1903364),0.14,8.82E-03,5.97E+01,0.08,1.78E-02,2.48E+01
mitochondrial protein processing (GO:0034982),0.13,4.68E-02,3.53E+01,0.08,3.33E-02,2.85E+01
TOR signaling (GO:0031929),0.16,3.76E-03,5.51E+01,0.08,1.82E-03,4.04E+01
regulation of fibroblast migration (GO:0010762),0.16,5.73E-03,6.11E+01,0.08,1.13E-02,2.73E+01
regulation of mitotic spindle assembly (GO:1901673),0.12,8.82E-03,4.85E+01,0.05,1.73E-02,2.94E+01
response to copper ion (GO:0046688),0.03,4.60E-02,7.30E+02,0.15,3.08E-02,9.04E+02
regulation of microtubule depolymerization (GO:0031114),0.09,2.67E-02,2.47E+01,0.10,1.37E-02,2.27E+01
regulation of glucose transmembrane transport (GO:0010827),0.09,2.30E-02,9.28E+02,0.05,4.58E-02,3.37E+02
positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.11,4.35E-02,4.45E+01,0.05,3.24E-02,3.99E+01
regulation of MAP kinase activity (GO:0043405),0.03,2.26E-02,5.13E+02,0.05,2.26E-02,5.13E+02
coronary vasculature development (GO:0060976),0.04,4.81E-02,1.85E+03,0.03,4.81E-02,6.26E+02
plus-end-directed vesicle transport along microtubule (GO:0072383),0.05,4.63E-03,7.59E+05,0.05,2.42E-02,6.49E+05
response to axon injury (GO:0048678),0.01,3.48E-02,5.43E+02,0.15,4.09E-02,5.43E+02
positive regulation of exosomal secretion (GO:1903543),0.13,2.91E-02,5.66E+01,0.08,2.99E-03,5.66E+01
chloride transmembrane transport (GO:1902476),0.09,1.37E-02,4.83E+02,0.10,4.44E-02,2.28E+02
regulation of neurotransmitter receptor activity (GO:0099601),0.00,1.00E+00,0.00E+00,0.15,3.34E-02,1.94E+01
pyrimidine nucleoside catabolic process (GO:0046135),0.02,4.81E-02,3.57E+02,0.00,1.00E+00,0.00E+00
vesicle organization (GO:0016050),0.14,4.95E-02,1.86E+02,0.05,2.42E-02,1.36E+01
central nervous system development (GO:0007417),0.05,1.72E-02,3.39E+01,0.08,2.70E-02,2.03E+01
cellular transition metal ion homeostasis (GO:0046916),0.19,3.80E-02,6.49E+02,0.08,2.32E-02,1.36E+01
L-alpha-amino acid transmembrane transport (GO:1902475),0.03,4.11E-02,4.97E+02,0.15,3.25E-02,4.97E+02
amino acid import across plasma membrane (GO:0089718),0.03,4.11E-02,5.77E+02,0.15,3.25E-02,5.77E+02
amino acid import (GO:0043090),0.03,4.11E-02,6.44E+02,0.15,3.25E-02,6.44E+02
positive regulation of microglial cell activation (GO:1903980),0.03,9.00E-03,4.21E+03,0.15,9.00E-03,4.21E+03
neurotransmitter uptake (GO:0001504),0.03,3.68E-02,1.39E+03,0.15,2.68E-02,1.39E+03
neuron remodeling (GO:0016322),0.04,1.23E-02,2.09E+03,0.00,1.00E+00,0.00E+00
positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.06,1.48E-02,1.25E+03,0.00,1.00E+00,0.00E+00
negative regulation of lipid metabolic process (GO:0045833),0.06,2.76E-02,6.92E+02,0.00,1.00E+00,0.00E+00
negative regulation of lipid catabolic process (GO:0050995),0.06,1.85E-02,9.93E+02,0.00,1.00E+00,0.00E+00
positive regulation of protein serine/threonine kinase activity (GO:0071902),0.08,4.26E-02,4.58E+02,0.05,2.26E-02,4.58E+02
aorta development (GO:0035904),0.04,3.09E-02,6.68E+02,0.08,3.16E-02,4.59E+02
RNA interference (GO:0016246),0.04,4.88E-02,2.96E+02,0.05,1.45E-02,1.71E+03
regulation of viral entry into host cell (GO:0046596),0.08,3.48E-02,4.68E+02,0.00,1.00E+00,0.00E+00
blood vessel morphogenesis (GO:0048514),0.03,3.84E-02,2.38E+02,0.05,4.57E-02,1.67E+02
cellular macromolecule catabolic process (GO:0044265),0.05,2.49E-02,4.15E+02,0.05,4.84E-02,1.21E+01
mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.05,3.96E-02,5.25E+02,0.00,1.00E+00,0.00E+00
regulation of T-helper 2 cell cytokine production (GO:2000551),0.08,6.36E-03,6.40E+03,0.08,6.36E-03,6.40E+03
GPI anchor biosynthetic process (GO:0006506),0.04,4.00E-02,4.01E+02,0.05,4.12E-02,4.01E+02
regulation of ion transport (GO:0043269),0.00,1.00E+00,0.00E+00,0.10,1.06E-02,2.30E+01
regulation of natural killer cell activation (GO:0032814),0.04,3.32E-02,7.35E+02,0.00,1.00E+00,0.00E+00
neuron projection extension (GO:1990138),0.17,4.05E-02,2.23E+02,0.08,2.19E-03,3.32E+01
regulation of protein autophosphorylation (GO:0031952),0.06,4.30E-02,2.46E+02,0.08,4.30E-02,2.46E+02
positive regulation of erythrocyte differentiation (GO:0045648),0.10,4.29E-02,3.59E+01,0.05,2.41E-02,1.86E+01
negative regulation of protein catabolic process (GO:0042177),0.08,4.68E-02,1.90E+01,0.03,2.34E-02,1.44E+01
regulation of phosphate metabolic process (GO:0019220),0.11,4.10E-02,4.46E+01,0.08,5.09E-03,4.46E+01
neuropeptide signaling pathway (GO:0007218),0.06,1.41E-02,6.05E+01,0.13,4.17E-02,6.05E+01
purine nucleobase metabolic process (GO:0006144),0.15,4.10E-02,8.27E+02,0.08,4.10E-02,8.27E+02
TRAIL-activated apoptotic signaling pathway (GO:0036462),0.02,4.35E-02,1.29E+03,0.10,4.35E-02,1.29E+03
glycosaminoglycan biosynthetic process (GO:0006024),0.04,4.24E-02,5.86E+02,0.10,4.24E-02,5.86E+02
negative regulation of organ growth (GO:0046621),0.12,3.05E-02,1.23E+02,0.13,4.07E-02,1.99E+03
negative regulation of T cell cytokine production (GO:0002725),0.08,5.61E-03,8.26E+03,0.08,5.61E-03,8.26E+03
lymphocyte differentiation (GO:0030098),0.08,1.52E-02,5.25E+02,0.08,1.52E-02,5.25E+02
RNA catabolic process (GO:0006401),0.12,4.77E-02,1.72E+02,0.05,3.51E-03,2.33E+01
protein targeting to peroxisome (GO:0006625),0.02,3.56E-02,3.43E+01,0.00,1.00E+00,0.00E+00
methionine metabolic process (GO:0006555),0.10,4.35E-02,9.38E+01,0.08,3.95E-02,3.99E+01
negative regulation of interleukin-1 beta production (GO:0032691),0.02,1.78E-02,6.26E+02,0.00,1.00E+00,0.00E+00
positive regulation of monocyte differentiation (GO:0045657),0.02,3.57E-02,2.58E+03,0.00,1.00E+00,0.00E+00
epithelial cell migration (GO:0010631),0.08,1.54E-02,7.99E+02,0.15,4.96E-03,2.16E+02
negative regulation of lipid biosynthetic process (GO:0051055),0.01,4.10E-02,3.37E+02,0.08,3.21E-02,5.49E+02
regulation of steroid biosynthetic process (GO:0050810),0.01,3.84E-02,4.69E+02,0.08,3.19E-02,7.61E+02
regulation of exocytosis (GO:0017157),0.07,1.97E-02,5.96E+02,0.05,4.98E-02,4.25E+02
negative regulation of cellular protein localization (GO:1903828),0.11,2.93E-02,2.83E+01,0.03,1.46E-02,1.77E+01
regulation of amyloid precursor protein catabolic process (GO:1902991),0.11,1.97E-02,4.61E+01,0.03,2.21E-02,3.18E+01
tRNA processing (GO:0008033),0.01,2.96E-02,1.85E+01,0.00,1.00E+00,0.00E+00
regulation of amyloid-beta clearance (GO:1900221),0.10,3.54E-02,8.22E+02,0.08,3.42E-02,5.63E+02
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.10,2.51E-02,2.56E+01,0.08,2.88E-02,2.56E+01
dendritic spine organization (GO:0097061),0.04,4.29E-02,1.69E+01,0.18,3.73E-02,2.88E+02
amyloid precursor protein catabolic process (GO:0042987),0.05,2.67E-02,3.29E+01,0.03,3.18E-02,2.39E+01
membrane depolarization during SA node cell action potential (GO:0086046),0.04,2.80E-02,2.95E+03,0.13,2.59E-02,2.95E+03
regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.00,1.00E+00,0.00E+00,0.10,6.89E-04,2.81E+02
positive regulation of nitric-oxide synthase activity (GO:0051000),0.04,3.54E-02,7.08E+02,0.05,1.45E-02,1.59E+03
positive regulation of I-kappaB phosphorylation (GO:1903721),0.05,1.20E-02,4.11E+03,0.00,1.00E+00,0.00E+00
regulation of I-kappaB phosphorylation (GO:1903719),0.05,1.20E-02,3.34E+03,0.00,1.00E+00,0.00E+00
glycerol transport (GO:0015793),0.02,4.01E-02,1.25E+03,0.23,4.59E-02,7.57E+01
positive regulation of natural killer cell mediated immunity (GO:0002717),0.01,2.89E-02,3.97E+02,0.00,1.00E+00,0.00E+00
regulation of microtubule motor activity (GO:2000574),0.04,2.17E-02,2.04E+03,0.08,2.17E-02,1.34E+03
protein kinase C signaling (GO:0070528),0.06,1.55E-02,1.16E+03,0.10,2.01E-02,1.16E+03
endosomal vesicle fusion (GO:0034058),0.07,3.10E-02,2.01E+03,0.08,3.10E-02,2.01E+03
organelle transport along microtubule (GO:0072384),0.16,7.40E-03,3.49E+01,0.08,1.04E-02,2.23E+01
actin filament depolymerization (GO:0030042),0.16,1.12E-02,1.13E+02,0.08,7.29E-03,5.70E+01
sensory perception (GO:0007600),0.04,1.96E-02,6.10E+02,0.18,3.13E-02,3.79E+01
endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.05,4.41E-02,2.10E+01,0.05,2.47E-02,2.07E+01
UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.11,3.70E-02,1.85E+03,0.05,3.33E-02,2.85E+01
cell migration involved in heart development (GO:0060973),0.00,1.00E+00,0.00E+00,0.08,3.35E-02,2.01E+03
regulation of cilium assembly (GO:1902017),0.01,3.63E-02,2.11E+01,0.00,1.00E+00,0.00E+00
endothelin receptor signaling pathway (GO:0086100),0.07,4.68E-02,1.01E+03,0.15,4.68E-02,1.01E+03
positive regulation of histone H3-K4 methylation (GO:0051571),0.17,2.05E-02,6.39E+01,0.05,4.59E-02,1.92E+01
regulation of chromosome organization (GO:0033044),0.17,2.42E-03,5.19E+01,0.05,1.60E-02,2.34E+01
positive regulation of Rho protein signal transduction (GO:0035025),0.01,4.07E-02,3.09E+02,0.18,3.70E-02,3.56E+02
positive regulation of dendritic cell cytokine production (GO:0002732),0.08,4.19E-02,1.55E+03,0.03,4.85E-02,5.21E+02
response to salt stress (GO:0009651),0.04,4.01E-02,3.81E+03,0.00,1.00E+00,0.00E+00
vesicle fusion with Golgi apparatus (GO:0048280),0.04,1.06E-02,7.51E+05,0.05,1.06E-02,7.76E+02
negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.15,3.68E-04,1.17E+03,0.00,1.00E+00,0.00E+00
mitotic spindle assembly checkpoint signaling (GO:0007094),0.15,3.40E-04,1.24E+03,0.00,1.00E+00,0.00E+00
mitotic spindle checkpoint signaling (GO:0071174),0.15,3.40E-04,1.24E+03,0.00,1.00E+00,0.00E+00
spindle assembly checkpoint signaling (GO:0071173),0.15,3.40E-04,1.24E+03,0.00,1.00E+00,0.00E+00
positive regulation of type I interferon-mediated signaling pathway (GO:0060340),0.02,2.00E-02,2.80E+03,0.03,2.00E-02,2.80E+03
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.14,4.60E-02,7.61E+02,0.05,3.78E-02,6.62E+02
brain development (GO:0007420),0.02,1.85E-02,1.26E+01,0.13,4.62E-02,1.10E+02
mitochondrial calcium ion transmembrane transport (GO:0006851),0.08,3.06E-02,2.08E+01,0.08,3.36E-02,1.78E+01
synaptic vesicle cycle (GO:0099504),0.06,1.39E-02,1.17E+03,0.05,4.79E-02,8.43E+02
defense response to tumor cell (GO:0002357),0.00,1.00E+00,0.00E+00,0.15,4.02E-02,1.16E+03
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.09,4.77E-04,2.56E+03,0.08,3.49E-02,1.27E+01
regulation of membrane depolarization (GO:0003254),0.05,3.54E-02,7.08E+02,0.05,3.01E-02,5.43E+02
negative regulation of regulatory T cell differentiation (GO:0045590),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
defense response to Gram-negative bacterium (GO:0050829),0.02,4.34E-02,1.70E+02,0.00,1.00E+00,0.00E+00
reticulophagy (GO:0061709),0.07,3.72E-02,6.14E+01,0.05,2.06E-02,3.08E+01
proximal/distal pattern formation (GO:0009954),0.02,3.81E-02,2.80E+03,0.15,9.98E-03,9.62E+02
negative regulation of glial cell apoptotic process (GO:0034351),0.06,3.81E-02,6.13E+03,0.15,3.81E-02,1.39E+03
regulation of glial cell apoptotic process (GO:0034350),0.06,3.75E-02,7.30E+03,0.15,3.75E-02,1.66E+03
serotonin transport (GO:0006837),0.01,3.07E-02,3.33E+03,0.15,2.59E-02,3.33E+03
serotonin uptake (GO:0051610),0.01,3.07E-02,3.33E+03,0.15,2.59E-02,3.33E+03
"base-excision repair, AP site formation (GO:0006285)",0.03,5.31E-03,9.10E+01,0.00,1.00E+00,0.00E+00
regulation of myeloid cell differentiation (GO:0045637),0.08,3.16E-02,2.32E+02,0.08,1.62E-02,2.01E+01
chaperone-mediated protein complex assembly (GO:0051131),0.13,2.42E-03,7.50E+01,0.05,1.55E-02,2.36E+01
negative regulation of toll-like receptor signaling pathway (GO:0034122),0.00,1.00E+00,0.00E+00,0.08,4.68E-02,1.99E+02
regulation of cell morphogenesis (GO:0022604),0.08,4.30E-02,1.98E+01,0.08,1.34E-02,1.98E+01
negative regulation of T cell mediated immunity (GO:0002710),0.01,2.37E-02,7.48E+02,0.05,3.33E-02,3.94E+01
histone H3-K4 methylation (GO:0051568),0.03,4.07E-02,2.58E+02,0.08,4.07E-02,2.58E+02
regulation of cell motility (GO:2000145),0.03,2.43E-02,2.04E+02,0.08,2.43E-02,1.55E+02
negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.05,4.07E-02,9.62E+02,0.00,1.00E+00,0.00E+00
negative regulation of anoikis (GO:2000811),0.06,3.05E-02,3.05E+01,0.15,2.44E-02,8.22E+02
regulation of epithelial cell differentiation (GO:0030856),0.06,2.00E-02,9.28E+02,0.15,4.42E-02,5.07E+02
regulation of cell projection organization (GO:0031344),0.06,4.49E-02,6.68E+02,0.15,3.35E-02,9.74E+02
actomyosin structure organization (GO:0031032),0.06,4.17E-02,4.08E+02,0.15,4.17E-02,1.61E+02
establishment of mitotic spindle orientation (GO:0000132),0.16,9.08E-03,4.82E+02,0.05,9.08E-03,4.82E+02
positive regulation of actin filament bundle assembly (GO:0032233),0.18,2.73E-02,2.68E+02,0.08,8.66E-04,3.85E+01
positive regulation of T-helper 17 cell differentiation (GO:2000321),0.04,3.32E-02,1.50E+03,0.00,1.00E+00,0.00E+00
positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.04,2.28E-02,1.36E+03,0.00,1.00E+00,0.00E+00
negative regulation of catabolic process (GO:0009895),0.04,3.28E-02,2.82E+02,0.00,1.00E+00,0.00E+00
rRNA transcription (GO:0009303),0.12,2.04E-02,4.71E+01,0.03,3.95E-02,1.82E+01
positive regulation of chromosome segregation (GO:0051984),0.09,8.54E-03,2.11E+02,0.00,1.00E+00,0.00E+00
cellular glucose homeostasis (GO:0001678),0.08,3.73E-02,2.03E+02,0.03,3.52E-02,1.32E+01
positive regulation of morphogenesis of an epithelium (GO:1905332),0.01,3.71E-02,9.31E+01,0.10,4.20E-02,3.97E+02
ureteric bud morphogenesis (GO:0060675),0.00,1.00E+00,0.00E+00,0.21,3.17E-02,7.00E+01
folic acid transport (GO:0015884),0.05,2.60E-02,1.26E+02,0.15,1.43E-02,8.29E+02
purine nucleotide metabolic process (GO:0006163),0.13,1.84E-02,4.77E+01,0.00,1.00E+00,0.00E+00
regulation of receptor internalization (GO:0002090),0.05,4.79E-02,5.61E+02,0.10,3.59E-02,9.38E+02
chitin catabolic process (GO:0006032),0.05,4.71E-02,7.76E+02,0.10,4.71E-02,7.76E+02
chitin metabolic process (GO:0006030),0.05,4.71E-02,7.76E+02,0.10,4.71E-02,7.76E+02
cellular response to bacterial lipopeptide (GO:0071221),0.01,3.04E-02,2.96E+03,0.05,3.04E-02,2.96E+03
response to lipoteichoic acid (GO:0070391),0.01,3.04E-02,2.96E+03,0.05,3.04E-02,2.96E+03
cellular response to lipoteichoic acid (GO:0071223),0.01,3.04E-02,2.96E+03,0.05,3.04E-02,2.96E+03
negative regulation of transport (GO:0051051),0.01,4.54E-02,1.89E+02,0.05,4.54E-02,1.89E+02
positive regulation of interleukin-18 production (GO:0032741),0.01,3.04E-02,3.81E+03,0.05,3.04E-02,3.81E+03
regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.09,2.10E-03,1.50E+03,0.00,1.00E+00,0.00E+00
glutathione transport (GO:0034635),0.07,2.49E-02,1.12E+02,0.08,2.98E-02,1.02E+02
regulation of cellular localization (GO:0060341),0.07,4.69E-02,1.74E+02,0.08,4.69E-02,1.74E+02
negative regulation of platelet activation (GO:0010544),0.14,1.41E-02,1.15E+03,0.08,3.73E-02,7.15E+02
negative regulation of receptor signaling pathway via STAT (GO:1904893),0.12,4.04E-02,1.02E+03,0.05,3.33E-02,5.74E+01
nucleoside catabolic process (GO:0009164),0.02,4.83E-02,3.18E+02,0.00,1.00E+00,0.00E+00
monocarboxylic acid transport (GO:0015718),0.01,1.43E-02,2.74E+01,0.08,3.83E-02,5.63E+01
response to X-ray (GO:0010165),0.15,2.73E-03,8.35E+01,0.05,3.18E-02,2.41E+01
neural crest cell migration (GO:0001755),0.05,1.05E-02,9.62E+02,0.08,1.05E-02,6.38E+02
negative regulation of JNK cascade (GO:0046329),0.04,3.68E-02,4.49E+02,0.13,3.68E-02,4.49E+02
regulation of receptor catabolic process (GO:2000644),0.06,2.42E-02,1.23E+02,0.08,2.42E-02,1.02E+02
regulation of cardiac muscle cell action potential (GO:0098901),0.02,4.15E-02,3.57E+02,0.13,3.25E-02,3.57E+02
negative regulation of BMP signaling pathway (GO:0030514),0.02,2.96E-02,2.17E+02,0.13,4.53E-02,5.96E+02
regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.03,3.79E-02,2.62E+02,0.00,1.00E+00,0.00E+00
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.03,3.26E-02,4.47E+02,0.00,1.00E+00,0.00E+00
regulation of cell junction assembly (GO:1901888),0.01,2.34E-02,2.23E+01,0.10,3.39E-02,4.24E+02
regulation of cell cycle checkpoint (GO:1901976),0.05,4.63E-02,1.26E+03,0.00,1.00E+00,0.00E+00
ncRNA catabolic process (GO:0034661),0.03,3.27E-02,2.30E+01,0.00,1.00E+00,0.00E+00
Golgi to endosome transport (GO:0006895),0.03,3.42E-02,3.45E+01,0.00,1.00E+00,0.00E+00
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.00,1.80E-02,4.99E+02,0.13,2.09E-02,2.85E+02
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.02,4.13E-02,4.58E+01,0.05,4.67E-02,2.96E+02
protein polyufmylation (GO:1990564),0.05,4.64E-02,6.50E+05,0.05,2.42E-02,1.02E+02
protein K69-linked ufmylation (GO:1990592),0.05,4.64E-02,6.50E+05,0.05,2.42E-02,1.02E+02
positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.05,1.40E-02,4.08E+03,0.05,3.24E-02,1.33E+03
neural crest cell development (GO:0014032),0.05,1.34E-02,7.46E+02,0.15,1.34E-02,4.93E+02
negative regulation of leukocyte adhesion to vascular endothelial cell (GO:1904995),0.05,4.68E-02,1.01E+03,0.15,4.68E-02,1.99E+03
aminoglycan biosynthetic process (GO:0006023),0.05,3.31E-02,5.34E+02,0.15,2.47E-02,5.34E+02
negative regulation of phosphate metabolic process (GO:0045936),0.10,2.59E-02,5.49E+02,0.08,4.88E-02,2.20E+02
negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.02,4.98E-03,1.06E+03,0.03,4.98E-03,1.06E+03
regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.01,3.19E-02,2.83E+02,0.00,1.00E+00,0.00E+00
cellular response to drug (GO:0035690),0.01,2.30E-02,6.26E+02,0.00,1.00E+00,0.00E+00
sno(s)RNA 3'-end processing (GO:0031126),0.02,3.45E-02,4.36E+02,0.08,3.45E-02,4.36E+02
establishment of protein localization to chromatin (GO:0071169),0.02,3.26E-02,5.82E+02,0.08,3.26E-02,5.82E+02
protein catabolic process in the vacuole (GO:0007039),0.02,3.03E-02,7.25E+02,0.08,3.03E-02,7.25E+02
regulation of tubulin deacetylation (GO:0090043),0.02,2.23E-02,1.03E+03,0.08,2.23E-02,1.03E+03
lysosomal lumen acidification (GO:0007042),0.02,3.86E-02,4.83E+02,0.08,3.86E-02,4.83E+02
nuclear RNA surveillance (GO:0071027),0.02,1.69E-02,8.46E+02,0.08,1.69E-02,8.46E+02
protein localization to ciliary membrane (GO:1903441),0.02,4.29E-02,1.03E+03,0.08,4.29E-02,1.03E+03
lysosomal protein catabolic process (GO:1905146),0.02,2.01E-02,1.32E+03,0.08,2.01E-02,1.32E+03
activation of NF-kappaB-inducing kinase activity (GO:0007250),0.02,6.44E-03,7.79E+02,0.08,6.44E-03,7.79E+02
response to UV-B (GO:0010224),0.02,4.91E-02,2.86E+02,0.08,4.35E-02,4.36E+02
positive regulation of mitochondrial translation (GO:0070131),0.02,4.92E-02,4.28E+02,0.08,4.92E-02,4.28E+02
regulation of smooth muscle cell apoptotic process (GO:0034391),0.02,4.69E-02,4.67E+02,0.08,4.02E-02,7.08E+02
positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.02,4.69E-02,4.67E+02,0.08,4.02E-02,7.08E+02
regulation of histone H2B ubiquitination (GO:2001166),0.02,1.08E-02,1.73E+03,0.08,1.08E-02,1.73E+03
positive regulation of production of molecular mediator of immune response (GO:0002702),0.06,2.53E-02,4.51E+02,0.08,2.53E-02,2.08E+02
cellular response to metal ion (GO:0071248),0.01,3.59E-02,1.61E+02,0.15,2.59E-02,2.09E+02
beta-catenin destruction complex assembly (GO:1904885),0.04,4.33E-02,1.23E+02,0.08,2.42E-02,1.02E+02
positive chemotaxis (GO:0050918),0.04,4.35E-02,9.93E+02,0.08,4.35E-02,3.33E+02
JNK cascade (GO:0007254),0.03,1.16E-02,2.47E+01,0.03,2.65E-02,6.73E+01
regulation of extracellular exosome assembly (GO:1903551),0.11,3.89E-02,1.82E+02,0.05,7.15E-03,1.63E+02
potassium ion import across plasma membrane (GO:1990573),0.03,2.69E-02,8.16E+02,0.05,3.91E-02,1.84E+02
chronic inflammatory response (GO:0002544),0.03,4.36E-03,6.50E+03,0.00,1.00E+00,0.00E+00
negative regulation of morphogenesis of an epithelium (GO:1905331),0.03,4.47E-03,5.05E+03,0.00,1.00E+00,0.00E+00
response to testosterone (GO:0033574),0.03,4.45E-02,4.71E+01,0.00,1.00E+00,0.00E+00
5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015),0.11,3.05E-02,1.23E+02,0.00,1.00E+00,0.00E+00
5-phosphoribose 1-diphosphate metabolic process (GO:0046391),0.11,3.05E-02,1.23E+02,0.00,1.00E+00,0.00E+00
purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
coenzyme A biosynthetic process (GO:0015937),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
maintenance of blood-brain barrier (GO:0035633),0.02,4.27E-03,1.43E+03,0.08,4.27E-03,1.43E+03
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.07,1.02E-04,3.10E+03,0.05,1.02E-04,3.10E+03
regulation of osteoclast differentiation (GO:0045670),0.07,2.40E-02,5.17E+02,0.05,4.30E-02,2.55E+02
aspartate family amino acid metabolic process (GO:0009066),0.07,4.20E-03,4.34E+01,0.05,2.20E-02,2.48E+01
negative regulation of defense response to virus (GO:0050687),0.06,4.35E-02,6.39E+02,0.08,4.35E-02,6.39E+02
B cell differentiation (GO:0030183),0.09,1.25E-02,7.80E+02,0.08,1.25E-02,7.80E+02
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.01,2.77E-02,8.70E+02,0.08,4.05E-02,3.05E+02
CD40 signaling pathway (GO:0023035),0.10,1.64E-02,6.05E+01,0.05,1.10E-02,6.05E+01
regulation of platelet activation (GO:0010543),0.10,4.91E-02,7.72E+02,0.05,3.89E-02,4.77E+02
heart morphogenesis (GO:0003007),0.00,3.22E-02,2.12E+02,0.23,4.48E-02,2.12E+02
"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.10,2.05E-02,4.39E+01,0.05,1.26E-02,4.39E+01
regulation of protein modification by small protein conjugation or removal (GO:1903320),0.10,1.34E-02,4.94E+01,0.05,1.86E-03,4.94E+01
"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.10,2.05E-02,4.39E+01,0.05,1.26E-02,4.39E+01
Notch receptor processing (GO:0007220),0.05,3.89E-02,7.34E+01,0.00,1.00E+00,0.00E+00
positive regulation of dendritic cell chemotaxis (GO:2000510),0.05,4.85E-02,5.48E+02,0.03,4.85E-02,5.21E+02
positive regulation of lipid localization (GO:1905954),0.02,3.25E-02,8.23E+02,0.00,1.00E+00,0.00E+00
maturation of 5.8S rRNA (GO:0000460),0.02,5.88E-03,4.50E+01,0.03,9.63E-03,3.62E+01
negative regulation of autophagosome maturation (GO:1901097),0.03,4.64E-02,1.23E+02,0.05,2.98E-02,1.02E+02
positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.04,4.51E-02,2.24E+01,0.03,8.99E-03,2.24E+01
negative regulation of viral entry into host cell (GO:0046597),0.07,4.62E-02,1.32E+03,0.00,1.00E+00,0.00E+00
negative regulation of viral life cycle (GO:1903901),0.07,4.62E-02,1.08E+03,0.00,1.00E+00,0.00E+00
gland morphogenesis (GO:0022612),0.10,2.30E-02,8.41E+01,0.05,1.67E-02,6.95E+01
regulation of exosomal secretion (GO:1903541),0.10,3.37E-02,3.86E+01,0.05,5.09E-03,3.86E+01
xenobiotic transport across blood-brain barrier (GO:1990962),0.02,3.59E-02,2.58E+03,0.13,2.59E-02,2.58E+03
positive regulation of B cell differentiation (GO:0045579),0.01,4.13E-02,8.61E+01,0.08,4.09E-02,1.33E+03
UV-damage excision repair (GO:0070914),0.10,1.66E-02,5.50E+02,0.00,1.00E+00,0.00E+00
amino acid transport (GO:0006865),0.01,4.69E-02,1.69E+02,0.21,3.13E-02,3.63E+02
L-serine metabolic process (GO:0006563),0.10,1.21E-02,8.11E+02,0.00,1.00E+00,0.00E+00
negative regulation of endothelial cell migration (GO:0010596),0.10,3.90E-02,2.75E+02,0.00,1.00E+00,0.00E+00
neurotransmitter reuptake (GO:0098810),0.01,3.07E-02,1.75E+03,0.15,2.59E-02,1.75E+03
cell-matrix adhesion (GO:0007160),0.01,3.48E-02,1.86E+02,0.15,1.98E-02,2.69E+01
cellular response to peptide hormone stimulus (GO:0071375),0.12,5.15E-03,1.70E+01,0.03,4.35E-02,8.41E+00
negative regulation of oxidative stress-induced cell death (GO:1903202),0.12,4.55E-02,3.43E+02,0.03,3.20E-02,1.55E+01
regulation of transforming growth factor beta activation (GO:1901388),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of dendrite development (GO:1900006),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of insulin-like growth factor receptor signaling pathway (GO:0043569),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of transforming growth factor beta1 production (GO:0032908),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
interleukin-7-mediated signaling pathway (GO:0038111),0.05,1.27E-02,2.30E+03,0.00,1.00E+00,0.00E+00
positive regulation of cell activation (GO:0050867),0.05,2.07E-02,1.50E+03,0.00,1.00E+00,0.00E+00
cellular response to interleukin-7 (GO:0098761),0.05,1.27E-02,2.30E+03,0.00,1.00E+00,0.00E+00
regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.11,4.68E-02,1.01E+03,0.10,4.68E-02,1.01E+03
natural killer cell activation involved in immune response (GO:0002323),0.08,7.72E-03,2.88E+03,0.08,7.72E-03,2.88E+03
regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139),0.08,7.69E-03,3.25E+03,0.08,7.69E-03,3.25E+03
negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.06,1.76E-02,2.01E+01,0.03,4.96E-02,1.34E+01
negative regulation of myeloid cell differentiation (GO:0045638),0.17,2.40E-02,9.56E+02,0.08,1.14E-03,5.13E+01
regulation of protein metabolic process (GO:0051246),0.17,3.03E-02,2.40E+02,0.08,3.03E-02,2.40E+02
protein localization to centrosome (GO:0071539),0.12,5.59E-03,5.81E+01,0.05,3.98E-02,1.82E+01
positive regulation of endothelial cell chemotaxis (GO:2001028),0.06,2.05E-02,5.74E+02,0.13,4.00E-02,4.21E+02
negative regulation of endopeptidase activity (GO:0010951),0.06,1.61E-02,7.44E+02,0.05,1.80E-02,7.44E+02
regulation of neurotransmitter transport (GO:0051588),0.03,1.40E-02,2.55E+03,0.05,4.79E-02,1.84E+03
regulation of neurotransmitter secretion (GO:0046928),0.03,1.76E-02,1.04E+03,0.05,4.79E-02,7.49E+02
signal release from synapse (GO:0099643),0.03,1.82E-02,7.54E+02,0.05,4.79E-02,5.39E+02
positive regulation of synaptic plasticity (GO:0031915),0.03,1.31E-02,7.30E+03,0.05,4.79E-02,5.29E+03
neurotransmitter secretion (GO:0007269),0.03,1.82E-02,7.33E+02,0.05,4.79E-02,5.24E+02
plasma membrane phospholipid scrambling (GO:0017121),0.03,3.07E-02,1.75E+03,0.05,3.07E-02,1.75E+03
negative regulation of myosin-light-chain-phosphatase activity (GO:0035509),0.02,3.54E-02,3.81E+03,0.00,1.00E+00,0.00E+00
response to lead ion (GO:0010288),0.02,4.69E-02,6.58E+02,0.00,1.00E+00,0.00E+00
negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.02,4.69E-02,6.58E+02,0.00,1.00E+00,0.00E+00
negative regulation of response to interferon-gamma (GO:0060331),0.02,4.69E-02,6.58E+02,0.00,1.00E+00,0.00E+00
regulation of viral release from host cell (GO:1902186),0.04,4.35E-02,3.94E+01,0.03,1.03E-02,2.64E+01
prostaglandin biosynthetic process (GO:0001516),0.00,2.08E-02,1.15E+03,0.00,1.00E+00,0.00E+00
hexose biosynthetic process (GO:0019319),0.11,3.27E-02,2.11E+01,0.08,1.62E-02,2.10E+01
regulation of receptor signaling pathway via STAT (GO:1904892),0.06,1.17E-02,1.85E+03,0.00,1.00E+00,0.00E+00
drug transport (GO:0015893),0.02,3.59E-02,2.39E+03,0.03,3.59E-02,2.39E+03
mitochondrial DNA metabolic process (GO:0032042),0.07,4.84E-02,8.19E+02,0.08,4.84E-02,8.19E+02
negative regulation of insulin receptor signaling pathway (GO:0046627),0.08,3.11E-02,5.97E+02,0.03,1.95E-02,1.86E+01
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.00,1.00E+00,0.00E+00,0.23,4.22E-02,2.32E+01
RNA polymerase II preinitiation complex assembly (GO:0051123),0.01,4.85E-02,4.75E+01,0.05,4.35E-03,8.57E+01
positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.08,2.03E-02,1.13E+02,0.05,2.42E-02,1.02E+02
3'-UTR-mediated mRNA destabilization (GO:0061158),0.08,3.05E-02,3.43E+01,0.05,1.93E-02,3.43E+01
folic acid metabolic process (GO:0046655),0.04,2.71E-02,2.93E+01,0.00,1.00E+00,0.00E+00
serine family amino acid biosynthetic process (GO:0009070),0.04,2.59E-02,6.86E+01,0.00,1.00E+00,0.00E+00
regulation of stem cell proliferation (GO:0072091),0.04,2.00E-02,8.91E+02,0.10,1.45E-02,1.71E+03
glycoside catabolic process (GO:0016139),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of cellular response to growth factor stimulus (GO:0090288),0.00,1.00E+00,0.00E+00,0.18,2.34E-02,3.48E+02
positive regulation of killing of cells of other organism (GO:0051712),0.02,4.71E-02,7.76E+02,0.03,4.71E-02,7.76E+02
regulation of smooth muscle contraction (GO:0006940),0.02,3.42E-02,6.19E+02,0.18,3.42E-02,6.19E+02
regulation of macromolecule biosynthetic process (GO:0010556),0.07,4.72E-03,1.40E+04,0.08,4.72E-03,1.40E+04
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.07,4.22E-02,3.09E+02,0.08,1.04E-02,3.05E+01
endothelial cell proliferation (GO:0001935),0.04,4.62E-02,8.29E+02,0.08,4.35E-02,3.33E+02
"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.01,2.69E-02,3.85E+01,0.00,1.00E+00,0.00E+00
neuron fate specification (GO:0048665),0.02,3.81E-02,2.80E+03,0.10,3.81E-02,9.62E+02
positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.01,3.07E-02,1.75E+03,0.21,3.84E-02,1.75E+03
regulation of vascular associated smooth muscle cell migration (GO:1904752),0.01,3.59E-02,1.03E+03,0.21,4.22E-02,1.03E+03
positive regulation of fibroblast migration (GO:0010763),0.10,4.35E-02,4.54E+01,0.08,3.24E-02,3.99E+01
positive regulation of receptor internalization (GO:0002092),0.01,3.89E-02,1.02E+03,0.08,3.25E-02,1.63E+03
negative regulation of mononuclear cell migration (GO:0071676),0.01,4.49E-02,7.35E+02,0.08,2.75E-02,3.30E+03
protein homooligomerization (GO:0051260),0.09,1.44E-02,1.55E+01,0.00,1.00E+00,0.00E+00
negative regulation of cellular response to insulin stimulus (GO:1900077),0.10,3.26E-02,5.71E+02,0.03,2.57E-02,1.64E+01
positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),0.07,4.99E-02,1.04E+03,0.00,1.00E+00,0.00E+00
dicarboxylic acid transport (GO:0006835),0.03,4.26E-02,4.54E+02,0.15,1.24E-02,4.54E+02
5S class rRNA transcription by RNA polymerase III (GO:0042791),0.11,9.62E-03,1.97E+02,0.05,6.84E-03,1.64E+02
amine transport (GO:0015837),0.03,1.66E-02,5.29E+03,0.10,2.59E-02,3.33E+03
choline transport (GO:0015871),0.03,1.22E-02,2.96E+03,0.10,2.59E-02,2.58E+03
organic cation transport (GO:0015695),0.03,2.49E-02,6.19E+02,0.10,3.13E-02,5.38E+02
regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.05,1.40E-02,3.01E+03,0.05,3.68E-02,9.74E+02
negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.08,2.03E-03,5.23E+03,0.05,2.03E-03,5.23E+03
regulation of podosome assembly (GO:0071801),0.08,8.83E-03,4.60E+03,0.05,3.23E-02,1.50E+03
cell migration involved in sprouting angiogenesis (GO:0002042),0.06,2.05E-02,4.84E+02,0.08,3.01E-02,2.20E+03
natural killer cell activation (GO:0030101),0.06,9.83E-03,1.20E+03,0.08,9.83E-03,1.20E+03
lymphocyte proliferation (GO:0046651),0.06,9.27E-03,1.39E+03,0.08,9.27E-03,1.39E+03
mucosal immune response (GO:0002385),0.06,8.39E-03,2.02E+03,0.08,8.39E-03,2.02E+03
positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141),0.06,7.67E-03,3.48E+03,0.08,7.67E-03,3.48E+03
negative regulation of lymphocyte differentiation (GO:0045620),0.06,4.72E-03,1.43E+04,0.08,4.72E-03,1.14E+04
regulation of vascular wound healing (GO:0061043),0.02,3.54E-02,2.01E+03,0.00,1.00E+00,0.00E+00
epithelium development (GO:0060429),0.02,3.87E-02,1.44E+02,0.00,1.00E+00,0.00E+00
type B pancreatic cell development (GO:0003323),0.02,3.75E-02,3.34E+03,0.10,3.75E-02,1.15E+03
"negative regulation of gene expression, epigenetic (GO:0045814)",0.04,3.55E-02,2.89E+02,0.08,3.55E-02,2.89E+02
positive regulation of stress fiber assembly (GO:0051496),0.16,7.83E-05,5.26E+01,0.08,8.68E-04,4.26E+01
stem cell differentiation (GO:0048863),0.00,2.67E-02,3.03E+02,0.03,2.67E-02,3.03E+02
negative regulation of smooth muscle cell proliferation (GO:0048662),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
snRNA metabolic process (GO:0016073),0.01,1.52E-02,6.98E+01,0.00,1.00E+00,0.00E+00
T cell differentiation (GO:0030217),0.00,1.00E+00,0.00E+00,0.13,3.73E-02,2.29E+01
regulation of dopamine secretion (GO:0014059),0.01,4.10E-02,2.86E+02,0.13,3.25E-02,3.57E+02
positive regulation of lymphocyte apoptotic process (GO:0070230),0.01,2.60E-02,3.34E+03,0.13,4.35E-02,6.91E+01
chemical synaptic transmission (GO:0007268),0.01,4.66E-02,9.37E+01,0.13,3.19E-02,9.37E+01
DNA recombination (GO:0006310),0.03,4.47E-02,3.49E+01,0.00,1.00E+00,0.00E+00
NLS-bearing protein import into nucleus (GO:0006607),0.09,3.37E-02,3.74E+01,0.03,3.32E-02,1.85E+01
positive regulation of transport (GO:0051050),0.09,1.76E-03,2.96E+02,0.03,4.68E-02,9.46E+01
positive regulation of telomere capping (GO:1904355),0.03,4.64E-02,4.50E+01,0.05,3.49E-02,2.20E+01
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),0.00,1.00E+00,0.00E+00,0.15,2.59E-02,7.30E+03
desmosome organization (GO:0002934),0.00,1.00E+00,0.00E+00,0.15,9.37E-03,2.40E+03
hydrogen peroxide metabolic process (GO:0042743),0.00,1.00E+00,0.00E+00,0.15,2.92E-02,6.77E+02
p38MAPK cascade (GO:0038066),0.07,3.05E-02,1.20E+02,0.05,2.41E-02,1.02E+02
"negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",0.02,1.66E-02,4.11E+03,0.00,1.00E+00,0.00E+00
positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.02,4.69E-02,9.12E+02,0.00,1.00E+00,0.00E+00
negative regulation of activated T cell proliferation (GO:0046007),0.02,1.66E-02,1.85E+03,0.00,1.00E+00,0.00E+00
membrane raft distribution (GO:0031580),0.08,3.95E-02,1.01E+03,0.10,4.68E-02,1.01E+03
response to cAMP (GO:0051591),0.05,2.40E-02,4.83E+02,0.05,3.64E-02,2.09E+02
protein ufmylation (GO:0071569),0.05,6.46E-03,9.36E+05,0.05,7.15E-03,1.63E+02
"positive regulation of gene expression, epigenetic (GO:0045815)",0.15,2.08E-03,3.42E+01,0.08,9.60E-03,1.70E+01
protein localization to phagophore assembly site (GO:0034497),0.06,2.97E-02,1.04E+02,0.05,3.33E-02,2.85E+01
positive regulation of endopeptidase activity (GO:0010950),0.08,4.10E-02,3.71E+02,0.10,4.10E-02,3.71E+02
positive regulation of pinocytosis (GO:0048549),0.14,2.30E-02,2.67E+02,0.05,1.69E-02,6.90E+01
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.15,3.92E-02,2.02E+01,0.08,1.62E-02,2.02E+01
cytoskeleton-dependent intracellular transport (GO:0030705),0.15,2.16E-02,1.17E+03,0.08,2.17E-02,2.03E+01
regulation of actin filament bundle assembly (GO:0032231),0.15,1.78E-02,6.26E+02,0.08,1.85E-02,2.13E+01
tRNA transcription by RNA polymerase III (GO:0042797),0.10,2.30E-02,8.41E+01,0.05,1.67E-02,6.95E+01
negative regulation of gene silencing by miRNA (GO:0060965),0.02,3.54E-02,1.19E+03,0.05,1.45E-02,2.64E+03
regulation of peptidyl-lysine acetylation (GO:2000756),0.10,4.69E-02,9.32E+02,0.00,1.00E+00,0.00E+00
mRNA 5'-splice site recognition (GO:0000395),0.04,4.45E-02,1.63E+02,0.03,7.15E-03,1.63E+02
positive regulation of metabolic process (GO:0009893),0.06,3.09E-02,1.42E+01,0.05,7.13E-03,1.42E+01
polyol transport (GO:0015791),0.02,4.01E-02,6.11E+02,0.13,1.44E-02,6.60E+01
carbohydrate transport (GO:0008643),0.02,4.18E-02,5.01E+02,0.13,2.95E-02,4.28E+01
positive regulation of signal transduction by p53 class mediator (GO:1901798),0.08,2.82E-02,4.20E+02,0.03,4.55E-02,1.53E+01
regulation of prostaglandin biosynthetic process (GO:0031392),0.02,2.08E-02,4.11E+03,0.00,1.00E+00,0.00E+00
positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),0.02,2.08E-02,4.11E+03,0.00,1.00E+00,0.00E+00
establishment of melanosome localization (GO:0032401),0.02,4.09E-02,5.07E+02,0.00,1.00E+00,0.00E+00
positive regulation of smoothened signaling pathway (GO:0045880),0.02,3.70E-02,8.18E+02,0.00,1.00E+00,0.00E+00
positive regulation of prostaglandin biosynthetic process (GO:0031394),0.02,2.08E-02,6.50E+03,0.00,1.00E+00,0.00E+00
lymphatic endothelial cell differentiation (GO:0060836),0.02,4.85E-02,5.21E+02,0.10,4.85E-02,8.29E+02
microvillus assembly (GO:0030033),0.02,4.30E-02,4.36E+02,0.10,4.62E-02,3.62E+02
neuronal action potential (GO:0019228),0.04,3.22E-02,7.72E+02,0.13,3.21E-02,5.49E+02
organophosphate biosynthetic process (GO:0090407),0.01,3.13E-02,3.59E+02,0.00,1.00E+00,0.00E+00
neural tube closure (GO:0001843),0.02,4.41E-02,1.33E+01,0.08,4.56E-02,2.41E+02
negative regulation by host of viral transcription (GO:0043922),0.03,4.00E-02,1.50E+03,0.08,4.00E-02,5.07E+02
regulation of myeloid leukocyte differentiation (GO:0002761),0.01,4.69E-02,1.25E+03,0.00,1.00E+00,0.00E+00
negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.15,2.30E-02,8.41E+01,0.08,1.69E-02,6.95E+01
protein autoprocessing (GO:0016540),0.05,1.72E-02,7.61E+02,0.08,4.06E-02,7.61E+02
"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.05,1.47E-02,2.20E+03,0.08,8.84E-03,2.23E+02
positive regulation of actin filament polymerization (GO:0030838),0.04,2.05E-02,2.82E+02,0.08,2.05E-02,1.17E+02
response to glucocorticoid (GO:0051384),0.04,3.39E-02,4.97E+02,0.08,4.45E-02,3.68E+02
regulation of axonogenesis (GO:0050770),0.01,4.68E-02,2.23E+02,0.13,2.03E-02,4.36E+02
regulation of granulocyte colony-stimulating factor production (GO:0071655),0.03,1.54E-02,1.71E+03,0.00,1.00E+00,0.00E+00
cellular response to hormone stimulus (GO:0032870),0.03,2.05E-02,1.42E+02,0.05,3.24E-02,1.69E+01
fat cell differentiation (GO:0045444),0.04,4.99E-02,2.84E+02,0.00,1.00E+00,0.00E+00
negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.05,7.79E-03,1.85E+03,0.00,1.00E+00,0.00E+00
negative regulation of cell-substrate adhesion (GO:0010812),0.05,1.58E-02,4.53E+02,0.00,1.00E+00,0.00E+00
negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.05,7.79E-03,1.85E+03,0.00,1.00E+00,0.00E+00
blood vessel diameter maintenance (GO:0097746),0.02,2.61E-02,3.58E+02,0.03,2.61E-02,3.58E+02
protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.06,3.74E-02,2.21E+02,0.00,1.00E+00,0.00E+00
granulocyte differentiation (GO:0030851),0.06,2.49E-02,8.70E+02,0.05,4.63E-02,3.16E+02
blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),0.03,3.75E-02,3.45E+03,0.08,3.75E-02,1.42E+03
regulation of mononuclear cell proliferation (GO:0032944),0.02,4.69E-02,1.06E+03,0.00,1.00E+00,0.00E+00
positive regulation of mononuclear cell proliferation (GO:0032946),0.02,4.69E-02,1.06E+03,0.00,1.00E+00,0.00E+00
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903588),0.02,4.69E-02,8.15E+02,0.00,1.00E+00,0.00E+00
positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),0.02,4.69E-02,8.15E+02,0.00,1.00E+00,0.00E+00
positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),0.02,4.69E-02,8.15E+02,0.00,1.00E+00,0.00E+00
vesicle tethering to Golgi (GO:0099041),0.04,4.64E-02,1.19E+02,0.05,2.42E-02,1.02E+02
axon extension (GO:0048675),0.14,3.39E-02,3.35E+02,0.08,1.01E-02,2.60E+01
nucleoside salvage (GO:0043174),0.04,4.83E-02,3.18E+02,0.00,1.00E+00,0.00E+00
positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.02,4.84E-02,3.87E+02,0.15,3.42E-02,7.35E+02
regulation of keratinocyte migration (GO:0051547),0.02,2.45E-02,6.68E+02,0.15,3.35E-02,1.19E+03
positive regulation of ATP biosynthetic process (GO:2001171),0.02,3.10E-02,6.74E+02,0.15,3.31E-02,1.19E+03
positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.02,3.69E-02,6.63E+02,0.15,3.19E-02,1.07E+03
regulation of alcohol biosynthetic process (GO:1902930),0.06,1.97E-02,4.61E+01,0.00,1.00E+00,0.00E+00
gas homeostasis (GO:0033483),0.13,2.30E-02,8.41E+01,0.00,1.00E+00,0.00E+00
response to steroid hormone (GO:0048545),0.13,4.66E-02,2.14E+02,0.00,1.00E+00,0.00E+00
receptor internalization (GO:0031623),0.02,1.74E-02,6.41E+02,0.03,4.14E-02,1.09E+01
regulation of T-helper 1 cell differentiation (GO:0045625),0.05,4.83E-02,3.34E+03,0.08,4.83E-02,3.53E+02
cellular response to cGMP (GO:0071321),0.05,3.59E-02,2.95E+03,0.08,2.59E-02,2.95E+03
negative regulation of smooth muscle contraction (GO:0045986),0.05,2.03E-02,1.13E+02,0.08,3.09E-02,3.81E+03
response to cGMP (GO:0070305),0.05,3.59E-02,2.95E+03,0.08,2.59E-02,2.95E+03
regulation of B cell receptor signaling pathway (GO:0050855),0.04,1.36E-02,6.08E+02,0.13,4.93E-02,4.15E+02
muscle organ development (GO:0007517),0.07,4.00E-02,2.28E+02,0.10,4.68E-02,1.60E+02
regulation of microtubule nucleation (GO:0010968),0.06,2.93E-02,8.57E+01,0.05,3.51E-03,8.57E+01
depurination (GO:0045007),0.03,3.40E-02,9.54E+01,0.00,1.00E+00,0.00E+00
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.10,4.35E-02,9.38E+01,0.03,4.72E-02,3.11E+01
carbohydrate biosynthetic process (GO:0016051),0.02,4.22E-02,4.27E+02,0.00,1.00E+00,0.00E+00
oligosaccharide biosynthetic process (GO:0009312),0.02,4.22E-02,4.51E+02,0.00,1.00E+00,0.00E+00
positive regulation of rRNA processing (GO:2000234),0.03,5.85E-03,4.57E+02,0.03,3.27E-02,3.10E+01
negative regulation of plasminogen activation (GO:0010757),0.14,3.05E-02,1.23E+02,0.08,2.42E-02,1.02E+02
ribosomal small subunit assembly (GO:0000028),0.14,4.35E-02,3.64E+01,0.08,2.86E-02,3.62E+01
regulation of miRNA mediated inhibition of translation (GO:1905616),0.02,1.72E-03,2.43E+02,0.05,2.12E-02,6.95E+01
positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.02,1.72E-03,2.43E+02,0.05,2.12E-02,6.95E+01
negative regulation of telomere maintenance (GO:0032205),0.14,3.05E-02,4.94E+01,0.03,1.96E-02,2.68E+01
mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.12,1.12E-03,5.11E+02,0.05,3.60E-02,2.99E+02
regulation of macrophage cytokine production (GO:0010935),0.03,2.99E-02,1.68E+03,0.08,2.07E-02,8.90E+01
negative regulation of low-density lipoprotein receptor activity (GO:1905598),0.04,2.30E-02,6.97E+01,0.00,1.00E+00,0.00E+00
positive regulation of icosanoid secretion (GO:0032305),0.01,2.28E-02,3.34E+03,0.00,1.00E+00,0.00E+00
hyaluronan biosynthetic process (GO:0030213),0.01,2.28E-02,3.34E+03,0.00,1.00E+00,0.00E+00
regulation of adiponectin secretion (GO:0070163),0.01,2.28E-02,4.11E+03,0.00,1.00E+00,0.00E+00
positive regulation of humoral immune response (GO:0002922),0.01,2.28E-02,3.34E+03,0.00,1.00E+00,0.00E+00
regulation of T-helper 1 cell cytokine production (GO:2000554),0.01,2.28E-02,5.29E+03,0.00,1.00E+00,0.00E+00
positive regulation of T-helper 1 cell cytokine production (GO:2000556),0.01,2.28E-02,5.29E+03,0.00,1.00E+00,0.00E+00
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.01,2.65E-02,4.75E+02,0.00,1.00E+00,0.00E+00
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),0.01,1.91E-02,2.28E+03,0.00,1.00E+00,0.00E+00
positive regulation of prostaglandin secretion (GO:0032308),0.01,2.28E-02,5.29E+03,0.00,1.00E+00,0.00E+00
positive regulation of histone phosphorylation (GO:0033129),0.01,2.28E-02,4.11E+03,0.00,1.00E+00,0.00E+00
tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.06,4.64E-02,6.69E+01,0.00,1.00E+00,0.00E+00
response to ATP (GO:0033198),0.00,3.29E-02,5.75E+02,0.08,4.09E-02,5.07E+02
regulation of actomyosin structure organization (GO:0110020),0.13,3.05E-02,4.38E+01,0.08,2.06E-02,4.38E+01
regulation of hair cycle (GO:0042634),0.01,1.02E-02,4.60E+03,0.13,1.45E-02,3.33E+03
error-prone translesion synthesis (GO:0042276),0.08,2.76E-02,2.10E+02,0.00,1.00E+00,0.00E+00
regulation of telomere maintenance via telomere lengthening (GO:1904356),0.11,2.41E-02,3.10E+01,0.05,1.23E-02,2.95E+01
purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.03,4.10E-02,3.45E+01,0.03,3.32E-02,2.03E+01
cellular response to organonitrogen compound (GO:0071417),0.03,4.18E-02,1.36E+02,0.10,9.87E-03,3.27E+01
regulation of trophoblast cell migration (GO:1901163),0.03,3.18E-02,3.29E+01,0.10,3.19E-02,9.74E+02
nuclear cell cycle DNA replication initiation (GO:1902315),0.05,1.05E-03,3.68E+03,0.05,1.05E-03,3.68E+03
mitotic DNA replication initiation (GO:1902975),0.05,1.05E-03,3.68E+03,0.05,1.05E-03,3.68E+03
macrophage activation involved in immune response (GO:0002281),0.04,2.16E-02,9.39E+01,0.08,3.42E-02,7.35E+02
positive regulation of JNK cascade (GO:0046330),0.04,4.35E-02,1.70E+02,0.08,3.86E-02,6.64E+01
ubiquinone metabolic process (GO:0006743),0.02,3.49E-02,3.20E+02,0.08,3.49E-02,3.20E+02
quinone biosynthetic process (GO:1901663),0.02,3.49E-02,3.54E+02,0.08,3.49E-02,3.54E+02
ubiquinone biosynthetic process (GO:0006744),0.02,3.49E-02,3.20E+02,0.08,3.49E-02,3.20E+02
bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),0.00,1.00E+00,0.00E+00,0.08,4.96E-03,4.54E+02
central nervous system neuron axonogenesis (GO:0021955),0.13,3.05E-02,3.85E+01,0.08,2.06E-02,3.10E+01
rRNA transport (GO:0051029),0.13,3.05E-02,1.23E+02,0.08,2.42E-02,1.02E+02
regulation of cell-substrate adhesion (GO:0010810),0.03,2.54E-02,3.33E+02,0.13,4.84E-02,2.03E+02
acidic amino acid transport (GO:0015800),0.03,1.61E-02,9.10E+02,0.13,1.61E-02,9.10E+02
epithelial to mesenchymal transition (GO:0001837),0.03,4.77E-02,1.81E+02,0.13,4.24E-02,2.09E+02
plasma membrane organization (GO:0007009),0.02,4.87E-02,1.42E+01,0.05,3.86E-02,1.42E+01
regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.03,1.56E-02,2.06E+03,0.08,4.22E-02,5.75E+02
negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.04,4.04E-02,1.16E+03,0.00,1.00E+00,0.00E+00
regulation of myelination (GO:0031641),0.05,3.23E-02,6.57E+02,0.00,1.00E+00,0.00E+00
plus-end-directed organelle transport along microtubule (GO:0072386),0.03,1.55E-02,1.91E+02,0.03,1.06E-02,1.31E+02
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.07,1.97E-02,5.62E+01,0.05,4.78E-03,5.62E+01
pyrimidine nucleobase metabolic process (GO:0006206),0.05,3.59E-02,1.03E+03,0.08,1.45E-02,2.64E+03
cellular response to cadmium ion (GO:0071276),0.09,3.22E-02,5.97E+02,0.03,4.78E-02,1.28E+01
negative regulation of DNA-binding transcription factor activity (GO:0043433),0.06,4.88E-02,5.56E+01,0.08,3.19E-02,2.55E+02
regulation of double-strand break repair via homologous recombination (GO:0010569),0.10,1.64E-03,2.78E+01,0.00,1.00E+00,0.00E+00
chromatin silencing at telomere (GO:0006348),0.02,4.97E-03,1.14E+02,0.00,1.00E+00,0.00E+00
oligosaccharide metabolic process (GO:0009311),0.02,4.77E-02,1.72E+02,0.05,4.94E-02,4.58E+02
negative regulation of epidermal cell differentiation (GO:0045605),0.02,3.75E-02,3.34E+03,0.15,3.75E-02,1.85E+03
negative regulation of cell adhesion mediated by integrin (GO:0033629),0.02,4.01E-02,7.76E+02,0.15,2.11E-02,1.50E+03
regulation of lamellipodium morphogenesis (GO:2000392),0.02,4.35E-02,6.39E+02,0.15,4.17E-02,6.39E+02
regulation of chaperone-mediated autophagy (GO:1904714),0.04,2.72E-02,1.75E+03,0.00,1.00E+00,0.00E+00
chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),0.00,1.00E+00,0.00E+00,0.13,4.07E-02,2.64E+03
"regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.10,4.35E-02,1.18E+02,0.05,3.24E-02,3.96E+01
negative regulation of growth (GO:0045926),0.09,3.92E-02,6.75E+01,0.03,3.32E-02,8.48E+00
regulation of DNA-directed DNA polymerase activity (GO:1900262),0.03,1.07E-02,6.66E+01,0.00,1.00E+00,0.00E+00
positive regulation of DNA-directed DNA polymerase activity (GO:1900264),0.03,1.07E-02,6.66E+01,0.00,1.00E+00,0.00E+00
body fluid secretion (GO:0007589),0.02,4.69E-02,7.15E+02,0.10,2.97E-02,7.15E+02
protein desumoylation (GO:0016926),0.02,4.83E-02,8.20E+01,0.00,1.00E+00,0.00E+00
cardiac ventricle formation (GO:0003211),0.01,3.48E-02,2.28E+03,0.00,1.00E+00,0.00E+00
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.01,3.14E-02,2.96E+02,0.00,1.00E+00,0.00E+00
negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.04,3.01E-02,1.39E+03,0.05,1.45E-02,2.64E+03
protein localization to microtubule cytoskeleton (GO:0072698),0.07,4.35E-02,2.11E+02,0.00,1.00E+00,0.00E+00
positive regulation of nitrogen compound metabolic process (GO:0051173),0.06,3.54E-02,6.19E+02,0.05,3.82E-02,5.38E+02
positive regulation of cell cycle phase transition (GO:1901989),0.10,4.11E-02,8.29E+02,0.05,4.11E-02,8.29E+02
regulation of heart rate by cardiac conduction (GO:0086091),0.02,4.82E-02,2.02E+02,0.08,3.70E-02,2.02E+02
negative regulation of toll-like receptor 2 signaling pathway (GO:0034136),0.00,1.00E+00,0.00E+00,0.08,3.31E-02,2.04E+03
regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.00,1.00E+00,0.00E+00,0.08,3.42E-02,9.12E+02
negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.00,1.00E+00,0.00E+00,0.08,3.31E-02,1.03E+03
regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.00,1.00E+00,0.00E+00,0.08,3.79E-02,3.54E+02
regulation of macrophage differentiation (GO:0045649),0.05,3.88E-02,3.24E+01,0.00,1.00E+00,0.00E+00
negative regulation of chemokine production (GO:0032682),0.04,9.33E-03,8.91E+02,0.08,9.33E-03,6.31E+02
negative regulation of lipid storage (GO:0010888),0.04,3.03E-02,7.26E+02,0.08,3.49E-02,4.23E+02
positive regulation of microtubule nucleation (GO:0090063),0.06,2.30E-02,8.41E+01,0.03,1.67E-02,6.95E+01
negative regulation of cellular component organization (GO:0051129),0.06,1.39E-02,1.32E+01,0.03,4.96E-02,8.65E+00
beta-catenin destruction complex disassembly (GO:1904886),0.06,2.58E-02,2.56E+01,0.03,3.36E-02,1.76E+01
pattern recognition receptor signaling pathway (GO:0002221),0.03,8.59E-04,1.50E+03,0.05,4.83E-02,1.50E+02
negative regulation of cell-matrix adhesion (GO:0001953),0.11,2.60E-02,2.00E+01,0.08,3.33E-02,2.00E+01
melanosome transport (GO:0032402),0.02,4.09E-02,5.43E+02,0.00,1.00E+00,0.00E+00
pigment granule transport (GO:0051904),0.02,4.09E-02,5.43E+02,0.00,1.00E+00,0.00E+00
cell junction assembly (GO:0034329),0.01,4.78E-02,1.10E+02,0.03,1.53E-02,1.86E+01
inorganic ion transmembrane transport (GO:0098660),0.02,3.59E-02,1.03E+03,0.15,3.19E-02,1.19E+03
ameboidal-type cell migration (GO:0001667),0.05,1.39E-02,6.18E+02,0.08,1.39E-02,4.08E+02
nuclear DNA replication (GO:0033260),0.06,2.48E-03,1.43E+03,0.05,2.48E-03,1.43E+03
melanosome localization (GO:0032400),0.01,3.57E-02,4.46E+02,0.00,1.00E+00,0.00E+00
positive regulation of neuron death (GO:1901216),0.02,4.20E-02,2.09E+02,0.08,6.09E-04,8.83E+01
regulation of store-operated calcium entry (GO:2001256),0.02,1.38E-02,1.35E+03,0.08,1.38E-02,1.35E+03
synaptic vesicle localization (GO:0097479),0.02,2.99E-02,5.11E+02,0.08,2.99E-02,5.11E+02
synaptic vesicle transport (GO:0048489),0.02,2.99E-02,6.54E+02,0.08,2.99E-02,6.54E+02
establishment of vesicle localization (GO:0051650),0.02,4.84E-02,3.20E+02,0.08,4.84E-02,3.20E+02
regulation of pinocytosis (GO:0048548),0.02,3.89E-02,3.21E+01,0.08,3.35E-02,1.72E+03
negative regulation of amyloid fibril formation (GO:1905907),0.02,4.24E-02,2.39E+01,0.08,3.42E-02,8.15E+02
prostaglandin metabolic process (GO:0006693),0.00,2.26E-02,6.23E+02,0.00,1.00E+00,0.00E+00
negative regulation of response to reactive oxygen species (GO:1901032),0.10,4.35E-02,7.25E+01,0.00,1.00E+00,0.00E+00
respiratory chain complex IV assembly (GO:0008535),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
mitochondrial cytochrome c oxidase assembly (GO:0033617),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
response to hepatocyte growth factor (GO:0035728),0.09,3.01E-02,9.77E+01,0.05,3.24E-02,3.96E+01
cellular response to hepatocyte growth factor stimulus (GO:0035729),0.09,3.01E-02,9.77E+01,0.05,3.24E-02,3.96E+01
cholesterol metabolic process (GO:0008203),0.02,2.33E-02,2.79E+01,0.03,3.95E-02,1.02E+01
bone marrow development (GO:0048539),0.05,4.68E-02,1.01E+03,0.10,4.68E-02,1.01E+03
ruffle assembly (GO:0097178),0.05,4.71E-02,7.76E+02,0.10,4.71E-02,7.76E+02
regulation of extracellular matrix assembly (GO:1901201),0.05,4.81E-02,6.26E+02,0.10,4.81E-02,6.26E+02
histone H3 deacetylation (GO:0070932),0.04,2.78E-02,2.57E+01,0.03,1.59E-02,3.36E+01
negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.04,2.34E-02,1.03E+02,0.05,2.42E-02,1.02E+02
positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),0.08,2.93E-02,4.48E+01,0.03,2.51E-02,4.00E+01
replicative senescence (GO:0090399),0.00,1.00E+00,0.00E+00,0.13,1.45E-02,2.64E+03
aromatic compound biosynthetic process (GO:0019438),0.01,3.32E-02,1.25E+03,0.05,4.07E-02,1.04E+03
heterocycle biosynthetic process (GO:0018130),0.01,3.40E-02,5.51E+02,0.05,4.13E-02,4.58E+02
protein depolymerization (GO:0051261),0.13,2.97E-02,3.05E+02,0.00,1.00E+00,0.00E+00
negative regulation of protein depolymerization (GO:1901880),0.04,2.55E-02,1.95E+01,0.05,2.90E-02,1.76E+01
microtubule depolymerization (GO:0007019),0.04,2.19E-02,5.61E+02,0.05,4.55E-02,2.79E+02
positive regulation of spindle checkpoint (GO:0090232),0.06,1.15E-03,2.85E+03,0.05,1.15E-03,2.85E+03
positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.06,1.15E-03,2.85E+03,0.05,1.15E-03,2.85E+03
vesicle transport along actin filament (GO:0030050),0.01,3.98E-02,1.86E+01,0.05,2.20E-02,2.48E+01
amino acid transmembrane transport (GO:0003333),0.01,4.54E-02,1.92E+02,0.10,4.11E-02,1.92E+02
regulation of interleukin-1-mediated signaling pathway (GO:2000659),0.03,1.22E-02,3.45E+03,0.08,3.74E-02,2.58E+03
estrogen biosynthetic process (GO:0006703),0.02,2.40E-02,2.01E+03,0.13,3.19E-02,2.01E+03
cell projection assembly (GO:0030031),0.02,4.07E-02,5.43E+02,0.13,4.30E-02,5.43E+02
CENP-A containing nucleosome assembly (GO:0034080),0.06,5.86E-03,3.28E+02,0.00,1.00E+00,0.00E+00
CENP-A containing chromatin organization (GO:0061641),0.06,5.86E-03,3.28E+02,0.00,1.00E+00,0.00E+00
chromatin remodeling at centromere (GO:0031055),0.06,6.33E-03,2.98E+02,0.00,1.00E+00,0.00E+00
negative regulation of protein secretion (GO:0050709),0.03,1.81E-02,8.50E+02,0.00,1.00E+00,0.00E+00
positive regulation of histone acetylation (GO:0035066),0.09,2.30E-02,7.30E+02,0.00,1.00E+00,0.00E+00
RNA biosynthetic process (GO:0032774),0.00,1.00E+00,0.00E+00,0.05,1.60E-02,7.78E+02
pyrimidine nucleobase catabolic process (GO:0006208),0.04,3.59E-02,1.75E+03,0.08,1.45E-02,4.44E+03
pyrimidine-containing compound catabolic process (GO:0072529),0.04,3.84E-02,6.62E+02,0.08,1.45E-02,1.71E+03
nucleobase catabolic process (GO:0046113),0.04,3.59E-02,2.09E+03,0.08,1.45E-02,5.29E+03
negative regulation of osteoblast differentiation (GO:0045668),0.01,4.91E-02,1.79E+02,0.08,3.40E-02,1.13E+03
positive regulation of alpha-beta T cell proliferation (GO:0046641),0.01,3.40E-02,5.07E+02,0.08,3.51E-02,4.18E+02
release of cytochrome c from mitochondria (GO:0001836),0.05,3.06E-02,2.07E+01,0.03,3.95E-02,1.82E+01
intracellular protein transmembrane transport (GO:0065002),0.04,3.54E-02,2.60E+02,0.10,3.54E-02,2.60E+02
glial cell migration (GO:0008347),0.04,1.31E-02,7.30E+03,0.10,4.59E-02,7.23E+01
negative regulation of catalytic activity (GO:0043086),0.04,5.14E-03,7.78E+02,0.10,5.14E-03,7.78E+02
regulation of ubiquitin protein ligase activity (GO:1904666),0.15,4.91E-02,2.96E+02,0.05,3.35E-02,2.05E+01
negative regulation of small GTPase mediated signal transduction (GO:0051058),0.05,1.97E-02,2.27E+01,0.05,1.39E-02,2.76E+01
immature B cell differentiation (GO:0002327),0.05,3.87E-02,1.71E+03,0.05,2.42E-02,1.02E+02
regulation of JUN kinase activity (GO:0043506),0.04,4.19E-02,3.05E+02,0.05,4.19E-02,3.05E+02
transport along microtubule (GO:0010970),0.10,3.05E-02,3.57E+01,0.08,2.06E-02,3.10E+01
pyrimidine-containing compound salvage (GO:0008655),0.04,4.81E-02,3.57E+02,0.00,1.00E+00,0.00E+00
pyrimidine nucleoside salvage (GO:0043097),0.04,4.81E-02,3.57E+02,0.00,1.00E+00,0.00E+00
positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.00,1.00E+00,0.00E+00,0.08,3.42E-02,5.63E+02
oxygen transport (GO:0015671),0.07,3.31E-02,1.25E+03,0.03,4.81E-02,6.26E+02
positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.07,3.81E-02,1.67E+01,0.03,3.80E-02,1.52E+01
positive regulation by symbiont of host autophagy (GO:0075044),0.06,4.42E-02,1.93E+02,0.00,1.00E+00,0.00E+00
glycosaminoglycan catabolic process (GO:0006027),0.02,1.56E-02,3.94E+02,0.05,1.56E-02,3.94E+02
defense response to Gram-positive bacterium (GO:0050830),0.12,1.78E-03,2.93E+02,0.00,1.00E+00,0.00E+00
cellular response to alcohol (GO:0097306),0.04,4.47E-02,3.60E+02,0.08,4.47E-02,2.42E+02
positive regulation of chromatin organization (GO:1905269),0.04,1.02E-02,4.17E+01,0.08,4.13E-02,4.58E+02
regulation of antifungal innate immune response (GO:1905034),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
type B pancreatic cell proliferation (GO:0044342),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of myoblast proliferation (GO:2000288),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of transforming growth factor beta1 production (GO:0032911),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
exocrine system development (GO:0035272),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
somatic recombination of immunoglobulin gene segments (GO:0016447),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
salivary gland morphogenesis (GO:0007435),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070426),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
salivary gland development (GO:0007431),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of heart contraction (GO:0008016),0.02,3.14E-02,3.29E+02,0.00,1.00E+00,0.00E+00
rRNA 3'-end processing (GO:0031125),0.02,3.74E-02,5.18E+01,0.00,1.00E+00,0.00E+00
histone H2A monoubiquitination (GO:0035518),0.02,1.18E-02,4.25E+01,0.00,1.00E+00,0.00E+00
negative regulation of secretion by cell (GO:1903531),0.03,3.45E-02,8.50E+02,0.00,1.00E+00,0.00E+00
positive regulation of immune response to tumor cell (GO:0002839),0.03,2.46E-02,4.11E+03,0.00,1.00E+00,0.00E+00
type B pancreatic cell differentiation (GO:0003309),0.02,3.85E-02,2.40E+03,0.08,3.85E-02,8.22E+02
glandular epithelial cell development (GO:0002068),0.02,3.75E-02,3.34E+03,0.08,3.75E-02,1.15E+03
negative regulation of calcium ion transport (GO:0051926),0.05,4.70E-02,4.85E+02,0.05,1.66E-02,4.85E+02
DNA unwinding involved in DNA replication (GO:0006268),0.07,5.08E-03,8.41E+02,0.05,5.08E-03,8.41E+02
mitotic G1/S transition checkpoint signaling (GO:0044819),0.05,3.50E-02,4.14E+01,0.00,1.00E+00,0.00E+00
kinetochore assembly (GO:0051382),0.05,3.06E-02,8.32E+01,0.00,1.00E+00,0.00E+00
UDP-N-acetylglucosamine metabolic process (GO:0006047),0.07,3.70E-02,1.50E+03,0.00,1.00E+00,0.00E+00
foam cell differentiation (GO:0090077),0.08,4.69E-02,8.15E+02,0.00,1.00E+00,0.00E+00
macrophage derived foam cell differentiation (GO:0010742),0.08,4.69E-02,8.15E+02,0.00,1.00E+00,0.00E+00
toxin transport (GO:1901998),0.01,3.42E-02,1.31E+03,0.10,2.68E-02,1.31E+03
dopamine transport (GO:0015872),0.01,3.07E-02,2.09E+03,0.10,2.59E-02,2.09E+03
catecholamine uptake (GO:0090493),0.01,3.07E-02,2.09E+03,0.10,2.59E-02,2.09E+03
L-arginine import across plasma membrane (GO:0097638),0.01,3.07E-02,3.33E+03,0.10,2.59E-02,3.33E+03
secretion (GO:0046903),0.01,3.62E-02,8.48E+02,0.10,2.75E-02,8.48E+02
norepinephrine transport (GO:0015874),0.01,3.07E-02,2.58E+03,0.10,2.59E-02,2.58E+03
dopamine uptake (GO:0090494),0.01,3.07E-02,1.75E+03,0.10,2.59E-02,1.75E+03
L-arginine transmembrane transport (GO:1903400),0.01,3.07E-02,2.58E+03,0.10,2.59E-02,2.58E+03
neuron projection organization (GO:0106027),0.02,4.10E-02,1.97E+01,0.00,1.00E+00,0.00E+00
regulation of cell activation (GO:0050865),0.02,4.62E-02,1.75E+03,0.08,3.31E-02,1.03E+03
negative regulation of MAPK cascade (GO:0043409),0.06,4.49E-02,1.22E+02,0.03,1.23E-02,1.26E+01
regulation of actin polymerization or depolymerization (GO:0008064),0.08,2.18E-02,1.81E+01,0.08,4.07E-02,1.44E+01
mitochondrial respiratory chain complex assembly (GO:0033108),0.01,2.67E-02,1.16E+01,0.03,5.97E-03,1.66E+01
regulation of centriole replication (GO:0046599),0.07,6.19E-03,6.63E+02,0.05,6.19E-03,6.63E+02
negative regulation of cytoskeleton organization (GO:0051494),0.04,4.07E-02,2.83E+02,0.03,6.40E-03,2.52E+01
negative regulation of nitrogen compound metabolic process (GO:0051172),0.07,4.35E-02,4.44E+01,0.00,1.00E+00,0.00E+00
amyloid fibril formation (GO:1990000),0.07,3.86E-02,2.05E+02,0.00,1.00E+00,0.00E+00
mesenchymal cell differentiation (GO:0048762),0.02,4.80E-02,1.63E+02,0.13,4.44E-02,1.89E+02
epiboly involved in wound healing (GO:0090505),0.02,1.60E-02,2.55E+03,0.13,4.62E-02,8.22E+02
cellular response to increased oxygen levels (GO:0036295),0.01,4.57E-02,3.40E+01,0.00,1.00E+00,0.00E+00
regulation of potassium ion transmembrane transporter activity (GO:1901016),0.08,3.55E-02,4.45E+02,0.08,1.85E-02,1.99E+01
glycogen catabolic process (GO:0005980),0.08,2.91E-02,2.56E+01,0.08,4.59E-02,2.56E+01
regulation of cardiac muscle contraction (GO:0055117),0.04,6.27E-03,8.88E+02,0.05,3.59E-02,2.24E+02
positive regulation of translation in response to stress (GO:0032056),0.04,3.45E-03,6.50E+05,0.05,2.42E-02,1.02E+02
interleukin-21-mediated signaling pathway (GO:0038114),0.05,1.20E-02,2.92E+03,0.00,1.00E+00,0.00E+00
cellular response to interleukin-21 (GO:0098757),0.05,1.20E-02,2.92E+03,0.00,1.00E+00,0.00E+00
histone H3-K9 demethylation (GO:0033169),0.04,4.57E-02,4.66E+01,0.03,2.21E-02,3.18E+01
regulation of dendritic cell cytokine production (GO:0002730),0.06,4.68E-02,5.29E+03,0.03,4.68E-02,1.01E+03
regulation of insulin receptor signaling pathway (GO:0046626),0.06,3.15E-02,3.14E+02,0.03,2.31E-02,1.36E+01
positive regulation of cardioblast differentiation (GO:0051891),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of cardioblast differentiation (GO:0051890),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
amino sugar biosynthetic process (GO:0046349),0.06,3.70E-02,1.66E+03,0.00,1.00E+00,0.00E+00
positive regulation of membrane invagination (GO:1905155),0.08,3.24E-02,1.25E+03,0.08,3.31E-02,1.39E+03
negative regulation of chemotaxis (GO:0050922),0.04,1.05E-02,7.73E+02,0.08,1.05E-02,7.73E+02
regulation of homotypic cell-cell adhesion (GO:0034110),0.04,2.60E-02,1.50E+03,0.00,1.00E+00,0.00E+00
telomere maintenance via telomere lengthening (GO:0010833),0.05,4.10E-02,1.82E+01,0.05,1.63E-02,6.72E+02
negative regulation of cell adhesion (GO:0007162),0.02,3.54E-02,1.70E+02,0.08,4.93E-02,7.48E+01
regulation of neutrophil activation (GO:1902563),0.02,1.70E-03,4.20E+03,0.08,1.70E-03,4.20E+03
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.02,4.54E-02,2.84E+02,0.08,4.92E-02,5.20E+02
regulation of hippocampal neuron apoptotic process (GO:0110089),0.02,1.20E-02,5.29E+03,0.08,3.31E-02,2.64E+03
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.02,2.03E-02,2.76E+02,0.08,2.03E-02,2.76E+02
sequestering of BMP from receptor via BMP binding (GO:0038098),0.02,4.69E-02,5.48E+02,0.08,2.59E-02,6.13E+03
amylin receptor signaling pathway (GO:0097647),0.02,4.33E-02,4.39E+02,0.08,4.33E-02,4.39E+02
fluid transport (GO:0042044),0.02,4.62E-02,7.08E+02,0.08,4.62E-02,2.85E+02
regulation of histone H3-K9 trimethylation (GO:1900112),0.02,2.42E-02,1.23E+02,0.05,2.98E-02,1.02E+02
positive regulation of growth (GO:0045927),0.12,1.04E-03,1.14E+03,0.05,2.81E-02,1.08E+01
mRNA pseudouridine synthesis (GO:1990481),0.01,3.06E-02,5.50E+01,0.00,1.00E+00,0.00E+00
regulation of phospholipid metabolic process (GO:1903725),0.01,4.93E-02,4.78E+01,0.00,1.00E+00,0.00E+00
negative regulation of T cell receptor signaling pathway (GO:0050860),0.02,3.54E-02,6.61E+02,0.00,1.00E+00,0.00E+00
negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.02,4.69E-02,4.06E+02,0.00,1.00E+00,0.00E+00
regulation of protein localization to membrane (GO:1905475),0.02,3.62E-02,3.71E+02,0.00,1.00E+00,0.00E+00
positive regulation of neuroblast proliferation (GO:0002052),0.02,1.23E-02,1.85E+03,0.00,1.00E+00,0.00E+00
positive regulation of leukocyte proliferation (GO:0070665),0.02,4.83E-02,3.18E+02,0.00,1.00E+00,0.00E+00
interleukin-35-mediated signaling pathway (GO:0070757),0.02,1.20E-04,5.13E+03,0.00,1.00E+00,0.00E+00
regulation of dendritic cell chemotaxis (GO:2000508),0.02,4.69E-02,5.48E+02,0.00,1.00E+00,0.00E+00
regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),0.02,4.69E-02,6.58E+02,0.00,1.00E+00,0.00E+00
positive regulation of myotube differentiation (GO:0010831),0.02,2.47E-02,1.02E+03,0.00,1.00E+00,0.00E+00
regulation of axon guidance (GO:1902667),0.02,3.14E-02,1.16E+03,0.00,1.00E+00,0.00E+00
regulation of protein localization to cell periphery (GO:1904375),0.02,3.54E-02,6.19E+02,0.00,1.00E+00,0.00E+00
negative regulation of interleukin-17 production (GO:0032700),0.02,4.81E-02,3.57E+02,0.00,1.00E+00,0.00E+00
negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.02,4.83E-02,3.18E+02,0.00,1.00E+00,0.00E+00
protein localization to vacuole (GO:0072665),0.02,3.54E-02,9.74E+02,0.00,1.00E+00,0.00E+00
snoRNA localization (GO:0048254),0.06,3.89E-02,1.97E+02,0.00,1.00E+00,0.00E+00
regulation of sterol biosynthetic process (GO:0106118),0.06,1.64E-02,6.72E+01,0.00,1.00E+00,0.00E+00
cellular response to superoxide (GO:0071451),0.00,4.09E-02,8.23E+02,0.15,4.17E-02,1.02E+03
establishment of skin barrier (GO:0061436),0.00,2.08E-02,1.15E+03,0.15,1.59E-02,2.40E+02
regulation of water loss via skin (GO:0033561),0.00,2.08E-02,1.15E+03,0.15,1.59E-02,2.40E+02
removal of superoxide radicals (GO:0019430),0.00,3.98E-02,9.32E+02,0.15,4.02E-02,1.16E+03
bile acid and bile salt transport (GO:0015721),0.03,3.30E-02,5.29E+02,0.10,2.63E-02,2.47E+02
negative regulation of axon extension (GO:0030517),0.07,1.05E-02,8.06E+02,0.08,1.05E-02,8.06E+02
N-terminal peptidyl-methionine acetylation (GO:0017196),0.04,3.89E-02,1.86E+02,0.00,1.00E+00,0.00E+00
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.04,4.99E-03,9.20E+01,0.00,1.00E+00,0.00E+00
positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.02,4.83E-02,8.41E+01,0.03,2.12E-02,6.95E+01
negative regulation of neuron death (GO:1901215),0.02,2.68E-02,2.69E+02,0.00,1.00E+00,0.00E+00
cardiac cell fate commitment (GO:0060911),0.01,3.48E-02,2.95E+03,0.10,2.05E-02,7.06E+02
synaptic membrane adhesion (GO:0099560),0.06,4.15E-02,7.48E+02,0.00,1.00E+00,0.00E+00
regulation of metaphase plate congression (GO:0090235),0.03,4.02E-02,1.38E+03,0.08,4.02E-02,1.38E+03
positive regulation of protein kinase C signaling (GO:0090037),0.00,1.00E+00,0.00E+00,0.05,3.19E-02,1.72E+03
protein localization to microtubule (GO:0035372),0.07,4.35E-02,1.01E+02,0.03,4.72E-02,3.11E+01
protein methylation (GO:0006479),0.07,4.63E-02,1.80E+01,0.03,4.32E-02,1.15E+01
glycolipid biosynthetic process (GO:0009247),0.04,4.60E-02,3.03E+02,0.05,4.12E-02,3.03E+02
SA node cell to atrial cardiac muscle cell signaling (GO:0086018),0.04,2.80E-02,2.95E+03,0.05,2.59E-02,2.95E+03
negative regulation of osteoclast differentiation (GO:0045671),0.04,2.32E-02,1.08E+03,0.05,3.82E-02,5.38E+02
cellular respiration (GO:0045333),0.04,4.29E-02,1.64E+01,0.00,1.00E+00,0.00E+00
cellular response to nitrogen compound (GO:1901699),0.04,4.54E-02,3.83E+02,0.00,1.00E+00,0.00E+00
ubiquitin-dependent SMAD protein catabolic process (GO:0030579),0.04,4.64E-02,1.23E+02,0.00,1.00E+00,0.00E+00
positive regulation of histone H3-K9 acetylation (GO:2000617),0.08,3.05E-02,1.23E+02,0.00,1.00E+00,0.00E+00
entry of bacterium into host cell (GO:0035635),0.05,3.12E-02,8.20E+01,0.05,3.24E-02,8.20E+01
histone lysine demethylation (GO:0070076),0.05,4.52E-02,2.25E+02,0.05,4.96E-02,4.27E+01
proteoglycan biosynthetic process (GO:0030166),0.05,3.08E-02,3.09E+02,0.00,1.00E+00,0.00E+00
DNA replication-dependent nucleosome organization (GO:0034723),0.05,2.93E-02,9.44E+01,0.00,1.00E+00,0.00E+00
DNA replication-dependent nucleosome assembly (GO:0006335),0.05,2.93E-02,9.44E+01,0.00,1.00E+00,0.00E+00
negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.06,4.75E-02,2.63E+01,0.00,1.00E+00,0.00E+00
protein localization to microtubule organizing center (GO:1905508),0.08,3.05E-02,3.54E+01,0.00,1.00E+00,0.00E+00
positive regulation of autophagosome maturation (GO:1901098),0.00,1.00E+00,0.00E+00,0.08,3.18E-02,2.96E+03
regulation of B cell differentiation (GO:0045577),0.00,1.00E+00,0.00E+00,0.08,4.09E-02,5.43E+02
regulation of histone H4 acetylation (GO:0090239),0.01,4.51E-02,2.92E+01,0.03,1.39E-02,6.05E+01
"regulation of phagocytosis, engulfment (GO:0060099)",0.02,3.24E-02,9.32E+02,0.08,3.31E-02,1.03E+03
vasodilation (GO:0042311),0.02,3.43E-02,6.02E+02,0.08,3.70E-02,9.74E+02
cellular ion homeostasis (GO:0006873),0.02,1.66E-02,3.34E+03,0.08,4.09E-02,1.85E+03
response to muramyl dipeptide (GO:0032495),0.02,4.10E-02,5.51E+02,0.08,4.15E-02,8.23E+02
atrioventricular valve morphogenesis (GO:0003181),0.01,4.03E-02,3.37E+02,0.13,3.19E-02,6.61E+02
regulation of monooxygenase activity (GO:0032768),0.06,3.11E-02,6.92E+02,0.08,2.32E-02,8.57E+02
positive regulation of secretion by cell (GO:1903532),0.06,4.15E-02,3.22E+02,0.08,3.73E-02,2.16E+02
positive regulation of epithelial to mesenchymal transition (GO:0010718),0.06,2.15E-02,3.43E+02,0.08,1.61E-02,7.76E+02
positive regulation of immunoglobulin production (GO:0002639),0.06,2.26E-02,5.04E+02,0.08,2.26E-02,2.33E+02
positive regulation of endothelial cell proliferation (GO:0001938),0.00,1.00E+00,0.00E+00,0.15,2.70E-02,1.98E+02
G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.00,1.00E+00,0.00E+00,0.15,4.15E-02,5.43E+02
negative regulation of response to wounding (GO:1903035),0.00,1.00E+00,0.00E+00,0.15,4.09E-02,5.82E+02
motor neuron axon guidance (GO:0008045),0.00,1.00E+00,0.00E+00,0.15,4.20E-02,8.22E+02
regulation of multicellular organismal development (GO:2000026),0.00,1.00E+00,0.00E+00,0.15,4.44E-02,7.07E+02
Rac protein signal transduction (GO:0016601),0.00,1.00E+00,0.00E+00,0.15,4.22E-02,5.75E+02
modified amino acid transport (GO:0072337),0.00,1.00E+00,0.00E+00,0.15,4.54E-02,3.07E+02
aromatic amino acid transport (GO:0015801),0.00,1.00E+00,0.00E+00,0.15,3.84E-02,2.28E+03
glycine transport (GO:0015816),0.00,1.00E+00,0.00E+00,0.15,4.02E-02,1.16E+03
L-alanine transport (GO:0015808),0.00,1.00E+00,0.00E+00,0.15,3.84E-02,1.85E+03
apoptotic cell clearance (GO:0043277),0.00,1.00E+00,0.00E+00,0.15,4.66E-02,2.85E+02
serine transport (GO:0032329),0.00,1.00E+00,0.00E+00,0.15,3.84E-02,1.85E+03
glutamine transport (GO:0006868),0.00,1.00E+00,0.00E+00,0.15,3.84E-02,1.85E+03
phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),0.00,1.00E+00,0.00E+00,0.15,4.15E-02,1.85E+03
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.02,2.28E-02,1.50E+03,0.00,1.00E+00,0.00E+00
"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.06,1.86E-02,6.93E+02,0.03,3.42E-02,2.00E+01
"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.02,1.86E-02,1.50E+03,0.00,1.00E+00,0.00E+00
negative regulation of alpha-beta T cell proliferation (GO:0046642),0.02,1.66E-02,2.09E+03,0.00,1.00E+00,0.00E+00
"negative regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000562)",0.02,1.66E-02,2.80E+03,0.00,1.00E+00,0.00E+00
negative regulation of hormone secretion (GO:0046888),0.02,3.22E-02,2.09E+03,0.00,1.00E+00,0.00E+00
positive regulation of small molecule metabolic process (GO:0062013),0.02,3.22E-02,1.15E+03,0.00,1.00E+00,0.00E+00
regulation of toll-like receptor 3 signaling pathway (GO:0034139),0.02,3.27E-02,3.86E+01,0.00,1.00E+00,0.00E+00
negative regulation of T cell apoptotic process (GO:0070233),0.04,2.60E-02,3.34E+03,0.00,1.00E+00,0.00E+00
interleukin-23-mediated signaling pathway (GO:0038155),0.04,3.32E-02,1.07E+03,0.00,1.00E+00,0.00E+00
nuclear retention of pre-mRNA at the site of transcription (GO:0071033),0.04,4.64E-02,1.23E+02,0.00,1.00E+00,0.00E+00
protein deglycosylation (GO:0006517),0.08,4.35E-02,4.40E+01,0.00,1.00E+00,0.00E+00
Golgi inheritance (GO:0048313),0.03,2.97E-02,4.46E+01,0.03,1.25E-02,4.46E+01
peptidyl-lysine hydroxylation (GO:0017185),0.05,8.36E-03,1.12E+03,0.05,3.24E-02,3.96E+01
acute-phase response (GO:0006953),0.05,3.54E-02,1.25E+03,0.05,3.54E-02,3.62E+02
response to growth factor (GO:0070848),0.05,4.54E-02,2.16E+02,0.05,4.54E-02,2.16E+02
DNA biosynthetic process (GO:0071897),0.02,2.41E-02,3.74E+02,0.05,1.45E-02,1.71E+03
water-soluble vitamin metabolic process (GO:0006767),0.02,4.86E-02,8.58E+00,0.00,1.00E+00,0.00E+00
regulation of membrane tubulation (GO:1903525),0.02,4.12E-02,1.03E+02,0.00,1.00E+00,0.00E+00
negative regulation of axonogenesis (GO:0050771),0.04,3.08E-02,3.51E+02,0.05,1.56E-02,9.18E+02
regulation of postsynaptic membrane potential (GO:0060078),0.00,1.00E+00,0.00E+00,0.10,1.62E-02,6.96E+02
phagosome maturation (GO:0090382),0.06,4.74E-02,2.16E+02,0.08,4.32E-02,1.21E+01
neuron maturation (GO:0042551),0.06,2.54E-02,1.02E+03,0.08,2.54E-02,1.02E+03
lamellipodium assembly (GO:0030032),0.06,3.02E-02,4.45E+02,0.08,4.09E-02,4.45E+02
negative regulation of protein processing (GO:0010955),0.10,2.91E-02,2.42E+01,0.05,4.59E-02,1.92E+01
smooth muscle cell differentiation (GO:0051145),0.00,1.00E+00,0.00E+00,0.05,1.59E-02,6.10E+01
maintenance of DNA repeat elements (GO:0043570),0.01,4.71E-02,1.88E+02,0.03,1.03E-02,8.96E+03
negative regulation of transporter activity (GO:0032410),0.02,6.46E-03,1.97E+02,0.05,8.57E-03,1.64E+02
positive regulation of macrophage cytokine production (GO:0060907),0.00,2.08E-02,2.96E+03,0.08,2.98E-02,1.21E+02
embryonic heart tube morphogenesis (GO:0003143),0.01,3.58E-02,2.97E+02,0.00,1.00E+00,0.00E+00
determination of heart left/right asymmetry (GO:0061371),0.01,3.58E-02,2.97E+02,0.00,1.00E+00,0.00E+00
regulation of organ growth (GO:0046620),0.02,1.96E-02,1.54E+02,0.08,4.07E-02,7.76E+02
semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.02,1.16E-02,2.44E+03,0.08,1.16E-02,2.44E+03
protection from natural killer cell mediated cytotoxicity (GO:0042270),0.05,2.44E-02,3.45E+03,0.00,1.00E+00,0.00E+00
negative regulation of IRE1-mediated unfolded protein response (GO:1903895),0.03,4.00E-02,1.02E+02,0.05,2.42E-02,1.02E+02
positive regulation of interleukin-17 production (GO:0032740),0.03,3.22E-02,7.30E+02,0.00,1.00E+00,0.00E+00
exit from mitosis (GO:0010458),0.03,4.01E-02,6.11E+02,0.00,1.00E+00,0.00E+00
telomere capping (GO:0016233),0.03,4.46E-02,3.12E+01,0.00,1.00E+00,0.00E+00
nephric duct morphogenesis (GO:0072178),0.02,4.71E-02,7.76E+02,0.10,2.34E-02,7.76E+02
skeletal muscle contraction (GO:0003009),0.02,2.14E-02,7.26E+02,0.10,4.05E-02,7.26E+02
ribosomal small subunit export from nucleus (GO:0000056),0.09,2.30E-02,8.41E+01,0.05,1.67E-02,6.95E+01
glycolytic process through glucose-6-phosphate (GO:0061620),0.09,2.79E-02,2.29E+01,0.05,1.37E-02,2.29E+01
positive regulation of early endosome to late endosome transport (GO:2000643),0.04,3.12E-02,4.00E+01,0.05,3.24E-02,3.96E+01
glycogen metabolic process (GO:0005977),0.04,4.42E-02,2.33E+01,0.05,3.20E-02,2.33E+01
transepithelial transport (GO:0070633),0.05,3.84E-02,1.15E+03,0.08,3.84E-02,9.62E+02
regulation of mesenchymal cell proliferation (GO:0010464),0.05,3.57E-02,1.02E+03,0.08,4.90E-02,7.61E+01
protein localization to kinetochore (GO:0034501),0.07,1.29E-02,7.22E+01,0.00,1.00E+00,0.00E+00
zinc ion homeostasis (GO:0055069),0.07,1.30E-02,5.23E+02,0.00,1.00E+00,0.00E+00
positive regulation of phosphatase activity (GO:0010922),0.04,4.13E-02,2.96E+02,0.00,1.00E+00,0.00E+00
negative regulation of mast cell activation involved in immune response (GO:0033007),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
response to increased oxygen levels (GO:0036296),0.01,3.31E-02,7.89E+01,0.00,1.00E+00,0.00E+00
platelet-derived growth factor receptor signaling pathway (GO:0048008),0.02,3.57E-02,7.15E+02,0.05,3.73E-02,7.15E+02
acetyl-CoA biosynthetic process (GO:0006085),0.04,3.47E-02,5.18E+01,0.03,3.27E-02,3.10E+01
positive regulation of monocyte chemotactic protein-1 production (GO:0071639),0.04,4.85E-02,2.80E+03,0.03,4.85E-02,5.21E+02
protein transmembrane import into intracellular organelle (GO:0044743),0.02,3.41E-02,4.09E+02,0.08,3.41E-02,4.09E+02
protein import into peroxisome matrix (GO:0016558),0.02,4.57E-02,6.34E+02,0.08,4.57E-02,6.34E+02
response to cadmium ion (GO:0046686),0.06,3.22E-02,5.46E+02,0.00,1.00E+00,0.00E+00
positive regulation of heterochromatin assembly (GO:0031453),0.02,1.97E-02,3.12E+01,0.05,2.51E-02,3.10E+01
plasma membrane tubulation (GO:0097320),0.02,1.97E-02,3.12E+01,0.05,2.51E-02,3.10E+01
negative regulation of cell communication (GO:0010648),0.04,3.22E-02,9.32E+02,0.00,1.00E+00,0.00E+00
positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),0.02,3.87E-02,4.11E+03,0.00,1.00E+00,0.00E+00
cellular response to corticosteroid stimulus (GO:0071384),0.02,4.44E-02,2.03E+01,0.03,3.32E-02,2.03E+01
positive regulation of protein-containing complex disassembly (GO:0043243),0.05,1.37E-02,9.74E+02,0.08,3.70E-02,9.74E+02
regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.05,5.56E-03,8.28E+02,0.08,5.56E-03,8.28E+02
negative regulation of interleukin-13 production (GO:0032696),0.05,4.62E-02,3.81E+03,0.08,3.86E-02,5.72E+02
positive regulation of dephosphorylation (GO:0035306),0.09,2.93E-02,2.81E+01,0.00,1.00E+00,0.00E+00
G-quadruplex DNA unwinding (GO:0044806),0.09,2.30E-02,7.71E+01,0.00,1.00E+00,0.00E+00
positive regulation of oligodendrocyte differentiation (GO:0048714),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
coenzyme A metabolic process (GO:0015936),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
protein localization to condensed chromosome (GO:1903083),0.06,1.97E-02,7.56E+01,0.00,1.00E+00,0.00E+00
positive regulation of transcription of Notch receptor target (GO:0007221),0.08,4.35E-02,3.61E+01,0.05,3.19E-02,7.61E+02
regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.02,2.53E-02,5.47E+01,0.00,1.00E+00,0.00E+00
bicellular tight junction assembly (GO:0070830),0.00,1.00E+00,0.00E+00,0.08,4.38E-02,1.80E+02
heart trabecula morphogenesis (GO:0061384),0.02,4.62E-02,6.61E+02,0.05,3.97E-02,6.61E+02
positive regulation of striated muscle cell differentiation (GO:0051155),0.01,3.98E-02,3.24E+02,0.08,3.25E-02,1.34E+03
positive regulation of macrophage chemotaxis (GO:0010759),0.01,2.60E-02,1.36E+03,0.08,4.15E-02,7.48E+02
signal transduction by p53 class mediator (GO:0072331),0.01,3.37E-02,2.51E+02,0.08,3.55E-02,1.04E+03
regulation of catecholamine secretion (GO:0050433),0.01,4.35E-02,2.26E+02,0.08,3.40E-02,2.83E+02
T cell chemotaxis (GO:0010818),0.01,2.46E-02,1.85E+03,0.08,4.38E-02,4.30E+01
negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.01,2.96E-02,8.92E+02,0.08,2.66E-02,5.26E+03
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.04,3.58E-02,3.87E+02,0.00,1.00E+00,0.00E+00
mRNA 3'-splice site recognition (GO:0000389),0.04,3.89E-02,5.14E+01,0.00,1.00E+00,0.00E+00
cellular response to glucocorticoid stimulus (GO:0071385),0.04,4.71E-02,3.62E+02,0.00,1.00E+00,0.00E+00
nucleobase-containing compound catabolic process (GO:0034655),0.03,4.57E-02,2.16E+02,0.03,4.51E-02,1.09E+01
nitric oxide metabolic process (GO:0046209),0.01,3.40E-02,5.07E+02,0.00,1.00E+00,0.00E+00
nitric oxide biosynthetic process (GO:0006809),0.01,3.40E-02,5.51E+02,0.00,1.00E+00,0.00E+00
catecholamine biosynthetic process (GO:0042423),0.01,3.32E-02,7.35E+02,0.00,1.00E+00,0.00E+00
dopamine biosynthetic process (GO:0042416),0.01,3.32E-02,2.39E+03,0.00,1.00E+00,0.00E+00
pteridine-containing compound metabolic process (GO:0042558),0.01,3.40E-02,6.63E+02,0.00,1.00E+00,0.00E+00
regulation of response to reactive oxygen species (GO:1901031),0.01,3.32E-02,1.85E+03,0.00,1.00E+00,0.00E+00
secondary heart field specification (GO:0003139),0.01,3.48E-02,2.95E+03,0.00,1.00E+00,0.00E+00
regulation of cellular response to oxidative stress (GO:1900407),0.01,3.32E-02,1.07E+03,0.00,1.00E+00,0.00E+00
organic cyclic compound biosynthetic process (GO:1901362),0.01,4.41E-02,1.93E+02,0.00,1.00E+00,0.00E+00
heart field specification (GO:0003128),0.01,3.48E-02,2.95E+03,0.00,1.00E+00,0.00E+00
cellular nitrogen compound biosynthetic process (GO:0044271),0.01,4.41E-02,2.17E+02,0.00,1.00E+00,0.00E+00
pteridine-containing compound biosynthetic process (GO:0042559),0.01,3.32E-02,1.85E+03,0.00,1.00E+00,0.00E+00
neuromuscular process (GO:0050905),0.01,3.40E-02,4.07E+02,0.00,1.00E+00,0.00E+00
regulation of superoxide metabolic process (GO:0090322),0.01,3.32E-02,1.85E+03,0.00,1.00E+00,0.00E+00
dopamine metabolic process (GO:0042417),0.01,3.40E-02,4.07E+02,0.00,1.00E+00,0.00E+00
diol metabolic process (GO:0034311),0.01,3.40E-02,4.07E+02,0.00,1.00E+00,0.00E+00
diol biosynthetic process (GO:0034312),0.01,3.40E-02,4.69E+02,0.00,1.00E+00,0.00E+00
heterochromatin assembly (GO:0031507),0.05,3.06E-02,1.94E+01,0.03,2.90E-02,1.75E+01
positive regulation of deoxyribonuclease activity (GO:0032077),0.10,3.05E-02,1.13E+02,0.03,3.32E-02,8.16E+01
negative regulation of proteolysis (GO:0045861),0.08,4.95E-02,7.54E+02,0.05,4.31E-02,2.35E+02
modulation by host of viral process (GO:0044788),0.04,2.55E-02,1.39E+03,0.05,2.55E-02,5.02E+02
regulation of glycoprotein metabolic process (GO:1903018),0.04,2.55E-02,4.44E+03,0.05,2.55E-02,2.10E+03
GPI anchor metabolic process (GO:0006505),0.04,3.76E-02,4.75E+02,0.05,4.11E-02,4.75E+02
respiratory system development (GO:0060541),0.00,1.00E+00,0.00E+00,0.10,3.38E-02,2.82E+01
respiratory tube development (GO:0030323),0.00,1.00E+00,0.00E+00,0.10,3.83E-02,3.07E+01
dendritic spine maintenance (GO:0097062),0.00,1.00E+00,0.00E+00,0.10,3.31E-02,1.39E+03
positive regulation of RNA binding (GO:1905216),0.06,4.45E-02,1.65E+02,0.00,1.00E+00,0.00E+00
chloride transport (GO:0006821),0.06,1.60E-02,2.71E+02,0.00,1.00E+00,0.00E+00
regulation of striated muscle contraction (GO:0006942),0.02,4.16E-02,2.83E+02,0.05,3.40E-02,2.83E+02
indolalkylamine catabolic process (GO:0046218),0.02,3.14E-02,1.16E+03,0.05,4.07E-02,7.76E+02
synaptic vesicle recycling (GO:0036465),0.02,1.39E-02,8.61E+02,0.05,3.57E-02,2.41E+02
sodium ion import across plasma membrane (GO:0098719),0.02,3.42E-02,5.43E+02,0.05,3.01E-02,5.43E+02
cardiac muscle contraction (GO:0060048),0.02,2.61E-02,3.72E+02,0.05,2.61E-02,3.72E+02
megakaryocyte differentiation (GO:0030219),0.02,3.87E-02,1.19E+03,0.05,4.07E-02,6.11E+02
regulation of hemopoiesis (GO:1903706),0.02,1.96E-02,2.04E+03,0.05,4.07E-02,6.11E+02
alpha-amino acid catabolic process (GO:1901606),0.02,4.16E-02,2.83E+02,0.05,2.66E-02,9.21E+02
tryptophan metabolic process (GO:0006568),0.02,3.14E-02,1.02E+03,0.05,4.07E-02,6.85E+02
tryptophan catabolic process (GO:0006569),0.02,3.14E-02,1.02E+03,0.05,4.07E-02,6.85E+02
cellular amino acid biosynthetic process (GO:0008652),0.04,1.31E-02,7.30E+03,0.08,4.83E-02,3.53E+02
negative regulation of cell motility (GO:2000146),0.04,3.64E-02,6.79E+02,0.08,4.83E-02,2.00E+01
positive regulation of sprouting angiogenesis (GO:1903672),0.04,4.00E-02,1.25E+03,0.08,4.00E-02,4.21E+02
primary neural tube formation (GO:0014020),0.00,1.00E+00,0.00E+00,0.08,4.46E-02,2.83E+02
tube closure (GO:0060606),0.00,1.00E+00,0.00E+00,0.08,4.46E-02,2.71E+02
epithelial cell differentiation (GO:0030855),0.00,1.00E+00,0.00E+00,0.08,4.13E-02,2.05E+01
regulation of ERBB signaling pathway (GO:1901184),0.00,1.00E+00,0.00E+00,0.08,4.62E-02,3.33E+02
positive regulation of trophoblast cell migration (GO:1901165),0.02,3.06E-02,6.27E+01,0.03,2.52E-02,5.47E+01
regulation of calcium ion import (GO:0090279),0.07,1.68E-02,1.47E+03,0.05,4.07E-02,4.06E+02
tRNA transcription (GO:0009304),0.07,4.35E-02,4.87E+01,0.05,3.26E-02,3.99E+01
galactolipid biosynthetic process (GO:0019375),0.01,2.80E-02,1.54E+03,0.05,2.86E-02,1.09E+02
regulation of protein exit from endoplasmic reticulum (GO:0070861),0.01,4.00E-02,2.76E+01,0.05,2.51E-02,3.10E+01
galactosylceramide biosynthetic process (GO:0006682),0.01,2.80E-02,1.54E+03,0.05,2.86E-02,1.09E+02
positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.02,4.33E-02,1.17E+02,0.00,1.00E+00,0.00E+00
positive regulation of epithelial cell apoptotic process (GO:1904037),0.05,1.67E-02,1.63E+03,0.00,1.00E+00,0.00E+00
cellular response to copper ion (GO:0071280),0.05,4.60E-02,9.28E+02,0.00,1.00E+00,0.00E+00
regulation of nuclear division (GO:0051783),0.05,4.04E-02,2.35E+01,0.00,1.00E+00,0.00E+00
positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.04,2.89E-02,3.57E+02,0.00,1.00E+00,0.00E+00
oxygen homeostasis (GO:0032364),0.04,3.89E-02,5.14E+01,0.00,1.00E+00,0.00E+00
regulation of mast cell activation (GO:0033003),0.04,4.18E-02,1.03E+03,0.00,1.00E+00,0.00E+00
intracellular lipid transport (GO:0032365),0.02,5.39E-03,6.01E+02,0.08,5.39E-03,6.01E+02
carnitine shuttle (GO:0006853),0.02,2.05E-03,1.62E+03,0.08,2.05E-03,1.62E+03
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.03,4.22E-02,4.27E+02,0.03,2.13E-02,1.94E+01
negative regulation of cellular senescence (GO:2000773),0.01,3.72E-02,3.70E+01,0.05,1.45E-02,2.39E+03
regulation of endodeoxyribonuclease activity (GO:0032071),0.09,4.35E-02,1.15E+02,0.03,4.72E-02,3.11E+01
myoblast differentiation (GO:0045445),0.09,2.91E-02,3.28E+01,0.03,4.59E-02,1.91E+01
protein hydroxylation (GO:0018126),0.04,3.38E-02,6.85E+02,0.03,4.59E-02,1.91E+01
negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.04,4.32E-02,1.94E+02,0.03,1.46E-02,1.52E+01
actin filament-based transport (GO:0099515),0.00,1.00E+00,0.00E+00,0.03,4.04E-02,1.78E+01
hepaticobiliary system development (GO:0061008),0.00,1.00E+00,0.00E+00,0.03,3.00E-02,2.09E+01
hepatocyte growth factor receptor signaling pathway (GO:0048012),0.00,1.00E+00,0.00E+00,0.03,4.02E-02,2.85E+01
dosage compensation (GO:0007549),0.08,2.93E-02,4.64E+01,0.00,1.00E+00,0.00E+00
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.08,4.35E-02,3.64E+01,0.00,1.00E+00,0.00E+00
endosome organization (GO:0007032),0.03,4.32E-02,1.51E+01,0.05,4.32E-02,1.15E+01
"chemical synaptic transmission, postsynaptic (GO:0099565)",0.01,4.66E-02,5.83E+02,0.08,1.56E-02,1.06E+03
positive regulation of T-helper 1 type immune response (GO:0002827),0.02,2.28E-02,1.66E+03,0.00,1.00E+00,0.00E+00
positive regulation of type 2 immune response (GO:0002830),0.02,1.59E-02,3.01E+03,0.00,1.00E+00,0.00E+00
cellular response to interleukin-2 (GO:0071352),0.02,1.23E-02,1.85E+03,0.00,1.00E+00,0.00E+00
positive regulation of activation of Janus kinase activity (GO:0010536),0.02,2.60E-02,3.34E+03,0.00,1.00E+00,0.00E+00
interleukin-2-mediated signaling pathway (GO:0038110),0.02,1.23E-02,1.85E+03,0.00,1.00E+00,0.00E+00
regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.02,1.54E-02,8.18E+02,0.00,1.00E+00,0.00E+00
regulation of activation of Janus kinase activity (GO:0010533),0.02,2.60E-02,2.80E+03,0.00,1.00E+00,0.00E+00
fatty-acyl-CoA biosynthetic process (GO:0046949),0.02,4.91E-02,1.87E+02,0.03,4.27E-02,1.28E+01
negative regulation of nitric oxide biosynthetic process (GO:0045019),0.07,3.87E-02,7.61E+02,0.05,1.13E-02,6.05E+01
negative regulation of nitric oxide metabolic process (GO:1904406),0.07,3.87E-02,7.61E+02,0.05,1.13E-02,6.05E+01
development of primary male sexual characteristics (GO:0046546),0.00,1.00E+00,0.00E+00,0.13,4.06E-02,2.35E+02
epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.00,1.00E+00,0.00E+00,0.13,3.19E-02,1.72E+03
Notch signaling involved in heart development (GO:0061314),0.00,1.00E+00,0.00E+00,0.13,3.19E-02,1.33E+03
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.00,1.00E+00,0.00E+00,0.13,4.27E-02,8.22E+02
cell surface receptor signaling pathway involved in heart development (GO:0061311),0.00,1.00E+00,0.00E+00,0.13,3.19E-02,7.61E+02
regulation of secretion (GO:0051046),0.00,1.00E+00,0.00E+00,0.13,4.13E-02,1.54E+03
mesenchymal cell development (GO:0014031),0.00,1.00E+00,0.00E+00,0.13,3.19E-02,6.61E+02
cardiac epithelial to mesenchymal transition (GO:0060317),0.00,1.00E+00,0.00E+00,0.13,3.19E-02,6.19E+02
male gonad development (GO:0008584),0.00,1.00E+00,0.00E+00,0.13,4.06E-02,2.35E+02
vascular endothelial growth factor signaling pathway (GO:0038084),0.00,1.00E+00,0.00E+00,0.13,3.19E-02,9.74E+02
gonad development (GO:0008406),0.00,1.00E+00,0.00E+00,0.13,4.44E-02,1.89E+02
negative regulation of cell growth (GO:0030308),0.09,2.63E-02,1.30E+01,0.03,3.32E-02,8.48E+00
regulation of plasma membrane bounded cell projection organization (GO:0120035),0.01,4.42E-02,1.38E+01,0.08,4.25E-02,2.75E+02
regulation of interleukin-18 production (GO:0032661),0.01,3.10E-02,2.01E+03,0.05,3.10E-02,2.01E+03
peptidyl-proline modification (GO:0018208),0.02,3.58E-02,4.68E+02,0.10,3.58E-02,4.68E+02
protein peptidyl-prolyl isomerization (GO:0000413),0.02,3.17E-02,5.88E+02,0.10,3.17E-02,5.88E+02
action potential (GO:0001508),0.02,3.66E-02,3.14E+02,0.10,4.11E-02,2.21E+02
cellular cation homeostasis (GO:0030003),0.01,4.31E-02,1.85E+03,0.00,1.00E+00,0.00E+00
negative regulation of neuron projection development (GO:0010977),0.02,2.72E-02,7.04E+02,0.05,2.18E-02,3.71E+02
establishment of protein localization to extracellular region (GO:0035592),0.04,3.58E-02,3.06E+02,0.03,1.32E-02,1.62E+01
protein secretion (GO:0009306),0.04,4.00E-02,2.01E+02,0.03,1.30E-02,1.42E+01
peptidyl-methionine modification (GO:0018206),0.05,3.50E-02,3.19E+01,0.00,1.00E+00,0.00E+00
interstrand cross-link repair (GO:0036297),0.05,7.61E-03,3.11E+02,0.00,1.00E+00,0.00E+00
covalent chromatin modification (GO:0016569),0.07,4.65E-02,7.85E+01,0.00,1.00E+00,0.00E+00
"DNA replication, synthesis of RNA primer (GO:0006269)",0.01,2.33E-02,2.90E+02,0.00,1.00E+00,0.00E+00
cellular response to X-ray (GO:0071481),0.03,3.89E-02,5.14E+01,0.00,1.00E+00,0.00E+00
morphogenesis of an epithelium (GO:0002009),0.03,1.78E-02,8.43E+02,0.00,1.00E+00,0.00E+00
zymogen activation (GO:0031638),0.03,4.95E-02,1.68E+02,0.00,1.00E+00,0.00E+00
protein tetramerization (GO:0051262),0.03,4.32E-02,1.76E+02,0.00,1.00E+00,0.00E+00
macrophage differentiation (GO:0030225),0.03,2.47E-02,1.25E+03,0.00,1.00E+00,0.00E+00
negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.04,7.89E-03,9.21E+02,0.08,7.89E-03,9.21E+02
positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.04,4.12E-02,6.61E+02,0.08,4.64E-02,2.66E+02
cardiac muscle tissue morphogenesis (GO:0055008),0.04,2.60E-02,4.01E+02,0.08,2.60E-02,4.01E+02
negative regulation of B cell receptor signaling pathway (GO:0050859),0.04,2.29E-03,3.45E+03,0.08,2.29E-03,3.03E+03
negative regulation of axon extension involved in axon guidance (GO:0048843),0.04,1.05E-02,1.44E+03,0.08,1.05E-02,1.44E+03
cardiac atrium morphogenesis (GO:0003209),0.04,3.48E-02,5.75E+02,0.08,8.84E-03,2.03E+02
response to corticosteroid (GO:0031960),0.04,3.01E-02,1.55E+03,0.08,3.74E-02,1.16E+03
mature conventional dendritic cell differentiation (GO:0097029),0.04,3.86E-02,2.64E+03,0.08,3.86E-02,5.72E+02
cytoplasmic sequestering of NF-kappaB (GO:0007253),0.14,4.69E-02,5.48E+02,0.00,1.00E+00,0.00E+00
regulation of peptidyl-threonine phosphorylation (GO:0010799),0.08,3.33E-02,1.76E+01,0.03,2.90E-02,1.37E+01
immunoglobulin mediated immune response (GO:0016064),0.03,2.07E-02,2.58E+03,0.00,1.00E+00,0.00E+00
response to purine-containing compound (GO:0014074),0.03,4.57E-02,6.62E+02,0.00,1.00E+00,0.00E+00
negative regulation of GTPase activity (GO:0034260),0.03,3.53E-02,2.67E+01,0.00,1.00E+00,0.00E+00
myeloid cell development (GO:0061515),0.02,4.77E-02,6.19E+02,0.05,3.97E-02,6.19E+02
regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.02,4.30E-02,2.46E+02,0.05,4.30E-02,2.46E+02
RNA modification (GO:0009451),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of response to external stimulus (GO:0032102),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
entry into host (GO:0044409),0.06,1.97E-02,4.38E+01,0.05,2.06E-02,4.38E+01
actin filament bundle organization (GO:0061572),0.06,3.22E-02,1.04E+03,0.05,4.10E-02,3.29E+02
actin filament bundle assembly (GO:0051017),0.06,3.22E-02,1.04E+03,0.05,4.10E-02,3.29E+02
mesodermal cell differentiation (GO:0048333),0.02,1.82E-02,4.73E+01,0.03,1.81E-02,4.73E+01
regulation of helicase activity (GO:0051095),0.01,4.30E-02,3.63E+01,0.00,1.00E+00,0.00E+00
negative regulation of neuron apoptotic process (GO:0043524),0.04,2.26E-02,4.04E+02,0.00,1.00E+00,0.00E+00
regulation of sprouting angiogenesis (GO:1903670),0.04,3.62E-02,4.64E+02,0.00,1.00E+00,0.00E+00
maintenance of DNA methylation (GO:0010216),0.06,9.62E-03,1.82E+02,0.00,1.00E+00,0.00E+00
glomerular visceral epithelial cell migration (GO:0090521),0.06,3.05E-02,1.17E+02,0.00,1.00E+00,0.00E+00
regulation of mast cell degranulation (GO:0043304),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
autophagy of peroxisome (GO:0030242),0.02,4.57E-02,4.14E+01,0.03,2.21E-02,3.18E+01
cellular response to acid chemical (GO:0071229),0.02,3.94E-02,2.47E+02,0.03,2.57E-02,1.64E+01
microvillus organization (GO:0032528),0.02,4.30E-02,4.82E+02,0.03,1.47E-02,3.29E+01
ovarian follicle development (GO:0001541),0.02,3.99E-02,7.48E+02,0.03,3.86E-02,2.41E+01
positive regulation of neuron apoptotic process (GO:0043525),0.03,3.69E-02,4.92E+02,0.00,1.00E+00,0.00E+00
heat acclimation (GO:0010286),0.03,3.89E-02,5.14E+01,0.00,1.00E+00,0.00E+00
cellular response to thyroid hormone stimulus (GO:0097067),0.03,3.26E-02,9.12E+02,0.00,1.00E+00,0.00E+00
positive regulation of gluconeogenesis (GO:0045722),0.03,4.24E-02,1.60E+02,0.00,1.00E+00,0.00E+00
positive regulation of JUN kinase activity (GO:0043507),0.03,3.54E-02,5.19E+02,0.00,1.00E+00,0.00E+00
plasma membrane raft assembly (GO:0044854),0.03,4.45E-02,4.71E+01,0.00,1.00E+00,0.00E+00
cellular heat acclimation (GO:0070370),0.03,3.89E-02,5.14E+01,0.00,1.00E+00,0.00E+00
positive regulation of exocytosis (GO:0045921),0.06,2.40E-02,5.00E+02,0.05,4.32E-02,2.14E+01
inorganic anion transmembrane transport (GO:0098661),0.06,1.50E-02,3.37E+02,0.05,4.98E-02,1.38E+02
regulation of filopodium assembly (GO:0051489),0.06,3.48E-02,1.27E+03,0.05,4.32E-02,1.15E+01
positive regulation of neuron projection arborization (GO:0150012),0.03,7.58E-03,2.92E+03,0.08,9.66E-03,2.92E+03
regulation of neuron projection arborization (GO:0150011),0.03,1.41E-02,1.17E+03,0.08,1.80E-02,1.17E+03
negative regulation of transforming growth factor beta production (GO:0071635),0.03,8.83E-03,4.60E+03,0.08,3.74E-02,1.31E+03
ribonucleoside bisphosphate metabolic process (GO:0033875),0.03,2.43E-02,1.13E+03,0.08,2.43E-02,4.36E+02
purine nucleoside bisphosphate metabolic process (GO:0034032),0.03,2.43E-02,1.13E+03,0.08,2.43E-02,4.36E+02
retinal metabolic process (GO:0042574),0.03,2.28E-02,1.36E+03,0.08,4.71E-02,6.68E+02
"negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.12,1.64E-02,7.36E+01,0.00,1.00E+00,0.00E+00
positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.07,3.54E-02,5.49E+02,0.03,3.14E-02,1.74E+01
ncRNA metabolic process (GO:0034660),0.02,4.45E-02,2.46E+02,0.05,3.62E-02,2.16E+02
piRNA metabolic process (GO:0034587),0.02,4.22E-02,5.75E+02,0.05,3.07E-02,5.07E+02
synaptic vesicle endocytosis (GO:0048488),0.02,1.54E-02,8.78E+02,0.05,3.64E-02,2.09E+02
T cell extravasation (GO:0072683),0.06,3.55E-02,1.15E+04,0.00,1.00E+00,0.00E+00
definitive hemopoiesis (GO:0060216),0.06,3.55E-02,2.80E+03,0.00,1.00E+00,0.00E+00
ammonium transport (GO:0015696),0.04,4.01E-02,3.34E+03,0.00,1.00E+00,0.00E+00
regulation of vascular endothelial cell proliferation (GO:1905562),0.04,1.47E-02,2.20E+03,0.00,1.00E+00,0.00E+00
proteoglycan metabolic process (GO:0006029),0.04,3.06E-02,3.86E+02,0.00,1.00E+00,0.00E+00
adrenal gland development (GO:0030325),0.01,3.59E-02,9.32E+02,0.08,3.19E-02,1.50E+03
regulation of DNA biosynthetic process (GO:2000278),0.05,4.07E-02,3.36E+02,0.05,4.07E-02,3.36E+02
gluconeogenesis (GO:0006094),0.05,4.06E-02,1.56E+01,0.05,4.32E-02,1.16E+01
glial cell development (GO:0021782),0.05,3.02E-02,7.76E+02,0.05,4.09E-02,4.45E+02
positive regulation of synaptic transmission (GO:0050806),0.02,2.26E-02,3.90E+02,0.05,2.54E-02,2.77E+02
positive regulation of cell growth (GO:0030307),0.07,1.42E-03,7.83E+02,0.03,4.59E-02,8.32E+00
positive regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901228),0.00,1.00E+00,0.00E+00,0.08,2.59E-02,1.15E+04
determination of dorsal/ventral asymmetry (GO:0048262),0.00,1.00E+00,0.00E+00,0.08,2.59E-02,1.15E+04
lipoxin biosynthetic process (GO:2001301),0.00,1.00E+00,0.00E+00,0.08,4.15E-02,1.85E+03
lipid oxidation (GO:0034440),0.00,1.00E+00,0.00E+00,0.08,4.15E-02,8.23E+02
negative regulation of monocyte chemotaxis (GO:0090027),0.00,1.00E+00,0.00E+00,0.08,2.59E-02,8.96E+03
cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),0.00,1.00E+00,0.00E+00,0.08,9.37E-03,2.78E+02
negative regulation of osteoblast proliferation (GO:0033689),0.00,1.00E+00,0.00E+00,0.08,2.59E-02,6.13E+03
negative regulation of leukocyte chemotaxis (GO:0002689),0.00,1.00E+00,0.00E+00,0.08,2.68E-02,3.65E+03
skin morphogenesis (GO:0043589),0.00,1.00E+00,0.00E+00,0.08,1.46E-02,2.34E+02
negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.00,1.00E+00,0.00E+00,0.08,4.88E-02,2.20E+02
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.00,1.00E+00,0.00E+00,0.08,4.71E-02,2.49E+02
dorsal/ventral pattern formation (GO:0009953),0.00,1.00E+00,0.00E+00,0.08,3.25E-02,1.55E+03
sequestering of extracellular ligand from receptor (GO:0035581),0.00,1.00E+00,0.00E+00,0.08,2.75E-02,3.01E+03
limb development (GO:0060173),0.00,1.00E+00,0.00E+00,0.08,3.40E-02,1.22E+03
cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.00,1.00E+00,0.00E+00,0.08,4.53E-02,3.96E+02
regulation of osteoblast proliferation (GO:0033688),0.00,1.00E+00,0.00E+00,0.08,3.01E-02,2.37E+03
regulation of bone remodeling (GO:0046850),0.00,1.00E+00,0.00E+00,0.08,2.59E-02,7.30E+03
regulation of cardiac muscle cell differentiation (GO:2000725),0.00,1.00E+00,0.00E+00,0.08,2.68E-02,4.08E+03
positive regulation of leukocyte apoptotic process (GO:2000108),0.00,1.00E+00,0.00E+00,0.08,4.17E-02,5.43E+02
positive regulation of ATP metabolic process (GO:1903580),0.00,1.00E+00,0.00E+00,0.08,4.49E-02,2.23E+02
positive regulation of cardiac muscle cell differentiation (GO:2000727),0.00,1.00E+00,0.00E+00,0.08,2.59E-02,7.30E+03
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.01,3.33E-02,1.41E+01,0.03,3.33E-02,1.41E+01
gap junction assembly (GO:0016264),0.06,4.99E-02,3.34E+03,0.00,1.00E+00,0.00E+00
regulation of cardiac muscle hypertrophy (GO:0010611),0.01,9.31E-03,2.63E+01,0.00,1.00E+00,0.00E+00
membrane lipid biosynthetic process (GO:0046467),0.01,3.32E-02,1.12E+01,0.00,1.00E+00,0.00E+00
insulin secretion (GO:0030073),0.02,4.61E-02,2.40E+02,0.05,4.61E-02,2.40E+02
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.02,3.69E-02,3.58E+02,0.05,1.39E-02,2.76E+01
signal complex assembly (GO:0007172),0.03,3.87E-02,1.47E+03,0.08,3.83E-02,1.47E+03
glomerular filtration (GO:0003094),0.03,3.87E-02,1.19E+03,0.08,4.71E-02,1.19E+03
semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.03,1.16E-02,1.43E+03,0.08,1.16E-02,1.43E+03
positive regulation of actin filament depolymerization (GO:0030836),0.03,4.00E-02,6.11E+02,0.08,4.00E-02,5.63E+02
regulation of actin filament depolymerization (GO:0030834),0.03,4.00E-02,6.11E+02,0.08,4.00E-02,5.63E+02
positive regulation of protein depolymerization (GO:1901881),0.03,4.00E-02,6.11E+02,0.08,4.00E-02,5.63E+02
regulation of small GTPase mediated signal transduction (GO:0051056),0.12,3.27E-02,2.74E+02,0.00,1.00E+00,0.00E+00
cell-cell junction assembly (GO:0007043),0.02,4.99E-02,1.93E+02,0.00,1.00E+00,0.00E+00
"Notch receptor processing, ligand-dependent (GO:0035333)",0.02,1.59E-02,8.38E+01,0.00,1.00E+00,0.00E+00
protein K29-linked deubiquitination (GO:0035523),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of germinal center formation (GO:0002634),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of macrophage migration (GO:1905521),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of cardiac conduction (GO:1903779),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of mast cell activation involved in immune response (GO:0033008),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
protein K48-linked deubiquitination (GO:0071108),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
protein K11-linked deubiquitination (GO:0035871),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
activation of GTPase activity (GO:0090630),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
digestive tract morphogenesis (GO:0048546),0.02,3.09E-02,5.63E+02,0.00,1.00E+00,0.00E+00
regulation of inclusion body assembly (GO:0090083),0.06,1.12E-02,4.65E+01,0.03,3.34E-02,2.85E+01
positive regulation of osteoclast differentiation (GO:0045672),0.04,3.54E-02,8.92E+02,0.00,1.00E+00,0.00E+00
positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.04,3.01E-02,9.62E+02,0.00,1.00E+00,0.00E+00
positive regulation of osteoblast differentiation (GO:0045669),0.04,4.95E-02,4.02E+02,0.00,1.00E+00,0.00E+00
positive regulation of T-helper 17 type immune response (GO:2000318),0.04,3.32E-02,7.35E+02,0.00,1.00E+00,0.00E+00
erythrocyte differentiation (GO:0030218),0.04,3.07E-02,4.40E+02,0.00,1.00E+00,0.00E+00
positive regulation of activated T cell proliferation (GO:0042104),0.04,2.32E-02,1.08E+03,0.00,1.00E+00,0.00E+00
regulation of excitatory synapse assembly (GO:1904889),0.00,4.99E-02,8.57E+02,0.00,1.00E+00,0.00E+00
intracellular estrogen receptor signaling pathway (GO:0030520),0.05,3.81E-02,1.83E+01,0.05,3.98E-02,1.82E+01
regulation of nervous system development (GO:0051960),0.05,3.01E-02,3.43E+02,0.05,4.06E-02,2.42E+02
regulation of cell development (GO:0060284),0.05,2.99E-02,3.53E+02,0.05,4.06E-02,2.49E+02
membrane invagination (GO:0010324),0.05,2.14E-02,1.26E+03,0.05,1.69E-02,6.90E+01
skeletal system morphogenesis (GO:0048705),0.00,1.00E+00,0.00E+00,0.03,4.88E-02,1.87E+01
negative regulation of DNA recombination (GO:0045910),0.05,4.38E-02,1.73E+01,0.00,1.00E+00,0.00E+00
regulation of endocytosis (GO:0030100),0.03,4.63E-02,2.13E+02,0.03,4.55E-02,1.04E+01
positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),0.02,4.45E-02,4.71E+01,0.00,1.00E+00,0.00E+00
cardiac pacemaker cell development (GO:0060926),0.02,2.72E-02,2.09E+03,0.00,1.00E+00,0.00E+00
cellular response to nitrogen levels (GO:0043562),0.02,4.91E-02,4.02E+01,0.00,1.00E+00,0.00E+00
cellular response to nitrogen starvation (GO:0006995),0.02,4.91E-02,4.02E+01,0.00,1.00E+00,0.00E+00
neurotrophin signaling pathway (GO:0038179),0.00,4.94E-02,1.56E+01,0.00,1.00E+00,0.00E+00
positive regulation of receptor catabolic process (GO:2000646),0.00,1.68E-02,7.63E+01,0.00,1.00E+00,0.00E+00
regulation of tissue remodeling (GO:0034103),0.01,3.40E-02,3.81E+02,0.05,3.19E-02,6.19E+02
cellular response to calcium ion (GO:0071277),0.01,4.90E-02,1.51E+02,0.05,2.59E-02,4.87E+02
pulmonary valve development (GO:0003177),0.01,3.97E-02,3.62E+02,0.05,3.19E-02,7.08E+02
cellular response to osmotic stress (GO:0071470),0.10,4.91E-02,2.79E+02,0.00,1.00E+00,0.00E+00
establishment of spindle localization (GO:0051293),0.10,2.05E-02,3.78E+01,0.00,1.00E+00,0.00E+00
myeloid cell differentiation (GO:0030099),0.03,3.09E-02,3.74E+02,0.00,1.00E+00,0.00E+00
regulation of dendritic spine development (GO:0060998),0.03,4.54E-02,1.31E+03,0.00,1.00E+00,0.00E+00
cellular response to zinc ion (GO:0071294),0.03,4.60E-02,9.93E+02,0.00,1.00E+00,0.00E+00
cellular zinc ion homeostasis (GO:0006882),0.03,4.60E-02,5.71E+02,0.00,1.00E+00,0.00E+00
response to zinc ion (GO:0010043),0.03,4.60E-02,5.46E+02,0.00,1.00E+00,0.00E+00
detection of bacterium (GO:0016045),0.03,2.99E-02,1.36E+03,0.00,1.00E+00,0.00E+00
positive regulation of mRNA binding (GO:1902416),0.03,1.65E-02,6.97E+01,0.00,1.00E+00,0.00E+00
response to laminar fluid shear stress (GO:0034616),0.03,3.10E-02,9.32E+02,0.00,1.00E+00,0.00E+00
positive regulation of MAP kinase activity (GO:0043406),0.04,2.26E-02,7.96E+02,0.05,2.26E-02,7.96E+02
sarcomere organization (GO:0045214),0.00,2.45E-02,4.75E+02,0.10,2.45E-02,5.71E+02
myofibril assembly (GO:0030239),0.00,2.75E-02,2.76E+02,0.10,2.75E-02,3.33E+02
regulation of JNK cascade (GO:0046328),0.05,4.23E-02,1.06E+02,0.00,1.00E+00,0.00E+00
negative regulation of cold-induced thermogenesis (GO:0120163),0.05,1.86E-02,6.75E+02,0.00,1.00E+00,0.00E+00
cardiac ventricle development (GO:0003231),0.00,1.00E+00,0.00E+00,0.05,3.19E-02,6.19E+02
induction of positive chemotaxis (GO:0050930),0.00,1.00E+00,0.00E+00,0.05,4.07E-02,6.85E+02
intracellular cholesterol transport (GO:0032367),0.01,4.38E-02,2.56E+01,0.03,2.31E-02,2.56E+01
cellular response to testosterone stimulus (GO:0071394),0.10,3.05E-02,1.13E+02,0.00,1.00E+00,0.00E+00
regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.04,3.01E-02,1.25E+03,0.00,1.00E+00,0.00E+00
amyloid-beta metabolic process (GO:0050435),0.02,2.00E-02,8.91E+02,0.03,2.00E-02,8.91E+02
negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.01,2.37E-02,6.85E+02,0.00,1.00E+00,0.00E+00
negative regulation of natural killer cell mediated immunity (GO:0002716),0.01,2.30E-02,1.02E+03,0.00,1.00E+00,0.00E+00
positive regulation of leukocyte activation (GO:0002696),0.01,4.97E-02,4.52E+02,0.00,1.00E+00,0.00E+00
astrocyte development (GO:0014002),0.02,3.75E-02,5.05E+03,0.08,3.75E-02,1.42E+03
erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.02,4.33E-02,4.39E+02,0.08,4.33E-02,4.39E+02
positive regulation of cilium assembly (GO:0045724),0.02,4.28E-02,3.65E+02,0.08,4.28E-02,3.65E+02
regulation of phosphatidylinositol biosynthetic process (GO:0010511),0.02,3.07E-02,3.33E+03,0.08,3.07E-02,3.33E+03
cellular response to UV-A (GO:0071492),0.02,1.51E-02,1.31E+02,0.08,4.90E-02,7.61E+01
regulation of anion channel activity (GO:0010359),0.02,4.33E-02,4.39E+02,0.08,4.33E-02,4.39E+02
G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.02,1.83E-02,7.52E+02,0.08,1.83E-02,7.52E+02
regulation of translational elongation (GO:0006448),0.02,4.33E-02,4.39E+02,0.08,4.33E-02,4.39E+02
microtubule anchoring at microtubule organizing center (GO:0072393),0.02,1.38E-02,1.03E+03,0.08,1.38E-02,1.03E+03
negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.02,1.38E-02,1.03E+03,0.08,1.38E-02,1.03E+03
calcium ion import (GO:0070509),0.02,4.17E-02,2.47E+02,0.08,3.62E-02,4.05E+02
regulation of cholesterol storage (GO:0010885),0.02,2.05E-02,4.93E+02,0.08,3.42E-02,5.63E+02
negative regulation of calcineurin-mediated signaling (GO:0106057),0.02,1.38E-02,1.03E+03,0.08,1.38E-02,1.03E+03
mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),0.02,7.63E-03,3.34E+03,0.08,7.63E-03,3.34E+03
positive regulation of regulated secretory pathway (GO:1903307),0.02,3.84E-02,4.69E+02,0.08,3.19E-02,7.61E+02
regulation of glomerular mesangial cell proliferation (GO:0072124),0.02,3.07E-02,3.33E+03,0.08,3.07E-02,3.33E+03
"positive regulation of phagocytosis, engulfment (GO:0060100)",0.02,3.24E-02,1.07E+03,0.08,3.31E-02,1.19E+03
negative regulation of macrophage differentiation (GO:0045650),0.02,3.86E-02,5.72E+02,0.08,3.86E-02,5.72E+02
positive regulation of blood coagulation (GO:0030194),0.02,1.43E-02,1.07E+03,0.08,2.32E-02,1.32E+03
regulation of chloride transport (GO:2001225),0.02,3.86E-02,5.72E+02,0.08,3.86E-02,5.72E+02
astrocyte differentiation (GO:0048708),0.02,3.75E-02,4.11E+03,0.08,3.75E-02,1.15E+03
catechol-containing compound biosynthetic process (GO:0009713),0.02,3.86E-02,5.72E+02,0.08,3.86E-02,5.72E+02
glutathione metabolic process (GO:0006749),0.02,3.16E-02,1.76E+02,0.08,3.16E-02,1.76E+02
cellular polysaccharide biosynthetic process (GO:0033692),0.02,3.05E-02,4.06E+02,0.08,2.92E-02,6.58E+02
cellular carbohydrate catabolic process (GO:0044275),0.02,2.58E-02,1.60E+03,0.08,2.58E-02,1.60E+03
positive regulation of reproductive process (GO:2000243),0.02,4.83E-02,9.21E+02,0.08,3.82E-02,9.21E+02
glucocorticoid biosynthetic process (GO:0006704),0.02,3.59E-02,1.85E+03,0.08,3.19E-02,1.33E+03
positive regulation of cellular senescence (GO:2000774),0.02,4.83E-02,3.18E+02,0.08,4.22E-02,4.84E+02
positive regulation of cell aging (GO:0090343),0.02,4.91E-02,2.86E+02,0.08,4.35E-02,4.36E+02
cellular response to indole-3-methanol (GO:0071681),0.10,3.05E-02,1.13E+02,0.00,1.00E+00,0.00E+00
response to indole-3-methanol (GO:0071680),0.10,3.05E-02,1.13E+02,0.00,1.00E+00,0.00E+00
purine-containing compound catabolic process (GO:0072523),0.00,1.00E+00,0.00E+00,0.03,4.49E-02,2.32E+02
purine nucleotide catabolic process (GO:0006195),0.00,1.00E+00,0.00E+00,0.03,4.49E-02,2.32E+02
transcription by RNA polymerase III (GO:0006383),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
snRNA transcription by RNA polymerase III (GO:0042796),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
epithelial cell differentiation involved in kidney development (GO:0035850),0.02,4.99E-02,1.66E+03,0.00,1.00E+00,0.00E+00
positive regulation of protein export from nucleus (GO:0046827),0.05,2.28E-02,1.25E+03,0.03,4.59E-02,1.91E+01
organelle fusion (GO:0048284),0.04,3.21E-02,1.79E+01,0.05,4.59E-02,1.53E+01
negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.04,4.24E-02,1.35E+02,0.05,4.24E-02,3.54E+02
negative regulation of immune effector process (GO:0002698),0.04,1.42E-02,8.22E+02,0.05,1.42E-02,6.16E+02
positive regulation of immune system process (GO:0002684),0.03,1.75E-02,1.82E+03,0.00,1.00E+00,0.00E+00
amyloid precursor protein metabolic process (GO:0042982),0.03,4.12E-02,7.08E+02,0.00,1.00E+00,0.00E+00
cellular response to erythropoietin (GO:0036018),0.03,3.87E-02,5.29E+03,0.00,1.00E+00,0.00E+00
regulation of MHC class II biosynthetic process (GO:0045346),0.03,2.96E-02,9.12E+02,0.00,1.00E+00,0.00E+00
positive regulation of cell projection organization (GO:0031346),0.03,3.68E-02,1.15E+02,0.00,1.00E+00,0.00E+00
negative regulation of cell differentiation (GO:0045596),0.00,4.39E-02,7.19E+00,0.03,4.66E-02,1.14E+02
tetrahydrofolate metabolic process (GO:0046653),0.04,4.68E-02,3.20E+01,0.00,1.00E+00,0.00E+00
regulation of protein localization to cell surface (GO:2000008),0.04,3.74E-02,3.29E+02,0.00,1.00E+00,0.00E+00
mitral valve development (GO:0003174),0.04,2.80E-02,1.25E+03,0.00,1.00E+00,0.00E+00
positive regulation of reactive oxygen species metabolic process (GO:2000379),0.01,4.65E-02,1.72E+02,0.05,4.65E-02,1.72E+02
embryonic hemopoiesis (GO:0035162),0.01,3.99E-02,4.69E+02,0.05,4.11E-02,5.51E+02
positive regulation of carbohydrate metabolic process (GO:0045913),0.01,4.02E-02,4.27E+02,0.05,4.02E-02,4.27E+02
pantothenate metabolic process (GO:0015939),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
formation of extrachromosomal circular DNA (GO:0001325),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
t-circle formation (GO:0090656),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
telomere maintenance via telomere trimming (GO:0090737),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of pseudopodium assembly (GO:0031272),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of pseudopodium assembly (GO:0031274),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
telomeric D-loop disassembly (GO:0061820),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of leukocyte cell-cell adhesion (GO:1903037),0.02,4.69E-02,8.15E+02,0.00,1.00E+00,0.00E+00
positive regulation of glucose metabolic process (GO:0010907),0.02,2.37E-02,7.48E+02,0.00,1.00E+00,0.00E+00
L-serine biosynthetic process (GO:0006564),0.02,4.45E-02,4.70E+01,0.00,1.00E+00,0.00E+00
negative regulation of alcohol biosynthetic process (GO:1902931),0.02,4.10E-02,5.51E+02,0.00,1.00E+00,0.00E+00
long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.02,4.52E-02,2.50E+02,0.00,1.00E+00,0.00E+00
ventricular cardiac muscle tissue development (GO:0003229),0.02,3.91E-02,2.86E+02,0.00,1.00E+00,0.00E+00
iron ion transport (GO:0006826),0.05,3.01E-02,3.42E+02,0.03,4.92E-02,1.02E+01
regulation of DNA recombination at telomere (GO:0072695),0.05,2.66E-02,2.98E+01,0.03,4.55E-02,1.53E+01
negative regulation of DNA recombination at telomere (GO:0048239),0.05,2.66E-02,2.98E+01,0.03,4.55E-02,1.53E+01
negative regulation of microglial cell activation (GO:1903979),0.05,4.85E-02,2.80E+03,0.03,4.85E-02,5.21E+02
regulation of intracellular transport (GO:0032386),0.04,1.81E-02,8.50E+02,0.05,4.31E-02,2.66E+02
positive regulation of ERBB signaling pathway (GO:1901186),0.04,1.49E-02,2.19E+01,0.05,3.80E-02,1.68E+01
eye development (GO:0001654),0.04,3.37E-02,2.28E+02,0.05,3.37E-02,1.44E+02
negative regulation of myeloid leukocyte differentiation (GO:0002762),0.04,2.40E-02,6.77E+02,0.05,4.07E-02,3.36E+02
regulation of ossification (GO:0030278),0.04,3.31E-02,2.94E+02,0.05,4.19E-02,2.94E+02
sensory organ development (GO:0007423),0.04,3.33E-02,2.97E+02,0.05,3.33E-02,1.51E+02
regulation of sodium ion transport (GO:0002028),0.00,1.00E+00,0.00E+00,0.10,4.71E-02,2.55E+02
negative regulation of fat cell differentiation (GO:0045599),0.04,3.71E-02,3.46E+02,0.00,1.00E+00,0.00E+00
regulation of DNA recombination (GO:0000018),0.04,2.15E-02,4.26E+02,0.00,1.00E+00,0.00E+00
heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.04,3.05E-02,5.75E+02,0.00,1.00E+00,0.00E+00
nucleobase-containing small molecule interconversion (GO:0015949),0.08,3.06E-02,3.68E+02,0.00,1.00E+00,0.00E+00
response to interleukin-6 (GO:0070741),0.00,3.42E-02,1.07E+03,0.05,3.42E-02,1.07E+03
neuron projection morphogenesis (GO:0048812),0.00,1.00E+00,0.00E+00,0.03,3.44E-02,1.29E+01
positive regulation of bone mineralization (GO:0030501),0.01,4.71E-02,1.79E+02,0.03,4.71E-02,1.79E+02
"negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)",0.01,4.00E-02,9.28E+01,0.03,3.32E-02,8.16E+01
regulation of type B pancreatic cell development (GO:2000074),0.01,3.93E-02,3.59E+01,0.03,3.27E-02,3.10E+01
regulation of microtubule cytoskeleton organization (GO:0070507),0.01,2.83E-02,2.08E+01,0.00,1.00E+00,0.00E+00
protein localization to cilium (GO:0061512),0.01,1.14E-02,3.42E+01,0.00,1.00E+00,0.00E+00
tight junction assembly (GO:0120192),0.00,1.00E+00,0.00E+00,0.08,4.49E-02,1.67E+02
regulation of fibroblast apoptotic process (GO:2000269),0.00,1.00E+00,0.00E+00,0.08,2.16E-02,1.45E+02
apical junction assembly (GO:0043297),0.00,1.00E+00,0.00E+00,0.08,4.62E-02,1.53E+02
positive regulation of myeloid cell differentiation (GO:0045639),0.02,3.24E-02,4.02E+02,0.00,1.00E+00,0.00E+00
pharyngeal system development (GO:0060037),0.02,3.10E-02,5.21E+02,0.00,1.00E+00,0.00E+00
regulation of cell-cell adhesion (GO:0022407),0.02,4.63E-02,2.03E+02,0.00,1.00E+00,0.00E+00
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.02,4.35E-02,7.37E+02,0.08,4.35E-02,7.37E+02
mitochondrial DNA repair (GO:0043504),0.02,4.84E-02,1.49E+03,0.08,4.84E-02,1.49E+03
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.02,3.83E-02,9.13E+02,0.08,3.83E-02,9.13E+02
embryonic camera-type eye development (GO:0031076),0.02,4.71E-02,2.04E+03,0.08,4.71E-02,2.04E+03
regulation of actin filament-based movement (GO:1903115),0.02,3.24E-02,9.32E+02,0.08,4.02E-02,6.15E+02
positive regulation of skeletal muscle tissue development (GO:0048643),0.02,4.00E-02,2.09E+03,0.08,4.00E-02,7.15E+02
regulation of platelet aggregation (GO:0090330),0.02,3.69E-02,4.36E+02,0.08,4.62E-02,2.85E+02
fatty acid transmembrane transport (GO:1902001),0.02,5.39E-03,6.97E+02,0.08,5.39E-03,6.97E+02
positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),0.02,4.71E-02,2.04E+03,0.08,4.71E-02,2.04E+03
mesenchymal to epithelial transition (GO:0060231),0.02,4.99E-02,1.03E+03,0.08,2.03E-02,1.77E+02
midbrain dopaminergic neuron differentiation (GO:1904948),0.02,4.35E-02,6.39E+02,0.08,4.35E-02,6.39E+02
positive regulation of epithelial cell differentiation (GO:0030858),0.02,4.77E-02,4.75E+02,0.08,4.26E-02,9.26E+01
long-chain fatty acid transport (GO:0015909),0.02,1.47E-02,3.26E+02,0.08,1.47E-02,3.26E+02
regulation of neutrophil migration (GO:1902622),0.02,4.01E-02,7.76E+02,0.08,3.74E-02,1.31E+03
negative regulation of myoblast differentiation (GO:0045662),0.02,4.00E-02,1.50E+03,0.08,4.00E-02,5.07E+02
positive regulation of extracellular matrix organization (GO:1903055),0.02,3.22E-02,9.93E+02,0.08,4.62E-02,2.85E+02
negative regulation of epithelial cell differentiation (GO:0030857),0.02,4.18E-02,1.15E+03,0.08,4.18E-02,3.87E+02
spinal cord development (GO:0021510),0.02,4.00E-02,1.50E+03,0.08,4.00E-02,5.07E+02
regulation of extracellular matrix disassembly (GO:0010715),0.02,3.22E-02,1.25E+03,0.08,4.62E-02,3.62E+02
regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),0.02,3.75E-02,5.29E+03,0.08,3.75E-02,1.84E+03
marginal zone B cell differentiation (GO:0002315),0.02,3.75E-02,3.34E+03,0.08,3.75E-02,1.15E+03
protein localization to mitochondrion (GO:0070585),0.02,4.71E-02,7.35E+02,0.08,4.71E-02,7.35E+02
positive regulation of extracellular matrix disassembly (GO:0090091),0.02,3.22E-02,2.80E+03,0.08,3.84E-02,8.29E+02
commissural neuron axon guidance (GO:0071679),0.04,4.35E-02,4.00E+01,0.03,4.72E-02,3.11E+01
response to angiotensin (GO:1990776),0.04,3.89E-02,1.65E+02,0.03,1.06E-02,1.31E+02
negative regulation of dephosphorylation (GO:0035305),0.08,1.34E-02,3.24E+01,0.00,1.00E+00,0.00E+00
positive regulation of cell junction assembly (GO:1901890),0.04,4.38E-02,1.25E+01,0.00,1.00E+00,0.00E+00
visual system development (GO:0150063),0.03,2.18E-02,2.32E+02,0.05,2.18E-02,2.32E+02
lipid droplet organization (GO:0034389),0.03,4.54E-02,1.53E+01,0.05,4.59E-02,1.53E+01
natural killer cell differentiation (GO:0001779),0.03,4.85E-02,5.21E+02,0.05,4.85E-02,5.21E+02
negative regulation of hydrolase activity (GO:0051346),0.03,1.96E-02,9.95E+02,0.05,4.75E-02,1.60E+02
sulfur compound catabolic process (GO:0044273),0.02,4.54E-02,1.37E+02,0.00,1.00E+00,0.00E+00
keratan sulfate catabolic process (GO:0042340),0.02,1.77E-02,7.46E+02,0.00,1.00E+00,0.00E+00
heterotypic cell-cell adhesion (GO:0034113),0.02,3.49E-02,2.05E+02,0.00,1.00E+00,0.00E+00
keratan sulfate biosynthetic process (GO:0018146),0.02,3.30E-02,2.25E+02,0.00,1.00E+00,0.00E+00
peptidyl-lysine acetylation (GO:0018394),0.02,7.61E-03,1.01E+02,0.00,1.00E+00,0.00E+00
regulation of protein acetylation (GO:1901983),0.02,3.38E-02,5.07E+01,0.00,1.00E+00,0.00E+00
keratan sulfate metabolic process (GO:0042339),0.02,3.80E-02,1.79E+02,0.00,1.00E+00,0.00E+00
acylglycerol catabolic process (GO:0046464),0.02,3.92E-02,1.65E+02,0.00,1.00E+00,0.00E+00
positive regulation of mitochondrial depolarization (GO:0051901),0.02,2.48E-02,2.46E+02,0.00,1.00E+00,0.00E+00
regulation of long-term synaptic potentiation (GO:1900271),0.02,2.40E-02,6.49E+02,0.00,1.00E+00,0.00E+00
chromatin organization involved in negative regulation of transcription (GO:0097549),0.02,1.18E-02,1.88E+02,0.00,1.00E+00,0.00E+00
negative regulation of complement activation (GO:0045916),0.00,1.03E-02,5.74E+03,0.00,1.00E+00,0.00E+00
regulation of mitochondrial translation (GO:0070129),0.00,4.94E-02,1.56E+01,0.00,1.00E+00,0.00E+00
respiratory electron transport chain (GO:0022904),0.01,3.18E-02,2.39E+01,0.05,3.18E-02,2.41E+01
pulmonary valve morphogenesis (GO:0003184),0.01,3.97E-02,3.89E+02,0.05,3.19E-02,7.61E+02
negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.01,3.62E-02,8.48E+02,0.05,3.62E-02,8.48E+02
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.01,3.12E-02,9.29E+00,0.05,2.94E-02,2.38E+02
low-density lipoprotein receptor particle metabolic process (GO:0032799),0.04,2.93E-02,4.57E+01,0.03,2.00E-02,4.00E+01
low-density lipoprotein particle receptor catabolic process (GO:0032802),0.04,2.93E-02,4.57E+01,0.03,2.00E-02,4.00E+01
regulation of blood coagulation (GO:0030193),0.07,2.16E-02,9.60E+02,0.00,1.00E+00,0.00E+00
protein acylation (GO:0043543),0.01,1.84E-02,2.96E+01,0.00,1.00E+00,0.00E+00
mitotic spindle elongation (GO:0000022),0.01,2.22E-02,1.22E+02,0.00,1.00E+00,0.00E+00
mitotic spindle midzone assembly (GO:0051256),0.01,2.22E-02,1.22E+02,0.00,1.00E+00,0.00E+00
positive regulation of cell fate commitment (GO:0010455),0.01,3.32E-02,2.39E+03,0.00,1.00E+00,0.00E+00
positive regulation of natural killer cell proliferation (GO:0032819),0.01,3.32E-02,2.39E+03,0.00,1.00E+00,0.00E+00
regulation of NK T cell proliferation (GO:0051140),0.01,3.32E-02,2.39E+03,0.00,1.00E+00,0.00E+00
regulation of T-helper 17 cell lineage commitment (GO:2000328),0.01,3.32E-02,1.85E+03,0.00,1.00E+00,0.00E+00
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.02,4.62E-02,8.70E+02,0.08,3.35E-02,6.19E+02
proton-transporting ATP synthase complex assembly (GO:0043461),0.02,3.48E-02,1.29E+03,0.08,3.48E-02,1.29E+03
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),0.02,3.48E-02,1.68E+03,0.08,3.48E-02,1.68E+03
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.02,2.26E-02,7.07E+02,0.08,3.39E-02,4.05E+02
retina homeostasis (GO:0001895),0.02,3.26E-02,9.38E+02,0.08,4.71E-02,2.55E+02
muscle cell differentiation (GO:0042692),0.02,4.22E-02,2.07E+02,0.08,4.92E-02,2.32E+02
postsynaptic membrane assembly (GO:0097104),0.00,1.00E+00,0.00E+00,0.05,2.66E-02,1.33E+03
postsynapse assembly (GO:0099068),0.00,1.00E+00,0.00E+00,0.05,2.68E-02,1.02E+03
neuron cell-cell adhesion (GO:0007158),0.00,1.00E+00,0.00E+00,0.05,2.97E-02,6.31E+02
presynapse organization (GO:0099172),0.00,1.00E+00,0.00E+00,0.05,2.68E-02,9.12E+02
presynapse assembly (GO:0099054),0.00,1.00E+00,0.00E+00,0.05,3.01E-02,5.43E+02
presynaptic membrane organization (GO:0097090),0.00,1.00E+00,0.00E+00,0.05,2.68E-02,1.02E+03
presynaptic membrane assembly (GO:0097105),0.00,1.00E+00,0.00E+00,0.05,2.68E-02,1.16E+03
postsynaptic membrane organization (GO:0001941),0.00,1.00E+00,0.00E+00,0.05,3.07E-02,5.07E+02
cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.00,1.00E+00,0.00E+00,0.05,3.82E-02,3.16E+02
regulation of trans-synaptic signaling (GO:0099177),0.00,1.00E+00,0.00E+00,0.05,3.59E-02,2.32E+02
presynaptic endocytosis (GO:0140238),0.00,1.00E+00,0.00E+00,0.05,3.25E-02,3.24E+02
response to calcium ion (GO:0051592),0.00,1.00E+00,0.00E+00,0.05,2.59E-02,2.73E+02
positive regulation of protein sumoylation (GO:0033235),0.01,1.96E-02,4.02E+01,0.03,2.51E-02,4.00E+01
NADH dehydrogenase complex assembly (GO:0010257),0.01,2.67E-02,1.35E+01,0.03,1.39E-02,1.59E+01
mitochondrial respiratory chain complex I assembly (GO:0032981),0.01,2.67E-02,1.35E+01,0.03,1.39E-02,1.59E+01
positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.01,3.19E-02,2.86E+01,0.03,4.02E-02,2.85E+01
clathrin-dependent endocytosis (GO:0072583),0.03,2.76E-02,6.26E+02,0.05,4.96E-02,1.46E+01
positive regulation of signaling (GO:0023056),0.03,4.25E-02,2.75E+02,0.05,4.25E-02,2.75E+02
positive regulation of cell communication (GO:0010647),0.03,4.02E-02,4.05E+02,0.05,4.02E-02,4.05E+02
cellular response to ketone (GO:1901655),0.03,2.41E-02,4.68E+02,0.00,1.00E+00,0.00E+00
positive regulation of DNA-dependent DNA replication (GO:2000105),0.03,4.68E-02,3.40E+01,0.00,1.00E+00,0.00E+00
negative regulation of developmental growth (GO:0048640),0.07,3.11E-02,2.96E+02,0.00,1.00E+00,0.00E+00
regulation of extent of cell growth (GO:0061387),0.07,4.35E-02,4.45E+01,0.00,1.00E+00,0.00E+00
bicarbonate transport (GO:0015701),0.07,2.40E-02,7.52E+02,0.00,1.00E+00,0.00E+00
negative regulation of actin filament bundle assembly (GO:0032232),0.07,1.18E-02,7.40E+02,0.00,1.00E+00,0.00E+00
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.07,4.35E-02,3.99E+01,0.00,1.00E+00,0.00E+00
hemostasis (GO:0007599),0.07,4.99E-02,4.25E+03,0.00,1.00E+00,0.00E+00
mesoderm formation (GO:0001707),0.01,3.48E-02,4.75E+02,0.00,1.00E+00,0.00E+00
liver development (GO:0001889),0.01,3.62E-02,4.01E+02,0.00,1.00E+00,0.00E+00
positive regulation of low-density lipoprotein receptor activity (GO:1905599),0.01,3.34E-02,8.15E+01,0.00,1.00E+00,0.00E+00
negative regulation of developmental process (GO:0051093),0.04,4.30E-02,1.58E+02,0.03,2.31E-02,3.65E+02
collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),0.04,1.20E-02,3.34E+03,0.03,4.57E-02,2.32E+02
organophosphate ester transport (GO:0015748),0.04,2.73E-02,4.67E+02,0.03,2.86E-02,1.68E+01
odontogenesis (GO:0042476),0.04,4.57E-02,6.53E+02,0.03,1.59E-02,8.50E+02
tRNA 5'-leader removal (GO:0001682),0.02,3.88E-02,5.64E+02,0.00,1.00E+00,0.00E+00
tRNA 5'-end processing (GO:0099116),0.02,4.18E-02,4.59E+02,0.00,1.00E+00,0.00E+00
positive regulation of lipid storage (GO:0010884),0.06,2.30E-02,3.58E+02,0.00,1.00E+00,0.00E+00
positive regulation of cation channel activity (GO:2001259),0.06,1.80E-02,8.24E+02,0.00,1.00E+00,0.00E+00
leukocyte chemotaxis involved in inflammatory response (GO:0002232),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
tRNA metabolic process (GO:0006399),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
pyrimidine nucleotide-sugar transmembrane transport (GO:0090481),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
chordate embryonic development (GO:0043009),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
histone arginine methylation (GO:0034969),0.03,3.42E-02,1.11E+03,0.00,1.00E+00,0.00E+00
sulfur compound transport (GO:0072348),0.03,2.84E-02,4.05E+02,0.00,1.00E+00,0.00E+00
negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.03,4.49E-02,3.98E+02,0.00,1.00E+00,0.00E+00
RNA secondary structure unwinding (GO:0010501),0.03,2.21E-02,9.13E+02,0.00,1.00E+00,0.00E+00
cellular response to muramyl dipeptide (GO:0071225),0.02,4.01E-02,8.92E+02,0.00,1.00E+00,0.00E+00
stress granule disassembly (GO:0035617),0.02,4.00E-02,9.28E+01,0.00,1.00E+00,0.00E+00
negative regulation of sprouting angiogenesis (GO:1903671),0.02,3.25E-02,8.23E+02,0.00,1.00E+00,0.00E+00
cellular response to fluid shear stress (GO:0071498),0.02,3.43E-02,7.35E+02,0.00,1.00E+00,0.00E+00
gas transport (GO:0015669),0.02,6.25E-03,3.16E+03,0.00,1.00E+00,0.00E+00
regulation of leukocyte activation (GO:0002694),0.02,4.69E-02,1.42E+03,0.00,1.00E+00,0.00E+00
regulation of neuron apoptotic process (GO:0043523),0.02,2.68E-02,2.69E+02,0.00,1.00E+00,0.00E+00
cellular response to laminar fluid shear stress (GO:0071499),0.02,3.24E-02,1.50E+03,0.00,1.00E+00,0.00E+00
embryonic digestive tract morphogenesis (GO:0048557),0.02,4.99E-02,1.19E+03,0.00,1.00E+00,0.00E+00
chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.06,3.57E-02,1.31E+03,0.00,1.00E+00,0.00E+00
positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.06,4.57E-02,8.91E+02,0.00,1.00E+00,0.00E+00
Roundabout signaling pathway (GO:0035385),0.06,3.05E-02,1.02E+02,0.00,1.00E+00,0.00E+00
regulation of cyclase activity (GO:0031279),0.06,3.05E-02,1.02E+02,0.00,1.00E+00,0.00E+00
regulation of centrosome cycle (GO:0046605),0.06,4.39E-02,2.53E+02,0.00,1.00E+00,0.00E+00
negative regulation of blood vessel endothelial cell migration (GO:0043537),0.06,4.26E-02,3.16E+02,0.00,1.00E+00,0.00E+00
regulation of T cell tolerance induction (GO:0002664),0.01,4.31E-02,1.85E+03,0.00,1.00E+00,0.00E+00
negative regulation of cell aging (GO:0090344),0.00,1.00E+00,0.00E+00,0.05,1.45E-02,1.71E+03
nucleobase-containing compound biosynthetic process (GO:0034654),0.00,1.00E+00,0.00E+00,0.05,1.45E-02,1.39E+03
regulation of protein localization to nucleolus (GO:1904749),0.00,1.00E+00,0.00E+00,0.05,1.45E-02,4.44E+03
establishment of protein localization to chromosome (GO:0070199),0.00,1.00E+00,0.00E+00,0.05,1.45E-02,2.39E+03
negative regulation of response to stimulus (GO:0048585),0.00,1.00E+00,0.00E+00,0.05,2.25E-02,3.48E+02
establishment of protein localization to telomere (GO:0070200),0.00,1.00E+00,0.00E+00,0.05,1.45E-02,8.35E+03
long-term synaptic potentiation (GO:0060291),0.00,1.00E+00,0.00E+00,0.05,1.45E-02,1.31E+03
regulation of chaperone-mediated protein folding (GO:1903644),0.00,1.00E+00,0.00E+00,0.05,4.66E-02,2.04E+02
calcium ion transmembrane transport (GO:0070588),0.00,1.00E+00,0.00E+00,0.05,2.92E-02,2.22E+02
response to chemokine (GO:1990868),0.01,3.18E-02,2.39E+01,0.08,4.11E-02,5.01E+02
positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.01,2.10E-02,1.85E+03,0.08,4.09E-02,1.02E+03
embryonic heart tube development (GO:0035050),0.01,3.48E-02,5.43E+02,0.08,3.39E-02,1.12E+02
neuron projection regeneration (GO:0031102),0.01,3.48E-02,1.16E+03,0.08,4.09E-02,1.16E+03
ketone biosynthetic process (GO:0042181),0.01,3.59E-02,1.07E+03,0.08,3.19E-02,1.72E+03
regulation of anoikis (GO:2000209),0.01,2.48E-02,2.03E+01,0.08,3.35E-02,5.82E+02
regulation of developmental growth (GO:0048638),0.01,2.94E-02,5.02E+02,0.08,3.39E-02,3.56E+02
cellular response to oxygen levels (GO:0071453),0.01,1.65E-02,2.32E+03,0.08,1.65E-02,2.32E+03
vacuolar acidification (GO:0007035),0.01,2.54E-02,8.25E+02,0.08,2.54E-02,8.25E+02
regulation of leukocyte migration (GO:0002685),0.01,4.49E-02,5.21E+02,0.08,4.22E-02,6.62E+02
regulation of AMPA receptor activity (GO:2000311),0.01,4.52E-02,2.37E+02,0.08,4.51E-02,4.67E+02
positive regulation of acrosome reaction (GO:2000344),0.01,3.59E-02,8.23E+02,0.08,3.19E-02,1.33E+03
positive regulation of cholesterol efflux (GO:0010875),0.01,4.49E-02,3.54E+02,0.08,3.79E-02,3.54E+02
plasminogen activation (GO:0031639),0.01,3.57E-02,1.33E+03,0.08,4.26E-02,1.84E+02
regulation of cholesterol efflux (GO:0010874),0.01,4.66E-02,2.23E+02,0.08,4.49E-02,2.23E+02
positive regulation of cholesterol transport (GO:0032376),0.01,4.66E-02,2.23E+02,0.08,4.49E-02,2.23E+02
regulation of acrosome reaction (GO:0060046),0.01,3.78E-02,6.02E+02,0.08,3.19E-02,9.74E+02
cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.01,4.49E-02,1.03E+03,0.08,3.31E-02,1.03E+03
C21-steroid hormone biosynthetic process (GO:0006700),0.01,3.84E-02,5.51E+02,0.08,3.19E-02,8.92E+02
regulation of astrocyte activation (GO:0061888),0.01,3.01E-02,4.44E+03,0.08,3.31E-02,2.64E+03
response to potassium ion (GO:0035864),0.01,3.59E-02,1.25E+03,0.08,3.19E-02,2.01E+03
myoblast fusion (GO:0007520),0.01,3.84E-02,5.51E+02,0.08,3.19E-02,8.92E+02
myotube differentiation (GO:0014902),0.01,4.10E-02,3.58E+02,0.08,3.19E-02,5.82E+02
negative regulation of signal transduction by p53 class mediator (GO:1901797),0.01,2.08E-02,1.23E+03,0.08,3.35E-02,7.08E+02
positive regulation of axonogenesis (GO:0050772),0.01,3.89E-02,2.81E+02,0.08,3.89E-02,2.81E+02
mineralocorticoid biosynthetic process (GO:0006705),0.01,3.59E-02,1.85E+03,0.08,3.19E-02,2.96E+03
lipid modification (GO:0030258),0.01,3.68E-02,3.15E+02,0.08,3.68E-02,3.15E+02
cell projection organization (GO:0030030),0.01,2.85E-02,6.17E+01,0.08,4.66E-02,3.22E+02
cellular response to potassium ion (GO:0035865),0.01,3.59E-02,1.25E+03,0.08,3.19E-02,2.01E+03
axon regeneration (GO:0031103),0.01,3.48E-02,1.33E+03,0.08,4.09E-02,1.33E+03
aldehyde biosynthetic process (GO:0046184),0.01,3.59E-02,1.50E+03,0.08,3.19E-02,2.40E+03
linoleic acid metabolic process (GO:0043651),0.01,4.36E-02,2.96E+02,0.08,4.15E-02,4.46E+02
pituitary gland development (GO:0021983),0.01,3.59E-02,1.50E+03,0.08,3.19E-02,2.40E+03
cGMP-mediated signaling (GO:0019934),0.03,3.78E-02,6.02E+02,0.03,3.78E-02,6.02E+02
organic hydroxy compound transport (GO:0015850),0.03,4.50E-02,3.27E+02,0.03,4.94E-02,1.56E+02
positive regulation of leukocyte mediated immunity (GO:0002705),0.03,4.68E-02,1.71E+03,0.03,4.68E-02,1.01E+03
negative regulation of metabolic process (GO:0009892),0.06,2.03E-02,5.43E+02,0.00,1.00E+00,0.00E+00
regulation of embryonic development (GO:0045995),0.06,2.93E-02,1.55E+01,0.00,1.00E+00,0.00E+00
antifungal humoral response (GO:0019732),0.06,3.95E-02,3.46E+02,0.00,1.00E+00,0.00E+00
regulation of secretion by cell (GO:1903530),0.06,2.09E-02,5.09E+02,0.00,1.00E+00,0.00E+00
response to peptide (GO:1901652),0.06,4.19E-02,3.20E+02,0.00,1.00E+00,0.00E+00
retinoid metabolic process (GO:0001523),0.06,4.35E-03,2.92E+02,0.00,1.00E+00,0.00E+00
positive regulation of T cell receptor signaling pathway (GO:0050862),0.01,4.69E-02,6.02E+02,0.00,1.00E+00,0.00E+00
negative regulation of cellular response to hypoxia (GO:1900038),0.01,3.87E-02,1.32E+03,0.00,1.00E+00,0.00E+00
regulation of T cell differentiation in thymus (GO:0033081),0.01,4.69E-02,6.63E+02,0.00,1.00E+00,0.00E+00
positive regulation of transforming growth factor beta production (GO:0071636),0.01,3.87E-02,5.84E+02,0.00,1.00E+00,0.00E+00
regulation of digestive system process (GO:0044058),0.02,4.69E-02,8.15E+02,0.05,4.07E-02,1.54E+03
integrin activation (GO:0033622),0.02,1.20E-02,2.80E+03,0.05,4.07E-02,1.04E+03
negative regulation of MAP kinase activity (GO:0043407),0.02,3.26E-02,2.90E+02,0.05,4.44E-02,2.04E+02
positive regulation of integrin activation (GO:0033625),0.02,3.42E-02,1.33E+03,0.05,3.42E-02,1.33E+03
regulation of integrin activation (GO:0033623),0.02,3.42E-02,2.32E+03,0.05,3.42E-02,8.92E+02
cellular biogenic amine biosynthetic process (GO:0042401),0.02,1.50E-02,6.31E+02,0.05,4.34E-02,3.89E+02
copper ion homeostasis (GO:0055070),0.02,3.42E-02,1.07E+03,0.05,3.42E-02,7.61E+02
nicotinamide nucleotide biosynthetic process (GO:0019359),0.02,3.14E-02,1.85E+03,0.05,4.07E-02,1.25E+03
somatic hypermutation of immunoglobulin genes (GO:0016446),0.02,4.94E-02,1.34E+03,0.05,4.94E-02,1.34E+03
response to acidic pH (GO:0010447),0.02,3.38E-02,6.85E+02,0.05,4.13E-02,4.58E+02
aromatic amino acid family catabolic process (GO:0009074),0.02,3.38E-02,6.31E+02,0.05,4.27E-02,4.21E+02
pyridine-containing compound metabolic process (GO:0072524),0.02,3.54E-02,3.81E+03,0.05,4.07E-02,1.99E+03
cellular copper ion homeostasis (GO:0006878),0.02,3.42E-02,1.36E+03,0.05,3.42E-02,9.74E+02
cation transmembrane transport (GO:0098655),0.02,3.64E-02,2.28E+02,0.05,4.06E-02,2.28E+02
lipoprotein localization (GO:0044872),0.00,4.57E-02,2.54E+01,0.05,4.07E-02,6.85E+02
B cell mediated immunity (GO:0019724),0.00,2.08E-02,2.28E+03,0.00,1.00E+00,0.00E+00
isoprenoid biosynthetic process (GO:0008299),0.01,3.25E-02,9.29E+02,0.03,1.39E-02,6.05E+01
positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.02,2.51E-02,5.43E+02,0.00,1.00E+00,0.00E+00
"DNA catabolic process, exonucleolytic (GO:0000738)",0.02,4.22E-02,3.33E+03,0.00,1.00E+00,0.00E+00
pyrimidine nucleoside biosynthetic process (GO:0046134),0.02,3.94E-02,4.66E+01,0.00,1.00E+00,0.00E+00
positive regulation of cellular respiration (GO:1901857),0.02,3.17E-02,3.17E+01,0.00,1.00E+00,0.00E+00
toll-like receptor 4 signaling pathway (GO:0034142),0.02,1.04E-02,1.94E+03,0.00,1.00E+00,0.00E+00
regulation of macrophage activation (GO:0043030),0.02,2.26E-02,6.49E+02,0.00,1.00E+00,0.00E+00
positive regulation of natural killer cell chemotaxis (GO:2000503),0.02,3.25E-02,5.29E+03,0.00,1.00E+00,0.00E+00
DNA catabolic process (GO:0006308),0.02,4.22E-02,9.32E+02,0.00,1.00E+00,0.00E+00
DNA double-strand break processing (GO:0000729),0.05,2.93E-02,2.81E+01,0.00,1.00E+00,0.00E+00
chondroitin sulfate metabolic process (GO:0030204),0.05,4.07E-02,3.22E+02,0.00,1.00E+00,0.00E+00
negative regulation of coagulation (GO:0050819),0.05,3.99E-02,2.17E+03,0.00,1.00E+00,0.00E+00
negative regulation of hemostasis (GO:1900047),0.05,3.87E-02,2.64E+03,0.00,1.00E+00,0.00E+00
purine ribonucleoside triphosphate metabolic process (GO:0009205),0.03,3.62E-02,3.58E+01,0.03,3.32E-02,2.37E+01
anterior/posterior axis specification (GO:0009948),0.03,3.56E-02,4.46E+02,0.03,4.99E-02,2.64E+01
clathrin coat assembly (GO:0048268),0.03,4.10E-02,3.89E+02,0.03,4.59E-02,1.91E+01
maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.00,4.91E-02,2.14E+01,0.00,1.00E+00,0.00E+00
embryonic forelimb morphogenesis (GO:0035115),0.00,4.99E-02,4.92E+02,0.00,1.00E+00,0.00E+00
forelimb morphogenesis (GO:0035136),0.00,4.99E-02,4.27E+02,0.00,1.00E+00,0.00E+00
ERK1 and ERK2 cascade (GO:0070371),0.00,2.01E-02,2.04E+01,0.00,1.00E+00,0.00E+00
regulation of mRNA binding (GO:1902415),0.02,2.34E-02,1.03E+02,0.00,1.00E+00,0.00E+00
regulation of lipid kinase activity (GO:0043550),0.02,2.74E-02,1.16E+03,0.00,1.00E+00,0.00E+00
retinoic acid receptor signaling pathway (GO:0048384),0.02,2.84E-02,1.03E+03,0.00,1.00E+00,0.00E+00
glutamine family amino acid biosynthetic process (GO:0009084),0.02,3.17E-02,3.17E+01,0.00,1.00E+00,0.00E+00
axonal fasciculation (GO:0007413),0.01,4.00E-02,5.63E+02,0.08,4.00E-02,5.63E+02
regulation of DNA-dependent DNA replication (GO:0090329),0.01,4.93E-02,2.12E+01,0.08,3.13E-02,1.12E+02
cellular response to interleukin-17 (GO:0097398),0.01,3.85E-02,8.22E+02,0.08,3.85E-02,8.22E+02
glycoprotein biosynthetic process (GO:0009101),0.01,2.73E-02,2.36E+02,0.08,4.39E-02,1.44E+02
regulation of cellular response to hypoxia (GO:1900037),0.01,3.87E-02,1.32E+03,0.08,4.09E-02,2.28E+03
regulation of melanin biosynthetic process (GO:0048021),0.01,1.02E-02,4.08E+03,0.08,3.74E-02,1.16E+03
mammary gland epithelial cell differentiation (GO:0060644),0.01,4.69E-02,1.25E+03,0.08,3.74E-02,1.75E+03
positive regulation of axon extension involved in axon guidance (GO:0048842),0.01,3.75E-02,1.84E+03,0.08,3.75E-02,1.84E+03
neuron projection fasciculation (GO:0106030),0.01,4.00E-02,7.15E+02,0.08,4.00E-02,7.15E+02
interleukin-17-mediated signaling pathway (GO:0097400),0.01,3.85E-02,8.22E+02,0.08,3.85E-02,8.22E+02
regulation of endothelial cell chemotaxis (GO:2001026),0.01,4.00E-02,4.21E+02,0.08,4.00E-02,4.21E+02
positive regulation of secondary metabolite biosynthetic process (GO:1900378),0.01,1.02E-02,6.13E+03,0.08,3.74E-02,1.75E+03
positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),0.01,1.02E-02,6.13E+03,0.08,3.74E-02,1.75E+03
mammary gland epithelium development (GO:0061180),0.01,4.69E-02,5.51E+02,0.08,4.13E-02,7.76E+02
positive regulation of melanin biosynthetic process (GO:0048023),0.01,1.02E-02,6.13E+03,0.08,3.74E-02,1.75E+03
positive regulation of ion transmembrane transporter activity (GO:0032414),0.05,2.40E-02,7.76E+02,0.00,1.00E+00,0.00E+00
positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.05,2.05E-02,4.18E+02,0.00,1.00E+00,0.00E+00
interleukin-9-mediated signaling pathway (GO:0038113),0.05,1.20E-02,2.40E+03,0.00,1.00E+00,0.00E+00
spermidine metabolic process (GO:0008216),0.05,6.25E-03,1.90E+03,0.00,1.00E+00,0.00E+00
cell-cell junction maintenance (GO:0045217),0.05,4.18E-02,9.12E+02,0.00,1.00E+00,0.00E+00
regulation of epidermal cell differentiation (GO:0045604),0.05,2.89E-02,6.58E+02,0.00,1.00E+00,0.00E+00
cellular response to interleukin-9 (GO:0071355),0.05,1.20E-02,2.40E+03,0.00,1.00E+00,0.00E+00
centromeric sister chromatid cohesion (GO:0070601),0.05,1.40E-03,2.41E+03,0.00,1.00E+00,0.00E+00
peptidyl-serine autophosphorylation (GO:0036289),0.01,4.38E-02,3.58E+01,0.03,4.72E-02,3.11E+01
cellular response to vitamin D (GO:0071305),0.01,4.00E-02,8.20E+01,0.03,3.32E-02,8.16E+01
negative regulation of regulated secretory pathway (GO:1903306),0.01,4.38E-02,3.58E+01,0.03,4.72E-02,3.11E+01
single strand break repair (GO:0000012),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
toll-like receptor 9 signaling pathway (GO:0034162),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of oligodendrocyte differentiation (GO:0048713),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
phospholipid dephosphorylation (GO:0046839),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
histone H3-K9 methylation (GO:0051567),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
isotype switching (GO:0045190),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
mitochondrial RNA metabolic process (GO:0000959),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
DNA ligation involved in DNA repair (GO:0051103),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of natural killer cell proliferation (GO:0032817),0.01,3.32E-02,1.50E+03,0.00,1.00E+00,0.00E+00
regulation of cell killing (GO:0031341),0.01,2.60E-02,1.07E+03,0.00,1.00E+00,0.00E+00
membrane lipid metabolic process (GO:0006643),0.01,4.40E-02,2.79E+02,0.00,1.00E+00,0.00E+00
renal filtration cell differentiation (GO:0061318),0.01,4.69E-02,2.58E+03,0.00,1.00E+00,0.00E+00
regulation of monocyte chemotactic protein-1 production (GO:0071637),0.01,2.28E-02,1.85E+03,0.00,1.00E+00,0.00E+00
regulation of T-helper 1 type immune response (GO:0002825),0.01,3.32E-02,1.07E+03,0.00,1.00E+00,0.00E+00
negative regulation of defense response (GO:0031348),0.01,4.27E-02,1.39E+02,0.00,1.00E+00,0.00E+00
smooth muscle cell migration (GO:0014909),0.01,3.57E-02,1.85E+03,0.00,1.00E+00,0.00E+00
positive regulation of tissue remodeling (GO:0034105),0.01,3.32E-02,9.32E+02,0.00,1.00E+00,0.00E+00
T-helper 17 cell lineage commitment (GO:0072540),0.01,3.01E-02,3.45E+03,0.00,1.00E+00,0.00E+00
T-helper 17 cell differentiation (GO:0072539),0.01,3.01E-02,2.80E+03,0.00,1.00E+00,0.00E+00
protein maturation by iron-sulfur cluster transfer (GO:0097428),0.01,1.02E-02,5.30E+01,0.00,1.00E+00,0.00E+00
positive regulation of leukocyte degranulation (GO:0043302),0.01,2.37E-02,7.48E+02,0.00,1.00E+00,0.00E+00
antifungal innate immune response (GO:0061760),0.01,2.60E-02,1.50E+03,0.00,1.00E+00,0.00E+00
T-helper cell lineage commitment (GO:0002295),0.01,3.01E-02,2.34E+03,0.00,1.00E+00,0.00E+00
glomerular epithelial cell differentiation (GO:0072311),0.01,4.69E-02,2.58E+03,0.00,1.00E+00,0.00E+00
regulation of natural killer cell cytokine production (GO:0002727),0.01,1.94E-02,1.85E+03,0.00,1.00E+00,0.00E+00
positive regulation of natural killer cell cytokine production (GO:0002729),0.01,1.94E-02,1.85E+03,0.00,1.00E+00,0.00E+00
regulation of leukocyte chemotaxis (GO:0002688),0.01,3.01E-02,7.74E+02,0.00,1.00E+00,0.00E+00
regulation of T-helper 17 type immune response (GO:2000316),0.01,3.32E-02,9.32E+02,0.00,1.00E+00,0.00E+00
sulfur compound biosynthetic process (GO:0044272),0.01,3.95E-02,2.41E+01,0.00,1.00E+00,0.00E+00
positive regulation of gamma-delta T cell activation (GO:0046645),0.02,5.59E-03,3.79E+03,0.05,5.59E-03,3.79E+03
L-glutamate transmembrane transport (GO:0015813),0.02,3.68E-02,1.75E+03,0.05,3.68E-02,1.75E+03
L-amino acid transport (GO:0015807),0.02,4.11E-02,4.75E+02,0.05,4.11E-02,4.75E+02
glucose catabolic process to pyruvate (GO:0061718),0.02,2.90E-02,1.76E+01,0.05,2.90E-02,1.76E+01
L-aspartate transmembrane transport (GO:0070778),0.02,2.96E-02,4.44E+03,0.05,2.96E-02,4.44E+03
actin crosslink formation (GO:0051764),0.02,1.46E-02,3.65E+03,0.05,3.27E-02,1.19E+03
canonical glycolysis (GO:0061621),0.02,2.90E-02,1.76E+01,0.05,2.90E-02,1.76E+01
exocyst localization (GO:0051601),0.02,3.24E-02,2.39E+03,0.05,5.00E-04,3.80E+04
protein kinase A signaling (GO:0010737),0.02,1.59E-02,2.76E+03,0.05,3.68E-02,8.92E+02
positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.02,2.16E-02,3.33E+03,0.05,4.07E-02,7.76E+02
"wound healing, spreading of cells (GO:0044319)",0.02,1.75E-02,1.55E+03,0.05,4.09E-02,4.92E+02
regulation of intracellular protein transport (GO:0033157),0.02,1.75E-02,1.08E+03,0.05,4.10E-02,3.42E+02
negative regulation of oxidoreductase activity (GO:0051354),0.02,1.16E-02,9.29E+02,0.05,1.16E-02,9.29E+02
bone resorption (GO:0045453),0.02,4.03E-02,1.50E+03,0.05,3.19E-02,1.50E+03
cardiac ventricle morphogenesis (GO:0003208),0.02,4.56E-02,1.38E+02,0.05,4.06E-02,2.28E+02
actin filament network formation (GO:0051639),0.02,1.44E-02,4.08E+03,0.05,3.24E-02,1.33E+03
regulation of oxidoreductase activity (GO:0051341),0.02,1.16E-02,8.28E+02,0.05,1.16E-02,8.28E+02
peptidyl-cysteine S-nitrosylation (GO:0018119),0.00,3.80E-05,4.70E+04,0.08,4.13E-02,2.07E+02
negative regulation of protein activation cascade (GO:2000258),0.00,1.03E-02,8.26E+03,0.08,2.24E-02,2.96E+03
"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.00,2.08E-02,1.68E+03,0.08,3.35E-02,9.74E+02
glycolipid metabolic process (GO:0006664),0.00,4.29E-02,1.20E+01,0.08,3.35E-02,2.62E+02
neural tube development (GO:0021915),0.00,3.25E-02,7.15E+02,0.08,4.15E-02,6.31E+02
lens fiber cell development (GO:0070307),0.00,4.99E-02,5.77E+02,0.08,4.09E-02,1.55E+03
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.00,2.26E-02,7.76E+02,0.08,3.39E-02,4.45E+02
negative regulation of response to DNA damage stimulus (GO:2001021),0.00,2.26E-02,6.23E+02,0.08,3.39E-02,3.56E+02
lens fiber cell differentiation (GO:0070306),0.00,4.99E-02,5.77E+02,0.08,4.09E-02,1.55E+03
cellular metal ion homeostasis (GO:0006875),0.04,3.27E-02,2.20E+02,0.00,1.00E+00,0.00E+00
regulation of fatty acid biosynthetic process (GO:0042304),0.04,2.80E-02,1.91E+01,0.00,1.00E+00,0.00E+00
regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.04,3.68E-02,1.87E+02,0.00,1.00E+00,0.00E+00
positive regulation of response to wounding (GO:1903036),0.04,1.36E-02,9.18E+02,0.00,1.00E+00,0.00E+00
response to hydroxyurea (GO:0072710),0.04,3.13E-02,8.99E+02,0.00,1.00E+00,0.00E+00
negative regulation of retinoic acid receptor signaling pathway (GO:0048387),0.04,2.30E-02,7.70E+01,0.00,1.00E+00,0.00E+00
positive regulation of wound healing (GO:0090303),0.04,2.16E-02,5.90E+02,0.00,1.00E+00,0.00E+00
cellular response to inorganic substance (GO:0071241),0.04,4.54E-02,3.58E+02,0.00,1.00E+00,0.00E+00
modulation of chemical synaptic transmission (GO:0050804),0.04,2.92E-02,2.35E+02,0.00,1.00E+00,0.00E+00
organic anion transport (GO:0015711),0.04,4.18E-02,1.90E+02,0.00,1.00E+00,0.00E+00
mesenchymal cell differentiation involved in kidney development (GO:0072161),0.04,4.99E-02,2.04E+03,0.00,1.00E+00,0.00E+00
cell differentiation involved in metanephros development (GO:0072202),0.04,4.99E-02,1.03E+03,0.00,1.00E+00,0.00E+00
pericardium morphogenesis (GO:0003344),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of cortisol biosynthetic process (GO:2000064),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
cardiac left ventricle morphogenesis (GO:0003214),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
PML body organization (GO:0030578),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of necroptotic process (GO:0060546),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
cellular response to sterol depletion (GO:0071501),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
morphogenesis of an epithelial sheet (GO:0002011),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
limb morphogenesis (GO:0035108),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
cellular response to sodium arsenite (GO:1903936),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
glucose homeostasis (GO:0042593),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
nerve growth factor signaling pathway (GO:0038180),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
response to sodium arsenite (GO:1903935),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
aminophospholipid transport (GO:0015917),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
peripheral nervous system development (GO:0007422),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of cardiac muscle cell proliferation (GO:0060044),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
cellular response to salt (GO:1902075),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of tau-protein kinase activity (GO:1902949),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
T cell mediated immunity (GO:0002456),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
His-Purkinje system development (GO:0003164),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of cardiac muscle tissue growth (GO:0055022),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of gap junction assembly (GO:1903598),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
embryonic appendage morphogenesis (GO:0035113),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
astral microtubule organization (GO:0030953),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of DNA-templated transcription in response to stress (GO:0043620),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of cardiac muscle cell proliferation (GO:0060043),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of aldosterone biosynthetic process (GO:0032347),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
membrane raft organization (GO:0031579),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of respiratory burst (GO:0060267),0.02,4.81E-02,6.26E+02,0.03,4.81E-02,6.26E+02
actin-myosin filament sliding (GO:0033275),0.02,2.61E-02,3.23E+02,0.03,2.61E-02,3.23E+02
mesonephric duct development (GO:0072177),0.02,4.68E-02,1.01E+03,0.03,4.68E-02,1.01E+03
muscle filament sliding (GO:0030049),0.02,2.61E-02,3.23E+02,0.03,2.61E-02,3.23E+02
vascular associated smooth muscle contraction (GO:0014829),0.02,4.85E-02,5.21E+02,0.03,4.85E-02,5.21E+02
cell migration involved in gastrulation (GO:0042074),0.02,4.68E-02,1.01E+03,0.03,4.68E-02,1.01E+03
regulation of cell maturation (GO:1903429),0.02,4.68E-02,1.01E+03,0.03,4.68E-02,1.01E+03
aminoglycan catabolic process (GO:0006026),0.02,1.98E-02,4.13E+02,0.03,1.98E-02,4.13E+02
positive regulation of interleukin-23 production (GO:0032747),0.02,4.81E-02,6.26E+02,0.03,4.81E-02,6.26E+02
autophagosome membrane docking (GO:0016240),0.02,1.69E-02,6.90E+01,0.03,1.69E-02,6.90E+01
glycosaminoglycan metabolic process (GO:0030203),0.02,3.61E-02,1.83E+02,0.00,1.00E+00,0.00E+00
positive regulation of neutrophil extravasation (GO:2000391),0.02,3.55E-02,3.33E+03,0.00,1.00E+00,0.00E+00
regulation of neutrophil extravasation (GO:2000389),0.02,3.55E-02,2.58E+03,0.00,1.00E+00,0.00E+00
"fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.02,2.80E-02,1.25E+03,0.00,1.00E+00,0.00E+00
"fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.02,2.80E-02,1.25E+03,0.00,1.00E+00,0.00E+00
"fatty acid elongation, saturated fatty acid (GO:0019367)",0.02,2.80E-02,1.25E+03,0.00,1.00E+00,0.00E+00
"fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.02,2.80E-02,1.25E+03,0.00,1.00E+00,0.00E+00
regulation of cellular respiration (GO:0043457),0.02,2.61E-02,2.47E+01,0.00,1.00E+00,0.00E+00
regulation of inositol phosphate biosynthetic process (GO:0010919),0.02,4.01E-02,1.25E+03,0.00,1.00E+00,0.00E+00
cardiac muscle cell development (GO:0055013),0.02,2.31E-02,5.77E+02,0.05,2.31E-02,5.77E+02
cardiac cell development (GO:0055006),0.02,2.00E-02,1.25E+03,0.05,2.00E-02,1.25E+03
regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.02,3.87E-02,2.09E+03,0.05,3.07E-02,2.09E+03
muscle cell development (GO:0055001),0.02,2.60E-02,3.86E+02,0.05,2.60E-02,3.86E+02
cytolysis in other organism involved in symbiotic interaction (GO:0051801),0.04,9.96E-03,3.81E+03,0.00,1.00E+00,0.00E+00
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.04,3.65E-02,3.94E+02,0.00,1.00E+00,0.00E+00
chondroitin sulfate biosynthetic process (GO:0030206),0.04,3.05E-02,5.06E+02,0.00,1.00E+00,0.00E+00
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.04,3.06E-02,3.68E+02,0.00,1.00E+00,0.00E+00
sensory organ morphogenesis (GO:0090596),0.04,2.84E-02,2.40E+03,0.00,1.00E+00,0.00E+00
positive regulation of endothelial cell apoptotic process (GO:2000353),0.04,1.40E-02,2.55E+03,0.00,1.00E+00,0.00E+00
"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.04,2.15E-02,4.51E+02,0.00,1.00E+00,0.00E+00
cytolysis by host of symbiont cells (GO:0051838),0.04,9.96E-03,3.81E+03,0.00,1.00E+00,0.00E+00
killing by host of symbiont cells (GO:0051873),0.04,1.34E-02,1.84E+03,0.00,1.00E+00,0.00E+00
positive regulation of ubiquitin protein ligase activity (GO:1904668),0.04,4.01E-02,6.11E+02,0.00,1.00E+00,0.00E+00
transition metal ion homeostasis (GO:0055076),0.04,1.30E-02,6.77E+02,0.00,1.00E+00,0.00E+00
negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.04,2.28E-02,1.26E+03,0.00,1.00E+00,0.00E+00
positive regulation of mesenchymal cell proliferation (GO:0002053),0.04,2.84E-02,1.03E+03,0.00,1.00E+00,0.00E+00
negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.04,2.28E-02,1.26E+03,0.00,1.00E+00,0.00E+00
mitochondrial outer membrane permeabilization (GO:0097345),0.01,2.37E-02,8.23E+02,0.00,1.00E+00,0.00E+00
regulation of astrocyte differentiation (GO:0048710),0.01,3.01E-02,1.39E+03,0.00,1.00E+00,0.00E+00
regulation of interleukin-4 production (GO:0032673),0.01,3.11E-02,7.30E+02,0.00,1.00E+00,0.00E+00
regulation of vasculogenesis (GO:2001212),0.01,5.04E-03,2.15E+03,0.00,1.00E+00,0.00E+00
alpha-beta T cell differentiation (GO:0046632),0.01,1.44E-02,1.15E+04,0.00,1.00E+00,0.00E+00
Rap protein signal transduction (GO:0032486),0.01,7.71E-03,7.72E+01,0.00,1.00E+00,0.00E+00
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.00,1.00E+00,0.00E+00,0.08,2.32E-02,1.85E+03
positive regulation of sodium ion transport (GO:0010765),0.00,1.00E+00,0.00E+00,0.08,3.96E-02,9.32E+02
engulfment of apoptotic cell (GO:0043652),0.00,1.00E+00,0.00E+00,0.08,4.13E-02,7.76E+02
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),0.00,1.00E+00,0.00E+00,0.08,4.26E-02,1.84E+02
regulation of hydrogen peroxide metabolic process (GO:0010310),0.00,1.00E+00,0.00E+00,0.08,3.74E-02,2.58E+03
regulation of macrophage apoptotic process (GO:2000109),0.00,1.00E+00,0.00E+00,0.08,3.84E-02,1.23E+03
regulation of chromatin assembly or disassembly (GO:0001672),0.00,1.00E+00,0.00E+00,0.08,4.07E-02,7.30E+03
regulation of respiratory burst (GO:0060263),0.00,1.00E+00,0.00E+00,0.08,3.74E-02,1.50E+03
positive regulation of myeloid cell apoptotic process (GO:0033034),0.00,1.00E+00,0.00E+00,0.08,3.84E-02,8.29E+02
glycosphingolipid metabolic process (GO:0006687),0.00,1.00E+00,0.00E+00,0.08,3.35E-02,2.97E+02
hair cell differentiation (GO:0035315),0.00,1.00E+00,0.00E+00,0.08,3.84E-02,8.29E+02
response to estrogen (GO:0043627),0.00,1.00E+00,0.00E+00,0.08,3.17E-02,4.31E+02
poly-N-acetyllactosamine metabolic process (GO:0030309),0.00,1.00E+00,0.00E+00,0.08,2.92E-02,1.50E+03
negative regulation of NLRP3 inflammasome complex assembly (GO:1900226),0.00,1.00E+00,0.00E+00,0.08,3.31E-02,1.66E+03
poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.00,1.00E+00,0.00E+00,0.08,2.92E-02,1.66E+03
response to hydroperoxide (GO:0033194),0.00,1.00E+00,0.00E+00,0.08,2.92E-02,2.80E+03
regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.00,1.00E+00,0.00E+00,0.08,3.42E-02,5.21E+02
negative regulation of serine-type peptidase activity (GO:1902572),0.00,1.00E+00,0.00E+00,0.08,3.84E-02,1.23E+03
negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.00,1.00E+00,0.00E+00,0.08,3.42E-02,4.52E+02
positive regulation of epidermal cell differentiation (GO:0045606),0.00,1.00E+00,0.00E+00,0.08,4.93E-02,1.92E+02
regulation of lamellipodium organization (GO:1902743),0.00,1.00E+00,0.00E+00,0.08,4.53E-02,3.96E+02
actin-mediated cell contraction (GO:0070252),0.00,1.00E+00,0.00E+00,0.08,4.02E-02,7.08E+02
L-phenylalanine metabolic process (GO:0006558),0.00,1.00E+00,0.00E+00,0.08,4.26E-02,1.84E+02
cellular response to vitamin (GO:0071295),0.00,1.00E+00,0.00E+00,0.08,4.17E-03,8.51E+02
negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),0.00,1.00E+00,0.00E+00,0.08,3.31E-02,1.03E+03
protein polymerization (GO:0051258),0.00,1.00E+00,0.00E+00,0.08,4.62E-02,1.56E+02
negative regulation of sequestering of triglyceride (GO:0010891),0.00,1.00E+00,0.00E+00,0.08,3.31E-02,2.04E+03
cellular response to ATP (GO:0071318),0.00,1.00E+00,0.00E+00,0.08,4.09E-02,6.85E+02
negative regulation of astrocyte differentiation (GO:0048712),0.00,1.00E+00,0.00E+00,0.08,3.31E-02,2.04E+03
regulation of inward rectifier potassium channel activity (GO:1901979),0.00,1.00E+00,0.00E+00,0.08,3.31E-02,2.64E+03
regulation of B cell apoptotic process (GO:0002902),0.00,1.00E+00,0.00E+00,0.08,4.09E-02,9.12E+02
positive regulation of AMPA receptor activity (GO:2000969),0.00,1.00E+00,0.00E+00,0.08,3.09E-02,3.81E+03
regulation of resting membrane potential (GO:0060075),0.00,1.00E+00,0.00E+00,0.08,3.31E-02,2.04E+03
positive regulation of cAMP-dependent protein kinase activity (GO:2000481),0.00,1.00E+00,0.00E+00,0.08,3.09E-02,3.81E+03
positive regulation of protein kinase A signaling (GO:0010739),0.00,1.00E+00,0.00E+00,0.08,3.70E-02,1.72E+03
desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.00,1.00E+00,0.00E+00,0.08,3.70E-02,1.33E+03
regulation of cAMP-dependent protein kinase activity (GO:2000479),0.00,1.00E+00,0.00E+00,0.08,3.70E-02,9.74E+02
adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.00,1.00E+00,0.00E+00,0.08,4.06E-02,7.61E+02
adrenergic receptor signaling pathway (GO:0071875),0.00,1.00E+00,0.00E+00,0.08,4.09E-02,6.19E+02
regulation of protein kinase A signaling (GO:0010738),0.00,1.00E+00,0.00E+00,0.08,4.09E-02,6.19E+02
activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),0.00,1.00E+00,0.00E+00,0.08,3.18E-02,2.96E+03
positive regulation of lymphocyte differentiation (GO:0045621),0.00,1.00E+00,0.00E+00,0.08,4.09E-02,4.75E+02
negative regulation of fat cell proliferation (GO:0070345),0.00,1.00E+00,0.00E+00,0.08,3.31E-02,2.04E+03
positive regulation of lipoprotein particle clearance (GO:0010986),0.00,1.00E+00,0.00E+00,0.08,3.31E-02,2.04E+03
regulation of low-density lipoprotein particle clearance (GO:0010988),0.00,1.00E+00,0.00E+00,0.08,3.31E-02,1.03E+03
positive regulation of voltage-gated potassium channel activity (GO:1903818),0.00,1.00E+00,0.00E+00,0.08,3.42E-02,9.12E+02
kidney epithelium development (GO:0072073),0.00,1.00E+00,0.00E+00,0.08,4.47E-02,1.44E+02
negative regulation of cholesterol storage (GO:0010887),0.00,1.00E+00,0.00E+00,0.08,3.31E-02,1.03E+03
regulation of sequestering of triglyceride (GO:0010889),0.00,1.00E+00,0.00E+00,0.08,3.42E-02,6.11E+02
regulation of establishment of protein localization (GO:0070201),0.00,1.00E+00,0.00E+00,0.08,3.42E-02,6.11E+02
regulation of ATP biosynthetic process (GO:2001169),0.00,1.00E+00,0.00E+00,0.08,3.42E-02,5.63E+02
"regulation of complement activation, classical pathway (GO:0030450)",0.00,1.00E+00,0.00E+00,0.08,3.31E-02,1.19E+03
regulation of oxidative stress-induced neuron death (GO:1903203),0.00,1.00E+00,0.00E+00,0.08,3.31E-02,1.39E+03
negative regulation of p38MAPK cascade (GO:1903753),0.00,1.00E+00,0.00E+00,0.08,3.31E-02,1.66E+03
neuromuscular synaptic transmission (GO:0007274),0.00,1.00E+00,0.00E+00,0.08,3.49E-02,4.23E+02
osteoclast differentiation (GO:0030316),0.00,1.00E+00,0.00E+00,0.08,3.73E-02,3.75E+02
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.00,1.00E+00,0.00E+00,0.08,3.31E-02,1.66E+03
positive regulation of amyloid-beta clearance (GO:1900223),0.00,1.00E+00,0.00E+00,0.08,3.31E-02,1.66E+03
regulation of fat cell proliferation (GO:0070344),0.00,1.00E+00,0.00E+00,0.08,3.31E-02,1.66E+03
regulation of cysteine-type endopeptidase activity (GO:2000116),0.00,1.00E+00,0.00E+00,0.08,4.25E-02,5.19E+02
negative regulation of axon regeneration (GO:0048681),0.00,1.00E+00,0.00E+00,0.08,4.09E-02,1.85E+03
negative regulation of neuron projection regeneration (GO:0070571),0.00,1.00E+00,0.00E+00,0.08,4.09E-02,1.55E+03
lipoxygenase pathway (GO:0019372),0.00,1.00E+00,0.00E+00,0.08,4.15E-02,6.85E+02
negative regulation of cellular biosynthetic process (GO:0031327),0.00,1.00E+00,0.00E+00,0.08,4.36E-02,1.84E+02
actin filament polymerization (GO:0030041),0.00,1.00E+00,0.00E+00,0.08,3.39E-02,3.87E+02
negative regulation of endocytosis (GO:0045806),0.00,1.00E+00,0.00E+00,0.08,3.39E-02,4.67E+02
neural crest cell differentiation (GO:0014033),0.00,1.00E+00,0.00E+00,0.08,3.35E-02,6.61E+02
negative regulation of vitamin metabolic process (GO:0046137),0.00,1.00E+00,0.00E+00,0.08,3.35E-02,2.96E+03
regulation of vitamin D receptor signaling pathway (GO:0070562),0.00,1.00E+00,0.00E+00,0.08,3.35E-02,3.81E+03
negative regulation of pinocytosis (GO:0048550),0.00,1.00E+00,0.00E+00,0.08,3.35E-02,3.81E+03
negative regulation of vitamin D biosynthetic process (GO:0010957),0.00,1.00E+00,0.00E+00,0.08,3.35E-02,3.81E+03
regulation of caveolin-mediated endocytosis (GO:2001286),0.00,1.00E+00,0.00E+00,0.08,3.35E-02,3.81E+03
regulation of keratinocyte differentiation (GO:0045616),0.00,1.00E+00,0.00E+00,0.08,4.56E-02,2.41E+02
long-chain fatty acid biosynthetic process (GO:0042759),0.00,1.00E+00,0.00E+00,0.08,4.46E-02,2.83E+02
neuron apoptotic process (GO:0051402),0.00,1.00E+00,0.00E+00,0.08,4.15E-02,4.46E+02
regulation of non-canonical Wnt signaling pathway (GO:2000050),0.00,1.00E+00,0.00E+00,0.08,4.09E-02,6.85E+02
urogenital system development (GO:0001655),0.00,1.00E+00,0.00E+00,0.08,4.15E-02,9.12E+02
regulation of DNA methylation (GO:0044030),0.00,1.00E+00,0.00E+00,0.08,4.15E-02,1.16E+03
regulation of axon regeneration (GO:0048679),0.00,1.00E+00,0.00E+00,0.08,4.09E-02,9.12E+02
protein O-linked glycosylation via serine (GO:0018242),0.00,1.00E+00,0.00E+00,0.08,4.15E-02,1.16E+03
negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.00,1.00E+00,0.00E+00,0.08,3.74E-02,1.31E+03
stem cell development (GO:0048864),0.00,1.00E+00,0.00E+00,0.08,3.35E-02,7.61E+02
regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.00,1.00E+00,0.00E+00,0.08,3.74E-02,1.31E+03
chondrocyte differentiation (GO:0002062),0.00,1.00E+00,0.00E+00,0.08,4.79E-02,2.61E+02
cartilage development (GO:0051216),0.00,1.00E+00,0.00E+00,0.08,3.55E-02,3.05E+01
negative regulation of keratinocyte differentiation (GO:0045617),0.00,1.00E+00,0.00E+00,0.08,4.15E-02,2.95E+03
lung epithelium development (GO:0060428),0.00,1.00E+00,0.00E+00,0.08,4.15E-02,1.16E+03
self proteolysis (GO:0097264),0.00,1.00E+00,0.00E+00,0.08,4.15E-02,1.55E+03
cannabinoid signaling pathway (GO:0038171),0.00,1.00E+00,0.00E+00,0.08,4.15E-02,2.95E+03
protein O-linked glycosylation via threonine (GO:0018243),0.00,1.00E+00,0.00E+00,0.08,4.15E-02,1.33E+03
unsaturated fatty acid biosynthetic process (GO:0006636),0.00,1.00E+00,0.00E+00,0.08,4.15E-02,1.33E+03
hepoxilin biosynthetic process (GO:0051122),0.00,1.00E+00,0.00E+00,0.08,4.15E-02,1.33E+03
hepoxilin metabolic process (GO:0051121),0.00,1.00E+00,0.00E+00,0.08,4.15E-02,1.33E+03
chromatin assembly or disassembly (GO:0006333),0.02,4.93E-02,2.37E+01,0.00,1.00E+00,0.00E+00
histone methylation (GO:0016571),0.02,4.99E-03,3.25E+01,0.00,1.00E+00,0.00E+00
regulation of histone H4-K16 acetylation (GO:2000618),0.02,2.03E-02,1.23E+02,0.00,1.00E+00,0.00E+00
positive regulation of peptidyl-lysine acetylation (GO:2000758),0.02,2.30E-02,8.70E+02,0.00,1.00E+00,0.00E+00
alpha-amino acid metabolic process (GO:1901605),0.02,4.15E-02,1.25E+01,0.00,1.00E+00,0.00E+00
inner ear morphogenesis (GO:0042472),0.02,3.39E-02,3.35E+02,0.00,1.00E+00,0.00E+00
regulation of centrosome duplication (GO:0010824),0.02,3.47E-02,1.41E+01,0.00,1.00E+00,0.00E+00
myelination (GO:0042552),0.04,1.39E-02,1.05E+03,0.00,1.00E+00,0.00E+00
odontogenesis of dentin-containing tooth (GO:0042475),0.04,3.09E-02,5.63E+02,0.00,1.00E+00,0.00E+00
vitamin transport (GO:0051180),0.04,4.04E-02,1.48E+02,0.00,1.00E+00,0.00E+00
response to dopamine (GO:1903350),0.04,1.18E-02,7.91E+02,0.00,1.00E+00,0.00E+00
dermatan sulfate proteoglycan metabolic process (GO:0050655),0.04,3.57E-02,2.58E+03,0.00,1.00E+00,0.00E+00
T cell homeostasis (GO:0043029),0.04,1.23E-02,1.85E+03,0.00,1.00E+00,0.00E+00
negative regulation of telomere capping (GO:1904354),0.04,3.06E-02,6.92E+01,0.00,1.00E+00,0.00E+00
dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.04,3.57E-02,7.76E+02,0.00,1.00E+00,0.00E+00
response to organonitrogen compound (GO:0010243),0.04,3.93E-02,3.03E+02,0.00,1.00E+00,0.00E+00
primary alcohol metabolic process (GO:0034308),0.04,5.63E-03,4.64E+02,0.00,1.00E+00,0.00E+00
positive regulation of ceramide biosynthetic process (GO:2000304),0.04,2.28E-02,1.33E+03,0.00,1.00E+00,0.00E+00
negative regulation of ubiquitin protein ligase activity (GO:1904667),0.04,4.51E-02,5.68E+01,0.00,1.00E+00,0.00E+00
R-loop disassembly (GO:0062176),0.04,3.53E-02,1.02E+02,0.00,1.00E+00,0.00E+00
regulation of axon extension (GO:0030516),0.04,3.61E-02,2.38E+02,0.00,1.00E+00,0.00E+00
sinoatrial node cell differentiation (GO:0060921),0.04,3.48E-02,3.33E+03,0.00,1.00E+00,0.00E+00
positive regulation of sphingolipid biosynthetic process (GO:0090154),0.04,2.28E-02,1.33E+03,0.00,1.00E+00,0.00E+00
interleukin-15-mediated signaling pathway (GO:0035723),0.04,3.22E-02,1.50E+03,0.00,1.00E+00,0.00E+00
regulation of histone acetylation (GO:0035065),0.04,4.19E-02,2.53E+03,0.00,1.00E+00,0.00E+00
pyrimidine ribonucleotide biosynthetic process (GO:0009220),0.04,2.72E-02,2.09E+03,0.00,1.00E+00,0.00E+00
positive regulation of lipid metabolic process (GO:0045834),0.04,2.30E-02,6.58E+02,0.00,1.00E+00,0.00E+00
regulation of cytokine production involved in inflammatory response (GO:1900015),0.04,4.03E-02,2.76E+02,0.00,1.00E+00,0.00E+00
antibacterial humoral response (GO:0019731),0.04,1.24E-03,4.02E+02,0.00,1.00E+00,0.00E+00
regulation of ceramide biosynthetic process (GO:2000303),0.04,3.94E-02,8.22E+02,0.00,1.00E+00,0.00E+00
mitral valve morphogenesis (GO:0003183),0.04,2.96E-02,8.92E+02,0.00,1.00E+00,0.00E+00
cellular response to dopamine (GO:1903351),0.04,1.18E-02,7.91E+02,0.00,1.00E+00,0.00E+00
granulocyte activation (GO:0036230),0.04,2.60E-02,2.09E+03,0.00,1.00E+00,0.00E+00
cellular response to interleukin-15 (GO:0071350),0.04,3.22E-02,1.50E+03,0.00,1.00E+00,0.00E+00
retinol metabolic process (GO:0042572),0.04,2.12E-02,8.18E+02,0.00,1.00E+00,0.00E+00
peripheral nervous system neuron development (GO:0048935),0.00,1.00E+00,0.00E+00,0.03,3.19E-02,1.17E+02
insulin-like growth factor receptor signaling pathway (GO:0048009),0.00,1.00E+00,0.00E+00,0.03,4.02E-02,2.85E+01
phosphate ion homeostasis (GO:0055062),0.00,1.00E+00,0.00E+00,0.03,3.42E-02,5.62E+01
dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),0.00,2.49E-02,1.12E+02,0.00,1.00E+00,0.00E+00
regulation of Rab protein signal transduction (GO:0032483),0.00,3.39E-02,8.12E+01,0.00,1.00E+00,0.00E+00
lipoprotein biosynthetic process (GO:0042158),0.00,1.04E-02,5.15E+01,0.00,1.00E+00,0.00E+00
inorganic cation import across plasma membrane (GO:0098659),0.00,4.52E-02,3.70E+02,0.00,1.00E+00,0.00E+00
arachidonate transport (GO:1903963),0.02,2.00E-02,1.75E+03,0.03,2.00E-02,1.75E+03
muscle tissue morphogenesis (GO:0060415),0.02,2.00E-02,8.91E+02,0.03,2.00E-02,8.91E+02
icosanoid secretion (GO:0032309),0.02,2.00E-02,1.25E+03,0.03,2.00E-02,1.25E+03
arachidonic acid secretion (GO:0050482),0.02,2.00E-02,1.75E+03,0.03,2.00E-02,1.75E+03
negative regulation of viral transcription (GO:0032897),0.02,3.15E-02,2.42E+01,0.03,3.17E-02,2.41E+01
regulation of biomineral tissue development (GO:0070167),0.01,4.09E-02,4.45E+02,0.05,4.09E-02,4.45E+02
sphingosine-1-phosphate receptor signaling pathway (GO:0003376),0.01,3.04E-02,2.40E+03,0.05,3.04E-02,2.40E+03
positive regulation of nervous system development (GO:0051962),0.01,2.45E-02,2.05E+02,0.05,2.45E-02,2.05E+02
I-kappaB phosphorylation (GO:0007252),0.01,3.23E-02,1.50E+03,0.05,3.23E-02,1.50E+03
negative regulation of glucose transmembrane transport (GO:0010829),0.01,2.28E-02,1.66E+03,0.05,4.07E-02,6.11E+02
negative regulation of JUN kinase activity (GO:0043508),0.01,3.27E-02,1.19E+03,0.05,3.27E-02,1.19E+03
glycosylceramide biosynthetic process (GO:0046476),0.01,2.80E-02,1.25E+03,0.05,4.68E-02,6.41E+01
negative regulation of transmembrane transport (GO:0034763),0.01,2.28E-02,2.09E+03,0.05,4.07E-02,7.76E+02
actin cytoskeleton reorganization (GO:0031532),0.01,4.89E-02,1.44E+02,0.05,4.89E-02,1.44E+02
steroid metabolic process (GO:0008202),0.03,2.82E-02,2.50E+02,0.00,1.00E+00,0.00E+00
phosphatidylcholine biosynthetic process (GO:0006656),0.03,3.07E-02,3.29E+02,0.00,1.00E+00,0.00E+00
regulation of interleukin-5 production (GO:0032674),0.03,2.25E-02,1.07E+03,0.00,1.00E+00,0.00E+00
steroid biosynthetic process (GO:0006694),0.03,2.15E-02,4.51E+02,0.00,1.00E+00,0.00E+00
regulation of transposition (GO:0010528),0.03,3.25E-02,5.06E+02,0.00,1.00E+00,0.00E+00
superoxide anion generation (GO:0042554),0.03,3.39E-02,1.25E+03,0.00,1.00E+00,0.00E+00
positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.03,4.50E-02,3.07E+02,0.00,1.00E+00,0.00E+00
negative regulation of platelet aggregation (GO:0090331),0.03,3.24E-02,1.07E+03,0.00,1.00E+00,0.00E+00
iron coordination entity transport (GO:1901678),0.03,7.58E-03,3.34E+03,0.00,1.00E+00,0.00E+00
energy derivation by oxidation of organic compounds (GO:0015980),0.03,3.85E-02,6.58E+02,0.00,1.00E+00,0.00E+00
digestive system development (GO:0055123),0.03,3.87E-02,1.19E+03,0.00,1.00E+00,0.00E+00
negative regulation of transposition (GO:0010529),0.03,3.60E-02,3.86E+02,0.00,1.00E+00,0.00E+00
negative regulation of cell projection organization (GO:0031345),0.03,4.03E-02,1.72E+02,0.00,1.00E+00,0.00E+00
glucose metabolic process (GO:0006006),0.03,2.79E-02,1.17E+01,0.00,1.00E+00,0.00E+00
positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.03,2.46E-02,1.68E+03,0.00,1.00E+00,0.00E+00
regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.03,3.25E-02,7.07E+02,0.00,1.00E+00,0.00E+00
positive regulation of insulin secretion (GO:0032024),0.03,3.36E-02,4.83E+02,0.00,1.00E+00,0.00E+00
alpha-beta T cell activation (GO:0046631),0.03,4.19E-02,6.13E+03,0.00,1.00E+00,0.00E+00
endothelial cell development (GO:0001885),0.03,2.77E-02,6.26E+02,0.00,1.00E+00,0.00E+00
serine family amino acid metabolic process (GO:0009069),0.03,2.26E-02,2.55E+03,0.00,1.00E+00,0.00E+00
protein localization to cell junction (GO:1902414),0.03,4.91E-02,3.75E+02,0.00,1.00E+00,0.00E+00
detection of mechanical stimulus (GO:0050982),0.02,2.13E-02,1.15E+03,0.03,2.13E-02,7.74E+02
peptide catabolic process (GO:0043171),0.02,2.32E-02,5.48E+02,0.03,2.32E-02,5.48E+02
myeloid leukocyte mediated immunity (GO:0002444),0.02,2.00E-02,2.34E+03,0.03,2.00E-02,2.34E+03
negative regulation of protein polymerization (GO:0032272),0.02,4.49E-02,2.88E+02,0.03,6.73E-03,2.66E+01
histone H3-K4 demethylation (GO:0034720),0.02,2.80E-02,1.04E+03,0.03,4.72E-02,3.11E+01
protein homotetramerization (GO:0051289),0.02,3.65E-02,5.02E+01,0.03,4.05E-02,5.02E+01
regulation of histone exchange (GO:1900049),0.01,2.97E-02,3.51E+01,0.00,1.00E+00,0.00E+00
regulation of histone H3-K9 methylation (GO:0051570),0.01,4.57E-02,3.69E+01,0.00,1.00E+00,0.00E+00
box C/D snoRNP assembly (GO:0000492),0.01,3.01E-02,4.86E+01,0.00,1.00E+00,0.00E+00
regulation of T cell mediated immunity (GO:0002709),0.01,2.28E-02,1.85E+03,0.00,1.00E+00,0.00E+00
positive regulation of helicase activity (GO:0051096),0.01,1.59E-02,8.38E+01,0.00,1.00E+00,0.00E+00
steroid catabolic process (GO:0006706),0.01,2.28E-02,1.36E+03,0.00,1.00E+00,0.00E+00
modulation by symbiont of host autophagy (GO:0075071),0.01,3.34E-02,8.15E+01,0.00,1.00E+00,0.00E+00
positive regulation of histone exchange (GO:1900051),0.01,2.97E-02,3.51E+01,0.00,1.00E+00,0.00E+00
activation of adenylate cyclase activity (GO:0007190),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of ion transmembrane transporter activity (GO:0032413),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of interleukin-4 production (GO:0032753),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
non-motile cilium assembly (GO:1905515),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of T-helper cell differentiation (GO:0045624),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of alpha-beta T cell differentiation (GO:0046638),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
amyloid-beta formation (GO:0034205),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
toll-like receptor 2 signaling pathway (GO:0034134),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of microglial cell mediated cytotoxicity (GO:1904149),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of osteoclast development (GO:2001204),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
tRNA aminoacylation for mitochondrial protein translation (GO:0070127),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
smoothened signaling pathway (GO:0007224),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
galactose catabolic process (GO:0019388),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
axoneme assembly (GO:0035082),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
immune response-inhibiting cell surface receptor signaling pathway (GO:0002767),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
leukotriene biosynthetic process (GO:0019370),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of membrane depolarization (GO:1904181),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
"regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)",0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
protein deacylation (GO:0035601),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
cellular response to estradiol stimulus (GO:0071392),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
toll-like receptor 3 signaling pathway (GO:0034138),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
phosphatidylserine metabolic process (GO:0006658),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
glycerophospholipid catabolic process (GO:0046475),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
tRNA wobble base modification (GO:0002097),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of hemoglobin biosynthetic process (GO:0046984),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
iron ion transmembrane transport (GO:0034755),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of dendritic spine development (GO:0060999),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
monoacylglycerol catabolic process (GO:0052651),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
monoacylglycerol metabolic process (GO:0046462),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of transcription regulatory region DNA binding (GO:2000678),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
neuron projection maintenance (GO:1990535),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of purine nucleotide metabolic process (GO:1900544),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of glycolytic process (GO:0045821),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of hemoglobin biosynthetic process (GO:0046985),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of core promoter binding (GO:1904796),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
cellular modified amino acid catabolic process (GO:0042219),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of glycoprotein biosynthetic process (GO:0010561),0.03,7.20E-03,5.26E+03,0.00,1.00E+00,0.00E+00
response to organophosphorus (GO:0046683),0.03,4.07E-02,7.15E+02,0.00,1.00E+00,0.00E+00
determination of left/right symmetry (GO:0007368),0.03,4.67E-02,3.43E+02,0.00,1.00E+00,0.00E+00
mitochondrial fission (GO:0000266),0.03,9.59E-03,2.20E+03,0.00,1.00E+00,0.00E+00
positive regulation of MHC class II biosynthetic process (GO:0045348),0.03,2.84E-02,1.55E+03,0.00,1.00E+00,0.00E+00
synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.03,7.20E-03,7.30E+03,0.00,1.00E+00,0.00E+00
synaptic vesicle budding (GO:0070142),0.03,7.20E-03,6.13E+03,0.00,1.00E+00,0.00E+00
dynamin family protein polymerization involved in membrane fission (GO:0003373),0.03,7.20E-03,6.13E+03,0.00,1.00E+00,0.00E+00
regulation of entry of bacterium into host cell (GO:2000535),0.03,9.96E-03,5.29E+03,0.00,1.00E+00,0.00E+00
determination of bilateral symmetry (GO:0009855),0.03,3.85E-02,5.46E+02,0.00,1.00E+00,0.00E+00
postsynaptic neurotransmitter receptor internalization (GO:0098884),0.03,7.20E-03,1.15E+04,0.00,1.00E+00,0.00E+00
organelle fission (GO:0048285),0.03,1.28E-02,1.40E+03,0.00,1.00E+00,0.00E+00
dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.03,7.20E-03,6.13E+03,0.00,1.00E+00,0.00E+00
fat-soluble vitamin metabolic process (GO:0006775),0.03,3.39E-02,4.06E+02,0.00,1.00E+00,0.00E+00
postsynaptic endocytosis (GO:0140239),0.03,7.20E-03,1.15E+04,0.00,1.00E+00,0.00E+00
regulation of morphogenesis of an epithelium (GO:1905330),0.03,4.99E-02,3.34E+03,0.00,1.00E+00,0.00E+00
divalent inorganic cation homeostasis (GO:0072507),0.03,1.18E-02,1.47E+03,0.00,1.00E+00,0.00E+00
regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.03,2.08E-02,1.85E+03,0.00,1.00E+00,0.00E+00
thyroid gland development (GO:0030878),0.03,2.10E-02,2.21E+03,0.00,1.00E+00,0.00E+00
regulation of kidney development (GO:0090183),0.03,4.99E-02,2.95E+03,0.00,1.00E+00,0.00E+00
outflow tract septum morphogenesis (GO:0003148),0.03,4.52E-02,3.18E+02,0.00,1.00E+00,0.00E+00
negative regulation of cellular metabolic process (GO:0031324),0.03,3.87E-02,3.13E+02,0.00,1.00E+00,0.00E+00
gliogenesis (GO:0042063),0.03,4.35E-02,1.73E+01,0.00,1.00E+00,0.00E+00
negative regulation of inclusion body assembly (GO:0090084),0.03,2.93E-02,3.24E+01,0.00,1.00E+00,0.00E+00
negative regulation of biosynthetic process (GO:0009890),0.03,3.15E-02,8.29E+02,0.00,1.00E+00,0.00E+00
negative chemotaxis (GO:0050919),0.03,4.05E-02,4.64E+02,0.00,1.00E+00,0.00E+00
tyrosine phosphorylation of STAT protein (GO:0007260),0.03,3.25E-02,2.80E+03,0.00,1.00E+00,0.00E+00
regulation of collagen biosynthetic process (GO:0032965),0.03,3.17E-02,7.74E+02,0.00,1.00E+00,0.00E+00
negative regulation of erythrocyte differentiation (GO:0045647),0.03,4.99E-02,5.05E+03,0.00,1.00E+00,0.00E+00
regulation of epithelial cell apoptotic process (GO:1904035),0.03,4.62E-02,1.50E+03,0.00,1.00E+00,0.00E+00
positive regulation of neuron projection development (GO:0010976),0.03,2.93E-02,1.67E+02,0.00,1.00E+00,0.00E+00
regulation of glomerular filtration (GO:0003093),0.01,3.07E-02,2.58E+03,0.05,3.07E-02,2.58E+03
interleukin-18-mediated signaling pathway (GO:0035655),0.01,3.07E-02,2.09E+03,0.05,3.07E-02,2.09E+03
negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.01,3.07E-02,1.75E+03,0.05,3.07E-02,1.75E+03
phospholipid translocation (GO:0045332),0.01,4.07E-02,3.09E+02,0.05,4.07E-02,3.09E+02
transition metal ion transport (GO:0000041),0.01,4.25E-02,5.17E+02,0.05,4.25E-02,2.94E+02
regulation of skeletal muscle contraction (GO:0014819),0.01,3.07E-02,2.09E+03,0.05,3.07E-02,2.09E+03
cellular response to interleukin-18 (GO:0071351),0.01,3.07E-02,2.09E+03,0.05,3.07E-02,2.09E+03
regulation of meiotic nuclear division (GO:0040020),0.00,3.42E-02,2.01E+03,0.05,3.42E-02,2.01E+03
bleb assembly (GO:0032060),0.00,3.42E-02,2.40E+03,0.05,3.42E-02,2.40E+03
negative regulation of fibroblast proliferation (GO:0048147),0.00,2.31E-02,2.24E+01,0.05,1.18E-02,2.20E+03
copper ion transport (GO:0006825),0.00,3.42E-02,1.33E+03,0.05,3.42E-02,1.33E+03
positive regulation of smooth muscle contraction (GO:0045987),0.00,3.42E-02,1.72E+03,0.05,3.42E-02,1.72E+03
positive regulation of muscle contraction (GO:0045933),0.00,3.42E-02,2.01E+03,0.05,3.42E-02,2.01E+03
positive regulation of meiotic nuclear division (GO:0045836),0.00,3.42E-02,2.01E+03,0.05,3.42E-02,2.01E+03
NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.01,2.37E-02,7.48E+02,0.03,1.03E-02,3.01E+03
negative regulation of actin filament polymerization (GO:0030837),0.01,3.92E-02,2.46E+01,0.03,1.00E-02,2.46E+01
regulation of transport (GO:0051049),0.01,4.99E-02,2.25E+01,0.03,1.89E-02,1.60E+01
regulation of BMP signaling pathway (GO:0030510),0.01,4.98E-02,1.33E+02,0.03,2.30E-02,3.71E+02
positive regulation of cartilage development (GO:0061036),0.01,3.98E-02,4.36E+02,0.03,3.98E-02,4.36E+02
positive regulation of chondrocyte differentiation (GO:0032332),0.01,3.59E-02,8.23E+02,0.03,3.59E-02,8.23E+02
regulation of vacuole organization (GO:0044088),0.01,4.59E-02,1.51E+01,0.03,4.59E-02,1.51E+01
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.01,3.59E-02,8.23E+02,0.03,3.59E-02,8.23E+02
cardiac muscle cell action potential involved in contraction (GO:0086002),0.01,4.91E-02,1.79E+02,0.03,4.59E-02,2.12E+01
positive regulation of ossification (GO:0045778),0.01,4.94E-02,1.56E+02,0.03,4.94E-02,1.56E+02
icosanoid transport (GO:0071715),0.01,3.59E-02,1.07E+03,0.03,3.59E-02,1.07E+03
cyclic-nucleotide-mediated signaling (GO:0019935),0.01,4.71E-02,1.79E+02,0.03,4.71E-02,1.79E+02
ornithine metabolic process (GO:0006591),0.01,3.59E-02,1.07E+03,0.03,3.59E-02,1.07E+03
positive regulation of vascular permeability (GO:0043117),0.01,3.59E-02,7.35E+02,0.03,3.59E-02,7.35E+02
regulation of Golgi to plasma membrane protein transport (GO:0042996),0.01,3.59E-02,1.25E+03,0.03,3.59E-02,1.25E+03
leukotriene transport (GO:0071716),0.01,3.59E-02,1.50E+03,0.03,3.59E-02,1.50E+03
pronephros development (GO:0048793),0.01,3.59E-02,1.85E+03,0.03,3.59E-02,1.85E+03
phospholipid homeostasis (GO:0055091),0.01,3.59E-02,7.35E+02,0.03,3.59E-02,7.35E+02
positive regulation of cell development (GO:0010720),0.01,4.86E-02,1.67E+02,0.03,4.86E-02,1.67E+02
regulation of calcium ion transmembrane transport (GO:1903169),0.01,4.10E-02,3.18E+02,0.03,4.10E-02,3.18E+02
regulation of cAMP-mediated signaling (GO:0043949),0.01,4.10E-02,2.86E+02,0.03,4.10E-02,2.86E+02
nephron tubule development (GO:0072080),0.01,3.59E-02,1.85E+03,0.03,3.59E-02,1.85E+03
regulation of osteoblast differentiation (GO:0045667),0.01,3.33E-02,1.80E+02,0.03,2.40E-02,3.32E+02
response to hexose (GO:0009746),0.01,4.10E-02,2.86E+02,0.03,4.10E-02,2.86E+02
cAMP-mediated signaling (GO:0019933),0.01,4.10E-02,2.86E+02,0.03,4.10E-02,2.86E+02
triglyceride homeostasis (GO:0070328),0.01,4.43E-02,2.17E+02,0.03,4.43E-02,2.17E+02
acylglycerol homeostasis (GO:0055090),0.01,4.10E-02,2.86E+02,0.03,4.10E-02,2.86E+02
positive regulation of centriole replication (GO:0046601),0.01,1.96E-02,1.03E+02,0.00,1.00E+00,0.00E+00
protein localization to nucleolus (GO:1902570),0.01,1.96E-02,1.03E+02,0.00,1.00E+00,0.00E+00
protein hexamerization (GO:0034214),0.01,3.49E-02,3.63E+01,0.00,1.00E+00,0.00E+00
protein localization to endoplasmic reticulum exit site (GO:0070973),0.01,4.48E-02,4.24E+01,0.00,1.00E+00,0.00E+00
negative regulation of protein kinase B signaling (GO:0051898),0.01,3.72E-02,2.39E+01,0.00,1.00E+00,0.00E+00
pentose-phosphate shunt (GO:0006098),0.01,3.07E-02,5.70E+01,0.00,1.00E+00,0.00E+00
negative regulation of cell division (GO:0051782),0.01,1.95E-02,7.15E+01,0.00,1.00E+00,0.00E+00
protection from non-homologous end joining at telomere (GO:0031848),0.01,4.83E-02,8.15E+01,0.00,1.00E+00,0.00E+00
regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.01,2.97E-02,2.69E+01,0.00,1.00E+00,0.00E+00
negative regulation of cardiac muscle hypertrophy (GO:0010614),0.01,4.91E-02,3.69E+01,0.00,1.00E+00,0.00E+00
mitochondrial RNA 3'-end processing (GO:0000965),0.01,4.61E-02,1.16E+02,0.00,1.00E+00,0.00E+00
"pentose-phosphate shunt, non-oxidative branch (GO:0009052)",0.01,3.72E-02,1.26E+02,0.00,1.00E+00,0.00E+00
activation of protein kinase C activity (GO:1990051),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of cell aging (GO:0090342),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
dolichyl diphosphate biosynthetic process (GO:0006489),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
dolichyl diphosphate metabolic process (GO:0046465),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of dendritic spine development (GO:0061000),0.02,4.69E-02,6.58E+02,0.00,1.00E+00,0.00E+00
positive regulation of extracellular matrix assembly (GO:1901203),0.02,3.89E-02,3.21E+01,0.00,1.00E+00,0.00E+00
negative regulation of cell-substrate junction organization (GO:0150118),0.02,4.10E-02,1.97E+01,0.00,1.00E+00,0.00E+00
negative regulation of focal adhesion assembly (GO:0051895),0.02,4.10E-02,1.97E+01,0.00,1.00E+00,0.00E+00
positive regulation of cation transmembrane transport (GO:1904064),0.02,4.84E-02,1.90E+02,0.00,1.00E+00,0.00E+00
glutamate receptor signaling pathway (GO:0007215),0.02,3.79E-02,2.84E+02,0.00,1.00E+00,0.00E+00
response to thyroid hormone (GO:0097066),0.02,3.37E-02,8.23E+02,0.00,1.00E+00,0.00E+00
aromatic amino acid family metabolic process (GO:0009072),0.02,3.14E-02,1.16E+03,0.00,1.00E+00,0.00E+00
response to vitamin (GO:0033273),0.02,3.14E-02,1.33E+03,0.00,1.00E+00,0.00E+00
kynurenine metabolic process (GO:0070189),0.02,3.14E-02,1.33E+03,0.00,1.00E+00,0.00E+00
benzene-containing compound metabolic process (GO:0042537),0.02,3.14E-02,1.55E+03,0.00,1.00E+00,0.00E+00
replication fork protection (GO:0048478),0.02,3.13E-02,1.46E+03,0.00,1.00E+00,0.00E+00
tryptophan catabolic process to kynurenine (GO:0019441),0.02,3.14E-02,2.95E+03,0.00,1.00E+00,0.00E+00
glutamine family amino acid metabolic process (GO:0009064),0.02,4.80E-02,2.16E+02,0.00,1.00E+00,0.00E+00
positive regulation of potassium ion transport (GO:0043268),0.02,3.79E-02,2.75E+02,0.00,1.00E+00,0.00E+00
regulation of SMAD protein signal transduction (GO:0060390),0.02,3.05E-02,4.51E+02,0.00,1.00E+00,0.00E+00
nucleotide metabolic process (GO:0009117),0.02,3.05E-02,4.51E+02,0.00,1.00E+00,0.00E+00
inositol metabolic process (GO:0006020),0.02,2.69E-02,8.65E+02,0.00,1.00E+00,0.00E+00
regulation of acyl-CoA biosynthetic process (GO:0050812),0.02,2.69E-02,1.04E+03,0.00,1.00E+00,0.00E+00
regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.02,2.69E-02,1.04E+03,0.00,1.00E+00,0.00E+00
aminoglycan metabolic process (GO:0006022),0.02,4.65E-02,6.39E+02,0.00,1.00E+00,0.00E+00
regulation of ion transmembrane transporter activity (GO:0032412),0.02,3.84E-02,2.66E+02,0.00,1.00E+00,0.00E+00
regulation of potassium ion transmembrane transport (GO:1901379),0.02,4.43E-02,1.75E+02,0.00,1.00E+00,0.00E+00
muscle contraction (GO:0006936),0.02,3.14E-02,2.13E+02,0.00,1.00E+00,0.00E+00
nucleoside diphosphate metabolic process (GO:0009132),0.02,2.89E-02,7.15E+02,0.00,1.00E+00,0.00E+00
cellular response to hydroxyurea (GO:0072711),0.02,3.13E-02,1.04E+03,0.00,1.00E+00,0.00E+00
regulation of protein polymerization (GO:0032271),0.02,4.66E-02,2.07E+02,0.00,1.00E+00,0.00E+00
ionotropic glutamate receptor signaling pathway (GO:0035235),0.02,3.54E-02,1.50E+03,0.00,1.00E+00,0.00E+00
triglyceride catabolic process (GO:0019433),0.02,2.54E-02,2.96E+02,0.00,1.00E+00,0.00E+00
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.02,2.15E-02,3.60E+02,0.00,1.00E+00,0.00E+00
regulation of cellular response to growth factor stimulus (GO:0090287),0.02,2.05E-02,4.53E+02,0.00,1.00E+00,0.00E+00
positive regulation of calcineurin-mediated signaling (GO:0106058),0.02,3.54E-02,1.07E+03,0.00,1.00E+00,0.00E+00
positive regulation of cholesterol storage (GO:0010886),0.02,8.92E-03,2.21E+03,0.00,1.00E+00,0.00E+00
purine ribonucleotide biosynthetic process (GO:0009152),0.02,4.01E-02,1.76E+02,0.00,1.00E+00,0.00E+00
positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.02,3.54E-02,1.07E+03,0.00,1.00E+00,0.00E+00
positive regulation of protein localization to cell surface (GO:2000010),0.02,3.54E-02,1.07E+03,0.00,1.00E+00,0.00E+00
carbohydrate catabolic process (GO:0016052),0.02,3.62E-02,2.16E+02,0.00,1.00E+00,0.00E+00
microtubule anchoring (GO:0034453),0.02,3.50E-02,2.65E+01,0.00,1.00E+00,0.00E+00
positive regulation of intracellular transport (GO:0032388),0.02,1.03E-02,4.83E+02,0.00,1.00E+00,0.00E+00
regulation of dendrite development (GO:0050773),0.02,3.61E-02,2.30E+02,0.00,1.00E+00,0.00E+00
regulation of metal ion transport (GO:0010959),0.02,3.54E-02,7.61E+02,0.00,1.00E+00,0.00E+00
glycolytic process (GO:0006096),0.02,3.08E-02,3.36E+02,0.00,1.00E+00,0.00E+00
nephric duct development (GO:0072176),0.02,3.17E-02,2.76E+03,0.00,1.00E+00,0.00E+00
negative regulation of fibrinolysis (GO:0051918),0.02,1.20E-02,2.40E+03,0.00,1.00E+00,0.00E+00
regulation of protein-containing complex disassembly (GO:0043244),0.02,3.54E-02,7.08E+02,0.00,1.00E+00,0.00E+00
positive regulation of oxidoreductase activity (GO:0051353),0.02,3.54E-02,6.61E+02,0.00,1.00E+00,0.00E+00
glucose 6-phosphate metabolic process (GO:0051156),0.02,3.05E-02,4.51E+02,0.00,1.00E+00,0.00E+00
negative regulation of signaling receptor activity (GO:2000272),0.02,3.55E-02,4.45E+02,0.00,1.00E+00,0.00E+00
regulation of synapse organization (GO:0050807),0.02,3.55E-02,4.45E+02,0.00,1.00E+00,0.00E+00
carboxylic acid metabolic process (GO:0019752),0.02,3.61E-02,2.23E+02,0.00,1.00E+00,0.00E+00
positive regulation of SMAD protein signal transduction (GO:0060391),0.02,2.74E-02,8.48E+02,0.00,1.00E+00,0.00E+00
nucleoside triphosphate metabolic process (GO:0009141),0.02,2.74E-02,8.48E+02,0.00,1.00E+00,0.00E+00
nucleoside phosphate biosynthetic process (GO:1901293),0.02,2.74E-02,8.48E+02,0.00,1.00E+00,0.00E+00
regulation of transmission of nerve impulse (GO:0051969),0.02,4.69E-02,8.15E+02,0.00,1.00E+00,0.00E+00
cellular response to cold (GO:0070417),0.02,4.69E-02,8.15E+02,0.00,1.00E+00,0.00E+00
cellular response to iron ion (GO:0071281),0.02,4.69E-02,8.15E+02,0.00,1.00E+00,0.00E+00
cytoplasmic sequestering of protein (GO:0051220),0.02,4.91E-02,2.86E+02,0.00,1.00E+00,0.00E+00
response to iron ion (GO:0010039),0.02,4.91E-02,2.86E+02,0.00,1.00E+00,0.00E+00
negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.02,4.91E-02,2.86E+02,0.00,1.00E+00,0.00E+00
pyrimidine-containing compound metabolic process (GO:0072527),0.02,4.83E-02,3.18E+02,0.00,1.00E+00,0.00E+00
metanephric mesenchyme development (GO:0072075),0.02,4.81E-02,3.57E+02,0.00,1.00E+00,0.00E+00
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.02,4.81E-02,3.57E+02,0.00,1.00E+00,0.00E+00
nucleoside metabolic process (GO:0009116),0.02,4.69E-02,4.06E+02,0.00,1.00E+00,0.00E+00
negative regulation of T-helper cell differentiation (GO:0045623),0.02,1.23E-02,1.85E+03,0.00,1.00E+00,0.00E+00
positive regulation of receptor binding (GO:1900122),0.02,4.69E-02,8.15E+02,0.00,1.00E+00,0.00E+00
response to interleukin-4 (GO:0070670),0.02,1.23E-02,2.09E+03,0.00,1.00E+00,0.00E+00
regulation of T-helper 17 cell differentiation (GO:2000319),0.02,4.69E-02,4.06E+02,0.00,1.00E+00,0.00E+00
negative regulation of cellular protein catabolic process (GO:1903363),0.02,4.69E-02,4.06E+02,0.00,1.00E+00,0.00E+00
regulation of glutamate receptor signaling pathway (GO:1900449),0.02,1.20E-02,4.11E+03,0.00,1.00E+00,0.00E+00
positive regulation of aspartic-type peptidase activity (GO:1905247),0.02,4.69E-02,5.48E+02,0.00,1.00E+00,0.00E+00
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.02,4.69E-02,4.67E+02,0.00,1.00E+00,0.00E+00
regulation of thymocyte apoptotic process (GO:0070243),0.02,1.20E-02,4.11E+03,0.00,1.00E+00,0.00E+00
negative regulation of neuron migration (GO:2001223),0.02,1.20E-02,4.11E+03,0.00,1.00E+00,0.00E+00
positive regulation of isomerase activity (GO:0010912),0.02,4.69E-02,5.48E+02,0.00,1.00E+00,0.00E+00
collagen-activated signaling pathway (GO:0038065),0.02,1.20E-02,2.40E+03,0.00,1.00E+00,0.00E+00
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.02,4.69E-02,6.58E+02,0.00,1.00E+00,0.00E+00
metanephric mesenchymal cell differentiation (GO:0072162),0.02,4.69E-02,1.06E+03,0.00,1.00E+00,0.00E+00
regulation of interleukin-13 production (GO:0032656),0.02,4.62E-02,8.22E+02,0.00,1.00E+00,0.00E+00
regulation of fibrinolysis (GO:0051917),0.02,1.32E-02,1.50E+03,0.00,1.00E+00,0.00E+00
regulation of intracellular pH (GO:0051453),0.02,2.40E-02,5.00E+02,0.00,1.00E+00,0.00E+00
secretory granule organization (GO:0033363),0.02,2.72E-02,1.31E+03,0.00,1.00E+00,0.00E+00
nucleoside diphosphate phosphorylation (GO:0006165),0.02,2.72E-02,1.50E+03,0.00,1.00E+00,0.00E+00
response to forskolin (GO:1904321),0.02,1.96E-02,2.96E+03,0.00,1.00E+00,0.00E+00
cellular response to forskolin (GO:1904322),0.02,1.96E-02,2.96E+03,0.00,1.00E+00,0.00E+00
intracellular pH elevation (GO:0051454),0.02,1.96E-02,5.05E+03,0.00,1.00E+00,0.00E+00
nucleotide phosphorylation (GO:0046939),0.02,2.72E-02,1.50E+03,0.00,1.00E+00,0.00E+00
nucleoside triphosphate biosynthetic process (GO:0009142),0.02,2.72E-02,1.50E+03,0.00,1.00E+00,0.00E+00
pyrimidine ribonucleotide metabolic process (GO:0009218),0.02,2.72E-02,3.33E+03,0.00,1.00E+00,0.00E+00
heparin metabolic process (GO:0030202),0.02,2.72E-02,3.33E+03,0.00,1.00E+00,0.00E+00
regulation of monocyte differentiation (GO:0045655),0.02,3.57E-02,1.42E+03,0.00,1.00E+00,0.00E+00
positive regulation of neurogenesis (GO:0050769),0.02,3.51E-02,1.73E+02,0.00,1.00E+00,0.00E+00
regulation of neuron migration (GO:2001222),0.02,1.86E-02,5.71E+02,0.00,1.00E+00,0.00E+00
negative regulation of synaptic transmission (GO:0050805),0.02,2.30E-02,6.92E+02,0.00,1.00E+00,0.00E+00
fibrinolysis (GO:0042730),0.02,3.57E-02,8.92E+02,0.00,1.00E+00,0.00E+00
triglyceride biosynthetic process (GO:0019432),0.02,4.67E-02,5.41E+02,0.00,1.00E+00,0.00E+00
positive regulation of neural precursor cell proliferation (GO:2000179),0.02,1.55E-02,7.72E+02,0.00,1.00E+00,0.00E+00
negative regulation of Notch signaling pathway (GO:0045746),0.02,4.07E-02,5.23E+02,0.00,1.00E+00,0.00E+00
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),0.02,4.69E-02,1.06E+03,0.00,1.00E+00,0.00E+00
renal tubule development (GO:0061326),0.02,4.69E-02,1.06E+03,0.00,1.00E+00,0.00E+00
growth hormone receptor signaling pathway (GO:0060396),0.02,1.49E-02,8.70E+02,0.00,1.00E+00,0.00E+00
regulation of neuroblast proliferation (GO:1902692),0.02,1.43E-02,1.07E+03,0.00,1.00E+00,0.00E+00
growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.02,1.32E-02,1.36E+03,0.00,1.00E+00,0.00E+00
tubulin complex assembly (GO:0007021),0.02,8.51E-03,8.43E+02,0.00,1.00E+00,0.00E+00
pre-miRNA processing (GO:0031054),0.02,3.88E-02,3.92E+02,0.00,1.00E+00,0.00E+00
cellular response to interleukin-4 (GO:0071353),0.02,1.23E-02,2.09E+03,0.00,1.00E+00,0.00E+00
positive regulation of cytokinesis (GO:0032467),0.02,2.36E-02,1.68E+02,0.00,1.00E+00,0.00E+00
miRNA mediated inhibition of translation (GO:0035278),0.02,2.88E-02,5.59E+02,0.00,1.00E+00,0.00E+00
"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.02,2.88E-02,5.59E+02,0.00,1.00E+00,0.00E+00
meiotic sister chromatid cohesion (GO:0051177),0.02,2.10E-03,1.50E+03,0.00,1.00E+00,0.00E+00
mitotic DNA replication checkpoint signaling (GO:0033314),0.02,3.13E-03,1.07E+03,0.00,1.00E+00,0.00E+00
mitotic DNA integrity checkpoint signaling (GO:0044774),0.02,4.58E-03,7.27E+02,0.00,1.00E+00,0.00E+00
positive regulation of cell division (GO:0051781),0.02,3.03E-02,1.32E+02,0.00,1.00E+00,0.00E+00
small RNA loading onto RISC (GO:0070922),0.02,2.44E-02,7.59E+02,0.00,1.00E+00,0.00E+00
negative regulation of protein serine/threonine kinase activity (GO:0071901),0.02,4.06E-02,3.64E+02,0.00,1.00E+00,0.00E+00
miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.02,2.00E-02,1.13E+03,0.00,1.00E+00,0.00E+00
embryonic axis specification (GO:0000578),0.02,3.48E-02,5.43E+02,0.00,1.00E+00,0.00E+00
regulation of nitrogen compound metabolic process (GO:0051171),0.02,3.54E-02,2.01E+03,0.00,1.00E+00,0.00E+00
positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.02,3.51E-02,2.18E+01,0.00,1.00E+00,0.00E+00
glyceraldehyde-3-phosphate metabolic process (GO:0019682),0.02,1.31E-02,7.30E+03,0.00,1.00E+00,0.00E+00
negative regulation of amyloid-beta clearance (GO:1900222),0.02,3.54E-02,2.01E+03,0.00,1.00E+00,0.00E+00
cleavage furrow formation (GO:0036089),0.02,2.00E-02,1.13E+03,0.00,1.00E+00,0.00E+00
negative regulation of protein-containing complex disassembly (GO:0043242),0.02,3.54E-02,1.72E+03,0.00,1.00E+00,0.00E+00
intestinal epithelial cell differentiation (GO:0060575),0.02,1.58E-02,2.11E+03,0.00,1.00E+00,0.00E+00
columnar/cuboidal epithelial cell differentiation (GO:0002065),0.02,1.58E-02,1.57E+03,0.00,1.00E+00,0.00E+00
cellular water homeostasis (GO:0009992),0.02,4.62E-02,2.96E+03,0.00,1.00E+00,0.00E+00
water homeostasis (GO:0030104),0.02,4.62E-02,2.01E+03,0.00,1.00E+00,0.00E+00
granulocyte migration (GO:0097530),0.02,3.25E-02,1.31E+03,0.00,1.00E+00,0.00E+00
negative regulation of centrosome duplication (GO:0010826),0.02,4.68E-02,3.20E+01,0.00,1.00E+00,0.00E+00
hydrogen peroxide biosynthetic process (GO:0050665),0.02,2.44E-02,2.09E+02,0.00,1.00E+00,0.00E+00
cellular response to catecholamine stimulus (GO:0071870),0.02,1.87E-03,5.85E+02,0.00,1.00E+00,0.00E+00
positive regulation of steroid biosynthetic process (GO:0010893),0.02,3.54E-02,2.01E+03,0.00,1.00E+00,0.00E+00
"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.02,2.00E-02,2.63E+02,0.00,1.00E+00,0.00E+00
fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),0.02,1.31E-02,1.15E+04,0.00,1.00E+00,0.00E+00
response to UV-A (GO:0070141),0.02,2.99E-02,8.01E+01,0.00,1.00E+00,0.00E+00
fructose catabolic process (GO:0006001),0.02,1.31E-02,1.15E+04,0.00,1.00E+00,0.00E+00
mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.02,2.00E-02,2.05E+03,0.00,1.00E+00,0.00E+00
anion homeostasis (GO:0055081),0.00,4.33E-02,1.17E+02,0.00,1.00E+00,0.00E+00
positive regulation of cytoplasmic transport (GO:1903651),0.00,4.57E-02,2.54E+01,0.00,1.00E+00,0.00E+00
regulation of histone methylation (GO:0031060),0.00,4.44E-02,2.14E+01,0.00,1.00E+00,0.00E+00
mitochondrial RNA processing (GO:0000963),0.00,4.38E-02,3.58E+01,0.00,1.00E+00,0.00E+00
negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.00,4.15E-02,1.94E+01,0.00,1.00E+00,0.00E+00
establishment of endothelial intestinal barrier (GO:0090557),0.00,1.04E-02,5.15E+01,0.00,1.00E+00,0.00E+00
chromatin maintenance (GO:0070827),0.00,2.61E-03,6.86E+05,0.00,1.00E+00,0.00E+00
rRNA modification (GO:0000154),0.00,4.94E-02,1.56E+01,0.00,1.00E+00,0.00E+00
negative regulation of protein tyrosine kinase activity (GO:0061099),0.00,1.59E-02,2.30E+01,0.00,1.00E+00,0.00E+00
regulation of histone modification (GO:0031056),0.00,2.98E-02,2.76E+01,0.00,1.00E+00,0.00E+00
endothelial cell apoptotic process (GO:0072577),0.00,4.33E-02,1.17E+02,0.00,1.00E+00,0.00E+00
negative regulation of TOR signaling (GO:0032007),0.00,3.79E-02,1.30E+01,0.00,1.00E+00,0.00E+00
regulation of double-strand break repair (GO:2000779),0.00,4.29E-02,1.23E+01,0.00,1.00E+00,0.00E+00
focal adhesion assembly (GO:0048041),0.00,4.94E-02,1.56E+01,0.00,1.00E+00,0.00E+00
RNA phosphodiester bond hydrolysis (GO:0090501),0.00,4.42E-02,1.38E+01,0.00,1.00E+00,0.00E+00
negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.00,1.00E+00,0.00E+00,0.05,4.34E-02,3.89E+02
"synaptic transmission, GABAergic (GO:0051932)",0.00,1.00E+00,0.00E+00,0.05,3.19E-02,1.33E+03
regulation of actin filament length (GO:0030832),0.00,1.00E+00,0.00E+00,0.05,4.07E-02,1.04E+03
histidine catabolic process (GO:0006548),0.00,1.00E+00,0.00E+00,0.05,4.07E-02,1.04E+03
regulation of blood vessel remodeling (GO:0060312),0.00,1.00E+00,0.00E+00,0.05,3.19E-02,2.96E+03
histidine metabolic process (GO:0006547),0.00,1.00E+00,0.00E+00,0.05,4.07E-02,1.04E+03
regulation of actin filament organization (GO:0110053),0.00,1.00E+00,0.00E+00,0.05,4.07E-02,8.92E+02
aspartate family amino acid catabolic process (GO:0009068),0.00,1.00E+00,0.00E+00,0.05,4.58E-02,3.37E+02
lipoprotein transport (GO:0042953),0.00,1.00E+00,0.00E+00,0.05,4.07E-02,7.76E+02
endocardial cushion development (GO:0003197),0.00,1.00E+00,0.00E+00,0.05,3.19E-02,5.82E+02
endocardial cushion morphogenesis (GO:0003203),0.00,1.00E+00,0.00E+00,0.05,3.19E-02,6.61E+02
mesenchyme morphogenesis (GO:0072132),0.00,1.00E+00,0.00E+00,0.05,3.19E-02,7.61E+02
monoamine transport (GO:0015844),0.00,1.00E+00,0.00E+00,0.05,4.07E-02,1.04E+03
nitric oxide mediated signal transduction (GO:0007263),0.00,1.00E+00,0.00E+00,0.05,4.52E-02,3.62E+02
positive regulation of myelination (GO:0031643),0.00,1.00E+00,0.00E+00,0.05,4.61E-02,4.30E+01
dicarboxylic acid catabolic process (GO:0043649),0.00,1.00E+00,0.00E+00,0.05,4.11E-02,5.01E+02
regulation of protein kinase C signaling (GO:0090036),0.00,1.00E+00,0.00E+00,0.05,3.19E-02,9.74E+02
positive regulation of B cell receptor signaling pathway (GO:0050861),0.00,1.00E+00,0.00E+00,0.05,4.07E-02,1.25E+03
negative regulation of trophoblast cell migration (GO:1901164),0.00,1.00E+00,0.00E+00,0.05,3.19E-02,2.96E+03
negative regulation of androgen receptor signaling pathway (GO:0060766),0.00,1.00E+00,0.00E+00,0.05,3.19E-02,8.92E+02
ventricular septum development (GO:0003281),0.00,1.00E+00,0.00E+00,0.05,3.88E-02,2.75E+02
estrogen metabolic process (GO:0008210),0.00,1.00E+00,0.00E+00,0.05,3.70E-02,3.71E+02
positive regulation of Ras protein signal transduction (GO:0046579),0.00,1.00E+00,0.00E+00,0.05,4.88E-02,1.44E+02
ventricular septum morphogenesis (GO:0060412),0.00,1.00E+00,0.00E+00,0.05,3.62E-02,4.05E+02
negative regulation of reproductive process (GO:2000242),0.00,1.00E+00,0.00E+00,0.05,3.19E-02,5.82E+02
atrioventricular valve development (GO:0003171),0.00,1.00E+00,0.00E+00,0.05,3.19E-02,9.74E+02
cellular amino acid catabolic process (GO:0009063),0.00,1.00E+00,0.00E+00,0.05,9.10E-03,5.81E+02
steroid hormone biosynthetic process (GO:0120178),0.00,1.00E+00,0.00E+00,0.05,3.70E-02,3.56E+02
stabilization of membrane potential (GO:0030322),0.00,1.00E+00,0.00E+00,0.05,3.19E-02,7.61E+02
G protein-coupled opioid receptor signaling pathway (GO:0038003),0.00,1.00E+00,0.00E+00,0.05,4.07E-02,1.99E+03
histone-threonine phosphorylation (GO:0035405),0.00,1.00E+00,0.00E+00,0.05,4.07E-02,1.99E+03
aspartate metabolic process (GO:0006531),0.00,1.00E+00,0.00E+00,0.05,4.07E-02,1.54E+03
histamine metabolic process (GO:0001692),0.00,1.00E+00,0.00E+00,0.05,4.07E-02,1.54E+03
positive regulation of neuron differentiation (GO:0045666),0.00,1.00E+00,0.00E+00,0.05,4.06E-02,2.35E+02
positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.01,4.74E-02,1.88E+02,0.03,4.74E-02,1.88E+02
skeletal muscle thin filament assembly (GO:0030240),0.00,2.00E-02,3.45E+03,0.03,2.00E-02,3.45E+03
skeletal myofibril assembly (GO:0014866),0.00,2.00E-02,2.34E+03,0.03,2.00E-02,2.34E+03
cardiac muscle hypertrophy (GO:0003300),0.00,2.00E-02,2.34E+03,0.03,2.00E-02,2.34E+03
adult heart development (GO:0007512),0.00,2.00E-02,2.01E+03,0.03,2.00E-02,2.01E+03
hematopoietic stem cell differentiation (GO:0060218),0.00,2.00E-02,1.75E+03,0.03,2.00E-02,1.75E+03
positive regulation of blood pressure (GO:0045777),0.00,2.00E-02,2.01E+03,0.03,2.00E-02,2.01E+03
regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.00,2.00E-02,3.45E+03,0.03,2.00E-02,3.45E+03
regulation of hematopoietic stem cell proliferation (GO:1902033),0.00,2.00E-02,3.45E+03,0.03,2.00E-02,3.45E+03
acyl-CoA biosynthetic process (GO:0071616),0.00,4.82E-02,1.65E+01,0.03,4.82E-02,1.65E+01
cellular response to amino acid stimulus (GO:0071230),0.00,4.72E-02,1.15E+01,0.03,4.72E-02,1.15E+01
regulation of miRNA metabolic process (GO:2000628),0.00,3.32E-02,8.16E+01,0.03,3.32E-02,8.16E+01
regulation of protein neddylation (GO:2000434),0.00,3.27E-02,3.10E+01,0.03,3.27E-02,3.10E+01
striated muscle hypertrophy (GO:0014897),0.00,2.00E-02,3.45E+03,0.03,2.00E-02,3.45E+03
endoplasmic reticulum membrane organization (GO:0090158),0.00,2.21E-02,3.18E+01,0.03,2.21E-02,3.18E+01
phosphatidylinositol acyl-chain remodeling (GO:0036149),0.00,2.07E-02,8.29E+02,0.03,2.07E-02,8.29E+02
detection of muscle stretch (GO:0035995),0.00,2.00E-02,2.80E+03,0.03,2.00E-02,2.80E+03
angiotensin maturation (GO:0002003),0.00,2.00E-02,1.39E+03,0.03,2.00E-02,1.39E+03
regulation of transferase activity (GO:0051338),0.00,2.00E-02,8.91E+02,0.03,2.00E-02,8.91E+02
organophosphate catabolic process (GO:0046434),0.00,2.00E-02,1.55E+03,0.03,2.00E-02,1.55E+03
cardiac myofibril assembly (GO:0055003),0.00,2.00E-02,1.04E+03,0.03,2.00E-02,1.04E+03
regulation of angiotensin levels in blood (GO:0002002),0.00,2.00E-02,1.39E+03,0.03,2.00E-02,1.39E+03
regulation of systemic arterial blood pressure (GO:0003073),0.00,2.00E-02,9.62E+02,0.03,2.00E-02,9.62E+02
regulation of systemic arterial blood pressure by hormone (GO:0001990),0.00,2.00E-02,9.62E+02,0.03,2.00E-02,9.62E+02
peptide metabolic process (GO:0006518),0.00,4.35E-02,1.19E+02,0.03,4.35E-02,1.19E+02
phosphatidylcholine metabolic process (GO:0046470),0.00,4.18E-02,1.31E+02,0.03,4.18E-02,1.31E+02
phospholipid metabolic process (GO:0006644),0.00,4.17E-02,1.33E+02,0.03,4.17E-02,1.33E+02
organonitrogen compound catabolic process (GO:1901565),0.00,3.68E-02,1.70E+02,0.03,3.68E-02,1.70E+02
response to muscle stretch (GO:0035994),0.00,2.00E-02,1.04E+03,0.03,2.00E-02,1.04E+03
striated muscle contraction (GO:0006941),0.00,3.24E-02,2.07E+02,0.03,3.24E-02,2.07E+02
regulation of vasoconstriction (GO:0019229),0.00,2.53E-02,4.35E+02,0.03,2.53E-02,4.35E+02
phosphatidylcholine acyl-chain remodeling (GO:0036151),0.00,2.53E-02,4.35E+02,0.03,2.53E-02,4.35E+02
cellular lipid catabolic process (GO:0044242),0.00,2.41E-02,4.97E+02,0.03,2.41E-02,4.97E+02
phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.00,2.36E-02,5.21E+02,0.03,2.36E-02,5.21E+02
phospholipid catabolic process (GO:0009395),0.00,2.31E-02,5.77E+02,0.03,2.31E-02,5.77E+02
vascular process in circulatory system (GO:0003018),0.00,2.00E-02,1.25E+03,0.03,2.00E-02,1.25E+03
regulation of tube diameter (GO:0035296),0.00,2.00E-02,1.25E+03,0.03,2.00E-02,1.25E+03
embryonic skeletal joint development (GO:0072498),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
embryonic skeletal joint morphogenesis (GO:0060272),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
peroxisome organization (GO:0007031),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
genitalia development (GO:0048806),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of transcription by RNA polymerase III (GO:0006359),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
pseudouridine synthesis (GO:0001522),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
cytochrome complex assembly (GO:0017004),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
dendrite self-avoidance (GO:0070593),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
lipid homeostasis (GO:0055088),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of extracellular matrix organization (GO:1903053),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
taurine metabolic process (GO:0019530),0.02,1.31E-02,8.96E+03,0.00,1.00E+00,0.00E+00
regulation of DNA-dependent DNA replication initiation (GO:0030174),0.02,4.45E-02,4.70E+01,0.00,1.00E+00,0.00E+00
positive regulation of protein deacetylation (GO:0090312),0.02,2.28E-02,1.36E+03,0.00,1.00E+00,0.00E+00
regulation of glucose import (GO:0046324),0.02,2.00E-02,1.59E+01,0.00,1.00E+00,0.00E+00
regulation of microtubule polymerization or depolymerization (GO:0031110),0.02,4.49E-02,2.75E+02,0.00,1.00E+00,0.00E+00
regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.02,3.87E-02,2.09E+03,0.00,1.00E+00,0.00E+00
inositol phosphate metabolic process (GO:0043647),0.02,3.13E-02,2.90E+02,0.00,1.00E+00,0.00E+00
polyol metabolic process (GO:0019751),0.02,3.13E-02,2.97E+02,0.00,1.00E+00,0.00E+00
positive regulation of glucose transmembrane transport (GO:0010828),0.02,4.21E-02,2.08E+02,0.00,1.00E+00,0.00E+00
bile acid biosynthetic process (GO:0006699),0.02,1.76E-02,1.34E+03,0.00,1.00E+00,0.00E+00
amino sugar catabolic process (GO:0046348),0.02,1.31E-02,7.30E+03,0.00,1.00E+00,0.00E+00
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.02,2.85E-02,5.29E+02,0.00,1.00E+00,0.00E+00
ethanol metabolic process (GO:0006067),0.02,1.51E-02,2.06E+03,0.00,1.00E+00,0.00E+00
regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.02,8.57E-03,1.54E+03,0.00,1.00E+00,0.00E+00
positive regulation of T-helper 2 cell cytokine production (GO:2000553),0.02,1.44E-02,6.13E+03,0.00,1.00E+00,0.00E+00
bile acid metabolic process (GO:0008206),0.02,1.76E-02,1.04E+03,0.00,1.00E+00,0.00E+00
acyl-CoA metabolic process (GO:0006637),0.02,1.76E-02,9.07E+02,0.00,1.00E+00,0.00E+00
ethanol oxidation (GO:0006069),0.02,1.40E-02,3.65E+03,0.00,1.00E+00,0.00E+00
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.02,3.76E-02,3.47E+02,0.00,1.00E+00,0.00E+00
diterpenoid metabolic process (GO:0016101),0.02,2.15E-02,4.60E+02,0.00,1.00E+00,0.00E+00
cellular amide metabolic process (GO:0043603),0.02,2.99E-02,2.20E+02,0.00,1.00E+00,0.00E+00
fatty acid metabolic process (GO:0006631),0.02,3.07E-02,2.00E+02,0.00,1.00E+00,0.00E+00
negative regulation of peptidyl-lysine acetylation (GO:2000757),0.02,4.69E-02,2.09E+03,0.00,1.00E+00,0.00E+00
negative regulation of homotypic cell-cell adhesion (GO:0034111),0.02,3.25E-02,8.23E+02,0.00,1.00E+00,0.00E+00
monocarboxylic acid metabolic process (GO:0032787),0.02,3.46E-02,1.66E+02,0.00,1.00E+00,0.00E+00
glycine metabolic process (GO:0006544),0.02,1.40E-02,3.65E+03,0.00,1.00E+00,0.00E+00
purine ribonucleotide metabolic process (GO:0009150),0.02,2.31E-02,3.65E+02,0.00,1.00E+00,0.00E+00
monocarboxylic acid biosynthetic process (GO:0072330),0.02,2.15E-02,4.69E+02,0.00,1.00E+00,0.00E+00
negative regulation of ATPase activity (GO:0032780),0.02,3.69E-02,4.69E+02,0.00,1.00E+00,0.00E+00
gamma-aminobutyric acid metabolic process (GO:0009448),0.02,1.31E-02,1.15E+04,0.00,1.00E+00,0.00E+00
adherens junction assembly (GO:0034333),0.02,4.01E-02,7.76E+02,0.00,1.00E+00,0.00E+00
apical protein localization (GO:0045176),0.02,4.01E-02,7.76E+02,0.00,1.00E+00,0.00E+00
ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.02,4.21E-02,1.93E+02,0.00,1.00E+00,0.00E+00
regulation of lipid biosynthetic process (GO:0046890),0.02,4.21E-02,1.86E+02,0.00,1.00E+00,0.00E+00
response to nitric oxide (GO:0071731),0.02,4.10E-02,5.51E+02,0.00,1.00E+00,0.00E+00
renal absorption (GO:0070293),0.02,4.18E-02,5.01E+02,0.00,1.00E+00,0.00E+00
regulation of triglyceride metabolic process (GO:0090207),0.02,3.24E-02,2.39E+03,0.00,1.00E+00,0.00E+00
positive regulation of secretion (GO:0051047),0.02,4.40E-02,4.58E+02,0.00,1.00E+00,0.00E+00
ammonium transmembrane transport (GO:0072488),0.02,1.66E-02,2.80E+03,0.00,1.00E+00,0.00E+00
metanephric renal vesicle morphogenesis (GO:0072283),0.02,4.99E-02,2.64E+03,0.00,1.00E+00,0.00E+00
mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337),0.02,4.99E-02,2.04E+03,0.00,1.00E+00,0.00E+00
mesodermal cell fate commitment (GO:0001710),0.02,4.99E-02,2.04E+03,0.00,1.00E+00,0.00E+00
kidney mesenchyme development (GO:0072074),0.02,4.99E-02,1.39E+03,0.00,1.00E+00,0.00E+00
organic hydroxy compound biosynthetic process (GO:1901617),0.02,1.95E-02,6.25E+02,0.00,1.00E+00,0.00E+00
bone development (GO:0060348),0.02,4.33E-02,1.56E+02,0.00,1.00E+00,0.00E+00
one-carbon compound transport (GO:0019755),0.02,4.01E-02,8.92E+02,0.00,1.00E+00,0.00E+00
regulation of morphogenesis of a branching structure (GO:0060688),0.02,4.99E-02,2.64E+03,0.00,1.00E+00,0.00E+00
cellular response to nitric oxide (GO:0071732),0.02,4.01E-02,8.92E+02,0.00,1.00E+00,0.00E+00
regulation of triglyceride biosynthetic process (GO:0010866),0.02,3.58E-02,5.51E+02,0.00,1.00E+00,0.00E+00
cellular response to reactive nitrogen species (GO:1902170),0.02,4.01E-02,8.92E+02,0.00,1.00E+00,0.00E+00
lipoprotein metabolic process (GO:0042157),0.02,3.24E-02,1.07E+03,0.00,1.00E+00,0.00E+00
regulation of anion transport (GO:0044070),0.02,3.24E-02,1.25E+03,0.00,1.00E+00,0.00E+00
cellular response to salt stress (GO:0071472),0.02,4.01E-02,1.99E+03,0.00,1.00E+00,0.00E+00
hematopoietic stem cell migration (GO:0035701),0.02,4.01E-02,1.99E+03,0.00,1.00E+00,0.00E+00
anion transmembrane transport (GO:0098656),0.02,4.73E-02,1.33E+02,0.00,1.00E+00,0.00E+00
carbon dioxide transport (GO:0015670),0.02,4.01E-02,1.99E+03,0.00,1.00E+00,0.00E+00
positive regulation of membrane permeability (GO:1905710),0.02,4.01E-02,1.99E+03,0.00,1.00E+00,0.00E+00
positive regulation of transmembrane transport (GO:0034764),0.02,3.43E-02,6.02E+02,0.00,1.00E+00,0.00E+00
cellular calcium ion homeostasis (GO:0006874),0.02,3.24E-02,1.53E+02,0.00,1.00E+00,0.00E+00
negative regulation of interleukin-5 production (GO:0032714),0.02,1.19E-02,3.81E+03,0.00,1.00E+00,0.00E+00
free ubiquitin chain polymerization (GO:0010994),0.02,4.01E-02,1.54E+03,0.00,1.00E+00,0.00E+00
hyperosmotic response (GO:0006972),0.02,4.01E-02,1.25E+03,0.00,1.00E+00,0.00E+00
endothelial cell morphogenesis (GO:0001886),0.02,3.24E-02,1.50E+03,0.00,1.00E+00,0.00E+00
cellular hyperosmotic response (GO:0071474),0.02,4.01E-02,1.54E+03,0.00,1.00E+00,0.00E+00
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.02,1.61E-02,1.23E+03,0.00,1.00E+00,0.00E+00
female gamete generation (GO:0007292),0.02,4.25E-02,2.74E+02,0.00,1.00E+00,0.00E+00
thymus development (GO:0048538),0.02,3.09E-02,6.68E+02,0.00,1.00E+00,0.00E+00
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),0.02,3.09E-02,6.11E+02,0.00,1.00E+00,0.00E+00
embryonic cranial skeleton morphogenesis (GO:0048701),0.02,3.09E-02,6.11E+02,0.00,1.00E+00,0.00E+00
sympathetic nervous system development (GO:0048485),0.02,3.09E-02,5.63E+02,0.00,1.00E+00,0.00E+00
regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.02,3.15E-02,4.84E+02,0.00,1.00E+00,0.00E+00
base conversion or substitution editing (GO:0016553),0.02,3.15E-02,4.84E+02,0.00,1.00E+00,0.00E+00
ear morphogenesis (GO:0042471),0.02,3.39E-02,3.54E+02,0.00,1.00E+00,0.00E+00
DNA deamination (GO:0045006),0.02,3.04E-02,7.35E+02,0.00,1.00E+00,0.00E+00
regulation of muscle contraction (GO:0006937),0.02,3.76E-02,2.75E+02,0.00,1.00E+00,0.00E+00
artery morphogenesis (GO:0048844),0.02,3.94E-02,2.52E+02,0.00,1.00E+00,0.00E+00
embryonic skeletal system morphogenesis (GO:0048704),0.02,3.96E-02,2.41E+02,0.00,1.00E+00,0.00E+00
cellular response to retinoic acid (GO:0071300),0.02,4.74E-02,1.58E+02,0.00,1.00E+00,0.00E+00
oogenesis (GO:0048477),0.02,4.22E-02,7.15E+02,0.00,1.00E+00,0.00E+00
negative regulation of activin receptor signaling pathway (GO:0032926),0.02,4.22E-02,1.16E+03,0.00,1.00E+00,0.00E+00
negative regulation of circadian rhythm (GO:0042754),0.02,4.22E-02,1.31E+03,0.00,1.00E+00,0.00E+00
piRNA biosynthetic process (GO:1990511),0.02,4.22E-02,2.58E+03,0.00,1.00E+00,0.00E+00
glycerolipid biosynthetic process (GO:0045017),0.02,3.89E-02,3.21E+01,0.00,1.00E+00,0.00E+00
inositol phosphate-mediated signaling (GO:0048016),0.02,3.17E-02,4.23E+02,0.00,1.00E+00,0.00E+00
cochlea morphogenesis (GO:0090103),0.02,2.96E-02,8.15E+02,0.00,1.00E+00,0.00E+00
muscle cell fate commitment (GO:0042693),0.02,2.84E-02,1.19E+03,0.00,1.00E+00,0.00E+00
cytidine to uridine editing (GO:0016554),0.02,2.94E-02,9.12E+02,0.00,1.00E+00,0.00E+00
artery development (GO:0060840),0.02,3.39E-02,3.54E+02,0.00,1.00E+00,0.00E+00
cell-cell junction organization (GO:0045216),0.02,4.64E-02,3.37E+02,0.00,1.00E+00,0.00E+00
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.02,2.08E-02,1.32E+03,0.00,1.00E+00,0.00E+00
aorta morphogenesis (GO:0035909),0.02,3.10E-02,5.21E+02,0.00,1.00E+00,0.00E+00
regulation of coagulation (GO:0050818),0.02,4.68E-02,2.29E+01,0.00,1.00E+00,0.00E+00
coronary artery morphogenesis (GO:0060982),0.02,2.84E-02,2.64E+03,0.00,1.00E+00,0.00E+00
middle ear morphogenesis (GO:0042474),0.02,2.84E-02,2.64E+03,0.00,1.00E+00,0.00E+00
negative regulation of histone acetylation (GO:0035067),0.02,2.28E-02,1.66E+03,0.00,1.00E+00,0.00E+00
embryonic viscerocranium morphogenesis (GO:0048703),0.02,2.84E-02,2.64E+03,0.00,1.00E+00,0.00E+00
ganglion development (GO:0061548),0.02,2.96E-02,8.15E+02,0.00,1.00E+00,0.00E+00
enamel mineralization (GO:0070166),0.02,2.84E-02,2.64E+03,0.00,1.00E+00,0.00E+00
regulation of establishment or maintenance of cell polarity (GO:0032878),0.02,4.62E-02,7.08E+02,0.00,1.00E+00,0.00E+00
ear development (GO:0043583),0.02,2.84E-02,2.04E+03,0.00,1.00E+00,0.00E+00
negative regulation by host of viral genome replication (GO:0044828),0.02,2.84E-02,1.66E+03,0.00,1.00E+00,0.00E+00
neuron projection extension involved in neuron projection guidance (GO:1902284),0.02,2.84E-02,1.39E+03,0.00,1.00E+00,0.00E+00
metal ion homeostasis (GO:0055065),0.02,1.71E-02,7.33E+02,0.00,1.00E+00,0.00E+00
axon extension involved in axon guidance (GO:0048846),0.02,2.84E-02,1.39E+03,0.00,1.00E+00,0.00E+00
sympathetic ganglion development (GO:0061549),0.02,2.84E-02,1.19E+03,0.00,1.00E+00,0.00E+00
DNA cytosine deamination (GO:0070383),0.02,2.84E-02,1.19E+03,0.00,1.00E+00,0.00E+00
regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.02,2.42E-02,1.23E+02,0.00,1.00E+00,0.00E+00
tongue development (GO:0043586),0.02,2.84E-02,2.04E+03,0.00,1.00E+00,0.00E+00
dorsal/ventral axis specification (GO:0009950),0.02,4.99E-02,1.99E+03,0.00,1.00E+00,0.00E+00
coronary vasculature morphogenesis (GO:0060977),0.02,2.84E-02,1.39E+03,0.00,1.00E+00,0.00E+00
negative regulation of RNA catabolic process (GO:1902369),0.02,4.99E-02,1.72E+03,0.00,1.00E+00,0.00E+00
regulation of growth rate (GO:0040009),0.02,3.88E-02,3.81E+03,0.00,1.00E+00,0.00E+00
cellular response to nutrient (GO:0031670),0.02,3.88E-02,3.81E+03,0.00,1.00E+00,0.00E+00
inhibitory synapse assembly (GO:1904862),0.00,1.00E+00,0.00E+00,0.03,4.61E-02,4.30E+01
regulation of protein K63-linked ubiquitination (GO:1900044),0.00,1.00E+00,0.00E+00,0.03,1.03E-02,6.13E+03
negative regulation of protein K63-linked ubiquitination (GO:1900045),0.00,1.00E+00,0.00E+00,0.03,1.03E-02,7.30E+03
negative regulation of protein polyubiquitination (GO:1902915),0.00,1.00E+00,0.00E+00,0.03,1.03E-02,1.15E+04
postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.01,2.80E-02,1.04E+03,0.00,1.00E+00,0.00E+00
regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.01,3.14E-02,2.96E+02,0.00,1.00E+00,0.00E+00
regulation of mitochondrial membrane permeability (GO:0046902),0.01,2.54E-02,5.07E+02,0.00,1.00E+00,0.00E+00
positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.01,2.37E-02,6.31E+02,0.00,1.00E+00,0.00E+00
positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.01,2.37E-02,8.23E+02,0.00,1.00E+00,0.00E+00
regulation of glucose metabolic process (GO:0010906),0.01,3.41E-02,2.41E+02,0.00,1.00E+00,0.00E+00
negative regulation of membrane potential (GO:0045837),0.01,2.01E-02,1.33E+03,0.00,1.00E+00,0.00E+00
negative regulation of mitochondrial membrane potential (GO:0010917),0.01,2.01E-02,1.55E+03,0.00,1.00E+00,0.00E+00
primary alcohol catabolic process (GO:0034310),0.01,3.48E-02,1.16E+03,0.00,1.00E+00,0.00E+00
cardiocyte differentiation (GO:0035051),0.01,3.48E-02,9.12E+02,0.00,1.00E+00,0.00E+00
"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.01,2.37E-02,6.85E+02,0.00,1.00E+00,0.00E+00
positive regulation of double-strand break repair (GO:2000781),0.01,3.86E-02,1.96E+02,0.00,1.00E+00,0.00E+00
glycolipid transport (GO:0046836),0.01,3.99E-02,2.04E+03,0.00,1.00E+00,0.00E+00
mesoderm morphogenesis (GO:0048332),0.01,3.48E-02,9.12E+02,0.00,1.00E+00,0.00E+00
regulation of microtubule binding (GO:1904526),0.01,4.26E-02,1.66E+03,0.00,1.00E+00,0.00E+00
regulation of extracellular matrix constituent secretion (GO:0003330),0.01,4.49E-02,1.39E+03,0.00,1.00E+00,0.00E+00
negative regulation of extracellular matrix organization (GO:1903054),0.01,4.49E-02,1.03E+03,0.00,1.00E+00,0.00E+00
regulation of microtubule-based movement (GO:0060632),0.01,4.49E-02,9.12E+02,0.00,1.00E+00,0.00E+00
negative regulation of lymphocyte migration (GO:2000402),0.01,4.49E-02,9.12E+02,0.00,1.00E+00,0.00E+00
regulation of lymphocyte migration (GO:2000401),0.01,4.49E-02,9.12E+02,0.00,1.00E+00,0.00E+00
negative regulation of microtubule polymerization (GO:0031115),0.01,4.49E-02,8.15E+02,0.00,1.00E+00,0.00E+00
ceramide transport (GO:0035627),0.01,4.49E-02,6.68E+02,0.00,1.00E+00,0.00E+00
central nervous system neuron development (GO:0021954),0.01,4.49E-02,6.11E+02,0.00,1.00E+00,0.00E+00
filopodium assembly (GO:0046847),0.01,4.49E-02,5.63E+02,0.00,1.00E+00,0.00E+00
carbohydrate derivative transport (GO:1901264),0.01,4.49E-02,4.84E+02,0.00,1.00E+00,0.00E+00
high-density lipoprotein particle remodeling (GO:0034375),0.01,4.49E-02,4.84E+02,0.00,1.00E+00,0.00E+00
cellular response to steroid hormone stimulus (GO:0071383),0.01,4.49E-02,3.98E+02,0.00,1.00E+00,0.00E+00
long-chain fatty acid catabolic process (GO:0042758),0.01,3.92E-02,2.64E+03,0.00,1.00E+00,0.00E+00
glucosamine-containing compound metabolic process (GO:1901071),0.01,3.48E-02,6.85E+02,0.00,1.00E+00,0.00E+00
negative regulation of insulin secretion (GO:0046676),0.01,3.48E-02,5.84E+02,0.00,1.00E+00,0.00E+00
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),0.01,1.91E-02,2.28E+03,0.00,1.00E+00,0.00E+00
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237),0.01,1.91E-02,2.28E+03,0.00,1.00E+00,0.00E+00
muscle cell migration (GO:0014812),0.01,3.57E-02,1.16E+03,0.00,1.00E+00,0.00E+00
phagolysosome assembly (GO:0001845),0.01,3.57E-02,9.12E+02,0.00,1.00E+00,0.00E+00
regulation of actin nucleation (GO:0051125),0.01,3.57E-02,9.12E+02,0.00,1.00E+00,0.00E+00
dermatan sulfate biosynthetic process (GO:0030208),0.01,3.57E-02,9.12E+02,0.00,1.00E+00,0.00E+00
dermatan sulfate metabolic process (GO:0030205),0.01,3.57E-02,8.23E+02,0.00,1.00E+00,0.00E+00
branching involved in blood vessel morphogenesis (GO:0001569),0.01,3.57E-02,7.48E+02,0.00,1.00E+00,0.00E+00
melanosome organization (GO:0032438),0.01,4.07E-02,3.24E+02,0.00,1.00E+00,0.00E+00
lysosome organization (GO:0007040),0.01,4.74E-02,2.09E+02,0.00,1.00E+00,0.00E+00
histone phosphorylation (GO:0016572),0.01,1.29E-02,1.38E+03,0.00,1.00E+00,0.00E+00
maintenance of apical/basal cell polarity (GO:0035090),0.01,1.29E-02,1.38E+03,0.00,1.00E+00,0.00E+00
maintenance of epithelial cell apical/basal polarity (GO:0045199),0.01,1.29E-02,1.38E+03,0.00,1.00E+00,0.00E+00
N-acetylglucosamine metabolic process (GO:0006044),0.01,3.48E-02,6.31E+02,0.00,1.00E+00,0.00E+00
female gonad development (GO:0008585),0.01,3.64E-02,4.20E+02,0.00,1.00E+00,0.00E+00
gastrulation (GO:0007369),0.01,3.48E-02,4.75E+02,0.00,1.00E+00,0.00E+00
striated muscle cell differentiation (GO:0051146),0.01,3.48E-02,5.07E+02,0.00,1.00E+00,0.00E+00
activin receptor signaling pathway (GO:0032924),0.01,3.48E-02,5.07E+02,0.00,1.00E+00,0.00E+00
telomere maintenance in response to DNA damage (GO:0043247),0.01,3.96E-02,2.71E+01,0.00,1.00E+00,0.00E+00
regulation of hydrogen peroxide-induced cell death (GO:1903205),0.01,3.96E-02,2.71E+01,0.00,1.00E+00,0.00E+00
negative regulation of peptide hormone secretion (GO:0090278),0.01,3.48E-02,5.43E+02,0.00,1.00E+00,0.00E+00
regulation of dopamine uptake involved in synaptic transmission (GO:0051584),0.01,2.02E-02,2.80E+03,0.00,1.00E+00,0.00E+00
galactosylceramide metabolic process (GO:0006681),0.01,2.80E-02,1.04E+03,0.00,1.00E+00,0.00E+00
positive regulation of dopamine receptor signaling pathway (GO:0060161),0.01,3.96E-02,7.24E+01,0.00,1.00E+00,0.00E+00
SCF complex assembly (GO:0010265),0.01,4.92E-02,4.25E+01,0.00,1.00E+00,0.00E+00
"regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.01,2.02E-02,2.40E+03,0.00,1.00E+00,0.00E+00
mesenchyme development (GO:0060485),0.01,3.48E-02,6.31E+02,0.00,1.00E+00,0.00E+00
very long-chain fatty acid metabolic process (GO:0000038),0.01,5.00E-02,1.65E+02,0.00,1.00E+00,0.00E+00
regulation of protein localization to cell cortex (GO:1904776),0.01,4.98E-02,1.39E+03,0.00,1.00E+00,0.00E+00
central nervous system neuron differentiation (GO:0021953),0.01,4.66E-02,2.14E+02,0.00,1.00E+00,0.00E+00
ERBB2 signaling pathway (GO:0038128),0.01,4.66E-02,2.32E+02,0.00,1.00E+00,0.00E+00
organic cyclic compound catabolic process (GO:1901361),0.01,2.28E-02,2.40E+03,0.00,1.00E+00,0.00E+00
regulation of histone phosphorylation (GO:0033127),0.01,2.28E-02,2.09E+03,0.00,1.00E+00,0.00E+00
regulation of epidermis development (GO:0045682),0.01,3.32E-02,1.07E+03,0.00,1.00E+00,0.00E+00
glucocorticoid metabolic process (GO:0008211),0.01,2.28E-02,1.85E+03,0.00,1.00E+00,0.00E+00
positive regulation of histone deacetylation (GO:0031065),0.01,2.28E-02,1.50E+03,0.00,1.00E+00,0.00E+00
regulation of histone deacetylation (GO:0031063),0.01,2.28E-02,1.36E+03,0.00,1.00E+00,0.00E+00
negative regulation of histone modification (GO:0031057),0.01,2.29E-02,1.15E+03,0.00,1.00E+00,0.00E+00
positive regulation of lipid catabolic process (GO:0050996),0.01,2.30E-02,7.72E+02,0.00,1.00E+00,0.00E+00
hyaluronan metabolic process (GO:0030212),0.01,2.30E-02,7.30E+02,0.00,1.00E+00,0.00E+00
lipid catabolic process (GO:0016042),0.01,2.36E-02,5.46E+02,0.00,1.00E+00,0.00E+00
sensory perception of mechanical stimulus (GO:0050954),0.01,4.78E-02,1.67E+02,0.00,1.00E+00,0.00E+00
regulation of sodium ion transmembrane transport (GO:1902305),0.01,4.60E-02,4.05E+02,0.00,1.00E+00,0.00E+00
venous blood vessel development (GO:0060841),0.01,2.02E-02,2.80E+03,0.00,1.00E+00,0.00E+00
regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.01,4.01E-02,1.46E+02,0.00,1.00E+00,0.00E+00
positive regulation of biosynthetic process (GO:0009891),0.01,3.11E-02,3.23E+02,0.00,1.00E+00,0.00E+00
regulation of postsynaptic density organization (GO:1905874),0.01,3.95E-02,2.40E+02,0.00,1.00E+00,0.00E+00
sensory perception of sound (GO:0007605),0.01,4.78E-02,1.60E+02,0.00,1.00E+00,0.00E+00
negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.01,2.68E-02,7.30E+02,0.00,1.00E+00,0.00E+00
osteoblast development (GO:0002076),0.01,3.32E-02,1.25E+03,0.00,1.00E+00,0.00E+00
organonitrogen compound biosynthetic process (GO:1901566),0.01,3.32E-02,1.25E+02,0.00,1.00E+00,0.00E+00
positive regulation of muscle cell differentiation (GO:0051149),0.01,3.98E-02,3.24E+02,0.00,1.00E+00,0.00E+00
regulation of interleukin-1 production (GO:0032652),0.01,2.29E-02,1.15E+03,0.00,1.00E+00,0.00E+00
T-helper cell differentiation (GO:0042093),0.01,3.01E-02,1.14E+03,0.00,1.00E+00,0.00E+00
negative regulation of lymphocyte apoptotic process (GO:0070229),0.01,2.60E-02,2.09E+03,0.00,1.00E+00,0.00E+00
receptor-mediated virion attachment to host cell (GO:0046813),0.01,2.60E-02,5.29E+03,0.00,1.00E+00,0.00E+00
regulation of myoblast differentiation (GO:0045661),0.01,3.09E-02,4.47E+02,0.00,1.00E+00,0.00E+00
positive regulation of developmental growth (GO:0048639),0.01,3.66E-02,2.62E+02,0.00,1.00E+00,0.00E+00
regulation of cell adhesion molecule production (GO:0060353),0.01,2.28E-02,2.40E+03,0.00,1.00E+00,0.00E+00
regulation of supramolecular fiber organization (GO:1902903),0.01,4.49E-02,3.54E+02,0.00,1.00E+00,0.00E+00
regulation of RNA biosynthetic process (GO:2001141),0.01,2.28E-02,2.80E+03,0.00,1.00E+00,0.00E+00
"synaptic transmission, cholinergic (GO:0007271)",0.01,3.40E-02,4.07E+02,0.00,1.00E+00,0.00E+00
negative regulation of actin nucleation (GO:0051126),0.01,3.57E-02,1.55E+03,0.00,1.00E+00,0.00E+00
dendrite morphogenesis (GO:0048813),0.01,4.66E-02,1.99E+02,0.00,1.00E+00,0.00E+00
vascular associated smooth muscle cell differentiation (GO:0035886),0.01,3.48E-02,1.55E+03,0.00,1.00E+00,0.00E+00
neutrophil extravasation (GO:0072672),0.01,3.80E-02,2.04E+03,0.00,1.00E+00,0.00E+00
positive regulation of protein maturation (GO:1903319),0.01,2.10E-02,1.66E+03,0.00,1.00E+00,0.00E+00
regulation of smooth muscle cell differentiation (GO:0051150),0.01,3.80E-02,1.66E+03,0.00,1.00E+00,0.00E+00
regulation of lysosomal protein catabolic process (GO:1905165),0.01,3.48E-02,1.85E+03,0.00,1.00E+00,0.00E+00
regulation of striated muscle cell differentiation (GO:0051153),0.01,3.48E-02,1.85E+03,0.00,1.00E+00,0.00E+00
positive regulation of protein processing (GO:0010954),0.01,2.49E-02,8.70E+02,0.00,1.00E+00,0.00E+00
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.01,4.54E-02,3.70E+02,0.00,1.00E+00,0.00E+00
regulation of pattern recognition receptor signaling pathway (GO:0062207),0.01,3.01E-02,4.86E+01,0.00,1.00E+00,0.00E+00
carbohydrate homeostasis (GO:0033500),0.01,4.90E-02,1.48E+02,0.00,1.00E+00,0.00E+00
negative regulation of gonadotropin secretion (GO:0032277),0.01,3.48E-02,2.95E+03,0.00,1.00E+00,0.00E+00
negative regulation of neuron differentiation (GO:0045665),0.01,2.76E-02,6.92E+02,0.00,1.00E+00,0.00E+00
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.01,4.78E-02,1.58E+02,0.00,1.00E+00,0.00E+00
regulation of type B pancreatic cell apoptotic process (GO:2000674),0.01,3.01E-02,4.44E+03,0.00,1.00E+00,0.00E+00
regulation of protein processing (GO:0070613),0.01,2.76E-02,6.58E+02,0.00,1.00E+00,0.00E+00
folic acid-containing compound metabolic process (GO:0006760),0.01,4.59E-02,1.55E+01,0.00,1.00E+00,0.00E+00
positive regulation of interleukin-5 production (GO:0032754),0.01,3.80E-02,1.66E+03,0.00,1.00E+00,0.00E+00
negative regulation of immunoglobulin production (GO:0002638),0.01,3.01E-02,4.44E+03,0.00,1.00E+00,0.00E+00
regulation of reactive oxygen species metabolic process (GO:2000377),0.01,2.83E-02,1.16E+01,0.00,1.00E+00,0.00E+00
regulation of glucagon secretion (GO:0070092),0.01,3.01E-02,3.45E+03,0.00,1.00E+00,0.00E+00
response to peptidoglycan (GO:0032494),0.01,3.01E-02,3.45E+03,0.00,1.00E+00,0.00E+00
positive regulation of mast cell activation (GO:0033005),0.01,3.80E-02,1.66E+03,0.00,1.00E+00,0.00E+00
negative regulation of muscle cell differentiation (GO:0051148),0.01,4.03E-02,1.39E+03,0.00,1.00E+00,0.00E+00
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.01,3.01E-02,1.55E+03,0.00,1.00E+00,0.00E+00
peptide hormone secretion (GO:0030072),0.01,3.39E-02,4.97E+02,0.00,1.00E+00,0.00E+00
cell junction maintenance (GO:0034331),0.01,4.43E-02,6.68E+02,0.00,1.00E+00,0.00E+00
microtubule polymerization or depolymerization (GO:0031109),0.01,2.97E-02,3.21E+02,0.00,1.00E+00,0.00E+00
regulation of neuron differentiation (GO:0045664),0.01,4.48E-02,1.53E+02,0.00,1.00E+00,0.00E+00
isoprenoid metabolic process (GO:0006720),0.01,3.25E-02,1.12E+03,0.00,1.00E+00,0.00E+00
membrane depolarization during AV node cell action potential (GO:0086045),0.01,2.80E-02,1.99E+03,0.00,1.00E+00,0.00E+00
protein insertion into mitochondrial membrane (GO:0051204),0.01,2.99E-02,3.76E+02,0.00,1.00E+00,0.00E+00
heme transport (GO:0015886),0.01,7.58E-03,1.42E+03,0.00,1.00E+00,0.00E+00
AV node cell to bundle of His cell communication (GO:0086067),0.01,2.80E-02,1.25E+03,0.00,1.00E+00,0.00E+00
T cell proliferation (GO:0042098),0.01,4.20E-02,6.85E+02,0.00,1.00E+00,0.00E+00
AV node cell action potential (GO:0086016),0.01,2.80E-02,1.25E+03,0.00,1.00E+00,0.00E+00
regulation of leukocyte mediated cytotoxicity (GO:0001910),0.01,2.60E-02,2.40E+03,0.00,1.00E+00,0.00E+00
macromolecule biosynthetic process (GO:0009059),0.01,4.45E-02,4.71E+01,0.00,1.00E+00,0.00E+00
positive regulation of filopodium assembly (GO:0051491),0.01,3.22E-02,2.22E+03,0.00,1.00E+00,0.00E+00
intracellular pH reduction (GO:0051452),0.01,3.43E-02,1.39E+01,0.00,1.00E+00,0.00E+00
regulation of nitric oxide metabolic process (GO:0080164),0.01,4.04E-02,1.55E+03,0.00,1.00E+00,0.00E+00
positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.01,2.02E-02,4.11E+03,0.00,1.00E+00,0.00E+00
neurotransmitter receptor diffusion trapping (GO:0099628),0.01,2.80E-02,1.04E+03,0.00,1.00E+00,0.00E+00
regulation of sensory perception (GO:0051931),0.01,3.87E-02,1.03E+03,0.00,1.00E+00,0.00E+00
tetrahydrofolate interconversion (GO:0035999),0.01,4.51E-02,2.92E+01,0.00,1.00E+00,0.00E+00
regulation of sensory perception of pain (GO:0051930),0.01,3.99E-02,8.48E+02,0.00,1.00E+00,0.00E+00
nucleic acid transport (GO:0050657),0.01,4.04E-02,1.16E+03,0.00,1.00E+00,0.00E+00
cytosolic calcium ion transport (GO:0060401),0.01,4.69E-02,3.09E+02,0.00,1.00E+00,0.00E+00
adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),0.01,2.80E-02,1.25E+03,0.00,1.00E+00,0.00E+00
glomerular visceral epithelial cell differentiation (GO:0072112),0.01,4.69E-02,1.03E+03,0.00,1.00E+00,0.00E+00
glycosylceramide metabolic process (GO:0006677),0.01,2.80E-02,1.54E+03,0.00,1.00E+00,0.00E+00
glycerolipid metabolic process (GO:0046486),0.01,3.31E-02,6.85E+02,0.00,1.00E+00,0.00E+00
regulation of actin filament-based process (GO:0032970),0.01,4.35E-02,1.70E+02,0.00,1.00E+00,0.00E+00
G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.01,3.10E-02,7.76E+02,0.00,1.00E+00,0.00E+00
phasic smooth muscle contraction (GO:0014821),0.01,3.43E-02,6.11E+02,0.00,1.00E+00,0.00E+00
acetyl-CoA metabolic process (GO:0006084),0.01,4.30E-02,4.36E+02,0.00,1.00E+00,0.00E+00
isopentenyl diphosphate biosynthetic process (GO:0009240),0.01,3.25E-02,2.50E+03,0.00,1.00E+00,0.00E+00
ganglioside biosynthetic process (GO:0001574),0.01,3.70E-02,1.25E+03,0.00,1.00E+00,0.00E+00
glycosphingolipid biosynthetic process (GO:0006688),0.01,3.70E-02,1.15E+03,0.00,1.00E+00,0.00E+00
N-glycan processing (GO:0006491),0.01,3.70E-02,9.28E+02,0.00,1.00E+00,0.00E+00
regulation of neuron projection development (GO:0010975),0.01,4.91E-02,9.69E+01,0.00,1.00E+00,0.00E+00
venous blood vessel morphogenesis (GO:0048845),0.01,2.02E-02,4.11E+03,0.00,1.00E+00,0.00E+00
thyroid hormone generation (GO:0006590),0.01,4.04E-02,9.12E+02,0.00,1.00E+00,0.00E+00
polyol biosynthetic process (GO:0046173),0.01,1.02E-02,1.20E+03,0.00,1.00E+00,0.00E+00
pyrimidine nucleobase biosynthetic process (GO:0019856),0.01,4.04E-02,2.95E+03,0.00,1.00E+00,0.00E+00
ganglioside metabolic process (GO:0001573),0.01,3.70E-02,8.70E+02,0.00,1.00E+00,0.00E+00
cardiac muscle cell contraction (GO:0086003),0.01,4.03E-02,3.37E+02,0.00,1.00E+00,0.00E+00
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.01,3.97E-02,3.62E+02,0.00,1.00E+00,0.00E+00
transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.01,4.04E-02,2.28E+03,0.00,1.00E+00,0.00E+00
gastro-intestinal system smooth muscle contraction (GO:0014831),0.01,2.80E-02,1.99E+03,0.00,1.00E+00,0.00E+00
fatty acid elongation (GO:0030497),0.01,3.43E-02,5.51E+02,0.00,1.00E+00,0.00E+00
pyrimidine-containing compound biosynthetic process (GO:0072528),0.01,4.04E-02,1.85E+03,0.00,1.00E+00,0.00E+00
inositol phosphate biosynthetic process (GO:0032958),0.01,9.40E-03,2.02E+03,0.00,1.00E+00,0.00E+00
very long-chain fatty acid biosynthetic process (GO:0042761),0.01,3.43E-02,5.51E+02,0.00,1.00E+00,0.00E+00
"positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)",0.01,2.02E-02,4.11E+03,0.00,1.00E+00,0.00E+00
alpha-linolenic acid metabolic process (GO:0036109),0.01,3.43E-02,5.51E+02,0.00,1.00E+00,0.00E+00
positive regulation of feeding behavior (GO:2000253),0.01,3.87E-02,1.71E+03,0.00,1.00E+00,0.00E+00
positive regulation of smooth muscle cell differentiation (GO:0051152),0.01,3.87E-02,1.71E+03,0.00,1.00E+00,0.00E+00
extracellular exosome biogenesis (GO:0097734),0.01,3.87E-02,1.71E+03,0.00,1.00E+00,0.00E+00
positive regulation of kidney development (GO:0090184),0.01,4.31E-02,2.28E+03,0.00,1.00E+00,0.00E+00
positive regulation of animal organ morphogenesis (GO:0110110),0.01,3.87E-02,1.32E+03,0.00,1.00E+00,0.00E+00
positive regulation of vasculogenesis (GO:2001214),0.01,3.75E-03,3.46E+03,0.00,1.00E+00,0.00E+00
regulation of T cell mediated immune response to tumor cell (GO:0002840),0.01,2.46E-02,3.34E+03,0.00,1.00E+00,0.00E+00
positive regulation of T cell mediated immune response to tumor cell (GO:0002842),0.01,2.46E-02,4.11E+03,0.00,1.00E+00,0.00E+00
axo-dendritic transport (GO:0008088),0.01,4.24E-02,4.80E+01,0.00,1.00E+00,0.00E+00
transferrin transport (GO:0033572),0.01,4.10E-02,1.27E+01,0.00,1.00E+00,0.00E+00
megakaryocyte development (GO:0035855),0.01,3.87E-02,1.32E+03,0.00,1.00E+00,0.00E+00
sodium ion transmembrane transport (GO:0035725),0.01,4.64E-02,1.35E+02,0.00,1.00E+00,0.00E+00
regulation of microvillus assembly (GO:0032534),0.01,3.22E-02,5.29E+03,0.00,1.00E+00,0.00E+00
adiponectin-activated signaling pathway (GO:0033211),0.01,4.24E-02,4.71E+01,0.00,1.00E+00,0.00E+00
regulation of protein localization to centrosome (GO:1904779),0.01,2.09E-02,3.87E+01,0.00,1.00E+00,0.00E+00
regulation of chromatin organization (GO:1902275),0.01,3.25E-02,2.33E+01,0.00,1.00E+00,0.00E+00
negative regulation of lipid kinase activity (GO:0090219),0.01,3.12E-02,4.00E+01,0.00,1.00E+00,0.00E+00
negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.01,4.88E-02,1.57E+01,0.00,1.00E+00,0.00E+00
positive regulation of cardiac muscle tissue growth (GO:0055023),0.01,4.84E-02,4.69E+02,0.00,1.00E+00,0.00E+00
phagosome acidification (GO:0090383),0.01,4.42E-02,1.38E+01,0.00,1.00E+00,0.00E+00
canonical Wnt signaling pathway (GO:0060070),0.01,2.64E-02,4.27E+02,0.00,1.00E+00,0.00E+00
positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),0.01,3.87E-02,1.07E+03,0.00,1.00E+00,0.00E+00
regulation of actin cytoskeleton organization (GO:0032956),0.01,4.64E-02,1.28E+02,0.00,1.00E+00,0.00E+00
establishment or maintenance of apical/basal cell polarity (GO:0035088),0.01,3.22E-02,9.28E+02,0.00,1.00E+00,0.00E+00
establishment of apical/basal cell polarity (GO:0035089),0.01,3.22E-02,1.25E+03,0.00,1.00E+00,0.00E+00
regulation of microvillus organization (GO:0032530),0.01,3.22E-02,2.80E+03,0.00,1.00E+00,0.00E+00
establishment of monopolar cell polarity (GO:0061162),0.01,3.22E-02,5.29E+03,0.00,1.00E+00,0.00E+00
adherens junction organization (GO:0034332),0.01,2.58E-02,6.41E+02,0.00,1.00E+00,0.00E+00
mast cell activation involved in immune response (GO:0002279),0.01,3.87E-02,8.91E+02,0.00,1.00E+00,0.00E+00
bone cell development (GO:0098751),0.01,3.87E-02,7.61E+02,0.00,1.00E+00,0.00E+00
mast cell degranulation (GO:0043303),0.01,3.87E-02,8.91E+02,0.00,1.00E+00,0.00E+00
regulation of toll-like receptor 7 signaling pathway (GO:0034155),0.01,1.44E-02,7.30E+03,0.00,1.00E+00,0.00E+00
sodium ion transport (GO:0006814),0.01,4.64E-02,1.29E+02,0.00,1.00E+00,0.00E+00
positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),0.01,1.44E-02,8.96E+03,0.00,1.00E+00,0.00E+00
regulation of dendritic spine morphogenesis (GO:0061001),0.01,2.16E-02,7.78E+02,0.00,1.00E+00,0.00E+00
positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.01,1.44E-02,1.15E+04,0.00,1.00E+00,0.00E+00
"CD4-positive, alpha-beta T cell activation (GO:0035710)",0.01,1.44E-02,1.15E+04,0.00,1.00E+00,0.00E+00
regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.01,1.44E-02,4.08E+03,0.00,1.00E+00,0.00E+00
glycoprotein metabolic process (GO:0009100),0.01,2.49E-02,3.96E+02,0.00,1.00E+00,0.00E+00
regulation of endothelial tube morphogenesis (GO:1901509),0.01,2.46E-02,5.29E+03,0.00,1.00E+00,0.00E+00
dense core granule cytoskeletal transport (GO:0099519),0.01,2.16E-02,5.29E+03,0.00,1.00E+00,0.00E+00
negative regulation of interleukin-8 production (GO:0032717),0.01,4.50E-02,3.07E+02,0.00,1.00E+00,0.00E+00
detection of mechanical stimulus involved in sensory perception (GO:0050974),0.01,4.10E-02,3.89E+02,0.00,1.00E+00,0.00E+00
glycoprotein catabolic process (GO:0006516),0.01,1.34E-02,1.59E+03,0.00,1.00E+00,0.00E+00
superoxide metabolic process (GO:0006801),0.01,3.22E-02,4.83E+02,0.00,1.00E+00,0.00E+00
carbohydrate derivative catabolic process (GO:1901136),0.01,1.34E-02,1.48E+03,0.00,1.00E+00,0.00E+00
negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.01,3.99E-02,4.26E+02,0.00,1.00E+00,0.00E+00
hematopoietic stem cell proliferation (GO:0071425),0.01,3.87E-02,5.84E+02,0.00,1.00E+00,0.00E+00
negative regulation of protein acetylation (GO:1901984),0.01,4.69E-02,2.39E+03,0.00,1.00E+00,0.00E+00
mast cell mediated immunity (GO:0002448),0.01,3.87E-02,7.61E+02,0.00,1.00E+00,0.00E+00
positive regulation of cardiac muscle cell proliferation (GO:0060045),0.01,4.69E-02,6.02E+02,0.00,1.00E+00,0.00E+00
regulation of hormone secretion (GO:0046883),0.01,3.22E-02,1.15E+03,0.00,1.00E+00,0.00E+00
detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.01,3.87E-02,7.61E+02,0.00,1.00E+00,0.00E+00
regulation of endothelial cell differentiation (GO:0045601),0.01,3.87E-02,7.61E+02,0.00,1.00E+00,0.00E+00
positive regulation of behavior (GO:0048520),0.01,3.87E-02,6.62E+02,0.00,1.00E+00,0.00E+00
T-helper 1 type immune response (GO:0042088),0.01,2.46E-02,2.40E+03,0.00,1.00E+00,0.00E+00
somite development (GO:0061053),0.01,3.87E-02,5.84E+02,0.00,1.00E+00,0.00E+00
regulation of postsynapse organization (GO:0099175),0.01,2.16E-02,9.18E+02,0.00,1.00E+00,0.00E+00
forebrain neuron differentiation (GO:0021879),0.01,4.69E-02,1.25E+03,0.00,1.00E+00,0.00E+00
mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.01,4.69E-02,1.07E+03,0.00,1.00E+00,0.00E+00
lactation (GO:0007595),0.01,4.69E-02,9.32E+02,0.00,1.00E+00,0.00E+00
regulation of feeding behavior (GO:0060259),0.01,3.87E-02,5.21E+02,0.00,1.00E+00,0.00E+00
melanocyte differentiation (GO:0030318),0.01,3.87E-02,5.21E+02,0.00,1.00E+00,0.00E+00
epithelial cell-cell adhesion (GO:0090136),0.01,3.87E-02,5.21E+02,0.00,1.00E+00,0.00E+00
transcription initiation from RNA polymerase III promoter (GO:0006384),0.00,2.55E-02,1.40E+03,0.00,1.00E+00,0.00E+00
negative regulation of fatty acid biosynthetic process (GO:0045717),0.00,4.01E-02,2.40E+01,0.00,1.00E+00,0.00E+00
sarcoplasmic reticulum calcium ion transport (GO:0070296),0.00,3.25E-02,1.31E+03,0.00,1.00E+00,0.00E+00
regulation of nephron tubule epithelial cell differentiation (GO:0072182),0.00,3.25E-02,1.50E+03,0.00,1.00E+00,0.00E+00
negative regulation of fatty acid metabolic process (GO:0045922),0.00,2.67E-02,2.21E+01,0.00,1.00E+00,0.00E+00
release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514),0.00,3.25E-02,2.09E+03,0.00,1.00E+00,0.00E+00
ectoderm development (GO:0007398),0.00,6.47E-03,2.58E+03,0.00,1.00E+00,0.00E+00
negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.00,7.20E-03,8.96E+03,0.00,1.00E+00,0.00E+00
chromatin assembly (GO:0031497),0.00,3.12E-02,1.03E+01,0.00,1.00E+00,0.00E+00
vitamin A metabolic process (GO:0006776),0.00,3.25E-02,2.09E+03,0.00,1.00E+00,0.00E+00
regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.00,7.82E-03,4.08E+03,0.00,1.00E+00,0.00E+00
response to sterol (GO:0036314),0.00,3.25E-02,1.16E+03,0.00,1.00E+00,0.00E+00
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.00,4.30E-02,2.92E+01,0.00,1.00E+00,0.00E+00
negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.00,1.18E-02,7.40E+02,0.00,1.00E+00,0.00E+00
response to cholesterol (GO:0070723),0.00,3.29E-02,5.75E+02,0.00,1.00E+00,0.00E+00
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.00,2.97E-02,3.51E+01,0.00,1.00E+00,0.00E+00
detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),0.00,4.87E-02,2.23E+02,0.00,1.00E+00,0.00E+00
sensory perception of bitter taste (GO:0050913),0.00,4.89E-02,2.16E+02,0.00,1.00E+00,0.00E+00
regulation of ruffle assembly (GO:1900027),0.00,1.18E-02,8.57E+02,0.00,1.00E+00,0.00E+00
detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.00,4.92E-02,1.97E+02,0.00,1.00E+00,0.00E+00
regulation of establishment of cell polarity (GO:2000114),0.00,4.74E-02,1.77E+01,0.00,1.00E+00,0.00E+00
"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.00,4.34E-02,1.34E+01,0.00,1.00E+00,0.00E+00
eye photoreceptor cell differentiation (GO:0001754),0.00,3.25E-02,1.03E+03,0.00,1.00E+00,0.00E+00
negative regulation of cellular component movement (GO:0051271),0.00,8.57E-03,1.54E+03,0.00,1.00E+00,0.00E+00
ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.00,4.99E-02,1.11E+03,0.00,1.00E+00,0.00E+00
sulfide oxidation (GO:0019418),0.00,4.99E-02,1.11E+03,0.00,1.00E+00,0.00E+00
"sulfide oxidation, using sulfide:quinone oxidoreductase (GO:0070221)",0.00,4.99E-02,1.11E+03,0.00,1.00E+00,0.00E+00
protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.00,4.99E-02,1.11E+03,0.00,1.00E+00,0.00E+00
negative regulation of locomotion (GO:0040013),0.00,7.79E-03,1.85E+03,0.00,1.00E+00,0.00E+00
retinoic acid metabolic process (GO:0042573),0.00,3.79E-02,3.86E+02,0.00,1.00E+00,0.00E+00
"regulation of blood coagulation, intrinsic pathway (GO:2000266)",0.00,8.62E-03,1.80E+04,0.00,1.00E+00,0.00E+00
"negative regulation of blood coagulation, intrinsic pathway (GO:2000267)",0.00,8.62E-03,1.80E+04,0.00,1.00E+00,0.00E+00
mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.00,4.99E-02,1.11E+03,0.00,1.00E+00,0.00E+00
regulation of mitotic centrosome separation (GO:0046602),0.00,4.30E-02,2.92E+01,0.00,1.00E+00,0.00E+00
copper ion import (GO:0015677),0.00,4.99E-02,1.11E+03,0.00,1.00E+00,0.00E+00
negative regulation of ruffle assembly (GO:1900028),0.00,4.78E-03,4.11E+03,0.00,1.00E+00,0.00E+00
hindlimb morphogenesis (GO:0035137),0.00,4.99E-02,6.92E+02,0.00,1.00E+00,0.00E+00
"wound healing, spreading of epidermal cells (GO:0035313)",0.00,4.99E-02,5.77E+02,0.00,1.00E+00,0.00E+00
peptidyl-cysteine modification (GO:0018198),0.00,4.42E-05,1.83E+04,0.00,1.00E+00,0.00E+00
regulation of muscle cell differentiation (GO:0051147),0.00,2.67E-02,1.48E+01,0.00,1.00E+00,0.00E+00
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808),0.00,3.25E-02,2.58E+03,0.00,1.00E+00,0.00E+00
regulation of integrin biosynthetic process (GO:0045113),0.00,4.36E-03,6.50E+03,0.00,1.00E+00,0.00E+00
actin nucleation (GO:0045010),0.00,3.21E-02,1.79E+01,0.00,1.00E+00,0.00E+00
protein neddylation (GO:0045116),0.00,3.62E-02,3.58E+01,0.00,1.00E+00,0.00E+00
camera-type eye photoreceptor cell differentiation (GO:0060219),0.00,3.25E-02,3.33E+03,0.00,1.00E+00,0.00E+00
epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.00,4.62E-02,6.19E+02,0.00,1.00E+00,0.00E+00
"complement activation, lectin pathway (GO:0001867)",0.00,4.62E-02,1.50E+03,0.00,1.00E+00,0.00E+00
postsynapse organization (GO:0099173),0.00,4.99E-02,5.77E+02,0.00,1.00E+00,0.00E+00
excitatory synapse assembly (GO:1904861),0.00,4.99E-02,5.77E+02,0.00,1.00E+00,0.00E+00
heart trabecula formation (GO:0060347),0.00,4.62E-02,2.40E+03,0.00,1.00E+00,0.00E+00
negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),0.00,4.92E-02,4.25E+01,0.00,1.00E+00,0.00E+00
tight junction organization (GO:0120193),0.00,4.62E-02,3.81E+03,0.00,1.00E+00,0.00E+00
negative regulation of viral release from host cell (GO:1902187),0.00,4.83E-02,3.72E+01,0.00,1.00E+00,0.00E+00
fructose metabolic process (GO:0006000),0.00,3.98E-02,1.25E+03,0.00,1.00E+00,0.00E+00
prostanoid biosynthetic process (GO:0046457),0.00,2.08E-02,1.54E+03,0.00,1.00E+00,0.00E+00
positive regulation of protein localization to synapse (GO:1902474),0.00,4.99E-02,1.11E+03,0.00,1.00E+00,0.00E+00
DNA dealkylation (GO:0035510),0.00,4.85E-02,4.75E+01,0.00,1.00E+00,0.00E+00
"fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.00,3.98E-02,1.07E+03,0.00,1.00E+00,0.00E+00
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.00,2.08E-02,1.85E+03,0.00,1.00E+00,0.00E+00
negative regulation of secretion (GO:0051048),0.00,2.08E-02,1.68E+03,0.00,1.00E+00,0.00E+00
embryonic hindlimb morphogenesis (GO:0035116),0.00,4.99E-02,8.57E+02,0.00,1.00E+00,0.00E+00
proton-transporting V-type ATPase complex assembly (GO:0070070),0.00,3.93E-02,1.85E+03,0.00,1.00E+00,0.00E+00
DNA dealkylation involved in DNA repair (GO:0006307),0.00,4.85E-02,4.75E+01,0.00,1.00E+00,0.00E+00
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.00,2.08E-02,1.68E+03,0.00,1.00E+00,0.00E+00
positive regulation of DNA recombination (GO:0045911),0.00,3.56E-02,1.43E+01,0.00,1.00E+00,0.00E+00
positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698),0.00,3.25E-02,2.58E+03,0.00,1.00E+00,0.00E+00
regulation of norepinephrine secretion (GO:0014061),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of oligodendrocyte differentiation (GO:0048715),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
angiotensin-activated signaling pathway (GO:0038166),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of catecholamine secretion (GO:0033604),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of acute inflammatory response (GO:0002674),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of calcium ion transmembrane transport (GO:1903170),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of endocytic recycling (GO:2001137),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of glial cell differentiation (GO:0045686),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
development of primary female sexual characteristics (GO:0046545),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of epinephrine secretion (GO:0014060),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of potassium ion transmembrane transport (GO:1901380),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of endocytic recycling (GO:2001135),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of T-helper 2 cell differentiation (GO:0045628),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of T-helper 2 cell differentiation (GO:0045630),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of calcium ion-dependent exocytosis (GO:0045955),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of sodium:proton antiporter activity (GO:0032415),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of histone H4 acetylation (GO:0090240),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
retina vasculature development in camera-type eye (GO:0061298),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of hormone metabolic process (GO:0032350),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of hormone biosynthetic process (GO:0046885),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
lysine catabolic process (GO:0006554),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
lysine metabolic process (GO:0006553),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of protein modification process (GO:0031399),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of plasminogen activation (GO:0010756),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of leukocyte tethering or rolling (GO:1903238),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of protein localization to cell surface (GO:2000009),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
receptor transactivation (GO:0035624),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
inorganic anion transport (GO:0015698),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of sodium ion transmembrane transporter activity (GO:2000649),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of megakaryocyte differentiation (GO:0045654),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of granulocyte differentiation (GO:0030854),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
morphogenesis of an endothelium (GO:0003159),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of myeloid cell apoptotic process (GO:0033033),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
exogenous drug catabolic process (GO:0042738),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of interleukin-23 production (GO:0032667),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
secondary palate development (GO:0062009),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
organic substance transport (GO:0071702),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
nucleoside phosphate catabolic process (GO:1901292),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of dendrite extension (GO:1903859),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of dendrite extension (GO:1903861),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of granulocyte differentiation (GO:0030852),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of long-term synaptic potentiation (GO:1900272),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
cell proliferation in forebrain (GO:0021846),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
nucleoside diphosphate catabolic process (GO:0009134),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
nucleobase-containing small molecule catabolic process (GO:0034656),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
neurotransmitter transport (GO:0006836),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
BMP signaling pathway (GO:0030509),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
arachidonic acid metabolic process (GO:0019369),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of catabolic process (GO:0009894),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of DNA metabolic process (GO:0051053),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of DNA biosynthetic process (GO:2000279),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of BMP signaling pathway (GO:0030513),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
response to fatty acid (GO:0070542),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
cellular response to fatty acid (GO:0071398),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
cellular response to BMP stimulus (GO:0071773),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
dendritic spine morphogenesis (GO:0060997),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
embryonic digit morphogenesis (GO:0042733),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of plasminogen activation (GO:0010755),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
negative regulation of potassium ion transport (GO:0043267),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
dorsal aorta development (GO:0035907),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
intestinal absorption (GO:0050892),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
dorsal aorta morphogenesis (GO:0035912),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
embryo development ending in birth or egg hatching (GO:0009792),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
epoxygenase P450 pathway (GO:0019373),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
endothelial tube morphogenesis (GO:0061154),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of excitatory postsynaptic potential (GO:2000463),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
lipid biosynthetic process (GO:0008610),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
anion transport (GO:0006820),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
androgen metabolic process (GO:0008209),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
androgen biosynthetic process (GO:0006702),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
embryonic limb morphogenesis (GO:0030326),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
sialic acid transport (GO:0015739),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
positive regulation of synapse assembly (GO:0051965),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
modulation of excitatory postsynaptic potential (GO:0098815),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of presynapse organization (GO:0099174),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
regulation of presynapse assembly (GO:1905606),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
carboxylic acid transport (GO:0046942),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
drug catabolic process (GO:0042737),0.00,1.00E+00,0.00E+00,0.00,1.00E+00,0.00E+00
